<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Make supplementary tables for protein results</title>

<script>/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:700}dfn{font-style:italic}h1{margin:.67em 0;font-size:2em}mark{color:#000;background:#ff0}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sup{top:-.5em}sub{bottom:-.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{height:0;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace,monospace;font-size:1em}button,input,optgroup,select,textarea{margin:0;font:inherit;color:inherit}button{overflow:visible}button,select{text-transform:none}button,html input[type=button],input[type=reset],input[type=submit]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{padding:0;border:0}input{line-height:normal}input[type=checkbox],input[type=radio]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type=number]::-webkit-inner-spin-button,input[type=number]::-webkit-outer-spin-button{height:auto}input[type=search]{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-appearance:textfield}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration{-webkit-appearance:none}fieldset{padding:.35em .625em .75em;margin:0 2px;border:1px solid silver}legend{padding:0;border:0}textarea{overflow:auto}optgroup{font-weight:700}table{border-spacing:0;border-collapse:collapse}td,th{padding:0}@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="javascript:"]:after,a[href^="#"]:after{content:""}blockquote,pre{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000!important}.label{border:1px solid #000}.table{border-collapse:collapse!important}.table td,.table th{background-color:#fff!important}.table-bordered td,.table-bordered th{border:1px solid #ddd!important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:application/font-woff;base64,d09GRgABAAAAAFuAAA8AAAAAsVwAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAABGRlRNAAABWAAAABwAAAAcbSqX3EdERUYAAAF0AAAAHwAAACABRAAET1MvMgAAAZQAAABFAAAAYGe5a4ljbWFwAAAB3AAAAsAAAAZy2q3jgWN2dCAAAAScAAAABAAAAAQAKAL4Z2FzcAAABKAAAAAIAAAACP//AANnbHlmAAAEqAAATRcAAJSkfV3Cb2hlYWQAAFHAAAAANAAAADYFTS/YaGhlYQAAUfQAAAAcAAAAJApEBBFobXR4AABSEAAAAU8AAAN00scgYGxvY2EAAFNgAAACJwAAAjBv+5XObWF4cAAAVYgAAAAgAAAAIAFqANhuYW1lAABVqAAAAZ4AAAOisyygm3Bvc3QAAFdIAAAELQAACtG6o+U1d2ViZgAAW3gAAAAGAAAABsMYVFAAAAABAAAAAMw9os8AAAAA0HaBdQAAAADQdnOXeNpjYGRgYOADYgkGEGBiYGRgZBQDkixgHgMABUgASgB42mNgZulmnMDAysDCzMN0gYGBIQpCMy5hMGLaAeQDpRCACYkd6h3ux+DAoPD/P/OB/wJAdSIM1UBhRiQlCgyMADGWCwwAAAB42u2UP2hTQRzHf5ekaVPExv6JjW3fvTQ0sa3QLA5xylBLgyBx0gzSWEUaXbIoBBQyCQGHLqXUqYNdtIIgIg5FHJxEtwqtpbnfaV1E1KFaSvX5vVwGEbW6OPngk8/vvXfv7pt3v4SImojIDw6BViKxRgIVBaZwVdSv+xvXA+Iuzqcog2cOkkvDNE8Lbqs74k64i+5Sf3u8Z2AnIRLbyVCyTflVSEXVoEqrrMqrgiqqsqqqWQ5xlAc5zWOc5TwXucxVnuE5HdQhHdFRHdNJndZZndeFLc/zsKJLQ/WV6BcrCdWkwspVKZVROaw0qUqqoqZZcJhdTnGGxznHBS5xhad5VhNWCuturBTXKZ3RObuS98pb9c57k6ql9rp2v1as5deb1r6s9q1GV2IrHSt73T631424YXzjgPwqt+Rn+VG+lRvyirwsS/KCPCfPytPypDwhj8mjctRZd9acF86y89x55jxxHjkPnXstXfbt/pNjj/nwXW+cHa6/SYvZ7yEwbDYazDcIgoUGzY3h2HtqgUcs1AFPWKgTXrRQF7xkoQhRf7uF9hPFeyzUTTSwY6EoUUJY6AC8bSGMS4Ys1Au3WaiPSGGsMtkdGH2rzJgYHAaYjxIwQqtB1CnYkEZ9BM6ALOpROAfyqI/DBQudgidBETXuqRIooz4DV0AV9UV4GsyivkTEyMMmw1UYGdhkuAYjA5sMGMvIwCbDDRgZeAz1TXgcmDy3YeRhk+cOjCxsMjyAkYFNhscwMrDJ8BQ2886gXoaRhedQvyTSkDZ7uA6HLLQBI5vGntAbGHugTc53cMxC7+E4SKL+ACOzNpk3YWTWJid+iRo5NXIKM3fBItAPW55FdJLY3FeHBDr90606JCIU9Jk+Ms3/Y/8L8jUq3y79bJ/0/+ROoP4v9v/4/mj+i7HBXUd0/elU6IHfHt8Aj9EPGAAoAvgAAAAB//8AAnjaxb0JfBvVtTA+dxaN1hltI1m2ZVuSJVneLVlSHCdy9oTEWchqtrBEJRAgCYEsQNhC2EsbWmpI2dqkQBoSYgKlpaQthVL0yusrpW77aEubfq/ly+ujvJampSTW5Dvnzmi1E+jr//3+Xmbu3Llz77nnbuece865DMu0MAy5jGtiOEZkOp8lTNeUwyLP/DH+rEH41ZTDHAtB5lkOowWMPiwayNiUwwTjE46AI5xwhFrINPXYn/7ENY0dbWHfZAiTZbL8ID/InAd5xz2NpIH4STpDGonHIJNE3OP1KG4ISaSNeBuITAyRLgIxoiEUhFAnmUpEiXSRSGqAQEw0kuyFUIb0k2gnGSApyBFi0il2SI5YLGb5MdFjXCey4mNHzQ7WwLGEdZiPPgYR64we8THZHAt+wnT84D/x8YTpGPgheKH4CMEDVF9xBOIeP3EbQgGH29BGgpGkIxCMTCW9qUTA0Zsir+QUP1mt+P2KusevwIO6Bx/Iaj8/OD5O0VNrZW2EsqZBWbO1skRiEKE0DdlKKaSVO5VAuRpqk8VQJAqY7ydxaK44YJvrO2EWjOoDBoFYzQbDNkON+UbiKoRkywMWWf1j4bEY2iIY1AeMgvmEz/kVo9v4FSc/aMZMrFbjl4zWLL0+Y5FlyzNlEVYDudJohg8gPUP7kcB/mn+G6cd+5PV4Q72dXCgocWJADBgUuDTwiXiGSyZo14HOEQ2lE6k0XDIEusexDzZOMXwt1Dutz+tqmxTvlskNWXXUQIbhaurum9GrePqm9Yaeabjkiqf+bUvzDOvb2Y1E+EX2DnemcTP/zLcuu7xjQXdAtjR0Lo5n4/Hs/GtntMlysHt+29NXbH6se//WbFcyu+r28H0MwzI30DYeYTLMXIA2EG8QlHpAsyS0EfEToR0a3utIxFPJ3kiIHCCrZ66b0e2xEmL1dM9YN/MwS5p01N5jMX/BLKt/1R83l0LyC29M6+iYxo/UNg/EF7c2WyyW5tYl8WnhWg2/hyySbD5UhnDyS7OcU0dnrFw+DfGdI7v4QfYIIzOMq9hFtY55gmvC7jZ2FK7sEdrn6IXBuucYhjsGdQ8z0yEbWkkczjjsE5hNAIZrPx2zOLZDmKNXcXtg7EMqidAEEWg+SJCBBNwxvxJfc/bZa+KKf+xoKZybnq5vaqpPTye7CiF+ZFjxZ8/7Qij0hfOG/cowPA1rT1l4ymWnrKmxxqfErTVrpgwPlz1kC+Oy8NMDz6c+IO38K/x0xkPnLW8Kx6qGAoQdL+TD9V9rb+/ctn//trxz8dUrZrD/zk/ferF0cNt1BzctmX2FZPXt/jnFCQNz4Ah/iKllGiCMs1w5Lkg0kiEwj6VTXCDKsX9rMpnvIj9pcDecXAIXMnqn2dTUbN6w0XQ9ue6FV/nnXCH7S3lPWGltVcLsH75ub3ab7A8M28caNrIeOr3o5Q0yFsYL80xaa0EY/UEczV7icUMY5pnelAkmUAXmHYjvFWFGxuqlSaow3OM+/iYY7/l/hVELF4EjRqNR/bvRbOY+DUGzGR/Oh3EqmE/ugIQQguGt/eMYz/+L0cimjeZfQDI3phXMbMQsqH+CjwVz/hf4idHovgVmB8gLvjbicDcC/NypP536E/9N/puMibExdohBmNwyiaZdJGoigos7GpF222xrfnZhML/7Z+ylaqP63Hr+m7bdUkQ6/2cXqdfmvwixY+s2ksXFeXcE+iX0Z+Iow76DBNgjJ7TOdUK18iPsPflfQD+DPsZG2Aj9VmKMMJ4fYRrhIaxhTDR0Elh2vA6h/AE6xUb29mj3sjmL72petXjejPy+oel60M99tFduCI59N3221xe7apOvxs6aHs7vab1IqY2tv7q2xsHeHGml/cV06u/8S/xTjJ+JYc0bWEX0ukW6YmIbGkJRMdjJ9mYIH5QIdJF4hvRGyK7cC7ctImQRcUET99fGXOoft35GYLMQu+g2smnkgZUrH8AL/9Si217IssJ916nv14ZrJrvdxLkQvrvtBcjgPC0NXOicO8Qf4mcxPqh3hgUw3DDfdvLJXngg7N3dN2zbPJSaed3OfZnMU7dvmznp3C3bruO+Nmue0LFsy7S+6265+fCKFYdvvuW6vmlblnUI8xCXp37CrOZv4B9gauDBlYp7adcUXB5DNCwYImlXOJJKkAdvExXxVvKEYnCo+3eIskP9qrrfIYs71CccBjfXRC52udTHHdaP1A1ui/VvH1otbrLrpNXBsGX5B89QghDyimlvNB2KfkxZ5C9/em3+d1+d//IfFp2+2Oxn/s+9n/79p39S3s8idN6g0yZObwJOgKUpNB3GyU0Ls0PbRzIRq4lcarLKOJBkLRzJQD4j2090XrbA7DW8K3jNF5hlGS5e4V2D17zgss4T20egOJte5iD0bReM9yjTxnQxCRj3c5kFzGJmGbNKmwGw39IJDJcXJZGMkaAB4jyJAKw0jt5IAuIE+A+U3cVAZZrq9zhDyBrU8oosuxcGNTzCKJfla7JjNVmuSb/+tuzN2H+X4vlB+PpdfMXXmuVsNiub1T34SFbjYw5itEvVi0K0Nt9pNJUMI7SLGRhf2xipfCYf8z5OdlGKayOucFeVPeS/dbo3lBrbSMmwUiQN5/ed7g0Ds1s17IuZC5kNzM3MZ6EWCa0DtekdJfAxz+R/OX28sND7yRMTBcf++s8mQCQWHya4qBv/ufeMoWyslPA9DtMxUknxkH/yfTnm2CMYzs+Cq3r7PxY/MXomrvTEsRpfEGHa+WN8E1AHjElb7d06ddA7oK/+5Mdsv9EtPms0jv0Z5kf1FqPxWdFtfFr0kHfgDX0Y+5PRSG7RUj0tQr7rmfX8DH4G5W28kKeJLtmQsQkuwMP1pk16EV4sl7vrMJATfyUWo/GwEco4rh4XFQgaiUX9qxZHrMQqKnz/c2d8b9TysYrAuXpP/Rf/Gr8b1qwwc5a+euLa6S6sneNXToG2XrEJi4R5SGs8Sq2S3d97bsfCRaTdaLwKClRHt37mkudvXbjwVrLhuYeGhh56bvfQkHpk2CwvwClqgWwuBfndC3c8dwmstj81KkagcUgbfPY8Zje0W/82VPWJHmSq6pP8hPWpotc/EexDOK3qU+wngPhOCiO9MJRm8TJefjelrzoKnG2Bn+1NCUmPE4gHFmBN9jrTigRIpsACrc9Gstg58ULkp9467+Gf/eFnD5/31lNrt2967dhrm7bzI+VT5m+fzKhvf2MzpICEm79Bopkn07lt1762adNr127LwVqQLdJ5+lpQDcvHPQtVY5knhYrK6q8/JsiP6EuhGZdFdaNszjvpqvc+PI0CdjN0AXsFOC3ZfALDJwr4q2Xq+GF+GNbsxUg5NLLIEXi8otcDQcUts0D8eQ1iVDRAMBTsYiNdRIxE09EIBJO9A2xqgERTaW86BUFn0OD2xFO97FAgFhF6OoQ7prYt4XwSeUgQHiJyDbeke9IdQntciLQ1FlJMaYcUNvZBg+FB1ubjlnRNvl3o6IEU2w7fdNPhm/hh+FLysUu6++DLHkOkrSHYEjH0tEPe7WdD3uyDgvAgK/m4szFFR7ch0toUgBTdWHr7EpaWru6+6dmbbnqWEbV2EtxAsXiZAPTtGPSbHsotI2leoM8TePEqgSQprs7AGFf8kuOkPdZPXGb55POAW1d/jLST9v5YflasP6v/CO7+GNAPC2BMZWmsOjp2NNbfHwMCJD+LPVL+D/OYlWEEI/9jpPddOFkB5d1GSuKZYggmCCd7JUxD7EXAzxyirYnNDLdDZoFdx14kivkvGc3579Jm36reTTvDgBnaO6vzyQ6chQmlsMoIkIQ2+bBDWBud1Va4pcCn8CPqxlh/fgtG8IPaPH8C5wk6/nZDv69jurV5QhtwE0x2iqOsj9Mx8B9/0EaUdiPfOYYDCi/q9jhWRuupMDEU0+CtX0sDFxv07T/K5niBPqN9+tQjgEc31NGCXFeMcCEuQBIc/BK4CO78u7EPYvl3yaEfK3vcb6qP1R2tI7vUjVDDUdKubsSrNjYKY1qBEa2P50SJoaXiksIoLiCwnxS6EBuBde87botNfdEWwYvF/R0/u5yCqhGeEOR2ynSeyXjt6ka7neyye8kryBSWE52y+RBgogrXPZ8E1yIHoHIFUM+AbJhE7lbMtt8ApL+xmZW7PwbjAO0fAVoXQOuiSP/ksIVdFZ0aulsamKUzwPZ/NYDMJRBPCxsBqLzqHyneXF6Ej9HlIFo7+pg+jUb3unRmGpstGkm6etOuDBGA5wCMefp1gTHcdZlvPBXlOslvYTp1cd8UjYLVd/J5awNrIOKLnIt9MD9qdrKrWCvA6ALm3QV9VrsPm60Q7+RHJHP+2hqfugo/MvI2H/mqr4b9tFnKSRY1Y5Ek80Nm/WIhr1ikKnxGz9TWXrokf9xwujfvcOTtNTWnxd0F37Y2W79tteBqZ4G5qLCuomw+nSr28QESCRVLTyYKILGJOPfcnaIFOsewhRdvv+rWa/Wih0vlbX6Zb75T5C0qNKVFvH1QL/vazSWgC2s6oWXXIuUxQelKiJbowuJDQViatLmLijg9CQBMg8WiPgiw3LEeYRmm5f+XdnvkDnxLLjMLxtvX74C3OlwPQqx4xwIdpPx38LrlDphiyWUWHWKAzzxurS/xTo+P5wGFak62ap1PVFFN4v/y+xuR39WnIO7lsWfwgVsK17wxrs9K8ltIKuhkw7f/6dhK6gQokFKhWX3urrjk/rnI0pgfpGMeuQIUaEM7+GF5q2iMkCaMQwxxOzcvU0eXbsnS9XknXvP7Gtw5dwPXlFu2ecvSHEZgNDsU6x/GdXBYXyOQjzZReSedeEPY6nEv9gJR4oBQJtFO6Kd0fwC6BO4LNHDeBujB6dSNcUQC9zIv2LnAzGk99bUDrdFY+9yGFQtEo0GQPNv6vS2drj4+1jHbv3aJSMUWP+QTZrmbNTjU8wyG/iXNNpskybLcJ3CiTF5Ir+JYzmJwE0mSVhlxbtbmvweB3ulB6Til5UuUZydpgiFVeobhU0WaBqpJ198d+/XeNRTZ9/1OPfG7+2hwzd5W3D+hmyjsRcUg/+Cavb++Vh2ls3L7zT/etOnHNxeerv313vzLVqPai4nJv+K1FC6040/4udw7sAb3laSg0XCkAAs0npBO6VJabS4Elk/U+D4gTXW+j0wnrMlqNamq4tMIYB87tE10i0FR3LZNhJsb7/R561btmes8YBCRkhYNByRtKd55mqTas9FYhJnbRGHuOh3M4QTdgQSqmgRxuzGdSvZGcbMxNQGk5C3ebLjoXIOFM4l+WKHmLTJwRv9E8GWJ6dYvf/FmEyEGr+gyrr1p5zrgkz0Cw2j94Hv8Jdx7dIVegBSNtgsqGsRQEYiIBoXwD0LNvQ5d7s5Z00QzwNhqZA0b+tMG1tQq5nd84uq8R0zPvX35G8uRaze4jcOHzz0w1+Q2BIRvf6J6Kgatnrbiem+CFvAxfkrndzD9MFPP1GWTUHclpASUkCNAQkpCCcCgDSUDAhDZ+CuEkgn8J7i9nMA7pA4lISappxILKfAeSAbIcSDuN2bJcfZILqeO5rLs0MnngSHYRdrHjmaz7JEsEPw51ZqDJDmUIOZIe34WaQeegNsJn1qz8AIpT3yCjyEih/xELkuJ0lEMYTLVCiWpo5oYMleMH6USyYJcD+uOe+kWKpn1Qns34iyYDjkSLvgnZXcgVQNeqINXr48m3iS7cjm8tedyY0f1QvTnHHdsrKby/+SSbPY8/NH6vpl/Esq3Ae4ZU1HC44KFiI9o7CEgab/RqHbj7s5KAg06s39ZP/zxI/mVuF/TbTSy+3Fb8If9/cv7+wt91yy8RfP1QXtW5RzQn7qIiZyuFM5QfJ5E9uVnqT85TanFx0lkP3ukBAMprvsRyi/C8NAJL1xbIIirSvnSj4O5netb4JxmNANHPssHAcHMHsFRgEug816gDBeMbdfiuRcghqYcm0+Xxx/5IAEtN3fqFF3LzAXqwoT0PN0OVTNqxo8sxMkd5Ig6k79Zk7VxxX6gMLOZFQgvpW2RrMW1D0BDihaXQ9wVRoBxPLfpknmkeMtoB/qM9cRc9IqmMD2XUmdZ7GSRKPUZvChf8BoykriM2MnKYbOHX8R7cLdNCxSFFVQqoYswnlWtlFS2mNkhswVpZiQW1J/UKFfipHGlUkM6UKBhMz1istELIHJLMSctu3ugzfaVSOjKvUgc/THK4Sdg2Wscz69leKIkkrwuuWiOe9yGYKQXRumkC3qbRcMwrvhjNXgdZk3RxAUEhuSPvn3nnd++U/3vlVOmrJzCD8JLxV1OHRjrZifbcFDOuRNTGqdgQm1tSNJ2OcQ04YiEXuxtII1ECSQRoQGYioEsgCfchB4ghAtw7FfJre4WZ9hkVi9MtjuWqtdNDlpMrfEG9fOT6q21okg+e4As38MfGquNt7oUws6Ysarj1/efE+yst86YUVNvDdts3Pv5c8m/aP0C+f8/Qb+IMnGq09BgwN01oIOAnAdagI8mBSrqk1gxTDUBOtk2ousEtBH2z4Ir2d3f6k8PXXVlt2qN9RODxRuoJT/v27wm09jRYVc/e++iyx2tyzJb/n3J0htXP87eSsQaf2Ly0s6Zmxela88REy1cf4273mI3iXNJ7KxrZibOm9xm6rl4fqy/t27smU8tOfdW2ucBzg2UfmOIVyLIl3kpYlwphDISTXJXsctmiDtN7fNV6zelgxwnWxsVr83Aj/S5ki1jL/a0GC6+2L6Um+aoddlNFuj+bJ8mH/iaLh8I0/U51NspIEfq0dohwyFXKgm4NggwQ4rRhCOUFtxxo8XnitT4cnGfT93IS8FaT85XE3H5LMY4zIEPL1hw443wz+1UmhTJyJGxZzw+wsKkKZgUiVtKOKMEb2AKHTv61FNc01PQFwKnvsZ/9pPA4RKTASWahmh+8MxwzHxKy74IRn5LGRjsPUUwTu64UYNY38caqd7HKucZ/tHnODtENw/2UfHRMaq1UUPDJQ0OKkWCeet5fYOhII1VRz8+/Elg5j4Gxur3J8o2PJ4rg+2d08T/fwEzSVbyZ9XPro95T477lRKqUSRXQnauHNsISAl27oWi6Fv9z48JMv8r/aMMj8onCP/DuDZOuN+GPPr/+p7bx+7JlbYdppcNhzKU/1Px5aiaGDn/s1iGMaBcleKUo/v9rcxkZj7DBEKOfrayytXNLYiUdBY+pleQXdnscKlQcpzuWluxsieeyuXIK6SdxozitWyGOV3vOHHjguyCQ6fpIYy2JwvrQEF/Qa9Pdf/QqOSqCiE/EE1/XIVKTc2tzWbHnimrEd+Vyz311Ml3P0GVTj7PD5aDnsvCvH36alEaPMePcMegXs7x8igTu4B9v7G9vTHvhCu/kzIdx+BxC0ay9zRSvoS0F2lIxI+X7klU63I40gLQ3w5ep5na+SFnba3z5D64zv+QtM4n4ffG3tq4aNHGRfxgrXPMim+5487abL7xhdseIRn1KDl+7aINixdv0OD+JSPwKf5+xoP6aiTeQIDVlIhMcL1H5R9PYXvprs3fv2bO7MOplCmweuiq2JRZ1zz+9a/v2PH1Hfz9236w+ZrPXvWfAxlj4NLLHpq3c/PQ3uvmvbrjG7fe+o2y/cLdtE6VUlXi0ASb1VLUBVSUWSU4HdvAraTyS8xzM8NxvxFkXV6pUVRiJwcgC5zEeht4rwcp7ki0k41G0qlQhG1Vzlq8alEmnFi58caB5Q9vn988MLhqyVlHvLEWjtQFeupdiocF/tkkOGPW2ibWaBTkeZ/dvPWazXfOnnvL6jkRXpi85sFzZt+55ZptW3bl1cCCHZPD06MhySha7UFzjcjbp8fOecFCirzAG/yVjBX6OFIaadSjQq1nNhyIe8tVbaaSdHlXIWKacMeuZA1uxS95zILhyrxAdsXTL6m7kNQlx2P9uZf2qhufePFFbpI6/OU0WcP99RrCsrwseVot5mtytpf6Y0gm9sdeyKnPQ7onyK4nXlR/rg7H95M1upzu89DH6pgUcikoiihJ6NJKmRxV1x+MJiOA3YwhDRQrWU0u/0rvq0VYXnyCwsLeTJYBq3dAtJDavuzyoVpzZ99Z0+a0uoiFH/xcqgDR7rUFeOrUn6Cywb8ZeNMbhLV5ugP9l0zv9UN5b5mFkjzxUcpPJCn3V402pRxtJd2GrnLdhtVk9ZSZh9W91fCSH5B7ofxPiWL+j3D/uwhBRdyAyozeZwvQzs79soi+BKSnafLviZCcfrpBpLyimfLfTyJtbyruIQKD01tUwJyKEo/ybaxkSNFUMdMkhQoJyRBQFhnUkDQSXhTM+3NmY0EDM7ffLIjqWEGt8lCO6mLia3PukFnghosJD5p5SIho/VDkzQfLE+IrYoJXkD19pdP7OwG/voIUtagiWiZ4PAFTHHlTVhRZ7dYmPar+NJ+8JhmR6DFK5DV1foHoLNO/pHrvZfmWZ15RQlwvoVDKhCWNK3CCch9lfFBuAqUgpFSShmNaPj+i5++WZfKeViJfW5HnUakVL4UCNVkA4+ETfIqx4B5xSaP2L1yn0zn2ltPn4+OqZGmwwEVCaCSqG53ldtL1oLGAhdMLd09MpCCF6tD6ZnAZBY9hDaYsP0jzZ0j5ZjKsF4i1UmLuhbJMCnYJPt5VwFNvmZawXjEvLJqIH8STonZjq7BZ8gKgR20C9MDFqJAX1H64QW2NEup6qgzLP8cvppL/NNTOBTCJABOHeWoXzLhw4Wuy7gaBtjKr9kgKq8ZlRYBS32Lpxc8vIhpNDTfyNXWybMJbn2RyQ5EmWc2QF9wmSZ0KYCE+cPuYO6b15Uotj2Kd4MItLS7gtFbkTdrFND6pvEZqv5Yv7jXAus7Pg7avo7KDot50NX3CPkP+Kps8J9/3mGQIteY/LGPC+L7872SPR2br5fy8MtKBMHedGuM28/MZmPJMrGgi3Gb1S+Si1/L/zrZwO9XH1ce/z7ZQ1WSoY/+pMb5FT4ua0Wm+Jf/298nFmChEQ+Ti71est4mq9VYI6RsymoRJKYidElT2FGnDTZvqtfhGAFTbeqEw68GqtfmbVa/1IFO1/jdWr/8BDRRtQh9XNjubEm4aWVpVonpTGR7PVGc+KJNoBIWF7kYi4gUV3r1U6723i6TxUl3n3/tM27aZfKb7THiHW9VzFSwHJ05VfK6Ar7kaB0XgPPE0BSkSFKsBUpaLihEWoA9wBt8qirh2VSOkZwXEwyrxZ5jyt2rJmSo9gX7cg6jsEUGJU9z9xJPOEM3uQQxKgkh35DNATnVyrmJ3mbCNyIB/yox4wH1bg2DwN7q9kov4pFqny8oSm3RQbGgJ1QQTs6ZMLilOVYJ9v6Wha3HcJ9jddsXp9YhGUXLXt/qMDnvLpPNTXfNa60z5/yjXQOMq+lNmwh5egpYrdfZQZV9rI47xlRkuyTjpzsmCBSWNkAXVoK8sgYWqQJWbo1RLo6QH0YW6pxqfCnRgkd+RiFjUQUQ7poIaYoakgXxwFd9BuuI38H1xBxXSFb/pBDIKQFn7YB3dB36l7sG1FLaKiBdp1KxLvfswap/30lnVESgNnvjbUoT6w9N+Xoio0qcYOIM+heg940YimsucQVvli9NEcft2UZwGQwLuilj1fFr1i3NP94X+PE7Hpvtj6lBJfJ4R6NvWiaL6MgzWHxiN66DExa+dAdAbMYX6HVF8A+7rjEZIXAVbDe7PVI9rmN69JOLV1DOSvRPxWNPZBZf/Nf+Ny65BhYxxxV+77XJ2wfQ389/IQPgajXbwMsuAz/0IaQcXJavKbRqR2IqyZruXjVC2+hdee/5vdnYOedpmVtR3NGXldxSzDSIiBVpkGb9by89UpEPKrSLZmyFDzMab/wXl2CNe7s/qCtTvWgG5kpBmCBlSzDS/r8N4uwBwohRW63JTS1y32f0TQsPfXVGEHQrV8/NCfiOUVirYcBbIeA2+iF68rQIo3B/S628vYESr79ehzS7Q9LEL9UXmik9XVHb1yBO3Ngvt5935+k1efkV51mzzrM0LL3/20avnwMeKuWyOUZg2TasSqZ+KcZQiOn1Iu2Vh497ALUVZiCKt/gh6IvTIj1ZLRjWAkpHKOKovNwp00eqPROiAbiNEKieXwMLcXhVJ1/uzmLP4tfxaHR59cBdJVG1kTAgl9ze9QKUEQ946Hkb+okJ5JRDyf54Axur1D+WS49cLr0tTPEu7UmXrxcSr3XNvumv4yXzInXKH4F7Tc7p17Zt+t/qW2+93k063X7VW6lALxTY7i1nBXMxcxmzQbabxz+tJo+wijYaIGMNS8AoSMgAPt84DdHOoMPfjXhF+kuH1tZvuFQrRCN07xGcXRX9MYxYchDe5BcHj+Z4i+42WyPc8Xofi7bbZJN5nJLJ5qr6IqRtzqNlM17SpFsnkEyTWoABEjz4JXOQvzWYuwdnV5LNGOwTM5v9r4RpQ8ZXsYodks3o31JBlzbYtNotisnm22MxiwGFXam5oN1n0TA/hRvshvTSDwHff4nNzRo9Dum6PaJbMXzDz+x+Fkj4L4bFNBb1asqsgH7Dyh4DvbkPtf5yMDKzEwyoaESMSNS9P9gJVA3/RTlwoMwZvxECFWxIPNw9gi01nOHjP32esZTtmXHnxvZd8ZtakqQ7ekajbXetpNa6ocTVxJtY+uSe69OLz77zh5bDR3xjZMzUz6fxrz1nqrZGcHQHfPVefN+fiK86LeXj+Sc5lPKy+k/vCUI/DaLFYCWHr6nbXuILTIsb5imNKY/rCm28fSMxPhkN1XbNMNZGuqwOBhtTSxWuTk6bw0ZaG86b1hKddePOKuBvmiguYBn4T/yOqOyGRBt7bKUI1GjioBC8aUKwF7Q319UgcmtFGIzCJGBqwQij0ynDsfdFGc3TS3BlNfJ25xmzniMkpXXTPvCaD3ZaZvyzjmZdudBostmhb0ORZNN2sJBeed1HXkrUsywueQH+L0eCPxmsa5ZpgRJSDZ11yDv+jmbd86vxZfc1WcZJ3UkMq1BOOOVtvu/+pB+en186d3GTwWAw2jheaJs09/+LNfZft37DALyrNj1wABMuUKbODyTVnT/KYbJ3Tpq8IrNh92dkxOj5P/YpZx4/ycyiVcDYdn4JbEoKdQi9054iBKsygLW46FRGxAb0NPNCm8BSNCPjoKcj6EAus4SuP3rB+cV99/eTF6294dA8+TK6v74MHVpYNRt/I30e8QGTOOdfGWzzxcy+87a7bLjw37rHw1nPzp0KyyRSeZO+QQhInt3dYgvycjrPOv+T8s1rptaP84VeywdWX2T4ysr0/7TLIs6+x9zib56ye1dM9e/XsZmePY3NDs9zlnNVt4+WgHJbbz3Livg4P9WWgviOMm4kCRT6I8vw0NbUUEnFvOuFKoxQW1gTsvFirsF5pb7qTUCx4i7VmtToveaDxvK9uOaedVvPRpVOnNz0Q6bry7uiSdQ8t7Vy4JQKVS+XPplV2ts4bvCwZu+KzgITtxepaPRzWdpv74muvv6RO0SorX6cu/dqKn/XWnrtp/Zragz13DUCl5myiFW2Ycvb0PtsXnU+tx8pvLFbUspLX68mdegwmOif/NPDONajTGoUh6tU56HBJCTBASVvNUB5VIiKpc9kd7kludodSFz7xQbiOmMk5dOYk56gzL6uaf7N8a6MQOHm0ae6snZpFDfuT3/jdYzjzwkXXIVHoXNuCfQslQZqBZjTsoHMqrkE4jaYdgkGz2ATOgB3cPkSukD01DnV3ttb1wx+6arPqbkcNAHoFPzKUUQ+qL0k97pjbZv1I/egC9zTFbrrlFpNdmea+gIgfWW3wqkcis8ky5FAcRd1If5nNZrl2FFpungc8wpoCl1BpQV/ScS+zjlASyUTVv/AJ46gkJI4bHX4lTnloctxPZE1ckS3+jG2fKIjkQFyzuo8jvYQG1OrGvJPSTu/nSp9PHNTl4z5hK/8gtXVKF6gEKiglgcKiRlCESsQCV5QIlKWKpr34lt/wkSx/JCmP5/cBKQfl/5gd+rOS/+p91/+YCg5CXK2W4M9fu+/6xxX+vnelVuldIDCG0VQTpU9Dw4pRfei+6zWx0MLie0gPbyrkmRU7OwT16JGeyXLHqOLqAfVN1GPlBzWtFNzj0TRTCjogtP1NjIvu5habN5Aoa1k66wGpqriVetJgiGdwDZtKhnN0y4n9sXYnsqGmZfDSR15+5NLBlhoDaedEm7sxmpqRija6ZEEg2EAnTiAC8IrmFbGz1q08P9PSkjl/5bqzYqT9hMmptEXDgTqP3Wiye+sD4Wir4jCeoHbbp5hRfpB7BakUIppIlPCD30dR1GtslDz8OsqbXmejFC/v8wu5X2myq7SJ8Avzv9DFUJySf5uNvq4+Ti7W9D/OZrLChdwxmPNiBRqVjnpK/aGxRCDspVYKAW9AN1JANoo8wP4BJUlGqdgw6m1qPQ2QW3+OfU5/ieLS/NuKpDU3uf8bcAXyBal5jMR2NEAbPAZt0K3hvxHBEDlUxfIGcD+N2gNSNx36nfqlAYow0puatNpRz0e4W2oahKzQHsjf2c16ad/3t2KTtPobnX6D8C8pd0MDP+Kx7wnXqGGlLQcvikMErm6TmfsuxJXbSAxqNjOogJLQBLiKEHAE+JGTS3JoEhTrz8/CB+5YlupJ58aOat8Kv4JvregxwcU5Cp8GFAFm1FyOfto6GS2m1NGTS6CPNKkbsTdCBlnN9onMho55BX8IJZtEQ35lk+htwN5A0V3RCPoD/yXAcv6pAtbZczRUA64JmcUf4q7Q89ZHLeJVZ5D1Ps/t+0iCT3AHVtZC7JDCXfR7OSb/Xja5H3zQbZL1B+ULX1BMTEk3AseSpmnKEK4T9ekMIidUCRQFfcbj7z8gNLvzF7mbhQN8h6ZbRset+nQWdS/ZX3k7WpS8P9sfo0iGS64wV516pOhjI6TZ2dApgI5+LhxywYoWxKUrykKJsIoDsR4mSrCTg0egMPnLW/3Q5Nn8BZEuzqEI7HK3n0+zFmuO3TtWQ5WJoG9YqCD6Gc32SxnbnVPfsxvrFXK2dILl7bLthDp6glhcsfp4bYvbSmj/mQ94uBTw0E73x2jbNRCvC6VL6GCFDwU7eWQDcC5FY5s0slieRDwtAbRsbLXbaXAuu14e2OJw1dc6jQ3ZdY8v7rv2/BWZLqvFWVvvcmwZkK9f5jS4muO9yR5res4kfkRxhV03L1RfPOiPtYi8pd7jNEsOpyTwxpaY/yCZu/Amd5Or9uS3DYaeqVOhH7gZN/8I/wi1fEuLXvyNivibjuKvN+1Nc01HF/3h+ef/sOhox8MPd5SFucPjorQwXT+ytA8EmA5mamHNFDVhBI5pjZbQpugBNkO8MvRub8KVDKST1Wag7D3xlin1ZF7LFP/79nbvCXFOY+PUjrT7/otsPXXZ4exdPzuhZuL5LUXVAn7k7PbhG89uz3b41X01gbjP1xwlu5rrvvf9+pbs6E/Vu7Nk642/PYRaAiUBdrmO6CDTBLPQFA1ur0uXoBR1INDMkypKpoTqnSMx5GiEdTEaSHLs0Alvu/19/5QW9Rv1U1ridT22i+53pzumbs+XFFXYC++CGsTj5JUT/GCgRt3n78i2n71FHG4/u6X++9+raya7os3ZbDmgWfXun44e+u2NZKuGZ0HiF8M4TlMPR+EU6rPKRJ8wOU2RFUFLex3egEsz3YqEAq0cqhAAW19dBZIlVzR61tuIdTnpXH7l+uXrbjPUyep+8cl6aXKWhPHpDcXl9KiTWDNr4mBQc8Tq+NzK/OKSbsfl79o9G20R+brBXYvUg0rLHhtrc4TN81TTOWSZ0gL1ZVlOYH2ery/7XVUjFMbzYpg7UswcqJPQwBd0LKLabJ8IaCr2otcjSkIrGwootKECaUd4XH1+SdazRrfddkBU98t1htvWrbjqSqjaCguxrffM/5zDCpBALUycmajhd+R6ww4SWafuZ5eU+tPid4lgd3gt+b/Y9rQoZNmiXYPXyRHbRs8zX/f4WIFjWZJtUdSD55AP3xtXH+ZipC0EqdBGDA4CoYEU6gRLGPU11QhkLTBiEYPiqOeQgwTCl9aok1Qr5pFf71qEeNxjy/8F0GoqYPv75Yh9j3x4DuJ+uEzHRpAq2lMqb+qfTdiq6kGtzfOWsv0c7lSeMXDHBDe1MT+LUgx0Pg/p87u2UicdIvqQi8DkxhcUwUXCedMpb4NQjwY3npTmgsURJavLwCRyEcN2HfWsDVGfv/u9ZUWUx+PYFueUKwaNvbtu+Xps3eVWbN1GcgVrdMnWJ7WmJz9SD66EBidag0NF1Ukep0t5A7sFCWdhzvYwHv6L/BehXuHqfaBwBEU7hfVLcXvS4VQv+T/vaSIl7cbeMc7ekv9i8S3e1L5xxpvMGcu1EYPbKyCiijjGXcDKckm43PqU2qNWlXusZMiqF82cuVzolUHN9NNR0HZPxFPV9V0wLtvq+k4DqOwVWDlzuQLVdqFiP08cRX7aRlBVfR8cb55bWe5LExnlcsDp1vAP8Q9BucPMk1Ulh4GnN0SAdxcNHv3q9ohx1Ati4S/tkWjIDe3hQdkUGrGRaFBiUdiTSkI41UkMuuQHP+EaSQYlPQTFWJF03BNPpTu5KFAdkWgDukzsZKMG0Q1TAQQglScOaP/dsZ8+fP75D/9Uu5Gs3FY/2SxPld0DHOciXI9gqjcEidXjE+3BLosy0OcX3T7O5g65ROGyzQ2BZs7WbZVnO5ydLe32hMwTQ4wnnKXW6XW5LAa7oaXOIHoUl0FgLQLH2by8wSTWeAx2Y5PDazK3BqZbeJZwXGPaYhX87ZNszoDdaRxotXO1nNlpdvAPFWHDm8PqEE0sZxDEqGzxisFNnuCWetPcGrObN0p23tTZwMuRVodSV8+LTrOV3eRvzjQZiSjaLYS1WEJe0kNsJlZu9LFun7++wW4gRDRbaxw2nrOGm+xOj9cmtbp9ZqeTM1m8UXfQQCSTVSQox6pvtjot/FpHvIUjJovFEoYvHYV9C5Y/xN9OfcalvII37UEhTbTg/AQIaPb4Vz6j5u8/aViycMod/fkDcpu8QZbZoeBi/vbzP3XPsZvOubMtaPHkD9jt6+U2O7vqU/9C9SMvgrXpQNG/E0oJxun+CiElUa0IKQSUwERxOntKSV7ekcuh9VBZBBo3VUcB58ofKBHCwLyf9qFosz9Ibf8dGqwaBMjRig4SGOZ2UkWI7UiO9OfUPdxOYFApUZyfpY7mgEc5rtNGGk2H1lPhAk1Hp/VAMqQEHEUfEYkkUQq1JMdzsX7kklRrTrUi1wMcDjmu1YYfATj7Y+pGpPEBXuoQIj8rR9mgCl4C9yqmF7xnVWxGVniNqtpVmXBvQ6iwni5YQ8a1jYrXtc2J13HvgkvqWxuva1sbr+P2S5ceKGyBwDv2DbrToe1u6BkAJV7xnVLUaq0sJB8pFqcUIPi3yuwxi4JuLr+P30f3OkPQ72aO0xYo3/EsmO3QO5qEF8S0qQH0UsKXv0brnl9+8M7jF174+DsfvPOl1au/RL5/9DsbNnwHL2pHR1NTRxMZhJtHktOOxLxErPF6YlLvpC9YP73x+4ofw+3xVdrHcDE0dQQCmCRgvt9b35xINDf1CDcRSfJ+pYl+Sf8YcurfmXP5F/kj6J82jNsrkWiEuhVlgFfyNkB3S5MUzLhoNiwSCYcxQ7Ui4J0Xh7fmqRbaPa1tzujxkBRlsEHy0/OM4pYLPb7g9O6BQJN6l9zQ0OGyCaZz0vMTbHOzXfQ7a2tsterTcqxeInODoemdktw+1SbVhKwtW9ffe8VKadK0OVuC3bWzyKm5LeddsWTeorWyY9IMtUFutdu5g+Rn533qkocdvLs2HmhU75br/MmWtD8zA3OP2t1ea636jEzqYxJZGAwFiDEd61oTsrRuW3/3pYNi3bS+Rd+GjOfVpAPNd6y64Gsz1GaZleWIPoYL/v9mTeQBENVEguiF1aC4YeXxFETw6QyPfn0m9g8IrMFAvKM1EI11DARnbqibHk/Iojy5rSdgCyZi06y8sS024PeuO4MfwQ5Y9yKRZCqyYaF30vzeHlmUprR21tR0t0yz8KZY66zWuGvxVQB/36kP+K38t2Hu6NQ9SFJfw0AdpqPEK2qTMpf2VCqJwqPoJezTL824b8akoL+x03nhh+oNo5e77psxg9Q5LzebIKD+fsY34f2MtB9fk9v5b8PT6tYrgv4kRPwd0q9z3gdJSJ0653KjCYPwCaR5aUY63eW48O/kdo33yxX9wCiMv2QTrk8eGSI6Ag6moG9t2P/F7GRNlDjl0gw7pJ5aOXXqyqn8SENnXBmbSwUYLyqJjv3UmY1nKr4t80no0faXsaIEiF/BRaIBnItSce4OUif7W6Vm9T9H1X9Vj71BEm+RdmIJQST/ZfVdudUvh9S/qqNvqT98g9SQ3lHibZY0mRVHooyDN/FHmTgzjdozKw28NwQ0hwN6BCoPKaEk3YtKwNhwRLXuk076CGoZNXDQcRwZvreTZY9EZi+d0s4+ztv8iei04JQl6ZbDD2eHV7X4uHuFVfPrOmcs6m6Kr7hssr+1VZFcEZ/PdJkn1hOs8SXS/NFFgqt94PIZzZ3tdaL6Q5vo6piSzdy737pwsX1VyxUrF15iJ4uNkq+rbyg1Z+O8VsNC1UmcvORPRfxtPrfRwL2p/oA1eZp6Z/aGffoewaXcA/xBlKlQLfhQL/oPgBGP3qsA7IQS8qDVNswHKRSheDUvA3Q7MZoRcJMxlEygujn1QdyzfPfq3dEp/bXh5e5YXW2Ngfvza0ZF6UgFL/E0fTq4LBlvTE2qb/KuuzYSXVnjTfM1osvqMHVbm9950quIZlbqaL6YP7jk3kUtA0GnX2nvq53f3WoSsvEdDRnULgo2fN7lNZJgI8/VWi33c3bBZnGY05+dm+3qc7fNmj4YGKLj2nfqFP+g7jdDlxEV5XsJQZP6hYrS1l0VQr4c69Xueixp90gnZPmE5OF22j+SYEWHlZ0K/Hgsh/Ztsbh6h2DNRlvv6jJh9XaJaHCZDiUDKNTMkvb8vsqCyf3ZNdSmO0fa0Y4baJTtpbKzuVzeeSI7fCKr2Z0WypapnXJ4gnoWy3PoUIlIQ1TXdqhQJIXp9Wx5fYdpeWh2TY5D+YVyKd0jw3iumwi/BC3cEy4o83QlZnW79MrCgCjbhWXBlRZVVZZv4rIKpXC01HFlHdHLoeWVl6UVc/J5uGm6CViW5mulYMk+HqNYr0AyUPivLg2oMs2MPqtuhHyRyiwvNJej1Br+fcLyoAyu8D9B7bgmzUqfFobF5nKnK4+t8MPJkI/xHUNWk117jugWF+xazTAALQn6+UE9lhoI5ApGA/iuJOsrlNP28SVVuBVajXmircLel46w2bJS1Q0Ft0KDuikDFL/3pYrid1Q4FvofwRIo4R9h2ftSwc6jHAMqLcCql8YPHtlzGoByNXYN6v8hXnRaOhUvx0sVLCexwupGDR4NOYC7PePa5keIPACnuAdD7dEadRuTIiS6Lb7uskb381My5yjzF8lGCjBRqdwrWJCagfB3yCy7XT1i92hbcZ5Ci1FJkgYMDf6n+jspIsHFjJrTOdzSMuOa9DbDcj/nH9N9bIoGVgzHPWIQuFuYtaMRaq8eCKI0gEF6lPOZjBz3EEvaaxwSUT9U/8JbJZPJJLBLolH1La/RbF9AbC8JJjv/mMnssKjLRBJyqj9QXxNko0Ux/X79epfiXkm6fmKwF/en1HLc6LxloXWKvGa5rVCVL83VuiPcDEX/K5pTXOxHfx6HHB0t2FI0qI2rCZFTrvPWU67zVuS/kTsLnc7IKhFg30e4FOkqNSfH5PtkmUy6Cpiv/36k2sbqCeCFNa+URpoY0sZoYmCgCr3qgZz6s8I0gP1bYiR+D79H56NOz0EVWCTy2/fffvSCCx59W7uRV9995eqrX8GLesOXNm360iZ+T/El3uZqL+FyzSZ8XxpTiI/G0nkT4zznFZ0t4ipMz5v4q9ssqbdKUZt6u82knPCrt6PZwsnn0XySVnyPR1ZXAn72yx48bWJsu7apnI3Hy8bygUK5Js32qcytapqgmn95uexccj205vGgJ+euOeG2SORmKZr/qKzcx9SFctMJdwMUFZDJITs7dnOp1EKZCxg304Cevyfya+vlKqv6aXK1qIj3imL+L6hL+yvUlFfE0VKZ7E8gBY3M/8VoJCFgizH1W6VyC76nH6b7jiibYVxUmVIEspry/LgZIlCeP11Z4zs/AwvVwtGFEut5S1JY4lfyT0N/evOLo+rUEgjcqc9IkGpQbv3iW7Co5b+KgjvpzYdH85PLcc4X21ouwEGl/S4qnUAvoSlXUUhR1eKr2VWFTB+GMl6FsiQsVD1R3urlAAIoSn7JQkmiVVCHSpCwDH/qPepXQ0Db77CJOAImohB+RPWr31ev5g/kE+zTa4lbvZo8xdWPffQu9yJTPCNB66s+zXoJt/0L6hSoCuBIoK8fnBGG87OoRckJpLqyWe4YbpGi50g0+3I3UD85Oa0fzubfoXxPLbW3FDWzigmyJeM0tQkax7PqTy80+UxfUHPlBZIRVNQ+v0xRm8REKPoLmNr0+Uo48v9GFbXPKylqQ2IKm00QddgyWGMROCTxdLB9nCY8P7j2DjlsV/+mfr0C0r/NkeXbbpPlOTBBwT0mVz1zx9S/wJecBF9Wgv3p032iP2v4VSgfgW2G+HUEdEXU6iq4CtpLJfIN9XQG8dwa1VoO8XC2SrPDDyCOQptXgbcPvlAgBfxBoGwftQKeKFrNTASPt3pGGqDt/QRasn2kri+H6L80MJRsmVYJrAKyDItpJUy3/15WYIJqcJ9Q5N/LFJ4c3dc1URpWl9hW6mu50MUIelg4ucTPf15zs5DFo1c0VSp1tKB9jkwIyuM45kb+IP8gHed+6jO3v0KbIknzLy636E8KPTdCuUpB0wLo9JKnAO6pv0vS31EtBha/fJemkgLVVnd8KCk4qBTpQ5m7FbifBKrPJcq0pZAFVG/XbOFz+Tcq2MLrcmV28Nmi/OHskh82bau0k8eWCaPijQPWQ5lUvslwVCfHkXBMIehqUgtDNLeauH1huvZTbYmw+luPjyWoNGEuxRLR7LK5fSyXFUyK7PURQv2v8D3XOt2NJ6liBbmPGOsakw1kbeOs+31Wm5qpH+iJWSzqdPr2O7zc2TmtnrzCig6bBd/vgQmzOlz0STWIlmZEQfupogOZFHUZ7EkUnMn0RrpIMqAgHRJAOjIJ3yGw1I/MAp9q9S3Q/clADNm1wEeO+xbwg5OIYHZLY3ehG5lJk2xhco+6JWybpEVz2wrR6hZyD0QXZbeDVB+onmlimpkWprdAs4WEZDSQppsDlcdCBJJESIYFuAtUnC4GIF2C3Uu2Kv7L1bdz6FxtqxpG4TqQOqOUNAJ2HLvPWA2GgDy4O4vaDrtyl6P+1fAll+SyFcQ28GHqh7fvvf37udylf0fNwhzgz87Y+cf5x9GnF6ygHu18sAbipWeF0YPBgp2GaKeQduxxdEr3SgbH1kvH7tvqSLhedomOvZyts2dw8acu3dY/f+ucuMtCuP/e4zC4XnH3OLZ8ZuxTWxy8dJfU5dhDeKPSlJy5pn/+7u3XrJhmr9C5CuleGflGQocKnlAUaRKp0BAHV0ZwUt9VCqk6zYOgRIuMfePJzdmBdpPJ7/6B23+f+sp9NMDZevovvfYHG5dGPISQq1DojqNckchVrCcCYz/Q0hI0m3NKDRfkgsrnamo+p0CAq1FyvC3a3Nak/s5VX282x9Ufy3E39VAx6o7LpCvO2wK+ch9jNqpJCutcIOooKnYWtDK8gTRVYygRQfwgzKM5+jP2jOZdx3r32Py7rQUPOzAnoRs95NvRAR0qLGU11Taqu1bUYSzMcWjMEir067JQQHfIrLBHsrgv00/Wavd8HRLMEEYFSW3HCSNQehnrHztKqHcDyo4VfZ6gPKCR+gufwA8GegxUEo4A+gd0BASHiH6jYMLIsUdQJTs/C641KN4oCHWolCMLlMfIdtWKScjx7SM5LD9HnfmhrGI0S139UWfUnxgOXdJFW+AMcGjKr6eHAttHF5sUoeArYKDcxMSYcKA/xUDhPiEOEAPafSIUFArN0r24ynI91EPARDXvIDYyvqZaWeroBOUABQA/E+DXC7PWafDLQY2oiwpUEyj4RQtVlUp1GrM7In2p2A7VuiOW6otMiGOo5Mrp05ejVuTy6dNX/k/7mybZQ0nUmfrbx3U4KueDnlHm5wdh8FFeKnoaKKh/TK18StOPhwG9Xo5mqXAxvw/79YQwwDR+nAKQQ4izVXioB84qcppWB7IqjU45z4CE17OvF1Dw+oTFqxtz8dxwtogBnF9MjIl/in+K8s3hM9laIn0TiCbTAXL0T798bPXqx36p3chrv0O+GC9Xaj48Ecv8U8UEeBvUEsDlTepiU5OvlpeNGvpnKF0RvUooWhIjnx6GeBapXCQYTw9DNg6/OC3gZjp76oNTj9Kz6Jqobxb9NDqc08vcKReOpcsQV2K8InXFaXW3aI6Ofr1k48rp7CX7rx+v1UKPsfvzQU0Kc83i2VdILmd2/yX55zT9luN2+Cu4nKfwPcK/CvDVU+pHh8+LaldIf1fA5h3ndT6Fln9/W/9Ce1vndfvJtnPVO2xhm3qbafHVCN1X363UXHq9xuVD8OSD29Z8pZ5cZrern9cAdGW/uib/ud+VK0L9a42r6C90kL8KzxwLQw9NkIQJL0ASU8M+VG0KsUdgdvpgP/6NqqP0/gHZFUfGEijZLHpiIgvV5/Bltrj8Qd7XQd5p4P+7tJo30NMO6VGBwahSPMYiaaBYoLY6uEnciyhhh1Z/vvacG/rjpsvnpzs0B1Id6fmX8119l88XnOxe/uGrzzHcdu7UtY3+2vmXN5zUyj3ZcPl8p1sZSs6/nGXtwrV7Ka0XZdz83fwjjINpZWYw85lL8BRK4nGyIir2RiOsEyipuEcIakpGjWgBjLiHWOgj0Yi34gW1kKPxHt2Na5q+lwg1RdRSpFDNzosb44YJXnAfoEOpZW//6u1lhYA6leevezbI26zNHO811M2dc5HFxpk4i1jPC0s21/BWW5DnPQbn2X1WK43/aM2n18DfSoybbNHijFpamzXI31eRibGUOxSu/lT96YZlq1Yt20DaSBuG6knw2eusHs5EPBfNmVvHKdaQzcDfz9ZsXmLDWGXy2U5OsYSsIn8CS12jQIyD12KKqZrLPy7mSPdICmd6WGHG8NDZkkHuE4h9TU8FpmUO/VjC/EinToFyoNDz2p9XD6g78WgQdPG7Z3R0T/Z5dTM9lsL8Ktek7szl2L+gQwGgwkZHc2g5Su7NvVqwGy2Ua4KSXUwt1X4PaM5paaEu6jQ5zVFyNabxvUksVt2T/4VeamYPlLtffdQsk+2sUTY/zDXl/05W53/Bz9UK3p7LjapZ2ZxOm+UlZXrL3HHGqO8+wVroDaCTTnTxitMxmiAAYQzVJQH+nj3oIHnPaN6Zq6sNSLjBl8tKgVr2mj/9CWi9dnKca8rBQBsd5R1tzVlgrl5pbnPw6kZclCr2CHxMnHohLz+3KRQokzALyeIKFU1TNCiayJdoHvDYe7K6mZLm8S3uJ9dojuaJ62/qN/tjQxnSnhnKPw+LNrLi8ZKyJ3x1YhiI1aNAtP6NzCGzYv3DmaGh/LvQZnt0evgIhTFV0kE/PYxAnOHhCQUZdCWY5JWJwMzlAGl1mpNbDU7yyGnhRMILsYhH3VRAijrPcBU8/Cj1Y9NY6cnGVW0CjTLaz7E3epvaT/LtTV72Rs+0WVVmd0dz/MGTI5F0OsIviaqDlbbO5X6xT3PeXbXHRtf/z+fdka+eKPr8KF7IF4vBsT9MFPuPJMBTBMq9hQxXelQ+bewnf18ap4Ib+mSMrtDU5zqlD8QANa5MBGh/OwOvSDfcV2d66mfEWsbGWmIz6nsyZDWQSmqmxDneYyvjHPmRXHZxeueyRGLZzvRioKnGto9nIPkibAJA16adcOZRQr1iAP3bUyBR7T4RgAWTKxhkCYFwshq+7iV9r0whk50cmRcTg4fy5x4OmmNkHndIA2+YuMbmE9dwGYB4KFTsvnDE6Ah47r/fE3AYI+oXADpkdlENcZ8OZEEf8FFGZNxMs6ZLpG3SUFLL7Q2kcFU/A/Jsw+vWDa/7emewLaoeibaF1B9qUNnuqWK3+UfXYVL1v/omD15xxeDkPnXTOKSVcCbDGtOu0YQNpGAP7U1HU58UrqGu8xIbHtkQ3LVhb7Dx46ET3Ffcm1q0YcOizNmf3bC3VjWfAcpSv3MyTlgJ23FHQgmgvk+gk8pL0mcCDOn08MDAQlf+/SlTZ1z12fnqntOhbOTL9/ZdevbAPN+yby1f/uUtC/ixm8ZBo59LTXEW060hGrTDplNprWd58fwB/b/E27BdS/s7U+rGVCeQ46nzaw9QccnmZerGZZs3Yw9aVHt+Kh6HN4ti6lxIhT/wahnZtWwzlY9QHQ2c79C+dxzvVDKy8GqKWQERO9YAKbpsDUTLdWV5dE8PVPjvj9pqw7ah/PFVtkit7aj6G5xY9mfJrCz1j1e0BcnPol4UjtrCdbahIVtd2HaURujnFJR8CuOuUUfhrGhgKKgjCYNSvCc1WKlEp8wHUaAYynFNyzZn+2MnYv36dbMDBTonl/T/ma5IKAyEGz+4eRnVtaX6tss2o34u8mWorFtuFgm4A6qK/yp/gLEBVat5WnPDdKA574ubuFJ/IUfZ/Y2Nt6mN+ZNNTSTaeI56gKwkXerTe9DDHUw8/H35FY3nNN7GGuBKWhrV9ep+0k1WjNWVaHkW1yA+QHWNu8rtBw2a5YXuE40rs7/GA+j09V3hA98yRnFPOGr8ltGlsFdD/7tRce3LH6Trcneuiy7K7J3khKu+3qUaXPWaX7T6/Kfj9BX2eZq2XAcZT79u1ClJzUtHUqfqSMWBcZS43Ena0cUGLgpkKxB1QM+0Fxz10wgg6r5rltnFpH05pepUq3Y2HfYqeKRntmUFNz+XmcOs1H31U6cC6RTVLfCg7RNBF1UF2/wBgu0fFQtPEU1sSg3VcNsR7dWq3af87tUFn1l3ltXpaJxpNvtcZkH2WmMst3JqRpxUH+WC0E1qOGtP66s1MYv+VLu8/XFXvV/ZbunYYBeVN64ls0ur6NzpV9xzlmQwB5qC4Tq70WC0tk8dWJXeHvkD0h9zJOM0vD86/1NJMaIAolctvlByferCsqOKDKceOfUu1PsmoFCamV5mCrMUOCi6V6FJosMF22AcrKJgQDVhfYh6tepp/lYgvnCEAbJQ1L0rOpajEmRcasMiPfxhgGoVo4rwreQpV6fUJHH2e8fa1s2c13Apl1b89a58ozdoap2sjgLN9uISl7P1DrulyeIkt0zr6JjWocoPOZsaXPb6jtqBblsgsaRre2xHi4nELm0MhG1+x1SXwLpFi53b+aHRYo/IrbZtuWAKu5cSEXfybnnmUCaXGTpQr0xK2O2WWY76f+nAjNVf7nCZHU5XqIkTnpt6VtvsFlPXg1031g/VRdpkkyVpD7jnmax88QwDvg/66NnMRdRXTcGTmQc3cuINwN5IQqi0yzb+YFVHuVqI5s4ADfg5oE4ybDLd28mFSFmYvRoomsWXEdLU2Wl3GJy93ZNb/d5gqmNaqJZSO1l6PVRy0nZIj/45EetjLguh1rLqR+SK0hO6NrsqcNX8zoUdjQYDJ7tb4os6+i+Y0qpY2AWlnLRDWdGFTfGY1gV0zNAtJ7pdo24se0D88AwLY/gZmE9iuP4V5v7CSR/RThaHLh+UeBkXwU6BC7lGOevK65udTv+tS/PfW7qj3ljTcj3b9OkbV85t8xsMj7Ddj7DGpthZKwKPvso/c/1K9aLE12fMWLV1y1D9ua8lyJdWXr/bG+noCFutf/mLILe39ITUV4igr3876fpX5g2zeB52sWnIL4fXHlgeUzOx5QfIvJQyrKQE9wHUqVq+PEaOrz0wVvNbJZVSfsuMzxN4l9PkedFzw9V5Dj+nzpgoT4ZxCxJfC5RWLc74YVHxKlExCYt0JAOMatREhHBSCAtSfod6x6Ls8HCWECLwXZ9nd5Dz1T24JUdWs6fU3++fcnT49Qe+kBs+wdsMZgPXMp3U5S958snPP/EE7bvkOPCuTUDTUQ/UzirLhML9yPahoe1D5Fj5jWsaoveyP00PehdUAHk/seDVWsvDWXXXsyn/4wfpXc2V3/Qxli3jl/5hj/83avSCfpTNxOEKLmTjxOEKuxgNlsQn0xgct724mhynupNW1Ph6o3RYS3/+2TJrzLlkFz+ip3qCHKf6eqW02QJLjBYuuj4sobhCWqa/YHGEHpcnumuWSOhxeaL7sOakNR6vvmo+YcfFA8UFXEPZf9UjyudIOyNwx/i90DdsujS/FX2UAwvWSVK4NxaMhAGw3oowp/uc8CTi7D2rBgZWwb/60faR7SPsEbjkXy4G0XaqhXPwe2cePjxjxuHD6ssQuR1fq6PF0E+o2t1nePTn8TUmxz/A3crMoCc7egESuoTHYc7mYdg6etORoOhR7BBGD+qJopELrl4S6cJNRtEAsLP/OdvnJq0Wo0GolY2Et9VFB2Kf+4bZvVyxfOMz3WdFfSIryj6DwWghre7aQbdiDrkTL3A3vNDuDpk93HqXwam+bWmUJZfNn5ozKV5Pmmq8PF/jVY+2Tlk2M2RzSXKjmbQ4RZcQavEYrN/9rlXwtIQqzxQNMzPPfHYLvuPoO9TbT8bpGw5CQPGd+SyX/Cyf0Vxjd2R9NmsunnXYa8xGHzn+sSfM5J0y0DZEXWWxkXjcR75KBLNLHi7XvX2G8VOrf4Ykg0AMdBESIpo7MgAfyakA6rkqpI6UjNs0px7cMV+D5BF49Tez1VGnYmq0WIijp985m4Sn2gJR9b07riPPFo97OYbUZbxJCpot7H/lpZBicglCPN7WOfJkcHqc3ElWqvvz/1E6bIQrG+tz6WkM1SM9FBTR7FSs8KyBBytSmNEoquJNFN5EQyTiCrnKDx1h58yxCepPHU5nxGoxEQeeOZi2m80DxNxncVhr6BmEfUarxejw+WSiHhWk19bSY7aKR5MsteblJpfTLtjimBouXsm3d3djjYM+wEW0El9dM/ueVRWIsXwe43R7SgbVZqrnqoJ1X/kuF7pcgf8duv4q6vayV5U9zMV91GxO59UUjW8rHV6u799WzKMT7umRCXbYUKM+foaCcwgaoqZUtmodV3p+X7akb4dnU9B9La38RPFUG2SCC90tVA4XwEFhyOpZZrUCsgWYHsczLFBBVGNtstoN1bw0Z+O4fYIbvZVt4EUcJEKOhHeincWqONw+q6w5Go+WGOSR7LhKV+KBqbBPpfUvOf9QqkpDyVhBeyyZQGMsdA5FBUqvFMtUyGq9vjnsAJU4UcrxldP1CCaofyDkSAifoP5QwWx+SyUGxp75BzGAvtG7uQ38LehlyEQMeh0TeE6Bm7tYdXqdkt0uOb3kfYlNwmOdDyacOq/qlFo1v+PTmTi3E/glC9W11b34A22zmLzvb231Q0L2Bgg60OTW4YdstO+YOJnO38TtpH7zy9ymokWyA79qlVSn38HtpFlImFnhu3b4boNWXklOXV0Iwo7lQ1hrZyPFcwtjwFP7iEKSHSSJw509kh8kj6pr+H1jR7km9vcvqN9657vffefkv+fKxge1X+7RdjYUPIESN7gTvRkB/RMYtEkaVkdHApmdBPpnKmz0n1xSWFOyVIuLrinZwpoCRe6kyiVZoHX088F+UX4+WKS4iBTP0IWxGtZgOdMaV4KTayqHQF/VihBwTbgDXTCmKoOBJeNhwJMzEVjtjIFLuU38fPR7hqNG1JS7g/qRCuy3vmQ3W9Vu8qbVbP+SzazGRJH83MzP90Ck2m31mMjP8TiLn5uwD2Ugr2PFvPQjB5BnSJvQxGQZZEB+LopqzGzDbMmbkAPkZVJjeO5FzOSBKCgJze2ZS4Gemc9twrwY6u9H61iUQTcRvtdT9RW3tRxAWwFs2tcuJRnI6xjmBdWjbgFNRHMHiF1uHYBfUR/ut5Ug2jXAaT96+9RH/FToRwIzGbKmVJ1AZQnoabSB1yyIg7ByAridHApPMjyw0OiV6RjSbCuzwLAvFizBliWJua1tsuAgvNPbmljYbpt8lkWam7b3XZiOiKJskMOtmfScnsbPW208knwjuXrXK4Q1iKIgNyYXXDVT9C2Ye/78GQ5BEEXfFdde2RwauOysdJNL5AzCy84ard/nGAVN8alecnFdgu5Gbd5DJTL+hHZK0vApVy3OfU8XTSJg1TlssivsPYUlIqvn66PzrVTymCc4wgF6SDNR0pDf+9Gp+VnsUH5WtpHYsuhOaey8zdwLN47V8MTbm78g687+P3cx6tcAeNpjYGRgYGBk8s0/zBIfz2/zlUGeZQNQhOFCWfF0GP0/8P8c1jusIkAuBwMTSBQAYwQM6HjaY2BkYGAV+d8KJgP/XWG9wwAUQQGLAYqPBl942n1TvUoDQRCe1VM8kWARjNrZGIurBAsRBIuA2vkAFsJiKTYW4guIjT5ARMgTxCLoA1hcb5OgDyGHrY7f7M65e8fpLF++2W/nZ2eTmGfaIJi5I0qGDlZZcD51QzTTJirZPAI9JIwVA+wT8L5nOdMaV0AuMJ+icRHq8of6LSD18fzq8ds7xjpwBnQiSI9V5QVl6NwPvgM15NXn/AtWZyj3W0HjEXitOc/dIdbetPdFTZ+P6t+X7xU0/k6GJtOe1/B3arN0/pmz1J4UZc+D6ExwjD7vioeGd5HvhvU+R+DZcGZ6YBPNfAi0G97iBPwFXqph2cW8+D7kjMfwtinHb6kLb6Wygk3cZytSEoptGrlScdHtLPeri1JKueACMZfU1ViJG1Sq5E43dIt7SZZFl1zuRhb/GOs44xFVDbrJzB5tYs35OmaXTrEmkv0DajnMWQB42mNgYNCCwk0MLxheMPrhgUuY2JiUmOqY2pjWMD1hdmPOY+5hPsLCwWLEksSyiOUOawzrLrYiti/sCuxJ7Kc45DiSOPZxmnG2cG7jvMelweXDNYXrEbcBdxf3KR4OngheLd443g18fHwZfFv4NfiX8T8TEBIIEZggsEpQS7BMcJsQl5CFUI3QAWEp4RLhCyJaIldEbURXiJ4RYxEzE0sQ2yD2TzxIfJkEk4SeRJbENIkNEg8k/klqSGZITpE8InlL8p2UmVSG1A6pb9Jx0ltkjGSmyDySlZF1kc2RnSK7R/aZnJ5cmdwB+ST5SwpuCvsUjRTLFHcoOShNU9qhzKespGyhXKV8SPmBCpOKgUqcyjSVR6omqgmqe9RE1OrUnqkHqO9R/6FholGgsUZzgeYZLTUtL60WbS7tKh0OnQydXTpvdGV0O3S/6Gnopekt0ruhz6fvpl+nv0n/h4GdQYvBJUMhwwTDdYYvjFSM4oxmGd0zVjK2M84w3mYiYZJgssLkkqmO6TzTF2Z2ZjVmd8ylzP3MJ5lfsRCwcLJoszhhyWXpZdlhecZKxirHapbVPesF1ndsJGwCbBbZ/LA1sn1jZ2XXY3fFXsM+z36V/S8HD4cGh2OOTI51ThJOK5zeOUs4OzmXOS9wPuUi4JLgss7lm2uU6zY3NrcSty1u39zN3Mvct7l/8xDzMPLw88jyaPM44ynkaeEZ59niucqLyUvPKwgAn3OqOQAAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAHjarZK9TgJBEMf/d6CRaAyRhMLqCgsbL4ciglTGRPEjSiSKlnLycXJ86CEniU/hM9jYWPgIFkYfwd6nsDD+d1mBIIUx3mZnfzs3MzszuwDCeIYG8UUwQxmAFgxxPeeuyxrmcaNYxzTuFAewi0fFQSTxqXgM11pC8TgS2oPiCUS1d8Uh8ofiSczpYcVT5LjiCPlY8Qui+ncOr7D02y6/BTCrP/m+b5bdTrPi2I26Z9qNGtbRQBMdXMJBGRW0YOCecxEWYoiTCvxrYBunqHPdoX2bLOyrMKlZg8thDETw5K7Itci1TXlGy0124QRZZLDFU/exhxztMozlosTpMH6ZPge0L+OKGnFKjJ4WRwppHPL0PP3SI2P9jLQwFOu3GRhDfkeyDo//G7IHgzllZQxLdquvrdCyBVvat3seJlYo06gxapUxhU2JWnFygR03sSxnEkvcpf5Y5eibGq315TDp7fKWm8zbUVl71Aqq/ZtNnlkWmLnQtno9ycvXYbA6W2pF3aKfCayyC0Ja7Fr/PW70/HO4YM0OKxFvzf0C1MyPjwAAeNpt1VWUU2cYRuHsgxenQt1d8/3JOUnqAyR1d/cCLQVKO22pu7tQd3d3d3d3d3cXmGzumrWy3pWLs/NdPDMpZaWu1783l1Lpf14MnfzO6FbqVupfGkD30iR60JNe9KYP09CXfvRnAAMZxGCGMG3pW6ZjemZgKDMyEzMzC7MyG7MzB3MyF3MzD/MyH/OzAAuyEAuzCIuyGIuzBGWCRIUqOQU16jRYkqVYmmVYluVYng6GMZwRNGmxAiuyEiuzCquyGquzBmuyFmuzDuuyHuuzARuyERuzCZuyGZuzBVuyFVuzDduyHdszklGMZgd2ZAw7MZZxjGdnJrALu9LJbuzOHkxkT/Zib/ZhX/Zjfw7gQA7iYA7hUA7jcI7gSI7iaI7hWI7jeE7gRE7iZE5hEqdyGqdzBmdyFmdzDudyHudzARdyERdzCZdyGZdzBVdyFVdzDddyHddzAzdyEzdzC7dyG7dzB3dyF3dzD/dyH/fzAA/yEA/zCI/yGI/zBE/yFE/zDM/yHM/zAi/yEi/zCq/yGq/zBm/yFm/zDu/yHu/zAR/yER/zCZ/yGZ/zBV/yFV/zDd/yHd/zAz/yEz/zC7/yG7/zB3/yF3/zD/9mpYwsy7pl3bMeWc+sV9Y765NNk/XN+mX9swHZwGxQNjgb0nPkmInjR0V7Uq/OsaPL5Y7ylE3l8tQNN7kVt+rmbuHW3LrbcDvam1rtzVvdm50TxrU/DBvRtZUY1rV5a3jXFn550Wo/XDNWK3dFmh7X9LimxzU9qulRTY9qelTTo5rlKLt2wk7YiaprL+yFvbAX9pK9ZC/ZS/aSvWQv2Uv2kr1kr2KvYq9ir2KvYq9ir2KvYq9ir2Kvaq9qr2qvaq9qr2qvaq9qr2qvai+3l9vL7eX2cnu5vdxebi+3l9sr7BV2CjuFncJOYaewU9gp7NTs1LyrZq9mr2avZq9mr2avZq9mr26vbq9ur26vbq9ur26vbq9ur26vYa9hr2GvYa9hr2GvYa/R7oXuQ/eh+2j/UU7e3C3cqc/V3fYdof/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D92H7kP3ofvQfeg+dB+6D92H7kP3ofvQfRT29B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6D/2H/kP/of/Qf+g/9B/6j6nuG3Ya7U5q/0hN3nCTW3Grbu4Wrs/rP+k/6T/pP+k/6T/pP+k+6T7pPek86TzpPOk86TzpOuk66TrpOuk66TrpOlWmPu/36zrpOuk66TrpOuk66TrpOvl/Pek76TvpO+k76TvpO+k76TvpO+k76TvpO7V9t+qtVs/OaOURU6bo6PgPt6rZbwAAAAABVFDDFwAA) format('woff'),url(data:application/x-font-truetype;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:400;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\2a"}.glyphicon-plus:before{content:"\2b"}.glyphicon-eur:before,.glyphicon-euro:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}button,input,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.carousel-inner>.item>a>img,.carousel-inner>.item>img,.img-responsive,.thumbnail a>img,.thumbnail>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:6px}.img-thumbnail{display:inline-block;max-width:100%;height:auto;padding:4px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.img-circle{border-radius:50%}hr{margin-top:20px;margin-bottom:20px;border:0;border-top:1px solid #eee}.sr-only{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role=button]{cursor:pointer}.h1,.h2,.h3,.h4,.h5,.h6,h1,h2,h3,h4,h5,h6{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-weight:400;line-height:1;color:#777}.h1,.h2,.h3,h1,h2,h3{margin-top:20px;margin-bottom:10px}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small{font-size:65%}.h4,.h5,.h6,h4,h5,h6{margin-top:10px;margin-bottom:10px}.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-size:75%}.h1,h1{font-size:36px}.h2,h2{font-size:30px}.h3,h3{font-size:24px}.h4,h4{font-size:18px}.h5,h5{font-size:14px}.h6,h6{font-size:12px}p{margin:0 0 10px}.lead{margin-bottom:20px;font-size:16px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:21px}}.small,small{font-size:85%}.mark,mark{padding:.2em;background-color:#fcf8e3}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#777}.text-primary{color:#337ab7}a.text-primary:focus,a.text-primary:hover{color:#286090}.text-success{color:#3c763d}a.text-success:focus,a.text-success:hover{color:#2b542c}.text-info{color:#31708f}a.text-info:focus,a.text-info:hover{color:#245269}.text-warning{color:#8a6d3b}a.text-warning:focus,a.text-warning:hover{color:#66512c}.text-danger{color:#a94442}a.text-danger:focus,a.text-danger:hover{color:#843534}.bg-primary{color:#fff;background-color:#337ab7}a.bg-primary:focus,a.bg-primary:hover{background-color:#286090}.bg-success{background-color:#dff0d8}a.bg-success:focus,a.bg-success:hover{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:focus,a.bg-info:hover{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:focus,a.bg-warning:hover{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:focus,a.bg-danger:hover{background-color:#e4b9b9}.page-header{padding-bottom:9px;margin:40px 0 20px;border-bottom:1px solid #eee}ol,ul{margin-top:0;margin-bottom:10px}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;margin-left:-5px;list-style:none}.list-inline>li{display:inline-block;padding-right:5px;padding-left:5px}dl{margin-top:0;margin-bottom:20px}dd,dt{line-height:1.42857143}dt{font-weight:700}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;overflow:hidden;clear:left;text-align:right;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[data-original-title],abbr[title]{cursor:help;border-bottom:1px dotted #777}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10px 20px;margin:0 0 20px;font-size:17.5px;border-left:5px solid #eee}blockquote ol:last-child,blockquote p:last-child,blockquote ul:last-child{margin-bottom:0}blockquote .small,blockquote footer,blockquote small{display:block;font-size:80%;line-height:1.42857143;color:#777}blockquote .small:before,blockquote footer:before,blockquote small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;text-align:right;border-right:5px solid #eee;border-left:0}.blockquote-reverse .small:before,.blockquote-reverse footer:before,.blockquote-reverse small:before,blockquote.pull-right .small:before,blockquote.pull-right footer:before,blockquote.pull-right small:before{content:''}.blockquote-reverse .small:after,.blockquote-reverse footer:after,.blockquote-reverse small:after,blockquote.pull-right .small:after,blockquote.pull-right footer:after,blockquote.pull-right small:after{content:'\00A0 \2014'}address{margin-bottom:20px;font-style:normal;line-height:1.42857143}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:4px}kbd{padding:2px 4px;font-size:90%;color:#fff;background-color:#333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,.25)}kbd kbd{padding:0;font-size:100%;font-weight:700;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:9.5px;margin:0 0 10px;font-size:13px;line-height:1.42857143;color:#333;word-break:break-all;word-wrap:break-word;background-color:#f5f5f5;border:1px solid #ccc;border-radius:4px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0}@media (min-width:768px){.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0}}@media (min-width:992px){.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0}}@media (min-width:1200px){.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#777;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:20px}.table>tbody>tr>td,.table>tbody>tr>th,.table>tfoot>tr>td,.table>tfoot>tr>th,.table>thead>tr>td,.table>thead>tr>th{padding:8px;line-height:1.42857143;vertical-align:top;border-top:1px solid #ddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #ddd}.table>caption+thead>tr:first-child>td,.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>td,.table>thead:first-child>tr:first-child>th{border-top:0}.table>tbody+tbody{border-top:2px solid #ddd}.table .table{background-color:#fff}.table-condensed>tbody>tr>td,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>td,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>thead>tr>th{padding:5px}.table-bordered{border:1px solid #ddd}.table-bordered>tbody>tr>td,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>td,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border:1px solid #ddd}.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*=col-]{position:static;display:table-column;float:none}table td[class*=col-],table th[class*=col-]{position:static;display:table-cell;float:none}.table>tbody>tr.active>td,.table>tbody>tr.active>th,.table>tbody>tr>td.active,.table>tbody>tr>th.active,.table>tfoot>tr.active>td,.table>tfoot>tr.active>th,.table>tfoot>tr>td.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>thead>tr.active>th,.table>thead>tr>td.active,.table>thead>tr>th.active{background-color:#f5f5f5}.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr.active:hover>th,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover{background-color:#e8e8e8}.table>tbody>tr.success>td,.table>tbody>tr.success>th,.table>tbody>tr>td.success,.table>tbody>tr>th.success,.table>tfoot>tr.success>td,.table>tfoot>tr.success>th,.table>tfoot>tr>td.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>thead>tr.success>th,.table>thead>tr>td.success,.table>thead>tr>th.success{background-color:#dff0d8}.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr.success:hover>th,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover{background-color:#d0e9c6}.table>tbody>tr.info>td,.table>tbody>tr.info>th,.table>tbody>tr>td.info,.table>tbody>tr>th.info,.table>tfoot>tr.info>td,.table>tfoot>tr.info>th,.table>tfoot>tr>td.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>thead>tr.info>th,.table>thead>tr>td.info,.table>thead>tr>th.info{background-color:#d9edf7}.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr.info:hover>th,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover{background-color:#c4e3f3}.table>tbody>tr.warning>td,.table>tbody>tr.warning>th,.table>tbody>tr>td.warning,.table>tbody>tr>th.warning,.table>tfoot>tr.warning>td,.table>tfoot>tr.warning>th,.table>tfoot>tr>td.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>thead>tr.warning>th,.table>thead>tr>td.warning,.table>thead>tr>th.warning{background-color:#fcf8e3}.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr.warning:hover>th,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover{background-color:#faf2cc}.table>tbody>tr.danger>td,.table>tbody>tr.danger>th,.table>tbody>tr>td.danger,.table>tbody>tr>th.danger,.table>tfoot>tr.danger>td,.table>tfoot>tr.danger>th,.table>tfoot>tr>td.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>thead>tr.danger>th,.table>thead>tr>td.danger,.table>thead>tr>th.danger{background-color:#f2dede}.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr.danger:hover>th,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover{background-color:#ebcccc}.table-responsive{min-height:.01%;overflow-x:auto}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #ddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>td,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>thead>tr>th{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;padding:0;margin-bottom:20px;font-size:21px;line-height:inherit;color:#333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:700}input[type=search]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type=checkbox],input[type=radio]{margin:4px 0 0;margin-top:1px\9;line-height:normal}input[type=file]{display:block}input[type=range]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type=file]:focus,input[type=checkbox]:focus,input[type=radio]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:14px;line-height:1.42857143;color:#555}.form-control{display:block;width:100%;height:34px;padding:6px 12px;font-size:14px;line-height:1.42857143;color:#555;background-color:#fff;background-image:none;border:1px solid #ccc;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6);box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6)}.form-control::-moz-placeholder{color:#999;opacity:1}.form-control:-ms-input-placeholder{color:#999}.form-control::-webkit-input-placeholder{color:#999}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type=search]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type=date].form-control,input[type=time].form-control,input[type=datetime-local].form-control,input[type=month].form-control{line-height:34px}.input-group-sm input[type=date],.input-group-sm input[type=time],.input-group-sm input[type=datetime-local],.input-group-sm input[type=month],input[type=date].input-sm,input[type=time].input-sm,input[type=datetime-local].input-sm,input[type=month].input-sm{line-height:30px}.input-group-lg input[type=date],.input-group-lg input[type=time],.input-group-lg input[type=datetime-local],.input-group-lg input[type=month],input[type=date].input-lg,input[type=time].input-lg,input[type=datetime-local].input-lg,input[type=month].input-lg{line-height:46px}}.form-group{margin-bottom:15px}.checkbox,.radio{position:relative;display:block;margin-top:10px;margin-bottom:10px}.checkbox label,.radio label{min-height:20px;padding-left:20px;margin-bottom:0;font-weight:400;cursor:pointer}.checkbox input[type=checkbox],.checkbox-inline input[type=checkbox],.radio input[type=radio],.radio-inline input[type=radio]{position:absolute;margin-top:4px\9;margin-left:-20px}.checkbox+.checkbox,.radio+.radio{margin-top:-5px}.checkbox-inline,.radio-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;font-weight:400;vertical-align:middle;cursor:pointer}.checkbox-inline+.checkbox-inline,.radio-inline+.radio-inline{margin-top:0;margin-left:10px}fieldset[disabled] input[type=checkbox],fieldset[disabled] input[type=radio],input[type=checkbox].disabled,input[type=checkbox][disabled],input[type=radio].disabled,input[type=radio][disabled]{cursor:not-allowed}.checkbox-inline.disabled,.radio-inline.disabled,fieldset[disabled] .checkbox-inline,fieldset[disabled] .radio-inline{cursor:not-allowed}.checkbox.disabled label,.radio.disabled label,fieldset[disabled] .checkbox label,fieldset[disabled] .radio label{cursor:not-allowed}.form-control-static{min-height:34px;padding-top:7px;padding-bottom:7px;margin-bottom:0}.form-control-static.input-lg,.form-control-static.input-sm{padding-right:0;padding-left:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}select[multiple].input-sm,textarea.input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm select[multiple].form-control,.form-group-sm textarea.form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:32px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-lg{height:46px;line-height:46px}select[multiple].input-lg,textarea.input-lg{height:auto}.form-group-lg .form-control{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.form-group-lg select.form-control{height:46px;line-height:46px}.form-group-lg select[multiple].form-control,.form-group-lg textarea.form-control{height:auto}.form-group-lg .form-control-static{height:46px;min-height:38px;padding:11px 16px;font-size:18px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:42.5px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:34px;height:34px;line-height:34px;text-align:center;pointer-events:none}.form-group-lg .form-control+.form-control-feedback,.input-group-lg+.form-control-feedback,.input-lg+.form-control-feedback{width:46px;height:46px;line-height:46px}.form-group-sm .form-control+.form-control-feedback,.input-group-sm+.form-control-feedback,.input-sm+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .checkbox,.has-success .checkbox-inline,.has-success .control-label,.has-success .help-block,.has-success .radio,.has-success .radio-inline,.has-success.checkbox label,.has-success.checkbox-inline label,.has-success.radio label,.has-success.radio-inline label{color:#3c763d}.has-success .form-control{border-color:#3c763d;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-success .form-control:focus{border-color:#2b542c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168}.has-success .input-group-addon{color:#3c763d;background-color:#dff0d8;border-color:#3c763d}.has-success .form-control-feedback{color:#3c763d}.has-warning .checkbox,.has-warning .checkbox-inline,.has-warning .control-label,.has-warning .help-block,.has-warning .radio,.has-warning .radio-inline,.has-warning.checkbox label,.has-warning.checkbox-inline label,.has-warning.radio label,.has-warning.radio-inline label{color:#8a6d3b}.has-warning .form-control{border-color:#8a6d3b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-warning .form-control:focus{border-color:#66512c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b}.has-warning .input-group-addon{color:#8a6d3b;background-color:#fcf8e3;border-color:#8a6d3b}.has-warning .form-control-feedback{color:#8a6d3b}.has-error .checkbox,.has-error .checkbox-inline,.has-error .control-label,.has-error .help-block,.has-error .radio,.has-error .radio-inline,.has-error.checkbox label,.has-error.checkbox-inline label,.has-error.radio label,.has-error.radio-inline label{color:#a94442}.has-error .form-control{border-color:#a94442;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-error .form-control:focus{border-color:#843534;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483}.has-error .input-group-addon{color:#a94442;background-color:#f2dede;border-color:#a94442}.has-error .form-control-feedback{color:#a94442}.has-feedback label~.form-control-feedback{top:25px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#737373}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .form-control,.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .checkbox,.form-inline .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .checkbox label,.form-inline .radio label{padding-left:0}.form-inline .checkbox input[type=checkbox],.form-inline .radio input[type=radio]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .checkbox,.form-horizontal .checkbox-inline,.form-horizontal .radio,.form-horizontal .radio-inline{padding-top:7px;margin-top:0;margin-bottom:0}.form-horizontal .checkbox,.form-horizontal .radio{min-height:27px}.form-horizontal .form-group{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.form-horizontal .control-label{padding-top:7px;margin-bottom:0;text-align:right}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:14.33px;font-size:18px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;padding:6px 12px;margin-bottom:0;font-size:14px;font-weight:400;line-height:1.42857143;text-align:center;white-space:nowrap;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;background-image:none;border:1px solid transparent;border-radius:4px}.btn.active.focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn:active:focus,.btn:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn.focus,.btn:focus,.btn:hover{color:#333;text-decoration:none}.btn.active,.btn:active{background-image:none;outline:0;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none;opacity:.65}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333;background-color:#fff;border-color:#ccc}.btn-default.focus,.btn-default:focus{color:#333;background-color:#e6e6e6;border-color:#8c8c8c}.btn-default:hover{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active.focus,.btn-default.active:focus,.btn-default.active:hover,.btn-default:active.focus,.btn-default:active:focus,.btn-default:active:hover,.open>.dropdown-toggle.btn-default.focus,.open>.dropdown-toggle.btn-default:focus,.open>.dropdown-toggle.btn-default:hover{color:#333;background-color:#d4d4d4;border-color:#8c8c8c}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled,.btn-default.disabled.active,.btn-default.disabled.focus,.btn-default.disabled:active,.btn-default.disabled:focus,.btn-default.disabled:hover,.btn-default[disabled],.btn-default[disabled].active,.btn-default[disabled].focus,.btn-default[disabled]:active,.btn-default[disabled]:focus,.btn-default[disabled]:hover,fieldset[disabled] .btn-default,fieldset[disabled] .btn-default.active,fieldset[disabled] .btn-default.focus,fieldset[disabled] .btn-default:active,fieldset[disabled] .btn-default:focus,fieldset[disabled] .btn-default:hover{background-color:#fff;border-color:#ccc}.btn-default .badge{color:#fff;background-color:#333}.btn-primary{color:#fff;background-color:#337ab7;border-color:#2e6da4}.btn-primary.focus,.btn-primary:focus{color:#fff;background-color:#286090;border-color:#122b40}.btn-primary:hover{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active.focus,.btn-primary.active:focus,.btn-primary.active:hover,.btn-primary:active.focus,.btn-primary:active:focus,.btn-primary:active:hover,.open>.dropdown-toggle.btn-primary.focus,.open>.dropdown-toggle.btn-primary:focus,.open>.dropdown-toggle.btn-primary:hover{color:#fff;background-color:#204d74;border-color:#122b40}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled,.btn-primary.disabled.active,.btn-primary.disabled.focus,.btn-primary.disabled:active,.btn-primary.disabled:focus,.btn-primary.disabled:hover,.btn-primary[disabled],.btn-primary[disabled].active,.btn-primary[disabled].focus,.btn-primary[disabled]:active,.btn-primary[disabled]:focus,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary,fieldset[disabled] .btn-primary.active,fieldset[disabled] .btn-primary.focus,fieldset[disabled] .btn-primary:active,fieldset[disabled] .btn-primary:focus,fieldset[disabled] .btn-primary:hover{background-color:#337ab7;border-color:#2e6da4}.btn-primary .badge{color:#337ab7;background-color:#fff}.btn-success{color:#fff;background-color:#5cb85c;border-color:#4cae4c}.btn-success.focus,.btn-success:focus{color:#fff;background-color:#449d44;border-color:#255625}.btn-success:hover{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active.focus,.btn-success.active:focus,.btn-success.active:hover,.btn-success:active.focus,.btn-success:active:focus,.btn-success:active:hover,.open>.dropdown-toggle.btn-success.focus,.open>.dropdown-toggle.btn-success:focus,.open>.dropdown-toggle.btn-success:hover{color:#fff;background-color:#398439;border-color:#255625}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled,.btn-success.disabled.active,.btn-success.disabled.focus,.btn-success.disabled:active,.btn-success.disabled:focus,.btn-success.disabled:hover,.btn-success[disabled],.btn-success[disabled].active,.btn-success[disabled].focus,.btn-success[disabled]:active,.btn-success[disabled]:focus,.btn-success[disabled]:hover,fieldset[disabled] .btn-success,fieldset[disabled] .btn-success.active,fieldset[disabled] .btn-success.focus,fieldset[disabled] .btn-success:active,fieldset[disabled] .btn-success:focus,fieldset[disabled] .btn-success:hover{background-color:#5cb85c;border-color:#4cae4c}.btn-success .badge{color:#5cb85c;background-color:#fff}.btn-info{color:#fff;background-color:#5bc0de;border-color:#46b8da}.btn-info.focus,.btn-info:focus{color:#fff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active.focus,.btn-info.active:focus,.btn-info.active:hover,.btn-info:active.focus,.btn-info:active:focus,.btn-info:active:hover,.open>.dropdown-toggle.btn-info.focus,.open>.dropdown-toggle.btn-info:focus,.open>.dropdown-toggle.btn-info:hover{color:#fff;background-color:#269abc;border-color:#1b6d85}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled,.btn-info.disabled.active,.btn-info.disabled.focus,.btn-info.disabled:active,.btn-info.disabled:focus,.btn-info.disabled:hover,.btn-info[disabled],.btn-info[disabled].active,.btn-info[disabled].focus,.btn-info[disabled]:active,.btn-info[disabled]:focus,.btn-info[disabled]:hover,fieldset[disabled] .btn-info,fieldset[disabled] .btn-info.active,fieldset[disabled] .btn-info.focus,fieldset[disabled] .btn-info:active,fieldset[disabled] .btn-info:focus,fieldset[disabled] .btn-info:hover{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#fff}.btn-warning{color:#fff;background-color:#f0ad4e;border-color:#eea236}.btn-warning.focus,.btn-warning:focus{color:#fff;background-color:#ec971f;border-color:#985f0d}.btn-warning:hover{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active.focus,.btn-warning.active:focus,.btn-warning.active:hover,.btn-warning:active.focus,.btn-warning:active:focus,.btn-warning:active:hover,.open>.dropdown-toggle.btn-warning.focus,.open>.dropdown-toggle.btn-warning:focus,.open>.dropdown-toggle.btn-warning:hover{color:#fff;background-color:#d58512;border-color:#985f0d}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled,.btn-warning.disabled.active,.btn-warning.disabled.focus,.btn-warning.disabled:active,.btn-warning.disabled:focus,.btn-warning.disabled:hover,.btn-warning[disabled],.btn-warning[disabled].active,.btn-warning[disabled].focus,.btn-warning[disabled]:active,.btn-warning[disabled]:focus,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning,fieldset[disabled] .btn-warning.active,fieldset[disabled] .btn-warning.focus,fieldset[disabled] .btn-warning:active,fieldset[disabled] .btn-warning:focus,fieldset[disabled] .btn-warning:hover{background-color:#f0ad4e;border-color:#eea236}.btn-warning .badge{color:#f0ad4e;background-color:#fff}.btn-danger{color:#fff;background-color:#d9534f;border-color:#d43f3a}.btn-danger.focus,.btn-danger:focus{color:#fff;background-color:#c9302c;border-color:#761c19}.btn-danger:hover{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active.focus,.btn-danger.active:focus,.btn-danger.active:hover,.btn-danger:active.focus,.btn-danger:active:focus,.btn-danger:active:hover,.open>.dropdown-toggle.btn-danger.focus,.open>.dropdown-toggle.btn-danger:focus,.open>.dropdown-toggle.btn-danger:hover{color:#fff;background-color:#ac2925;border-color:#761c19}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled,.btn-danger.disabled.active,.btn-danger.disabled.focus,.btn-danger.disabled:active,.btn-danger.disabled:focus,.btn-danger.disabled:hover,.btn-danger[disabled],.btn-danger[disabled].active,.btn-danger[disabled].focus,.btn-danger[disabled]:active,.btn-danger[disabled]:focus,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger,fieldset[disabled] .btn-danger.active,fieldset[disabled] .btn-danger.focus,fieldset[disabled] .btn-danger:active,fieldset[disabled] .btn-danger:focus,fieldset[disabled] .btn-danger:hover{background-color:#d9534f;border-color:#d43f3a}.btn-danger .badge{color:#d9534f;background-color:#fff}.btn-link{font-weight:400;color:#337ab7;border-radius:0}.btn-link,.btn-link.active,.btn-link:active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:active,.btn-link:focus,.btn-link:hover{border-color:transparent}.btn-link:focus,.btn-link:hover{color:#23527c;text-decoration:underline;background-color:transparent}.btn-link[disabled]:focus,.btn-link[disabled]:hover,fieldset[disabled] .btn-link:focus,fieldset[disabled] .btn-link:hover{color:#777;text-decoration:none}.btn-group-lg>.btn,.btn-lg{padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.btn-group-sm>.btn,.btn-sm{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-group-xs>.btn,.btn-xs{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type=button].btn-block,input[type=reset].btn-block,input[type=submit].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity .15s linear;-o-transition:opacity .15s linear;transition:opacity .15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease;-webkit-transition-duration:.35s;-o-transition-duration:.35s;transition-duration:.35s;-webkit-transition-property:height,visibility;-o-transition-property:height,visibility;transition-property:height,visibility}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid\9;border-right:4px solid transparent;border-left:4px solid transparent}.dropdown,.dropup{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;font-size:14px;text-align:left;list-style:none;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.15);border-radius:4px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,.175);box-shadow:0 6px 12px rgba(0,0,0,.175)}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:400;line-height:1.42857143;color:#333;white-space:nowrap}.dropdown-menu>li>a:focus,.dropdown-menu>li>a:hover{color:#262626;text-decoration:none;background-color:#f5f5f5}.dropdown-menu>.active>a,.dropdown-menu>.active>a:focus,.dropdown-menu>.active>a:hover{color:#fff;text-decoration:none;background-color:#337ab7;outline:0}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{color:#777}.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{text-decoration:none;cursor:not-allowed;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false)}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{right:0;left:auto}.dropdown-menu-left{right:auto;left:0}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.42857143;color:#777;white-space:nowrap}.dropdown-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{content:"";border-top:0;border-bottom:4px dashed;border-bottom:4px solid\9}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{right:0;left:auto}.navbar-right .dropdown-menu-left{right:auto;left:0}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group-vertical>.btn,.btn-group>.btn{position:relative;float:left}.btn-group-vertical>.btn.active,.btn-group-vertical>.btn:active,.btn-group-vertical>.btn:focus,.btn-group-vertical>.btn:hover,.btn-group>.btn.active,.btn-group>.btn:active,.btn-group>.btn:focus,.btn-group>.btn:hover{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-top-left-radius:0;border-bottom-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-bottom-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-right:8px;padding-left:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-right:12px;padding-left:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-left-radius:0;border-top-right-radius:0;border-bottom-left-radius:4px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-top-right-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{display:table-cell;float:none;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle=buttons]>.btn input[type=checkbox],[data-toggle=buttons]>.btn input[type=radio],[data-toggle=buttons]>.btn-group>.btn input[type=checkbox],[data-toggle=buttons]>.btn-group>.btn input[type=radio]{position:absolute;clip:rect(0,0,0,0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*=col-]{float:none;padding-right:0;padding-left:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:46px;line-height:46px}select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn,textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn,textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn{height:auto}.input-group .form-control,.input-group-addon,.input-group-btn{display:table-cell}.input-group .form-control:not(:first-child):not(:last-child),.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 12px;font-size:14px;font-weight:400;line-height:1;color:#555;text-align:center;background-color:#eee;border:1px solid #ccc;border-radius:4px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:18px;border-radius:6px}.input-group-addon input[type=checkbox],.input-group-addon input[type=radio]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn-group:not(:last-child)>.btn,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:first-child>.btn-group:not(:first-child)>.btn,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle{border-top-left-radius:0;border-bottom-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:active,.input-group-btn>.btn:focus,.input-group-btn>.btn:hover{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.nav>li.disabled>a{color:#777}.nav>li.disabled>a:focus,.nav>li.disabled>a:hover{color:#777;text-decoration:none;cursor:not-allowed;background-color:transparent}.nav .open>a,.nav .open>a:focus,.nav .open>a:hover{background-color:#eee;border-color:#337ab7}.nav .nav-divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #ddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.42857143;border:1px solid transparent;border-radius:4px 4px 0 0}.nav-tabs>li>a:hover{border-color:#eee #eee #ddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus,.nav-tabs>li.active>a:hover{color:#555;cursor:default;background-color:#fff;border:1px solid #ddd;border-bottom-color:transparent}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border-bottom-color:#fff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:4px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:focus,.nav-pills>li.active>a:hover{color:#fff;background-color:#337ab7}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border-bottom-color:#fff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-left-radius:0;border-top-right-radius:0}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse{padding-right:0;padding-left:0}}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:200px}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-bottom,.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-bottom,.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;padding:9px 10px;margin-top:8px;margin-right:15px;margin-bottom:8px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:4px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu .dropdown-header,.navbar-nav .open .dropdown-menu>li>a{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:20px}.navbar-nav .open .dropdown-menu>li>a:focus,.navbar-nav .open .dropdown-menu>li>a:hover{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}.navbar-form{padding:10px 15px;margin-top:8px;margin-right:-15px;margin-bottom:8px;margin-left:-15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .form-control,.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .checkbox,.navbar-form .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .checkbox label,.navbar-form .radio label{padding-left:0}.navbar-form .checkbox input[type=checkbox],.navbar-form .radio input[type=radio]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;padding-top:0;padding-bottom:0;margin-right:0;margin-left:0;border:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-left-radius:0;border-top-right-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:8px;margin-bottom:8px}.navbar-btn.btn-sm{margin-top:10px;margin-bottom:10px}.navbar-btn.btn-xs{margin-top:14px;margin-bottom:14px}.navbar-text{margin-top:15px;margin-bottom:15px}@media (min-width:768px){.navbar-text{float:left;margin-right:15px;margin-left:15px}}@media (min-width:768px){.navbar-left{float:left!important}.navbar-right{float:right!important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-text{color:#777}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:focus,.navbar-default .navbar-nav>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:focus,.navbar-default .navbar-nav>.disabled>a:hover{color:#ccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:#ddd}.navbar-default .navbar-toggle:focus,.navbar-default .navbar-toggle:hover{background-color:#ddd}.navbar-default .navbar-toggle .icon-bar{background-color:#888}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#e7e7e7}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:focus,.navbar-default .navbar-nav>.open>a:hover{color:#555;background-color:#e7e7e7}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#777}.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#ccc;background-color:transparent}}.navbar-default .navbar-link{color:#777}.navbar-default .navbar-link:hover{color:#333}.navbar-default .btn-link{color:#777}.navbar-default .btn-link:focus,.navbar-default .btn-link:hover{color:#333}.navbar-default .btn-link[disabled]:focus,.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:focus,fieldset[disabled] .navbar-default .btn-link:hover{color:#ccc}.navbar-inverse{background-color:#222;border-color:#080808}.navbar-inverse .navbar-brand{color:#9d9d9d}.navbar-inverse .navbar-brand:focus,.navbar-inverse .navbar-brand:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-text{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a:focus,.navbar-inverse .navbar-nav>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:focus,.navbar-inverse .navbar-nav>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:focus,.navbar-inverse .navbar-nav>.disabled>a:hover{color:#444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:#333}.navbar-inverse .navbar-toggle:focus,.navbar-inverse .navbar-toggle:hover{background-color:#333}.navbar-inverse .navbar-toggle .icon-bar{background-color:#fff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#101010}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:focus,.navbar-inverse .navbar-nav>.open>a:hover{color:#fff;background-color:#080808}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#444;background-color:transparent}}.navbar-inverse .navbar-link{color:#9d9d9d}.navbar-inverse .navbar-link:hover{color:#fff}.navbar-inverse .btn-link{color:#9d9d9d}.navbar-inverse .btn-link:focus,.navbar-inverse .btn-link:hover{color:#fff}.navbar-inverse .btn-link[disabled]:focus,.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:focus,fieldset[disabled] .navbar-inverse .btn-link:hover{color:#444}.breadcrumb{padding:8px 15px;margin-bottom:20px;list-style:none;background-color:#f5f5f5;border-radius:4px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{padding:0 5px;color:#ccc;content:"/\00a0"}.breadcrumb>.active{color:#777}.pagination{display:inline-block;padding-left:0;margin:20px 0;border-radius:4px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 12px;margin-left:-1px;line-height:1.42857143;color:#337ab7;text-decoration:none;background-color:#fff;border:1px solid #ddd}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-top-left-radius:4px;border-bottom-left-radius:4px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-top-right-radius:4px;border-bottom-right-radius:4px}.pagination>li>a:focus,.pagination>li>a:hover,.pagination>li>span:focus,.pagination>li>span:hover{z-index:3;color:#23527c;background-color:#eee;border-color:#ddd}.pagination>.active>a,.pagination>.active>a:focus,.pagination>.active>a:hover,.pagination>.active>span,.pagination>.active>span:focus,.pagination>.active>span:hover{z-index:2;color:#fff;cursor:default;background-color:#337ab7;border-color:#337ab7}.pagination>.disabled>a,.pagination>.disabled>a:focus,.pagination>.disabled>a:hover,.pagination>.disabled>span,.pagination>.disabled>span:focus,.pagination>.disabled>span:hover{color:#777;cursor:not-allowed;background-color:#fff;border-color:#ddd}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:18px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-top-left-radius:6px;border-bottom-left-radius:6px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-top-right-radius:6px;border-bottom-right-radius:6px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-top-left-radius:3px;border-bottom-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-top-right-radius:3px;border-bottom-right-radius:3px}.pager{padding-left:0;margin:20px 0;text-align:center;list-style:none}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#fff;border:1px solid #ddd;border-radius:15px}.pager li>a:focus,.pager li>a:hover{text-decoration:none;background-color:#eee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:focus,.pager .disabled>a:hover,.pager .disabled>span{color:#777;cursor:not-allowed;background-color:#fff}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:focus,a.label:hover{color:#fff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#777}.label-default[href]:focus,.label-default[href]:hover{background-color:#5e5e5e}.label-primary{background-color:#337ab7}.label-primary[href]:focus,.label-primary[href]:hover{background-color:#286090}.label-success{background-color:#5cb85c}.label-success[href]:focus,.label-success[href]:hover{background-color:#449d44}.label-info{background-color:#5bc0de}.label-info[href]:focus,.label-info[href]:hover{background-color:#31b0d5}.label-warning{background-color:#f0ad4e}.label-warning[href]:focus,.label-warning[href]:hover{background-color:#ec971f}.label-danger{background-color:#d9534f}.label-danger[href]:focus,.label-danger[href]:hover{background-color:#c9302c}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:middle;background-color:#777;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-group-xs>.btn .badge,.btn-xs .badge{top:0;padding:1px 5px}a.badge:focus,a.badge:hover{color:#fff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#337ab7;background-color:#fff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#eee}.jumbotron .h1,.jumbotron h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:21px;font-weight:200}.jumbotron>hr{border-top-color:#d5d5d5}.container .jumbotron,.container-fluid .jumbotron{border-radius:6px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-right:60px;padding-left:60px}.jumbotron .h1,.jumbotron h1{font-size:63px}}.thumbnail{display:block;padding:4px;margin-bottom:20px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail a>img,.thumbnail>img{margin-right:auto;margin-left:auto}a.thumbnail.active,a.thumbnail:focus,a.thumbnail:hover{border-color:#337ab7}.thumbnail .caption{padding:9px;color:#333}.alert{padding:15px;margin-bottom:20px;border:1px solid transparent;border-radius:4px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:700}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#2b542c}.alert-info{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.alert-info hr{border-top-color:#a6e1ec}.alert-info .alert-link{color:#245269}.alert-warning{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.alert-warning hr{border-top-color:#f7e1b5}.alert-warning .alert-link{color:#66512c}.alert-danger{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.alert-danger hr{border-top-color:#e4b9c0}.alert-danger .alert-link{color:#843534}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{height:20px;margin-bottom:20px;overflow:hidden;background-color:#f5f5f5;border-radius:4px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,.1);box-shadow:inset 0 1px 2px rgba(0,0,0,.1)}.progress-bar{float:left;width:0;height:100%;font-size:12px;line-height:20px;color:#fff;text-align:center;background-color:#337ab7;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);-webkit-transition:width .6s ease;-o-transition:width .6s ease;transition:width .6s ease}.progress-bar-striped,.progress-striped .progress-bar{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress-bar.active,.progress.active .progress-bar{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#5cb85c}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-warning{background-color:#f0ad4e}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-danger{background-color:#d9534f}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{overflow:hidden;zoom:1}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-body,.media-left,.media-right{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{padding-left:0;margin-bottom:20px}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#fff;border:1px solid #ddd}.list-group-item:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:4px;border-bottom-left-radius:4px}a.list-group-item,button.list-group-item{color:#555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333}a.list-group-item:focus,a.list-group-item:hover,button.list-group-item:focus,button.list-group-item:hover{color:#555;text-decoration:none;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:focus,.list-group-item.disabled:hover{color:#777;cursor:not-allowed;background-color:#eee}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text{color:#777}.list-group-item.active,.list-group-item.active:focus,.list-group-item.active:hover{z-index:2;color:#fff;background-color:#337ab7;border-color:#337ab7}.list-group-item.active .list-group-item-heading,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:focus .list-group-item-text,.list-group-item.active:hover .list-group-item-text{color:#c7ddef}.list-group-item-success{color:#3c763d;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#3c763d}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:focus,a.list-group-item-success:hover,button.list-group-item-success:focus,button.list-group-item-success:hover{color:#3c763d;background-color:#d0e9c6}a.list-group-item-success.active,a.list-group-item-success.active:focus,a.list-group-item-success.active:hover,button.list-group-item-success.active,button.list-group-item-success.active:focus,button.list-group-item-success.active:hover{color:#fff;background-color:#3c763d;border-color:#3c763d}.list-group-item-info{color:#31708f;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#31708f}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:focus,a.list-group-item-info:hover,button.list-group-item-info:focus,button.list-group-item-info:hover{color:#31708f;background-color:#c4e3f3}a.list-group-item-info.active,a.list-group-item-info.active:focus,a.list-group-item-info.active:hover,button.list-group-item-info.active,button.list-group-item-info.active:focus,button.list-group-item-info.active:hover{color:#fff;background-color:#31708f;border-color:#31708f}.list-group-item-warning{color:#8a6d3b;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#8a6d3b}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:focus,a.list-group-item-warning:hover,button.list-group-item-warning:focus,button.list-group-item-warning:hover{color:#8a6d3b;background-color:#faf2cc}a.list-group-item-warning.active,a.list-group-item-warning.active:focus,a.list-group-item-warning.active:hover,button.list-group-item-warning.active,button.list-group-item-warning.active:focus,button.list-group-item-warning.active:hover{color:#fff;background-color:#8a6d3b;border-color:#8a6d3b}.list-group-item-danger{color:#a94442;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#a94442}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:focus,a.list-group-item-danger:hover,button.list-group-item-danger:focus,button.list-group-item-danger:hover{color:#a94442;background-color:#ebcccc}a.list-group-item-danger.active,a.list-group-item-danger.active:focus,a.list-group-item-danger.active:hover,button.list-group-item-danger.active,button.list-group-item-danger.active:focus,button.list-group-item-danger.active:hover{color:#fff;background-color:#a94442;border-color:#a94442}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:20px;background-color:#fff;border:1px solid transparent;border-radius:4px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,.05);box-shadow:0 1px 1px rgba(0,0,0,.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-left-radius:3px;border-top-right-radius:3px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:16px;color:inherit}.panel-title>.small,.panel-title>.small>a,.panel-title>a,.panel-title>small,.panel-title>small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #ddd;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-left-radius:3px;border-top-right-radius:3px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-left-radius:0;border-top-right-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.panel-collapse>.table,.panel>.table,.panel>.table-responsive>.table{margin-bottom:0}.panel>.panel-collapse>.table caption,.panel>.table caption,.panel>.table-responsive>.table caption{padding-right:15px;padding-left:15px}.panel>.table-responsive:first-child>.table:first-child,.panel>.table:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table:first-child>thead:first-child>tr:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child{border-top-left-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child{border-top-right-radius:3px}.panel>.table-responsive:last-child>.table:last-child,.panel>.table:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:3px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #ddd}.panel>.table>tbody:first-child>tr:first-child td,.panel>.table>tbody:first-child>tr:first-child th{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{margin-bottom:0;border:0}.panel-group{margin-bottom:20px}.panel-group .panel{margin-bottom:0;border-radius:4px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.list-group,.panel-group .panel-heading+.panel-collapse>.panel-body{border-top:1px solid #ddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #ddd}.panel-default{border-color:#ddd}.panel-default>.panel-heading{color:#333;background-color:#f5f5f5;border-color:#ddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ddd}.panel-primary{border-color:#337ab7}.panel-primary>.panel-heading{color:#fff;background-color:#337ab7;border-color:#337ab7}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#337ab7}.panel-primary>.panel-heading .badge{color:#337ab7;background-color:#fff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#337ab7}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#dff0d8;background-color:#3c763d}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#bce8f1}.panel-info>.panel-heading{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#bce8f1}.panel-info>.panel-heading .badge{color:#d9edf7;background-color:#31708f}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#bce8f1}.panel-warning{border-color:#faebcc}.panel-warning>.panel-heading{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#faebcc}.panel-warning>.panel-heading .badge{color:#fcf8e3;background-color:#8a6d3b}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#faebcc}.panel-danger{border-color:#ebccd1}.panel-danger>.panel-heading{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ebccd1}.panel-danger>.panel-heading .badge{color:#f2dede;background-color:#a94442}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ebccd1}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive embed,.embed-responsive iframe,.embed-responsive object,.embed-responsive video{position:absolute;top:0;bottom:0;left:0;width:100%;height:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f5f5f5;border:1px solid #e3e3e3;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.05);box-shadow:inset 0 1px 1px rgba(0,0,0,.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,.15)}.well-lg{padding:24px;border-radius:6px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:21px;font-weight:700;line-height:1;color:#000;text-shadow:0 1px 0 #fff;filter:alpha(opacity=20);opacity:.2}.close:focus,.close:hover{color:#000;text-decoration:none;cursor:pointer;filter:alpha(opacity=50);opacity:.5}button.close{-webkit-appearance:none;padding:0;cursor:pointer;background:0 0;border:0}.modal-open{overflow:hidden}.modal{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;display:none;overflow:hidden;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out;-webkit-transform:translate(0,-25%);-ms-transform:translate(0,-25%);-o-transform:translate(0,-25%);transform:translate(0,-25%)}.modal.in .modal-dialog{-webkit-transform:translate(0,0);-ms-transform:translate(0,0);-o-transform:translate(0,0);transform:translate(0,0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #999;border:1px solid rgba(0,0,0,.2);border-radius:6px;outline:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,.5);box-shadow:0 3px 9px rgba(0,0,0,.5)}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000}.modal-backdrop.fade{filter:alpha(opacity=0);opacity:0}.modal-backdrop.in{filter:alpha(opacity=50);opacity:.5}.modal-header{min-height:16.43px;padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.42857143}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-bottom:0;margin-left:5px}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,.5);box-shadow:0 5px 15px rgba(0,0,0,.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:12px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;filter:alpha(opacity=0);opacity:0;line-break:auto}.tooltip.in{filter:alpha(opacity=90);opacity:.9}.tooltip.top{padding:5px 0;margin-top:-3px}.tooltip.right{padding:0 5px;margin-left:3px}.tooltip.bottom{padding:5px 0;margin-top:3px}.tooltip.left{padding:0 5px;margin-left:-3px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#fff;text-align:center;background-color:#000;border-radius:4px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-left .tooltip-arrow{right:5px;bottom:0;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#000}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#000}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.2);border-radius:6px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,.2);box-shadow:0 5px 10px rgba(0,0,0,.2);line-break:auto}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{padding:8px 14px;margin:0;font-size:14px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:5px 5px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{content:"";border-width:10px}.popover.top>.arrow{bottom:-11px;left:50%;margin-left:-11px;border-top-color:#999;border-top-color:rgba(0,0,0,.25);border-bottom-width:0}.popover.top>.arrow:after{bottom:1px;margin-left:-10px;content:" ";border-top-color:#fff;border-bottom-width:0}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-right-color:#999;border-right-color:rgba(0,0,0,.25);border-left-width:0}.popover.right>.arrow:after{bottom:-10px;left:1px;content:" ";border-right-color:#fff;border-left-width:0}.popover.bottom>.arrow{top:-11px;left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#999;border-bottom-color:rgba(0,0,0,.25)}.popover.bottom>.arrow:after{top:1px;margin-left:-10px;content:" ";border-top-width:0;border-bottom-color:#fff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#999;border-left-color:rgba(0,0,0,.25)}.popover.left>.arrow:after{right:1px;bottom:-10px;content:" ";border-right-width:0;border-left-color:#fff}.carousel{position:relative}.carousel-inner{position:relative;width:100%;overflow:hidden}.carousel-inner>.item{position:relative;display:none;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>a>img,.carousel-inner>.item>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.active.right,.carousel-inner>.item.next{left:0;-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.carousel-inner>.item.active.left,.carousel-inner>.item.prev{left:0;-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}.carousel-inner>.item.active,.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right{left:0;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;bottom:0;left:0;width:15%;font-size:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6);filter:alpha(opacity=50);opacity:.5}.carousel-control.left{background-image:-webkit-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.5)),to(rgba(0,0,0,.0001)));background-image:linear-gradient(to right,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);background-repeat:repeat-x}.carousel-control.right{right:0;left:auto;background-image:-webkit-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.0001)),to(rgba(0,0,0,.5)));background-image:linear-gradient(to right,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);background-repeat:repeat-x}.carousel-control:focus,.carousel-control:hover{color:#fff;text-decoration:none;filter:alpha(opacity=90);outline:0;opacity:.9}.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{position:absolute;top:50%;z-index:5;display:inline-block;margin-top:-10px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{left:50%;margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{right:50%;margin-right:-10px}.carousel-control .icon-next,.carousel-control .icon-prev{width:20px;height:20px;font-family:serif;line-height:1}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;padding-left:0;margin-left:-30%;text-align:center;list-style:none}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;cursor:pointer;background-color:#000\9;background-color:rgba(0,0,0,0);border:1px solid #fff;border-radius:10px}.carousel-indicators .active{width:12px;height:12px;margin:0;background-color:#fff}.carousel-caption{position:absolute;right:15%;bottom:20px;left:15%;z-index:10;padding-top:20px;padding-bottom:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{width:30px;height:30px;margin-top:-15px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-15px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-15px}.carousel-caption{right:20%;left:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.btn-group-vertical>.btn-group:after,.btn-group-vertical>.btn-group:before,.btn-toolbar:after,.btn-toolbar:before,.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.dl-horizontal dd:after,.dl-horizontal dd:before,.form-horizontal .form-group:after,.form-horizontal .form-group:before,.modal-footer:after,.modal-footer:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.pager:after,.pager:before,.panel-body:after,.panel-body:before,.row:after,.row:before{display:table;content:" "}.btn-group-vertical>.btn-group:after,.btn-toolbar:after,.clearfix:after,.container-fluid:after,.container:after,.dl-horizontal dd:after,.form-horizontal .form-group:after,.modal-footer:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.pager:after,.panel-body:after,.row:after{clear:both}.center-block{display:block;margin-right:auto;margin-left:auto}.pull-right{float:right!important}.pull-left{float:left!important}.hide{display:none!important}.show{display:block!important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none!important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-lg,.visible-md,.visible-sm,.visible-xs{display:none!important}.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block{display:none!important}@media (max-width:767px){.visible-xs{display:block!important}table.visible-xs{display:table!important}tr.visible-xs{display:table-row!important}td.visible-xs,th.visible-xs{display:table-cell!important}}@media (max-width:767px){.visible-xs-block{display:block!important}}@media (max-width:767px){.visible-xs-inline{display:inline!important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block!important}table.visible-sm{display:table!important}tr.visible-sm{display:table-row!important}td.visible-sm,th.visible-sm{display:table-cell!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block!important}table.visible-md{display:table!important}tr.visible-md{display:table-row!important}td.visible-md,th.visible-md{display:table-cell!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block!important}}@media (min-width:1200px){.visible-lg{display:block!important}table.visible-lg{display:table!important}tr.visible-lg{display:table-row!important}td.visible-lg,th.visible-lg{display:table-cell!important}}@media (min-width:1200px){.visible-lg-block{display:block!important}}@media (min-width:1200px){.visible-lg-inline{display:inline!important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block!important}}@media (max-width:767px){.hidden-xs{display:none!important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none!important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none!important}}@media (min-width:1200px){.hidden-lg{display:none!important}}.visible-print{display:none!important}@media print{.visible-print{display:block!important}table.visible-print{display:table!important}tr.visible-print{display:table-row!important}td.visible-print,th.visible-print{display:table-cell!important}}.visible-print-block{display:none!important}@media print{.visible-print-block{display:block!important}}.visible-print-inline{display:none!important}@media print{.visible-print-inline{display:inline!important}}.visible-print-inline-block{display:none!important}@media print{.visible-print-inline-block{display:inline-block!important}}@media print{.hidden-print{display:none!important}}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<style type="text/css">.pagedtable {
overflow: auto;
padding-left: 8px;
padding-right: 8px;
}
.pagedtable-wrapper {
border: 1px solid #ccc;
border-radius: 4px;
margin-bottom: 10px;
}
.pagedtable table {
width: 100%;
max-width: 100%;
margin: 0;
}
.pagedtable th {
padding: 0 5px 0 5px;
border: none;
border-bottom: 2px solid #dddddd;
min-width: 45px;
}
.pagedtable-empty th {
display: none;
}
.pagedtable td {
padding: 0 4px 0 4px;
}
.pagedtable .even {
background-color: rgba(140, 140, 140, 0.1);
}
.pagedtable-padding-col {
display: none;
}
.pagedtable a {
-webkit-touch-callout: none;
-webkit-user-select: none;
-khtml-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.pagedtable-index-nav {
cursor: pointer;
padding: 0 5px 0 5px;
float: right;
border: 0;
}
.pagedtable-index-nav-disabled {
cursor: default;
text-decoration: none;
color: #999;
}
a.pagedtable-index-nav-disabled:hover {
text-decoration: none;
color: #999;
}
.pagedtable-indexes {
cursor: pointer;
float: right;
border: 0;
}
.pagedtable-index-current {
cursor: default;
text-decoration: none;
font-weight: bold;
color: #333;
border: 0;
}
a.pagedtable-index-current:hover {
text-decoration: none;
font-weight: bold;
color: #333;
}
.pagedtable-index {
width: 30px;
display: inline-block;
text-align: center;
border: 0;
}
.pagedtable-index-separator-left {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 0 0 0;
cursor: default;
}
.pagedtable-index-separator-right {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 4px 0 0;
cursor: default;
}
.pagedtable-footer {
padding-top: 4px;
padding-bottom: 5px;
}
.pagedtable-not-empty .pagedtable-footer {
border-top: 2px solid #dddddd;
}
.pagedtable-info {
overflow: hidden;
color: #999;
white-space: nowrap;
text-overflow: ellipsis;
}
.pagedtable-header-name {
overflow: hidden;
text-overflow: ellipsis;
}
.pagedtable-header-type {
color: #999;
font-weight: 400;
}
.pagedtable-na-cell {
font-style: italic;
opacity: 0.3;
}
</style>
<script>// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = Math.max(
          column.label.toString().length,
          column.type.toString().length
        );

        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    function retryFit() {
      if (tableDiv.clientWidth <= 0) {
        setTimeout(retryFit, 100);
      } else {
        me.render();
        triggerOnChange();
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<script>
window.initializeCodeFolding = function(show) {

  // handlers for show-all and hide all
  $("#rmd-show-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('show');
    });
  });
  $("#rmd-hide-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('hide');
    });
  });

  // index for unique code element ids
  var currentIndex = 1;

  // select all R code blocks
  var rCodeBlocks = $('pre.r, pre.python, pre.bash, pre.sql, pre.cpp, pre.stan, pre.julia, pre.foldable');
  rCodeBlocks.each(function() {

    // create a collapsable div to wrap the code in
    var div = $('<div class="collapse r-code-collapse"></div>');
    var showThis = (show || $(this).hasClass('fold-show')) && !$(this).hasClass('fold-hide');
    var id = 'rcode-643E0F36' + currentIndex++;
    div.attr('id', id);
    $(this).before(div);
    $(this).detach().appendTo(div);

    // add a show code button right above
    var showCodeText = $('<span>' + (showThis ? 'Hide' : 'Code') + '</span>');
    var showCodeButton = $('<button type="button" class="btn btn-default btn-xs btn-secondary btn-sm code-folding-btn pull-right float-right"></button>');
    showCodeButton.append(showCodeText);
    showCodeButton
        .attr('data-toggle', 'collapse')
        .attr('data-target', '#' + id)
        .attr('aria-expanded', showThis)
        .attr('aria-controls', id);

    var buttonRow = $('<div class="row"></div>');
    var buttonCol = $('<div class="col-md-12"></div>');

    buttonCol.append(showCodeButton);
    buttonRow.append(buttonCol);

    div.before(buttonRow);

    // show the div if necessary
    if (showThis) div.collapse('show');

    // update state of button on show/hide
    //   * Change text
    //   * add a class for intermediate states styling
    div.on('hide.bs.collapse', function () {
      showCodeText.text('Code');
      showCodeButton.addClass('btn-collapsing');
    });
    div.on('hidden.bs.collapse', function () {
      showCodeButton.removeClass('btn-collapsing');
    });
    div.on('show.bs.collapse', function () {
      showCodeText.text('Hide');
      showCodeButton.addClass('btn-expanding');
    });
    div.on('shown.bs.collapse', function () {
      showCodeButton.removeClass('btn-expanding');
    });

  });

}
</script>
<script>
window.initializeSourceEmbed = function(filename) {
  $("#rmd-download-source").click(function() {
    var src = $("#rmd-source-code").html();
    var a = document.createElement('a');
    a.href = "data:text/x-r-markdown;base64," + src;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    document.body.removeChild(a);
  });
};
</script>
<style type="text/css">.hljs-literal {
color: rgb(88, 72, 246);
}
.hljs-number {
color: rgb(0, 0, 205);
}
.hljs-comment {
color: rgb(76, 136, 107);
}
.hljs-keyword {
color: rgb(0, 0, 255);
}
.hljs-string {
color: rgb(3, 106, 7);
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>



<style type="text/css">
#rmd-source-code {
  display: none;
}
</style>





<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
pre code {
  padding: 0;
}
</style>

<style type="text/css">
.kable-table {
  border: 1px solid #ccc;
  border-radius: 4px;
  overflow: auto;
  padding-left: 8px;
  padding-right: 8px;
  margin-bottom: 20px;
  max-height: 350px;
}

.kable-table table {
  margin-bottom: 0px;
}

.kable-table table>thead>tr>th {
  border: none;
  border-bottom: 2px solid #dddddd;
}

.kable-table table>thead {
  background-color: #fff;
}
</style>


<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>




</head>

<body>


<div class="container-fluid main-container">




<div id="header">

<div class="btn-group pull-right float-right">
<button type="button" class="btn btn-default btn-xs btn-secondary btn-sm dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu dropdown-menu-right" style="min-width: 50px;">
<li><a id="rmd-show-all-code" href="#">Show All Code</a></li>
<li><a id="rmd-hide-all-code" href="#">Hide All Code</a></li>
<li role="separator" class="divider"></li>
<li><a id="rmd-download-source" href="#">Download Rmd</a></li>
</ul>
</div>



<h1 class="title toc-ignore">Make supplementary tables for protein results</h1>

</div>


<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuc3VwcHJlc3NNZXNzYWdlcyhsaWJyYXJ5KE1TbmJhc2UpKVxuc3VwcHJlc3NNZXNzYWdlcyhsaWJyYXJ5KHRpZHl2ZXJzZSkpXG5zdXBwcmVzc01lc3NhZ2VzKGxpYnJhcnkod3JpdGV4bCkpXG5gYGAifQ== -->
<pre class="r"><code>suppressMessages(library(MSnbase))
suppressMessages(library(tidyverse))
suppressMessages(library(writexl))</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuZGxvcGl0IDwtIHJlYWRSRFMoJy4uLzZfc2hpbnlfYXBwL291dC9kbG9waXQucmRzJylcbmBgYCJ9 -->
<pre class="r"><code>dlopit &lt;- readRDS(&#39;../6_shiny_app/out/dlopit.rds&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuZkRhdGEoZGxvcGl0JERNU08pXG5gYGAifQ== -->
<pre class="r"><code>fData(dlopit$DMSO)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["data.frame"],"nrow":5314,"ncol":12},"rdf":"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"} -->
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":[""],"name":["_rn_"],"type":[""],"align":["left"]},{"label":["gene_names"],"name":[1],"type":["chr"],"align":["left"]},{"label":["UniProtKB_name"],"name":[2],"type":["chr"],"align":["left"]},{"label":["markers"],"name":[3],"type":["chr"],"align":["left"]},{"label":["protein_name"],"name":[4],"type":["chr"],"align":["left"]},{"label":["function"],"name":[5],"type":["chr"],"align":["left"]},{"label":["tsne_dim1"],"name":[6],"type":["dbl"],"align":["right"]},{"label":["tsne_dim2"],"name":[7],"type":["dbl"],"align":["right"]},{"label":["primary_localisation"],"name":[8],"type":["chr"],"align":["left"]},{"label":["primary_localisation_per_rep"],"name":[9],"type":["chr"],"align":["left"]},{"label":["diff_loc_level"],"name":[10],"type":["fctr"],"align":["left"]},{"label":["n_diff_loc_reps"],"name":[11],"type":["int"],"align":["right"]},{"label":["diff_loc_reps"],"name":[12],"type":["chr"],"align":["left"]}],"data":[{"1":"TTC26 IFT56","2":"IFT56_HUMAN","3":"unknown","4":"Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)","5":"Component of the intraflagellar transport (IFT) complex B required for transport of proteins in the motile cilium. Required for transport of specific ciliary cargo proteins related to motility, while it is neither required for IFT complex B assembly or motion nor for cilium assembly. Required for efficient coupling between the accumulation of GLI2 and GLI3 at the ciliary tips and their dissociation from the negative regulator SUFU. Plays a key role in maintaining the integrity of the IFT complex B and the proper ciliary localization of the IFT complex B components. Not required for IFT complex A ciliary localization or function. Essential for maintaining proper microtubule organization within the ciliary axoneme. {ECO:0000250|UniProtKB:Q8BS45}.","6":"14.61796359","7":"24.387075282","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A0AVF1"},{"1":"UBA6 MOP4 UBE1L2","2":"UBA6_HUMAN","3":"CYTOSOL","4":"Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2)","5":"Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP. Specific for ubiquitin, does not activate ubiquitin-like peptides. Differs from UBE1 in its specificity for substrate E2 charging. Does not charge cell cycle E2s, such as CDC34. Essential for embryonic development. Required for UBD/FAT10 conjugation. Isoform 2 may play a key role in ubiquitin system and may influence spermatogenesis and male fertility. {ECO:0000269|PubMed:15202508, ECO:0000269|PubMed:17597759, ECO:0000269|PubMed:17889673}.","6":"10.75120214","7":"24.961985056","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"A0AVT1"},{"1":"ESYT2 FAM62B KIAA1228","2":"ESYT2_HUMAN","3":"unknown","4":"Extended synaptotagmin-2 (E-Syt2) (Chr2Syt)","5":"Tethers the endoplasmic reticulum to the cell membrane and promotes the formation of appositions between the endoplasmic reticulum and the cell membrane. Binds glycerophospholipids in a barrel-like domain and may play a role in cellular lipid transport. Plays a role in FGF signaling via its role in the rapid internalization of FGFR1 that has been activated by FGF1 binding; this occurs most likely via the AP-2 complex. Promotes the localization of SACM1L at endoplasmic reticulum-plasma membrane contact sites (EPCS) (PubMed:27044890). {ECO:0000269|PubMed:17360437, ECO:0000269|PubMed:20833364, ECO:0000269|PubMed:23791178, ECO:0000269|PubMed:24847877, ECO:0000269|PubMed:27044890}.","6":"0.75142213","7":"-41.819178403","8":"Undefined","9":"PM,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A0FGR8"},{"1":"SHTN1 KIAA1598","2":"SHOT1_HUMAN","3":"unknown","4":"Shootin-1 (Shootin1)","5":"Involved in the generation of internal asymmetric signals required for neuronal polarization and neurite outgrowth. Mediates netrin-1-induced F-actin-substrate coupling or 'clutch engagement' within the axon growth cone through activation of CDC42, RAC1 and PAK1-dependent signaling pathway, thereby converting the F-actin retrograde flow into traction forces, concomitantly with filopodium extension and axon outgrowth. Plays a role in cytoskeletal organization by regulating the subcellular localization of phosphoinositide 3-kinase (PI3K) activity at the axonal growth cone. Plays also a role in regenerative neurite outgrowth. In the developing cortex, cooperates with KIF20B to promote both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex. Involved in the accumulation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the growth cone of primary hippocampal neurons. {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.","6":"-13.65700103","7":"5.759477041","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"A0MZ66"},{"1":"ILVBL AHAS HACL2","2":"HACL2_HUMAN","3":"unknown","4":"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","5":"Endoplasmic reticulum 2-OH acyl-CoA lyase involved in the cleavage (C1 removal) reaction in the fatty acid alpha-oxydation in a thiamine pyrophosphate (TPP)-dependent manner. Involved in the phytosphingosine degradation pathway. {ECO:0000269|PubMed:28289220}.","6":"-10.43489150","7":"-32.241830632","8":"Undefined","9":"PM,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"A1L0T0"},{"1":"PLEKHG3 KIAA0599","2":"PKHG3_HUMAN","3":"unknown","4":"Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3)","5":"NA","6":"-20.72732272","7":"-11.992319302","8":"Undefined","9":"PEROXISOME,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A1L390"},{"1":"SH3PXD2B FAD49 KIAA1295 TKS4","2":"SPD2B_HUMAN","3":"unknown","4":"SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)","5":"Adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. Plays a role in mitotic clonal expansion during the immediate early stage of adipocyte differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497}.","6":"16.41653586","7":"5.227322296","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A1X283"},{"1":"NBAS NAG","2":"NBAS_HUMAN","3":"unknown","4":"Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein)","5":"Involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport; the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER (PubMed:19369418). {ECO:0000269|PubMed:19369418, ECO:0000305}.","6":"-0.24704614","7":"-34.258147797","8":"PM","9":"Undefined,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"A2RRP1"},{"1":"TARS3 TARSL2","2":"SYTC2_HUMAN","3":"unknown","4":"Threonine--tRNA ligase 2, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase protein 3)","5":"Catalyzes the attachment of threonine to tRNA(Thr) in a two-step reaction: threonine is first activated by ATP to form Thr-AMP and then transferred to the acceptor end of tRNA(Thr). Also edits incorrectly charged tRNA(Thr) via its editing domain, at the post-transfer stage. {ECO:0000250|UniProtKB:Q8BLY2}.","6":"14.38431034","7":"38.897257795","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A2RTX5"},{"1":"VWA8 KIAA0564","2":"VWA8_HUMAN","3":"unknown","4":"von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2) (P7BP2)","5":"Exhibits ATPase activity in vitro. {ECO:0000250|UniProtKB:Q8CC88}.","6":"-31.99510270","7":"-5.797509145","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"A3KMH1"},{"1":"SBNO1 MOP3","2":"SBNO1_HUMAN","3":"unknown","4":"Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3)","5":"NA","6":"10.84842281","7":"25.216241994","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A3KN83"},{"1":"GTPBP10 OBGH2 UG0751c10","2":"GTPBA_HUMAN","3":"unknown","4":"GTP-binding protein 10 (Protein obg homolog 2) (ObgH2)","5":"May be involved in the ribosome maturation process. Complements an ObgE(CgtA) function in E.coli ribosome maturation. Plays a role of GTPase in vitro. When missing, disorganization of the nucleolar architecture is observed. {ECO:0000269|PubMed:17054726}.","6":"-37.63278494","7":"-6.973904753","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"A4D1E9"},{"1":"WDR91 HSPC049","2":"WDR91_HUMAN","3":"unknown","4":"WD repeat-containing protein 91","5":"Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May play a role in meiosis (By similarity). {ECO:0000250|UniProtKB:Q7TMQ7, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989}.","6":"2.44516159","7":"-14.601288929","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A4D1P6"},{"1":"PEDS1 KUA PDES TMEM189","2":"PDES1_HUMAN","3":"unknown","4":"Plasmanylethanolamine desaturase (EC 1.14.19.77) (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)","5":"Plasmanylethanolamine desaturase involved in plasmalogen biogenesis in the endoplasmic reticulum membrane (PubMed:31604315, PubMed:32209662). Plasmalogens are glycerophospholipids with a hydrocarbon chain linked by a vinyl ether bond at the glycerol sn-1 position, and are involved in antioxidative and signaling mechanisms (PubMed:31604315). {ECO:0000269|PubMed:31604315, ECO:0000269|PubMed:32209662, ECO:0000303|PubMed:31604315}.","6":"-6.58218950","7":"-42.473199241","8":"Undefined","9":"PM,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A5PLL7"},{"1":"TRAPPC13 C5orf44","2":"TPC13_HUMAN","3":"unknown","4":"Trafficking protein particle complex subunit 13","5":"NA","6":"22.76929786","7":"9.293842917","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"A5PLN9"},{"1":"CNOT1 CDC39 KIAA1007 NOT1 AD-005","2":"CNOT1_HUMAN","3":"unknown","4":"CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)","5":"Scaffolding component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Its scaffolding function implies its interaction with the catalytic complex module and diverse RNA-binding proteins mediating the complex recruitment to selected mRNA 3'UTRs. Involved in degradation of AU-rich element (ARE)-containing mRNAs probably via association with ZFP36. Mediates the recruitment of the CCR4-NOT complex to miRNA targets and to the RISC complex via association with TNRC6A, TNRC6B or TNRC6C. Acts as a transcriptional repressor. Represses the ligand-dependent transcriptional activation by nuclear receptors. Involved in the maintenance of embryonic stem (ES) cell identity. {ECO:0000269|PubMed:10637334, ECO:0000269|PubMed:16778766, ECO:0000269|PubMed:21278420, ECO:0000269|PubMed:21976065, ECO:0000269|PubMed:21984185, ECO:0000269|PubMed:22367759, ECO:0000269|PubMed:23644599, ECO:0000269|PubMed:27558897, ECO:0000269|PubMed:32354837}.","6":"13.80531063","7":"18.440200486","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A5YKK6"},{"1":"FAM83G PAWS1","2":"FA83G_HUMAN","3":"unknown","4":"Protein FAM83G (Protein associated with SMAD1)","5":"May regulate the bone morphogenetic proteins (BMP) pathway. {ECO:0000269|PubMed:24554596}.","6":"-7.11736156","7":"7.618781771","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A6ND36"},{"1":"PALM3","2":"PALM3_HUMAN","3":"unknown","4":"Paralemmin-3","5":"ATP-binding protein, which may act as a adapter in the Toll-like receptor (TLR) signaling. {ECO:0000269|PubMed:21187075}.","6":"-1.61995095","7":"-41.640306523","8":"Undefined","9":"PM,LYSOSOME,PM","10":"NA","11":"NA","12":"NA","_rn_":"A6NDB9"},{"1":"PGP","2":"PGP_HUMAN","3":"CYTOSOL","4":"Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP)","5":"Glycerol-3-phosphate phosphatase hydrolyzing glycerol-3-phosphate into glycerol. Thereby, regulates the cellular levels of glycerol-3-phosphate a metabolic intermediate of glucose, lipid and energy metabolism. Was also shown to have a 2-phosphoglycolate phosphatase activity and a tyrosine-protein phosphatase activity. However, their physiological relevance is unclear (PubMed:26755581). In vitro, has also a phosphatase activity toward ADP, ATP, GDP and GTP (By similarity). {ECO:0000250|UniProtKB:Q8CHP8, ECO:0000269|PubMed:26755581}.","6":"41.68998725","7":"2.214767364","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"A6NDG6"},{"1":"C5orf51","2":"CE051_HUMAN","3":"unknown","4":"UPF0600 protein C5orf51","5":"NA","6":"3.51346251","7":"11.700120220","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A6NDU8"},{"1":"ZNF316","2":"ZN316_HUMAN","3":"unknown","4":"Zinc finger protein 316","5":"May be involved in transcriptional regulation. {ECO:0000250}.","6":"-6.00757254","7":"31.209606197","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"A6NFI3"},{"1":"SMCHD1 KIAA0650","2":"SMHD1_HUMAN","3":"unknown","4":"Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)","5":"Non-canonical member of the structural maintenance of chromosomes (SMC) protein family that plays a key role in epigenetic silencing by regulating chromatin architecture (By similarity). Promotes heterochromatin formation in both autosomes and chromosome X, probably by mediating the merge of chromatin compartments (By similarity). Plays a key role in chromosome X inactivation in females by promoting the spreading of heterochromatin (PubMed:23542155). Recruited to inactivated chromosome X by Xist RNA and acts by mediating the merge of chromatin compartments: promotes random chromatin interactions that span the boundaries of existing structures, leading to create a compartment-less architecture typical of inactivated chromosome X (By similarity). Required to facilitate Xist RNA spreading (By similarity). Also required for silencing of a subset of clustered autosomal loci in somatic cells, such as the DUX4 locus (PubMed:23143600). Has ATPase activity; may participate in structural manipulation of chromatin in an ATP-dependent manner as part of its role in gene expression regulation (PubMed:29748383). Also plays a role in DNA repair: localizes to sites of DNA double-strand breaks in response to DNA damage to promote the repair of DNA double-strand breaks (PubMed:25294876, PubMed:24790221). Acts by promoting non-homologous end joining (NHEJ) and inhibiting homologous recombination (HR) repair (PubMed:25294876). {ECO:0000250|UniProtKB:Q6P5D8, ECO:0000269|PubMed:23143600, ECO:0000269|PubMed:23542155, ECO:0000269|PubMed:24790221, ECO:0000269|PubMed:25294876, ECO:0000269|PubMed:29748383}.","6":"18.80599102","7":"29.924879075","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A6NHR9"},{"1":"CASTOR2 GATSL1 GATSL2","2":"CAST2_HUMAN","3":"unknown","4":"Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2)","5":"Functions as a negative regulator of the TORC1 signaling pathway through the GATOR complex. As part of homodimers or heterodimers with CASTOR1, directly binds and inhibits the GATOR subcomplex GATOR2 and thereby mTORC1. Does not directly bind arginine, but binding of arginine to CASTOR1 disrupts the interaction of CASTOR2-containing heterodimers with GATOR2 which can in turn activate mTORC1 and the TORC1 signaling pathway. {ECO:0000269|PubMed:26972053}.","6":"2.25123214","7":"6.887172304","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A6NHX0"},{"1":"UNC119B","2":"U119B_HUMAN","3":"unknown","4":"Protein unc-119 homolog B","5":"Myristoyl-binding protein that acts as a cargo adapter: specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization. Binds myristoylated NPHP3 and plays a key role in localization of NPHP3 to the primary cilium membrane. Does not bind all myristoylated proteins. Probably plays a role in trafficking proteins in photoreceptor cells. {ECO:0000269|PubMed:22085962}.","6":"2.83330798","7":"9.746425984","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A6NIH7"},{"1":"METTL15 METT5D1","2":"MET15_HUMAN","3":"unknown","4":"12S rRNA N4-methylcytidine (m4C) methyltransferase (12S rRNA m4C methyltransferase) (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1) (Methyltransferase-like protein 15)","5":"N4-methylcytidine (m4C) methyltransferase responsible for the methylation of position C839 in mitochondrial 12S rRNA (PubMed:31665743). Involved in the stabilization of 12S rRNA folding, therefore facilitating the assembly of the mitochondrial small ribosomal subunits (PubMed:31665743). {ECO:0000269|PubMed:31665743}.","6":"-37.42321655","7":"-1.335596875","8":"MITOCHONDRIA","9":"MITOCHONDRIA,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"A6NJ78"},{"1":"CCDC85C","2":"CC85C_HUMAN","3":"unknown","4":"Coiled-coil domain-containing protein 85C","5":"May play a role in cell-cell adhesion and epithelium development through its interaction with proteins of the beta-catenin family (Probable). May play an important role in cortical development, especially in the maintenance of radial glia (By similarity). {ECO:0000250|UniProtKB:E9Q6B2, ECO:0000305|PubMed:25009281}.","6":"0.16348105","7":"-8.552535607","8":"Undefined","9":"Undefined,CYTOSOL,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"A6NKD9"},{"1":"SAC3D1 SHD1","2":"SAC31_HUMAN","3":"unknown","4":"SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1)","5":"Involved in centrosome duplication and mitotic progression. {ECO:0000250}.","6":"21.04225927","7":"17.185508016","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"A6NKF1"},{"1":"NUDT19","2":"NUD19_HUMAN","3":"unknown","4":"Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)","5":"Coenzyme A diphosphatase that mediates the hydrolysis of a wide range of CoA esters, including choloyl-CoA and branched-chain fatty-acyl-CoA esters. At low substrate concentrations medium and long-chain fatty-acyl-CoA esters are the primary substrates (By similarity). {ECO:0000250}.","6":"-26.69314970","7":"-9.556129357","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A8MXV4"},{"1":"CXorf49; CXorf49B","2":"CX049_HUMAN","3":"unknown","4":"Uncharacterized protein CXorf49","5":"NA","6":"11.76013755","7":"2.910375055","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A8MYA2"},{"1":"MIF4GD SLIP1","2":"MI4GD_HUMAN","3":"unknown","4":"MIF4G domain-containing protein (SLBP-interacting protein 1) (hSLIP1)","5":"Functions in replication-dependent translation of histone mRNAs which differ from other eukaryotic mRNAs in that they do not end with a poly-A tail but a stem-loop. May participate in circularizing those mRNAs specifically enhancing their translation. {ECO:0000269|PubMed:18025107}.","6":"18.48519209","7":"15.719588171","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"A9UHW6"},{"1":"IQCJ-SCHIP1","2":"IQIP1_HUMAN","3":"unknown","4":"IQCJ-SCHIP1 readthrough transcript protein","5":"May play a role in action potential conduction in myelinated cells through the organization of molecular complexes at nodes of Ranvier and axon initial segments (PubMed:25950943). May also play a role in axon outgrowth and guidance (By similarity). {ECO:0000250|UniProtKB:A0A088MLT8, ECO:0000269|PubMed:25950943}.","6":"-2.41634388","7":"-2.029479647","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"B3KU38"},{"1":"NACA","2":"NACAM_HUMAN","3":"unknown","4":"Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC)","5":"Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}.","6":"-13.02810518","7":"-2.344764295","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Candidate","11":"2","12":"1,3","_rn_":"E9PAV3"},{"1":"C11orf98","2":"CK098_HUMAN","3":"unknown","4":"Uncharacterized protein C11orf98","5":"NA","6":"-9.30646750","7":"14.947879102","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"E9PRG8"},{"1":"DNASE2 DNASE2A DNL2","2":"DNS2A_HUMAN","3":"LYSOSOME","4":"Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (DNase II alpha) (Lysosomal DNase II) (R31240_2)","5":"Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the degradation of nuclear DNA in cellular apoptosis during development. Necessary for proper fetal development and for definitive erythropoiesis in fetal liver, where it degrades nuclear DNA expelled from erythroid precursor cells.","6":"9.53568599","7":"-42.859721794","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00115"},{"1":"AGPS AAG5","2":"ADAS_HUMAN","3":"PEROXISOME","4":"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)","5":"Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis. {ECO:0000269|PubMed:8399344, ECO:0000269|PubMed:9553082}.","6":"-22.64726776","7":"-16.960319632","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00116"},{"1":"KIF2A KIF2 KNS2","2":"KIF2A_HUMAN","3":"unknown","4":"Kinesin-like protein KIF2A (Kinesin-2) (hK2)","5":"Plus end-directed microtubule-dependent motor required for normal brain development. May regulate microtubule dynamics during axonal growth. Required for normal progression through mitosis. Required for normal congress of chromosomes at the metaphase plate. Required for normal spindle dynamics during mitosis. Promotes spindle turnover. Implicated in formation of bipolar mitotic spindles. Has microtubule depolymerization activity. {ECO:0000269|PubMed:15843429, ECO:0000269|PubMed:17538014, ECO:0000269|PubMed:18411309}.","6":"-9.26588849","7":"18.464119036","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00139"},{"1":"DDX39A DDX39","2":"DX39A_HUMAN","3":"unknown","4":"ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)","5":"[Isoform 1]: Involved in pre-mRNA splicing. Required for the export of mRNA out of the nucleus. {ECO:0000269|PubMed:15047853, ECO:0000269|PubMed:17548965}.","6":"-3.34082934","7":"3.906915110","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00148"},{"1":"PDLIM1 CLIM1 CLP36","2":"PDLI1_HUMAN","3":"unknown","4":"PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36)","5":"Cytoskeletal protein that may act as an adapter that brings other proteins (like kinases) to the cytoskeleton (PubMed:10861853). Involved in assembly, disassembly and directioning of stress fibers in fibroblasts. Required for the localization of ACTN1 and PALLD to stress fibers. Required for cell migration and in maintaining cell polarity of fibroblasts (By similarity). {ECO:0000250|UniProtKB:P52944, ECO:0000269|PubMed:10861853}.","6":"11.19190189","7":"-4.249354605","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00151"},{"1":"ACOT7 BACH","2":"BACH_HUMAN","3":"unknown","4":"Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (hBACH) (CTE-IIa) (CTE-II) (Long chain acyl-CoA thioester hydrolase)","5":"Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH (PubMed:10578051). Acyl-coenzyme A thioesterase 7/ACOT7 preferentially hydrolyzes palmitoyl-CoA, but has a broad specificity acting on other fatty acyl-CoAs with chain-lengths of C8-C18 (PubMed:10578051). May play an important physiological function in brain (PubMed:10578051). {ECO:0000269|PubMed:10578051, ECO:0000303|PubMed:10578051}.","6":"31.22295169","7":"8.670323709","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00154"},{"1":"MYO1C","2":"MYO1C_HUMAN","3":"unknown","4":"Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)","5":"Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Involved in glucose transporter recycling in response to insulin by regulating movement of intracellular GLUT4-containing vesicles to the plasma membrane. Component of the hair cell's (the sensory cells of the inner ear) adaptation-motor complex. Acts as a mediator of adaptation of mechanoelectrical transduction in stereocilia of vestibular hair cells. Binds phosphoinositides and links the actin cytoskeleton to cellular membranes. {ECO:0000269|PubMed:24636949}.; Isoform 3 is involved in regulation of transcription. Associated with transcriptional active ribosomal genes. Appears to cooperate with the WICH chromatin-remodeling complex to facilitate transcription. Necessary for the formation of the first phosphodiester bond during transcription initiation (By similarity). {ECO:0000250}.","6":"-5.68458341","7":"-31.042649546","8":"Undefined","9":"PM,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O00159"},{"1":"SNAP23","2":"SNP23_HUMAN","3":"PM","4":"Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23)","5":"Essential component of the high affinity receptor for the general membrane fusion machinery and an important regulator of transport vesicle docking and fusion.","6":"-8.62225040","7":"-40.100700493","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00161"},{"1":"HAX1 HS1BP1","2":"HAX1_HUMAN","3":"unknown","4":"HCLS1-associated protein X-1 (HS1-associating protein X-1) (HAX-1) (HS1-binding protein 1) (HSP1BP-1)","5":"Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex (PubMed:26997484). Slows down the rate of inactivation of KCNC3 channels (PubMed:26997484). Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools. {ECO:0000269|PubMed:15339924, ECO:0000269|PubMed:16857965, ECO:0000269|PubMed:17545607, ECO:0000269|PubMed:18319618, ECO:0000269|PubMed:18971376, ECO:0000269|PubMed:26997484, ECO:0000269|PubMed:9058808}.","6":"-34.22780221","7":"-6.288436356","8":"Undefined","9":"MITOCHONDRIA,PM,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O00165"},{"1":"AIP XAP2","2":"AIP_HUMAN","3":"unknown","4":"AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9)","5":"May play a positive role in AHR-mediated (aromatic hydrocarbon receptor) signaling, possibly by influencing its receptivity for ligand and/or its nuclear targeting.; Cellular negative regulator of the hepatitis B virus (HBV) X protein.","6":"23.01657154","7":"-0.538615032","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00170"},{"1":"GTPBP1","2":"GTPB1_HUMAN","3":"unknown","4":"GTP-binding protein 1 (G-protein 1) (GP-1) (GP1)","5":"Promotes degradation of target mRNA species. Plays a role in the regulation of circadian mRNA stability. Binds GTP and has GTPase activity (By similarity). {ECO:0000250}.","6":"27.57247331","7":"8.109609548","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00178"},{"1":"STXBP3","2":"STXB3_HUMAN","3":"unknown","4":"Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C)","5":"Together with STX4 and VAMP2, may play a role in insulin-dependent movement of GLUT4 and in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes. {ECO:0000250}.","6":"-5.86698857","7":"-37.562018800","8":"PM","9":"PM,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"O00186"},{"1":"ARVCF","2":"ARVC_HUMAN","3":"unknown","4":"Armadillo repeat protein deleted in velo-cardio-facial syndrome","5":"Involved in protein-protein interactions at adherens junctions.","6":"-20.39964436","7":"-30.754998913","8":"Undefined","9":"ER,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O00192"},{"1":"SMAP C11orf58","2":"SMAP_HUMAN","3":"unknown","4":"Small acidic protein","5":"NA","6":"-9.38030337","7":"-0.049282550","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00193"},{"1":"AP3B1 ADTB3A","2":"AP3B1_HUMAN","3":"unknown","4":"AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)","5":"Subunit of non-clathrin- and clathrin-associated adaptor protein complex 3 (AP-3) that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. AP-3 appears to be involved in the sorting of a subset of transmembrane proteins targeted to lysosomes and lysosome-related organelles. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. {ECO:0000305|PubMed:9151686}.","6":"10.41482206","7":"-20.918091961","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Highly confident","11":"2","12":"1,3","_rn_":"O00203"},{"1":"APBB1 FE65 RIR","2":"APBB1_HUMAN","3":"unknown","4":"Amyloid-beta A4 precursor protein-binding family B member 1 (Protein Fe65)","5":"Transcription coregulator that can have both coactivator and corepressor functions. Adapter protein that forms a transcriptionally active complex with the gamma-secretase-derived amyloid precursor protein (APP) intracellular domain. Plays a central role in the response to DNA damage by translocating to the nucleus and inducing apoptosis. May act by specifically recognizing and binding histone H2AX phosphorylated on 'Tyr-142' (H2AXY142ph) at double-strand breaks (DSBs), recruiting other pro-apoptosis factors such as MAPK8/JNK1. Required for histone H4 acetylation at double-strand breaks (DSBs). Its ability to specifically bind modified histones and chromatin modifying enzymes such as KAT5/TIP60, probably explains its transcription activation activity. Functions in association with TSHZ3, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s). {ECO:0000269|PubMed:15031292, ECO:0000269|PubMed:18468999, ECO:0000269|PubMed:18922798, ECO:0000269|PubMed:19234442, ECO:0000269|PubMed:19343227, ECO:0000269|PubMed:25342469}.","6":"-2.44212984","7":"-2.122954426","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00213"},{"1":"LGALS8","2":"LEG8_HUMAN","3":"unknown","4":"Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1)","5":"Beta-galactoside-binding lectin that acts as a sensor of membrane damage caused by infection and restricts the proliferation of infecting pathogens by targeting them for autophagy (PubMed:22246324, PubMed:28077878). Detects membrane rupture by binding beta-galactoside ligands located on the lumenal side of the endosome membrane; these ligands becoming exposed to the cytoplasm following rupture (PubMed:22246324, PubMed:28077878). Restricts infection by initiating autophagy via interaction with CALCOCO2/NDP52 (PubMed:22246324, PubMed:28077878). Required to restrict infection of bacterial invasion such as S.typhimurium (PubMed:22246324). Also required to restrict infection of Picornaviridae viruses (PubMed:28077878). Has a marked preference for 3'-O-sialylated and 3'-O-sulfated glycans (PubMed:21288902). {ECO:0000269|PubMed:21288902, ECO:0000269|PubMed:22246324, ECO:0000269|PubMed:28077878}.","6":"-0.55173531","7":"-37.295334935","8":"LYSOSOME","9":"LYSOSOME,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00214"},{"1":"NDUFS8","2":"NDUS8_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)","5":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22499348). Essential for the catalytic activity and assembly of complex I (PubMed:22499348). {ECO:0000269|PubMed:22499348}.","6":"-40.09818496","7":"-13.672094963","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00217"},{"1":"PSMD11","2":"PSD11_HUMAN","3":"PROTEIN COMPLEX","4":"26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5)","5":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. In the complex, PSMD11 is required for proteasome assembly. Plays a key role in increased proteasome activity in embryonic stem cells (ESCs): its high expression in ESCs promotes enhanced assembly of the 26S proteasome, followed by higher proteasome activity. {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:22972301}.","6":"-5.05743107","7":"39.174205920","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00231"},{"1":"PSMD12","2":"PSD12_HUMAN","3":"PROTEIN COMPLEX","4":"26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)","5":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. {ECO:0000269|PubMed:1317798}.","6":"-5.63015631","7":"40.181259834","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00232"},{"1":"PSMD9","2":"PSMD9_HUMAN","3":"unknown","4":"26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27)","5":"Acts as a chaperone during the assembly of the 26S proteasome, specifically of the base subcomplex of the PA700/19S regulatory complex (RC). During the base subcomplex assembly is part of an intermediate PSMD9:PSMC6:PSMC3 module, also known as modulator trimer complex; PSMD9 is released during the further base assembly process. {ECO:0000269|PubMed:19490896}.","6":"26.17590846","7":"17.444920765","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00233"},{"1":"MEN1 SCG2","2":"MEN1_HUMAN","3":"unknown","4":"Menin","5":"Essential component of a MLL/SET1 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3 (H3K4). Functions as a transcriptional regulator. Binds to the TERT promoter and represses telomerase expression. Plays a role in TGFB1-mediated inhibition of cell-proliferation, possibly regulating SMAD3 transcriptional activity. Represses JUND-mediated transcriptional activation on AP1 sites, as well as that mediated by NFKB subunit RELA. Positively regulates HOXC8 and HOXC6 gene expression. May be involved in normal hematopoiesis through the activation of HOXA9 expression (By similarity). May be involved in DNA repair. {ECO:0000250|UniProtKB:O88559, ECO:0000269|PubMed:11274402, ECO:0000269|PubMed:11526476, ECO:0000269|PubMed:12837246, ECO:0000269|PubMed:12874027, ECO:0000269|PubMed:14992727, ECO:0000269|PubMed:22327296}.","6":"-10.79586353","7":"25.087581526","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00255"},{"1":"PGRMC1 HPR6.6 PGRMC","2":"PGRC1_HUMAN","3":"ER","4":"Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA)","5":"Component of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins (PubMed:27599036). {ECO:0000250|UniProtKB:O55022, ECO:0000269|PubMed:25675345, ECO:0000269|PubMed:27599036, ECO:0000303|PubMed:28396637}.","6":"-14.12441650","7":"-34.731351721","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00264"},{"1":"SUPT5H SPT5 SPT5H","2":"SPT5H_HUMAN","3":"unknown","4":"Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein)","5":"Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II. DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A. DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter. Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex. DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II. TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme. Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites. DSIF can also positively regulate transcriptional elongation and is required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences. {ECO:0000269|PubMed:10075709, ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10421630, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11553615, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:12653964, ECO:0000269|PubMed:12718890, ECO:0000269|PubMed:14701750, ECO:0000269|PubMed:15136722, ECO:0000269|PubMed:15380072, ECO:0000269|PubMed:16214896, ECO:0000269|PubMed:9450929, ECO:0000269|PubMed:9514752, ECO:0000269|PubMed:9857195}.","6":"19.47123462","7":"25.127368847","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00267"},{"1":"TAF4 TAF2C TAF2C1 TAF4A TAFII130 TAFII135","2":"TAF4_HUMAN","3":"unknown","4":"Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135)","5":"Part of the TFIID complex, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Potentiates transcriptional activation by the AF-2S of the retinoic acid, vitamin D3 and thyroid hormone.","6":"-28.21308880","7":"18.418003820","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O00268"},{"1":"DFFA DFF1 DFF45 H13","2":"DFFA_HUMAN","3":"unknown","4":"DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD)","5":"Inhibitor of the caspase-activated DNase (DFF40).","6":"-7.82858246","7":"0.777228190","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00273"},{"1":"HIP1","2":"HIP1_HUMAN","3":"unknown","4":"Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I)","5":"Plays a role in clathrin-mediated endocytosis and trafficking (PubMed:11532990, PubMed:11577110, PubMed:11889126). Involved in regulating AMPA receptor trafficking in the central nervous system in an NMDA-dependent manner (By similarity). Regulates presynaptic nerve terminal activity (By similarity). Enhances androgen receptor (AR)-mediated transcription (PubMed:16027218). May act as a proapoptotic protein that induces cell death by acting through the intrinsic apoptosis pathway (PubMed:11007801). Binds 3-phosphoinositides (via ENTH domain) (PubMed:14732715). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis (PubMed:14732715). May play a functional role in the cell filament networks (PubMed:18790740). May be required for differentiation, proliferation, and/or survival of somatic and germline progenitors (PubMed:11007801, PubMed:12163454). {ECO:0000250|UniProtKB:Q8VD75, ECO:0000269|PubMed:11007801, ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:11577110, ECO:0000269|PubMed:11889126, ECO:0000269|PubMed:12163454, ECO:0000269|PubMed:14732715, ECO:0000269|PubMed:16027218, ECO:0000269|PubMed:18790740, ECO:0000269|PubMed:9147654}.","6":"-8.94553122","7":"10.227532123","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00291"},{"1":"CLIC1 G6 NCC27","2":"CLIC1_HUMAN","3":"unknown","4":"Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)","5":"Can insert into membranes and form chloride ion channels. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Involved in regulation of the cell cycle. {ECO:0000269|PubMed:10834939, ECO:0000269|PubMed:11195932, ECO:0000269|PubMed:11551966, ECO:0000269|PubMed:11940526, ECO:0000269|PubMed:11978800, ECO:0000269|PubMed:14613939, ECO:0000269|PubMed:9139710}.","6":"-3.31001489","7":"3.331618876","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00299"},{"1":"EIF3F EIF3S5","2":"EIF3F_HUMAN","3":"PROTEIN COMPLEX","4":"Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)","5":"Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03005, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; Deubiquitinates activated NOTCH1, promoting its nuclear import, thereby acting as a positive regulator of Notch signaling. {ECO:0000269|PubMed:21124883}.","6":"11.62637162","7":"37.295571002","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00303"},{"1":"WWP2","2":"WWP2_HUMAN","3":"unknown","4":"NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)","5":"E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Polyubiquitinates POU5F1 by 'Lys-63'-linked conjugation and promotes it to proteasomal degradation; in embryonic stem cells (ESCs) the ubiquitination is proposed to regulate POU5F1 protein level. Ubiquitinates EGR2 and promotes it to proteasomal degradation; in T-cells the ubiquitination inhibits activation-induced cell death. Ubiquitinates SLC11A2; the ubiquitination is enhanced by presence of NDFIP1 and NDFIP2. Ubiquitinates RPB1 and promotes it to proteasomal degradation. {ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:19651900}.","6":"3.27957723","7":"-19.479824360","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"Candidate","11":"2","12":"1,2","_rn_":"O00308"},{"1":"CDC7 CDC7L1","2":"CDC7_HUMAN","3":"unknown","4":"Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)","5":"Seems to phosphorylate critical substrates that regulate the G1/S phase transition and/or DNA replication. Can phosphorylate MCM2 and MCM3. {ECO:0000269|PubMed:12065429}.","6":"1.19305273","7":"18.665964764","8":"Undefined","9":"NUCLEOPLASM-2,PROTEIN COMPLEX,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00311"},{"1":"PDHX PDX1","2":"ODPX_HUMAN","3":"MITOCHONDRIA","4":"Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX)","5":"Required for anchoring dihydrolipoamide dehydrogenase (E3) to the dihydrolipoamide transacetylase (E2) core of the pyruvate dehydrogenase complexes of eukaryotes. This specific binding is essential for a functional PDH complex.","6":"-37.88336467","7":"-14.051393210","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00330"},{"1":"DCTN6 WS3","2":"DCTN6_HUMAN","3":"unknown","4":"Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3)","5":"NA","6":"19.79851377","7":"21.133067133","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00399"},{"1":"SLC33A1 ACATN AT1","2":"ACATN_HUMAN","3":"unknown","4":"Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)","5":"Probable acetyl-CoA transporter necessary for O-acetylation of gangliosides (PubMed:9096318). Negatively regulates BMP signaling (PubMed:25402622). {ECO:0000269|PubMed:25402622, ECO:0000269|PubMed:9096318}.","6":"8.21411150","7":"-41.094403622","8":"Undefined","9":"GOLGI,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00400"},{"1":"WASL","2":"WASL_HUMAN","3":"unknown","4":"Neural Wiskott-Aldrich syndrome protein (N-WASP)","5":"Regulates actin polymerization by stimulating the actin-nucleating activity of the Arp2/3 complex (PubMed:9422512, PubMed:16767080, PubMed:19366662, PubMed:19487689, PubMed:22847007, PubMed:22921828). Involved in various processes, such as mitosis and cytokinesis, via its role in the regulation of actin polymerization (PubMed:9422512, PubMed:19366662, PubMed:19487689, PubMed:22847007, PubMed:22921828). Together with CDC42, involved in the extension and maintenance of the formation of thin, actin-rich surface projections called filopodia (PubMed:9422512). In addition to its role in the cytoplasm, also plays a role in the nucleus by regulating gene transcription, probably by promoting nuclear actin polymerization (PubMed:16767080). Binds to HSF1/HSTF1 and forms a complex on heat shock promoter elements (HSE) that negatively regulates HSP90 expression (By similarity). Plays a role in dendrite spine morphogenesis (By similarity). Decreasing levels of DNMBP (using antisense RNA) alters apical junction morphology in cultured enterocytes, junctions curve instead of being nearly linear (PubMed:19767742). {ECO:0000250|UniProtKB:Q91YD9, ECO:0000269|PubMed:16767080, ECO:0000269|PubMed:19366662, ECO:0000269|PubMed:19487689, ECO:0000269|PubMed:19767742, ECO:0000269|PubMed:22847007, ECO:0000269|PubMed:22921828, ECO:0000269|PubMed:9422512}.","6":"17.35089246","7":"1.202682027","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00401"},{"1":"PDE2A","2":"PDE2A_HUMAN","3":"unknown","4":"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)","5":"Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Plays an important role in growth and invasion of malignant melanoma cells (e.g. pseudomyxoma peritonei (PMP) cell line) (PubMed:24705027). {ECO:0000269|PubMed:24705027}.; [Isoform PDE2A2]: Regulates mitochondrial cAMP levels and respiration (By similarity). Involved in the regulation of mitochondria morphology/dynamics and apoptotic cell death via local modulation of cAMP/PKA signaling in the mitochondrion, including the monitoring of local cAMP levels at the outer mitochondrial membrane and of PKA-dependent phosphorylation of DNM1L (PubMed:28463107). {ECO:0000250|UniProtKB:Q922S4, ECO:0000269|PubMed:28463107}.","6":"9.91685308","7":"17.818426248","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00408"},{"1":"IPO5 KPNB3 RANBP5","2":"IPO5_HUMAN","3":"unknown","4":"Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)","5":"Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. Binds to CPEB3 and mediates its nuclear import following neuronal stimulation (By similarity). In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. {ECO:0000250|UniProtKB:Q8BKC5, ECO:0000269|PubMed:9687515}.","6":"22.07275095","7":"6.718218357","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00410"},{"1":"POLRMT","2":"RPOM_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)","5":"DNA-dependent RNA polymerase catalyzes the transcription of mitochondrial DNA into RNA using the four ribonucleoside triphosphates as substrates (PubMed:21278163). Component of the mitochondrial transcription initiation complex, composed at least of TFB2M, TFAM and POLRMT that is required for basal transcription of mitochondrial DNA (PubMed:29149603). In this complex, TFAM recruits POLRMT to a specific promoter whereas TFB2M induces structural changes in POLRMT to enable promoter opening and trapping of the DNA non-template strand (PubMed:29149603). {ECO:0000269|PubMed:21278163, ECO:0000269|PubMed:29149603}.","6":"-36.69241935","7":"-3.440475968","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O00411"},{"1":"EEF2K","2":"EF2K_HUMAN","3":"unknown","4":"Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)","5":"Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced. {ECO:0000269|PubMed:14709557, ECO:0000269|PubMed:9144159}.","6":"1.34948158","7":"18.435720065","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00418"},{"1":"SAP18 GIG38","2":"SAP18_HUMAN","3":"unknown","4":"Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18)","5":"Component of the SIN3-repressing complex. Enhances the ability of SIN3-HDAC1-mediated transcriptional repression. When tethered to the promoter, it can direct the formation of a repressive complex to core histone proteins. Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP and PSAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. The ASAP complex can inhibit mRNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits the formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. {ECO:0000269|PubMed:12665594, ECO:0000269|PubMed:20966198, ECO:0000269|PubMed:22203037, ECO:0000269|PubMed:9150135}.","6":"-34.39782080","7":"20.437359081","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O00422"},{"1":"DNM1L DLP1 DRP1","2":"DNM1L_HUMAN","3":"unknown","4":"Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)","5":"Functions in mitochondrial and peroxisomal division (PubMed:9570752, PubMed:9786947, PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17553808, PubMed:17460227, PubMed:18695047, PubMed:18838687, PubMed:19638400, PubMed:19411255, PubMed:19342591, PubMed:23921378, PubMed:23283981, PubMed:23530241, PubMed:29478834, PubMed:32484300, PubMed:27145208, PubMed:26992161, PubMed:27301544, PubMed:27328748). Mediates membrane fission through oligomerization into membrane-associated tubular structures that wrap around the scission site to constrict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism (PubMed:23530241, PubMed:23584531). The specific recruitment at scission sites is mediated by membrane receptors like MFF, MIEF1 and MIEF2 for mitochondrial membranes (PubMed:23921378, PubMed:23283981, PubMed:29899447). While the recruitment by the membrane receptors is GTP-dependent, the following hydrolysis of GTP induces the dissociation from the receptors and allows DNM1L filaments to curl into closed rings that are probably sufficient to sever a double membrane (PubMed:29899447). Acts downstream of PINK1 to promote mitochondrial fission in a PRKN-dependent manner (PubMed:32484300). Plays an important role in mitochondrial fission during mitosis (PubMed:19411255, PubMed:26992161, PubMed:27301544, PubMed:27328748). Through its function in mitochondrial division, ensures the survival of at least some types of postmitotic neurons, including Purkinje cells, by suppressing oxidative damage (By similarity). Required for normal brain development, including that of cerebellum (PubMed:17460227, PubMed:27145208, PubMed:26992161, PubMed:27301544, PubMed:27328748). Facilitates developmentally regulated apoptosis during neural tube formation (By similarity). Required for a normal rate of cytochrome c release and caspase activation during apoptosis; this requirement may depend upon the cell type and the physiological apoptotic cues (By similarity). Required for formation of endocytic vesicles (PubMed:9570752, PubMed:20688057, PubMed:23792689). Proposed to regulate synaptic vesicle membrane dynamics through association with BCL2L1 isoform Bcl-X(L) which stimulates its GTPase activity in synaptic vesicles; the function may require its recruitment by MFF to clathrin-containing vesicles (PubMed:17015472, PubMed:23792689). Required for programmed necrosis execution (PubMed:22265414). Rhythmic control of its activity following phosphorylation at Ser-637 is essential for the circadian control of mitochondrial ATP production (PubMed:29478834). {ECO:0000250|UniProtKB:Q8K1M6, ECO:0000269|PubMed:11514614, ECO:0000269|PubMed:12499366, ECO:0000269|PubMed:17015472, ECO:0000269|PubMed:17301055, ECO:0000269|PubMed:17460227, ECO:0000269|PubMed:17553808, ECO:0000269|PubMed:18695047, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19342591, ECO:0000269|PubMed:19411255, ECO:0000269|PubMed:19638400, ECO:0000269|PubMed:20688057, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23584531, ECO:0000269|PubMed:23792689, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:26992161, ECO:0000269|PubMed:27145208, ECO:0000269|PubMed:27301544, ECO:0000269|PubMed:27328748, ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:29899447, ECO:0000269|PubMed:32484300, ECO:0000269|PubMed:9570752, ECO:0000269|PubMed:9786947}.; [Isoform 1]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}.; [Isoform 4]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}.","6":"33.09672170","7":"12.479261440","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00429"},{"1":"RTCA RPC RPC1 RTC1 RTCD1","2":"RTCA_HUMAN","3":"NUCLEOPLASM-1","4":"RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1)","5":"Catalyzes the conversion of 3'-phosphate to a 2',3'-cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA-N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'-phosphorus in the diester linkage to produce the cyclic end product. The biological role of this enzyme is unknown but it is likely to function in some aspects of cellular RNA processing.","6":"24.00268526","7":"-2.940975814","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00442"},{"1":"PIK3C2A","2":"P3C2A_HUMAN","3":"unknown","4":"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha)","5":"Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers. Has a role in several intracellular trafficking events. Functions in insulin signaling and secretion. Required for translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane and glucose uptake in response to insulin-mediated RHOQ activation. Regulates insulin secretion through two different mechanisms: involved in glucose-induced insulin secretion downstream of insulin receptor in a pathway that involves AKT1 activation and TBC1D4/AS160 phosphorylation, and participates in the late step of insulin granule exocytosis probably in insulin granule fusion. Synthesizes PtdIns3P in response to insulin signaling. Functions in clathrin-coated endocytic vesicle formation and distribution. Regulates dynamin-independent endocytosis, probably by recruiting EEA1 to internalizing vesicles. In neurosecretory cells synthesizes PtdIns3P on large dense core vesicles. Participates in calcium induced contraction of vascular smooth muscle by regulating myosin light chain (MLC) phosphorylation through a mechanism involving Rho kinase-dependent phosphorylation of the MLCP-regulatory subunit MYPT1. May play a role in the EGF signaling cascade. May be involved in mitosis and UV-induced damage response. Required for maintenance of normal renal structure and function by supporting normal podocyte function. Involved in the regulation of ciliogenesis and trafficking of ciliary components (PubMed:31034465). {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:12719431, ECO:0000269|PubMed:16215232, ECO:0000269|PubMed:21081650, ECO:0000269|PubMed:31034465, ECO:0000269|PubMed:9337861}.","6":"34.96259073","7":"15.660359283","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00443"},{"1":"PIK3R2","2":"P85B_HUMAN","3":"unknown","4":"Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta)","5":"Regulatory subunit of phosphoinositide-3-kinase (PI3K), a kinase that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Indirectly regulates autophagy (PubMed:23604317). Promotes nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (By similarity). {ECO:0000250|UniProtKB:O08908, ECO:0000269|PubMed:23604317}.","6":"32.86591318","7":"4.382479278","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00459"},{"1":"GOLIM4 GIMPC GOLPH4 GPP130","2":"GOLI4_HUMAN","3":"GOLGI","4":"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)","5":"Plays a role in endosome to Golgi protein trafficking; mediates protein transport along the late endosome-bypass pathway from the early endosome to the Golgi. {ECO:0000269|PubMed:15331763}.","6":"16.11500430","7":"-38.506514220","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00461"},{"1":"AGRN AGRIN","2":"AGRIN_HUMAN","3":"unknown","4":"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","5":"[Isoform 1]: heparan sulfate basal lamina glycoprotein that plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ) and directs key events in postsynaptic differentiation. Component of the AGRN-LRP4 receptor complex that induces the phosphorylation and activation of MUSK. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Calcium ions are required for maximal AChR clustering. AGRN function in neurons is highly regulated by alternative splicing, glycan binding and proteolytic processing. Modulates calcium ion homeostasis in neurons, specifically by inducing an increase in cytoplasmic calcium ions. Functions differentially in the central nervous system (CNS) by inhibiting the alpha(3)-subtype of Na+/K+-ATPase and evoking depolarization at CNS synapses. This secreted isoform forms a bridge, after release from motor neurons, to basal lamina through binding laminin via the NtA domain.; [Isoform 2]: transmembrane form that is the predominate form in neurons of the brain, induces dendritic filopodia and synapse formation in mature hippocampal neurons in large part due to the attached glycosaminoglycan chains and the action of Rho-family GTPases.; Isoform 1, isoform 4 and isoform 5: neuron-specific (z+) isoforms that contain C-terminal insertions of 8-19 AA are potent activators of AChR clustering. Isoform 5, agrin (z+8), containing the 8-AA insert, forms a receptor complex in myotubules containing the neuronal AGRN, the muscle-specific kinase MUSK and LRP4, a member of the LDL receptor family. The splicing factors, NOVA1 and NOVA2, regulate AGRN splicing and production of the 'z' isoforms.; Isoform 3 and isoform 6: lack any 'z' insert, are muscle-specific and may be involved in endothelial cell differentiation.; [Agrin N-terminal 110 kDa subunit]: is involved in regulation of neurite outgrowth probably due to the presence of the glycosaminoglcan (GAG) side chains of heparan and chondroitin sulfate attached to the Ser/Thr- and Gly/Ser-rich regions. Also involved in modulation of growth factor signaling (By similarity). {ECO:0000250, ECO:0000269|PubMed:19631309, ECO:0000269|PubMed:21969364}.; [Agrin C-terminal 22 kDa fragment]: this released fragment is important for agrin signaling and to exert a maximal dendritic filopodia-inducing effect. All 'z' splice variants (z+) of this fragment also show an increase in the number of filopodia.","6":"-15.27612791","7":"-27.425431608","8":"Undefined","9":"ER,PEROXISOME,ER","10":"NA","11":"NA","12":"NA","_rn_":"O00468"},{"1":"PLOD2","2":"PLOD2_HUMAN","3":"ER","4":"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)","5":"Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links. {ECO:0000250|UniProtKB:P24802}.","6":"-20.43262338","7":"-22.359328331","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00469"},{"1":"EXOC5 SEC10 SEC10L1","2":"EXOC5_HUMAN","3":"unknown","4":"Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10)","5":"Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.","6":"3.79494290","7":"-11.793773463","8":"Undefined","9":"CYTOSOL,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O00471"},{"1":"NDUFA4","2":"NDUA4_HUMAN","3":"unknown","4":"Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)","5":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules unsing 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix (PubMed:22902835). NDUFA4 is required for complex IV maintenance (PubMed:22902835). {ECO:0000269|PubMed:22902835}.","6":"-41.15046512","7":"1.595106900","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O00483"},{"1":"PSMD14 POH1","2":"PSDE_HUMAN","3":"PROTEIN COMPLEX","4":"26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)","5":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. The PSMD14 subunit is a metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains within the complex. Plays a role in response to double-strand breaks (DSBs): acts as a regulator of non-homologous end joining (NHEJ) by cleaving 'Lys-63'-linked polyubiquitin, thereby promoting retention of JMJD2A/KDM4A on chromatin and restricting TP53BP1 accumulation. Also involved in homologous recombination repair by promoting RAD51 loading. {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:22909820, ECO:0000269|PubMed:9374539}.","6":"-5.43086217","7":"39.739995294","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00487"},{"1":"ZNF593 ZT86","2":"ZN593_HUMAN","3":"unknown","4":"Zinc finger protein 593 (Zinc finger protein T86)","5":"Negatively modulates the DNA binding activity of Oct-2 and therefore its transcriptional regulatory activity. Could act either by binding to DNA octamer or by interacting with Oct-2. May also be a modulator of other octamer-binding proteins.","6":"-14.33868490","7":"17.529886158","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00488"},{"1":"BIN1 AMPHL","2":"BIN1_HUMAN","3":"unknown","4":"Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1)","5":"Is a key player in the control of plasma membrane curvature, membrane shaping and membrane remodeling. Required in muscle cells for the formation of T-tubules, tubular invaginations of the plasma membrane that function in depolarization-contraction coupling (PubMed:24755653). Is a negative regulator of endocytosis (By similarity). Is also involved in the regulation of intracellular vesicles sorting, modulation of BACE1 trafficking and the control of amyloid-beta production (PubMed:27179792). In neuronal circuits, endocytosis regulation may influence the internalization of PHF-tau aggregates (By similarity). May be involved in the regulation of MYC activity and the control cell proliferation (PubMed:8782822). Has actin bundling activity and stabilizes actin filaments against depolymerization in vitro (PubMed:28893863). {ECO:0000250|UniProtKB:O08839, ECO:0000269|PubMed:24755653, ECO:0000269|PubMed:27179792, ECO:0000269|PubMed:28893863, ECO:0000269|PubMed:8782822}.","6":"-12.68570741","7":"4.555107930","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00499"},{"1":"KPNA3 QIP2","2":"IMA4_HUMAN","3":"unknown","4":"Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma)","5":"Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS. Recognizes NLSs of influenza A virus nucleoprotein probably through ARM repeats 7-9.","6":"-2.82867121","7":"21.187016527","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00505"},{"1":"KRIT1 CCM1","2":"KRIT1_HUMAN","3":"unknown","4":"Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein)","5":"Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1; this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels. {ECO:0000250|UniProtKB:Q6S5J6, ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:17916086, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:20616044, ECO:0000269|PubMed:20668652, ECO:0000269|PubMed:21633110, ECO:0000269|PubMed:23317506}.","6":"4.13962822","7":"-35.283898205","8":"LYSOSOME","9":"LYSOSOME,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00522"},{"1":"PES1","2":"PESC_HUMAN","3":"unknown","4":"Pescadillo homolog","5":"Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome. {ECO:0000255|HAMAP-Rule:MF_03028, ECO:0000269|PubMed:16738141, ECO:0000269|PubMed:17189298, ECO:0000269|PubMed:17353269}.","6":"-24.92395886","7":"19.789668745","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O00541"},{"1":"SDCBP MDA9 SYCL","2":"SDCB1_HUMAN","3":"unknown","4":"Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)","5":"Multifunctional adapter protein involved in diverse array of functions including trafficking of transmembrane proteins, neuro and immunomodulation, exosome biogenesis, and tumorigenesis (PubMed:26291527). Positively regulates TGFB1-mediated SMAD2/3 activation and TGFB1-induced epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types. May increase TGFB1 signaling by enhancing cell-surface expression of TGFR1 by preventing the interaction between TGFR1 and CAV1 and subsequent CAV1-dependent internalization and degradation of TGFR1 (PubMed:25893292). In concert with SDC1/4 and PDCD6IP, regulates exosome biogenesis (PubMed:22660413). Regulates migration, growth, proliferation, and cell cycle progression in a variety of cancer types (PubMed:26539120). In adherens junctions may function to couple syndecans to cytoskeletal proteins or signaling components. Seems to couple transcription factor SOX4 to the IL-5 receptor (IL5RA) (PubMed:11498591). May also play a role in vesicular trafficking (PubMed:11179419). Seems to be required for the targeting of TGFA to the cell surface in the early secretory pathway (PubMed:10230395). {ECO:0000269|PubMed:10230395, ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:11498591, ECO:0000269|PubMed:22660413, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:26539120, ECO:0000303|PubMed:26291527}.","6":"1.06544680","7":"-27.650630298","8":"Undefined","9":"Undefined,ER,PM","10":"NA","11":"NA","12":"NA","_rn_":"O00560"},{"1":"MPHOSPH10 MPP10","2":"MPP10_HUMAN","3":"NUCLEUS","4":"U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)","5":"Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing.","6":"-37.18968797","7":"20.338562815","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00566"},{"1":"NOP56 NOL5A","2":"NOP56_HUMAN","3":"unknown","4":"Nucleolar protein 56 (Nucleolar protein 5A)","5":"Involved in the early to middle stages of 60S ribosomal subunit biogenesis. Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such U3, U8 and U14 snoRNAs. {ECO:0000269|PubMed:12777385, ECO:0000269|PubMed:15574333}.","6":"-40.71770564","7":"22.485518290","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O00567"},{"1":"DDX3X DBX DDX3","2":"DDX3X_HUMAN","3":"unknown","4":"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)","5":"Multifunctional ATP-dependent RNA helicase (PubMed:17357160, PubMed:21589879, PubMed:31575075). The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity (PubMed:29222110). In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs (PubMed:17357160, PubMed:21589879). Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA (PubMed:30256975). Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities (Probable). Involved in transcription regulation (PubMed:16818630, PubMed:18264132). Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity (PubMed:16818630, PubMed:18264132). CDKN1A up-regulation may be cell-type specific (PubMed:18264132). Binds CDH1/E-cadherin promoter and represses its transcription (PubMed:18264132). Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis (PubMed:28128295). May positively regulate TP53 transcription (PubMed:28842590). Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC) (PubMed:17095540, PubMed:18596238). Involved in the regulation of translation initiation (PubMed:18628297, PubMed:17667941, PubMed:22872150). Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR) (PubMed:20837705, PubMed:22872150). This function depends on helicase activity (PubMed:20837705, PubMed:22872150). Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning (PubMed:20837705). Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety (PubMed:22872150). Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process (PubMed:22323517). Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle (PubMed:20837705). May activate TP53 translation (PubMed:28842590). Required for endoplasmic reticulum stress-induced ATF4 mRNA translation (PubMed:29062139). Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E (PubMed:17667941, PubMed:22323517). Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E (PubMed:17667941). Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:31575075, PubMed:20127681, PubMed:21170385). Potentiate MAVS/DDX58-mediated induction of IFNB in early stages of infection (PubMed:20127681, PubMed:21170385). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:18583960, PubMed:18636090, PubMed:21170385, PubMed:27980081, PubMed:19913487). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation (PubMed:23478265). Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7 (PubMed:30341167). Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling (PubMed:30341167). Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm (PubMed:27736973). May also bind IFNB promoter; the function is independent of IRF3 (PubMed:18583960). Involved in both stress and inflammatory responses (By similarity). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (PubMed:21883093). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity (By similarity). Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (By similarity). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation (PubMed:18846110). Cleavage by caspases may inactivate DDX3X and relieve the inhibition (PubMed:18846110). Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant (PubMed:23413191, PubMed:29222110). ATPase and casein kinase-activating functions are mutually exclusive (PubMed:29222110). May be involved in mitotic chromosome segregation (PubMed:21730191). {ECO:0000250|UniProtKB:Q62167, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:17095540, ECO:0000269|PubMed:17357160, ECO:0000269|PubMed:17667941, ECO:0000269|PubMed:18264132, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18628297, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:18846110, ECO:0000269|PubMed:19913487, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:20837705, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:21883093, ECO:0000269|PubMed:22323517, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:23478265, ECO:0000269|PubMed:27736973, ECO:0000269|PubMed:27980081, ECO:0000269|PubMed:28128295, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:29062139, ECO:0000269|PubMed:29222110, ECO:0000269|PubMed:30256975, ECO:0000269|PubMed:30341167, ECO:0000269|PubMed:31575075, ECO:0000305}.; (Microbial infection) Facilitates hepatitis C virus (HCV) replication (PubMed:29899501). During infection, HCV core protein inhibits the interaction between MAVS and DDX3X and therefore impairs MAVS-dependent INFB induction and might recruit DDX3X to HCV replication complex (PubMed:21170385). {ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:29899501}.; (Microbial infection) Facilitates HIV-1 replication (PubMed:15507209, PubMed:18583960, PubMed:21589879, PubMed:22872150, PubMed:29899501). Acts as a cofactor for XPO1-mediated nuclear export of HIV-1 Rev RNAs (PubMed:15507209, PubMed:18583960, PubMed:29899501). This function is strongly stimulated in the presence of TBK1 and requires DDX3X ATPase activity (PubMed:18583960). {ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:29899501}.; (Microbial infection) Facilitates Zika virus (ZIKV) replication. {ECO:0000269|PubMed:29899501}.; (Microbial infection) Facilitates Dengue virus (DENV) replication. {ECO:0000269|PubMed:29899501}.; (Microbial infection) Facilitates Venezuelan equine encephalitis virus (VEEV) replication. {ECO:0000269|PubMed:27105836}.","6":"43.94745799","7":"-0.802964603","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O00571"},{"1":"RNASET2 RNASE6PL","2":"RNT2_HUMAN","3":"LYSOSOME","4":"Ribonuclease T2 (EC 4.6.1.19) (Ribonuclease 6)","5":"Ribonuclease that plays an essential role in innate immune response by recognizing and degrading RNAs from microbial pathogens that are subsequently sensed by TLR8 (PubMed:31778653). Cleaves preferentially single-stranded RNA molecules between purine and uridine residues, which critically contributes to the supply of catabolic uridine and the generation of purine-2',3'-cyclophosphate-terminated oligoribonucleotides (PubMed:31778653). In turn, RNase T2 degradation products promote the RNA-dependent activation of TLR8 (PubMed:31778653). Plays also a key role in degradation of mitochondrial RNA and processing of non-coding RNA imported from the cytosol into mitochondria (PubMed:28730546, PubMed:30184494). Participates as well in degradation of mitochondrion-associated cytosolic rRNAs (PubMed:30385512). {ECO:0000269|PubMed:16620762, ECO:0000269|PubMed:19525954, ECO:0000269|PubMed:22735700, ECO:0000269|PubMed:28730546, ECO:0000269|PubMed:30184494, ECO:0000269|PubMed:30385512, ECO:0000269|PubMed:31778653}.","6":"11.82632583","7":"-42.611274735","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00584"},{"1":"PODXL PCLP PCLP1","2":"PODXL_HUMAN","3":"unknown","4":"Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1)","5":"Involved in the regulation of both adhesion and cell morphology and cancer progression. Functions as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell-cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR-dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells. {ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}.","6":"-17.19371576","7":"-35.178275358","8":"Undefined","9":"ER,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O00592"},{"1":"CCN1 CYR61 GIG1 IGFBP10","2":"CCN1_HUMAN","3":"unknown","4":"CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)","5":"Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion. Appears to play a role in wound healing by up-regulating, in skin fibroblasts, the expression of a number of genes involved in angiogenesis, inflammation and matrix remodeling including VEGA-A, VEGA-C, MMP1, MMP3, TIMP1, uPA, PAI-1 and integrins alpha-3 and alpha-5. CCN1-mediated gene regulation is dependent on heparin-binding. Down-regulates the expression of alpha-1 and alpha-2 subunits of collagen type-1. Promotes cell adhesion and adhesive signaling through integrin alpha-6/beta-1, cell migration through integrin alpha-v/beta-5 and cell proliferation through integrin alpha-v/beta-3. {ECO:0000269|PubMed:11584015}.","6":"14.28003682","7":"-39.737839356","8":"Undefined","9":"GOLGI,LYSOSOME,Undefined","10":"Candidate","11":"2","12":"1,3","_rn_":"O00622"},{"1":"PIR","2":"PIR_HUMAN","3":"unknown","4":"Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase)","5":"Transcriptional coregulator of NF-kappa-B which facilitates binding of NF-kappa-B proteins to target kappa-B genes in a redox-state-dependent manner. May be required for efficient terminal myeloid maturation of hematopoietic cells. Has quercetin 2,3-dioxygenase activity (in vitro). {ECO:0000269|PubMed:17288615, ECO:0000269|PubMed:20010624, ECO:0000269|PubMed:20711196, ECO:0000269|PubMed:23716661}.","6":"22.07510610","7":"-2.683493905","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00625"},{"1":"KPNA4 QIP1","2":"IMA3_HUMAN","3":"unknown","4":"Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4)","5":"Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS.","6":"-2.86269411","7":"22.529428047","8":"NUCLEOPLASM-2","9":"Undefined,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O00629"},{"1":"TRIM38 RNF15 RORET","2":"TRI38_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase TRIM38 (EC 2.3.2.27) (RING finger protein 15) (RING-type E3 ubiquitin transferase TRIM38) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet)","5":"E3 ubiquitin-protein ligase. Mediates 'Lys-48'-linked polyubiquitination and proteasomal degradation of the critical TLR adapter TICAM1, inhibiting TLR3-mediated type I interferon signaling. {ECO:0000269|PubMed:23056470}.","6":"23.96218431","7":"0.234872945","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00635"},{"1":"NFIB","2":"NFIB_HUMAN","3":"unknown","4":"Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein)","5":"Transcriptional activator of GFAP, essential for proper brain development (PubMed:30388402). Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. {ECO:0000269|PubMed:30388402}.","6":"5.65237913","7":"24.419869299","8":"Undefined","9":"PROTEIN COMPLEX,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00712"},{"1":"PPP6C PPP6","2":"PPP6_HUMAN","3":"unknown","4":"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]","5":"Catalytic subunit of protein phosphatase 6 (PP6) (PubMed:17079228, PubMed:29053956). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation (PubMed:10227379). N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1 (PubMed:17568194). During mitosis, regulates spindle positioning (PubMed:27335426). Downregulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7 (PubMed:17079228). Participates also in the innate immune defense against viruses by desphosphorylating RIG-I/DDX58, an essential step that triggers RIG-I/DDX58-mediated signaling activation (PubMed:29053956). {ECO:0000269|PubMed:10227379, ECO:0000269|PubMed:17079228, ECO:0000269|PubMed:17568194, ECO:0000269|PubMed:27335426, ECO:0000269|PubMed:29053956}.","6":"-2.15463564","7":"26.118539663","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O00743"},{"1":"NME4 NM23D","2":"NDKM_HUMAN","3":"unknown","4":"Nucleoside diphosphate kinase, mitochondrial (NDK) (NDP kinase, mitochondrial) (EC 2.7.4.6) (Nucleoside diphosphate kinase D) (NDPKD) (nm23-H4)","5":"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Through the catalyzed exchange of gamma-phosphate between di- and triphosphonucleosides participates in regulation of intracellular nucleotide homeostasis (PubMed:10799505). Binds to anionic phospholipids, predominantly to cardiolipin; the binding inhibits its phosphotransfer activity (PubMed:18635542, PubMed:23150663). Acts as mitochondria-specific NDK; its association with cardiolipin-containing mitochondrial inner membrane is coupled to respiration suggesting that ADP locally regenerated in the mitochondrion innermembrane space by its activity is directly taken up via ANT ADP/ATP translocase into the matrix space to stimulate respiratory ATP regeneration (PubMed:18635542). Proposed to increase GTP-loading on dynamin-related GTPase OPA1 in mitochondria (PubMed:24970086). In vitro can induce liposome cross-linking suggesting that it can cross-link inner and outer membranes to form contact sites, and promotes intermembrane migration of anionic phosphoplipids. Promotes the redistribution of cardiolipin between the mitochondrial inner membrane and outer membrane which is implicated in pro-apoptotic signaling (PubMed:18635542, PubMed:17028143, PubMed:23150663). {ECO:0000269|PubMed:10799505, ECO:0000269|PubMed:17028143, ECO:0000269|PubMed:18635542, ECO:0000269|PubMed:23150663, ECO:0000305, ECO:0000305|PubMed:24970086}.","6":"-32.85790270","7":"2.048423561","8":"MITOCHONDRIA","9":"Undefined,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O00746"},{"1":"MAN2B1 LAMAN MANB","2":"MA2B1_HUMAN","3":"LYSOSOME","4":"Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]","5":"Necessary for the catabolism of N-linked carbohydrates released during glycoprotein turnover. Cleaves all known types of alpha-mannosidic linkages.","6":"10.91151508","7":"-42.518077128","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O00754"},{"1":"PDXK C21orf124 C21orf97 PKH PNK PRED79","2":"PDXK_HUMAN","3":"unknown","4":"Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)","5":"Catalyzes the phosphorylation of the dietary vitamin B6 vitamers pyridoxal (PL), pyridoxine (PN) and pyridoxamine (PM) to form pyridoxal 5'-phosphate (PLP), pyridoxine 5'-phosphate (PNP) and pyridoxamine 5'-phosphate (PMP), respectively (PubMed:9099727, PubMed:10987144, PubMed:17766369, PubMed:19351586, PubMed:31187503) (Probable). PLP is the active form of vitamin B6, and acts as a cofactor for over 140 different enzymatic reactions. {ECO:0000269|PubMed:10987144, ECO:0000269|PubMed:17766369, ECO:0000269|PubMed:19351586, ECO:0000269|PubMed:31187503, ECO:0000269|PubMed:9099727, ECO:0000305}.","6":"31.93064537","7":"8.754180543","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O00764"},{"1":"ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1","2":"ARI1A_HUMAN","3":"unknown","4":"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)","5":"Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:A2BH40, ECO:0000303|PubMed:12672490, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.","6":"24.50036698","7":"34.612773409","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14497"},{"1":"CDK2AP1 CDKAP1 DOC1","2":"CDKA1_HUMAN","3":"unknown","4":"Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor)","5":"specific inhibitor of the cell-cycle kinase CDK2. {ECO:0000250}.","6":"-7.27902718","7":"37.203899745","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O14519"},{"1":"NEMP1 KIAA0286 TMEM194 TMEM194A","2":"NEMP1_HUMAN","3":"unknown","4":"Nuclear envelope integral membrane protein 1","5":"NA","6":"-24.99091401","7":"9.282956978","8":"NUCLEUS","9":"Undefined,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O14524"},{"1":"TXNDC9 APACD","2":"TXND9_HUMAN","3":"unknown","4":"Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4)","5":"Significantly diminishes the chaperonin TCP1 complex ATPase activity, thus negatively impacts protein folding, including that of actin or tubulin. {ECO:0000269|PubMed:16415341}.","6":"18.48955174","7":"-0.873009814","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14530"},{"1":"DPYSL4 CRMP3 ULIP4","2":"DPYL4_HUMAN","3":"unknown","4":"Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4)","5":"Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity). {ECO:0000250}.","6":"36.42052617","7":"5.374978762","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14531"},{"1":"TRAFD1 FLN29","2":"TRAD1_HUMAN","3":"unknown","4":"TRAF-type zinc finger domain-containing protein 1 (Protein FLN29)","5":"Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3 (By similarity). {ECO:0000250, ECO:0000269|PubMed:16221674}.","6":"10.39308168","7":"14.192694762","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14545"},{"1":"COX7A2L COX7AR COX7RP","2":"COX7R_HUMAN","3":"MITOCHONDRIA","4":"Cytochrome c oxidase subunit 7A-related protein, mitochondrial (COX7a-related protein) (Cytochrome c oxidase subunit VIIa-related protein) (EB1)","5":"Involved in the regulation of oxidative phosphorylation and energy metabolism (By similarity). Necessary for the assembly of mitochondrial respiratory supercomplex (By similarity). {ECO:0000250|UniProtKB:Q61387}.","6":"-43.27179041","7":"4.460724554","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O14548"},{"1":"NDUFAB1","2":"ACPM_HUMAN","3":"unknown","4":"Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)","5":"Carrier of the growing fatty acid chain in fatty acid biosynthesis (By similarity). Accessory and non-catalytic subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), which functions in the transfer of electrons from NADH to the respiratory chain (PubMed:27626371). {ECO:0000250|UniProtKB:P52505, ECO:0000269|PubMed:27626371}.","6":"-42.04700464","7":"4.466877653","8":"MITOCHONDRIA","9":"MITOCHONDRIA,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O14561"},{"1":"UBFD1 UBPH","2":"UBFD1_HUMAN","3":"unknown","4":"Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)","5":"May play a role as NF-kappa-B regulator. {ECO:0000269|PubMed:19285159}.","6":"-4.04367282","7":"6.250338208","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14562"},{"1":"CIT CRIK KIAA0949 STK21","2":"CTRO_HUMAN","3":"unknown","4":"Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)","5":"Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}.","6":"-0.84434618","7":"-8.221472214","8":"RIBOSOME","9":"Undefined,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O14578"},{"1":"COPE","2":"COPE_HUMAN","3":"unknown","4":"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","5":"The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. The coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated with ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.","6":"1.23479755","7":"37.485407862","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14579"},{"1":"CDC42EP2 BORG1 CEP2","2":"BORG1_HUMAN","3":"unknown","4":"Cdc42 effector protein 2 (Binder of Rho GTPases 1)","5":"Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation in fibroblasts in a CDC42-dependent manner. {ECO:0000269|PubMed:10490598, ECO:0000269|PubMed:11035016}.","6":"1.08199207","7":"-20.590694528","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Candidate","11":"2","12":"1,3","_rn_":"O14613"},{"1":"AP3D1 PRO0039","2":"AP3D1_HUMAN","3":"unknown","4":"AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)","5":"Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. Involved in process of CD8+ T-cell and NK cell degranulation (PubMed:26744459). In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals (By similarity). {ECO:0000250|UniProtKB:O54774, ECO:0000269|PubMed:26744459}.","6":"10.25381334","7":"-20.760888052","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"Highly confident","11":"2","12":"1,3","_rn_":"O14617"},{"1":"CCS","2":"CCS_HUMAN","3":"unknown","4":"Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone)","5":"Delivers copper to copper zinc superoxide dismutase (SOD1).","6":"21.64519599","7":"1.194365049","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14618"},{"1":"ABLIM1 ABLIM KIAA0059 LIMAB1","2":"ABLM1_HUMAN","3":"unknown","4":"Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin)","5":"May act as scaffold protein (By similarity). May play a role in the development of the retina. Has been suggested to play a role in axon guidance. {ECO:0000250, ECO:0000269|PubMed:9245787}.","6":"0.34177170","7":"-7.468067002","8":"Undefined","9":"Undefined,CYTOSOL,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O14639"},{"1":"DVL2","2":"DVL2_HUMAN","3":"unknown","4":"Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2)","5":"Plays a role in the signal transduction pathways mediated by multiple Wnt genes. Participates both in canonical and non-canonical Wnt signaling by binding to the cytoplasmic C-terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Promotes internalization and degradation of frizzled proteins upon Wnt signaling. {ECO:0000250|UniProtKB:Q60838, ECO:0000269|PubMed:19252499}.","6":"6.55884962","7":"-2.294956972","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14641"},{"1":"CHD1","2":"CHD1_HUMAN","3":"unknown","4":"Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)","5":"ATP-dependent chromatin-remodeling factor which functions as substrate recognition component of the transcription regulatory histone acetylation (HAT) complex SAGA. Regulates polymerase II transcription. Also required for efficient transcription by RNA polymerase I, and more specifically the polymerase I transcription termination step. Regulates negatively DNA replication. Not only involved in transcription-related chromatin-remodeling, but also required to maintain a specific chromatin configuration across the genome. Is also associated with histone deacetylase (HDAC) activity (By similarity). Required for the bridging of SNF2, the FACT complex, the PAF complex as well as the U2 snRNP complex to H3K4me3. Functions to modulate the efficiency of pre-mRNA splicing in part through physical bridging of spliceosomal components to H3K4me3 (PubMed:18042460, PubMed:28866611). Required for maintaining open chromatin and pluripotency in embryonic stem cells (By similarity). {ECO:0000250|UniProtKB:P40201, ECO:0000269|PubMed:18042460, ECO:0000269|PubMed:28866611}.","6":"-37.23121427","7":"16.862195235","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O14646"},{"1":"CHD2","2":"CHD2_HUMAN","3":"unknown","4":"Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2)","5":"DNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression (By similarity). {ECO:0000250}.","6":"-33.41108314","7":"17.761373034","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O14647"},{"1":"TOR1A DQ2 DYT1 TA TORA","2":"TOR1A_HUMAN","3":"unknown","4":"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A) (EC 3.6.4.-) (Torsin family 1 member A)","5":"Protein with chaperone functions important for the control of protein folding, processing, stability and localization as well as for the reduction of misfolded protein aggregates. Involved in the regulation of synaptic vesicle recycling, controls STON2 protein stability in collaboration with the COP9 signalosome complex (CSN). In the nucleus, may link the cytoskeleton with the nuclear envelope, this mechanism seems to be crucial for the control of nuclear polarity, cell movement and, specifically in neurons, nuclear envelope integrity. Participates in the cellular trafficking and may regulate the subcellular location of multipass membrane proteins such as the dopamine transporter SLC6A3, leading to the modulation of dopamine neurotransmission. In the endoplasmic reticulum, plays a role in the quality control of protein folding by increasing clearance of misfolded proteins such as SGCE variants or holding them in an intermediate state for proper refolding. May have a redundant function with TOR1B in non-neural tissues. {ECO:0000269|PubMed:15505207, ECO:0000269|PubMed:16361107, ECO:0000269|PubMed:17428918, ECO:0000269|PubMed:18167355, ECO:0000269|PubMed:18827015, ECO:0000269|PubMed:19339278, ECO:0000269|PubMed:20169475, ECO:0000269|PubMed:23569223}.","6":"-6.24768935","7":"-41.919649812","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"O14656"},{"1":"TOR1B DQ1 FKSG18","2":"TOR1B_HUMAN","3":"unknown","4":"Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B)","5":"May serve as a molecular chaperone assisting in the proper folding of secreted and/or membrane proteins. Plays a role in non-neural cells nuclear envelope and endoplasmic reticulum integrity. May have a redundant function with TOR1A in non-neural tissues. {ECO:0000269|PubMed:23569223, ECO:0000269|PubMed:24275647}.","6":"-6.39739271","7":"-42.208264405","8":"Undefined","9":"PM,ER,PM","10":"NA","11":"NA","12":"NA","_rn_":"O14657"},{"1":"STX16","2":"STX16_HUMAN","3":"unknown","4":"Syntaxin-16 (Syn16)","5":"SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}.","6":"18.75692282","7":"-35.141393794","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O14662"},{"1":"ADAM10 KUZ MADM","2":"ADA10_HUMAN","3":"unknown","4":"Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","5":"Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-|-Val-77' to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (PubMed:20592283). Responsible for the proteolytic release of several other cell-surface proteins, including heparin-binding epidermal growth-like factor, ephrin-A2, CD44, CDH2 and for constitutive and regulated alpha-secretase cleavage of amyloid precursor protein (APP) (PubMed:26686862, PubMed:11786905, PubMed:29224781). Contributes to the normal cleavage of the cellular prion protein (PubMed:11477090). Involved in the cleavage of the adhesion molecule L1 at the cell surface and in released membrane vesicles, suggesting a vesicle-based protease activity (PubMed:12475894). Controls also the proteolytic processing of Notch and mediates lateral inhibition during neurogenesis (By similarity). Responsible for the FasL ectodomain shedding and for the generation of the remnant ADAM10-processed FasL (FasL APL) transmembrane form (PubMed:17557115). Also cleaves the ectodomain of the integral membrane proteins CORIN and ITM2B (PubMed:19114711, PubMed:21288900). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R and IL11RA, leading to the release of secreted forms of IL6R and IL11RA (PubMed:26876177). Enhances the cleavage of CHL1 by BACE1 (By similarity). Cleaves NRCAM (By similarity). Cleaves TREM2, resulting in shedding of the TREM2 ectodomain (PubMed:24990881). Involved in the development and maturation of glomerular and coronary vasculature (By similarity). During development of the cochlear organ of Corti, promotes pillar cell separation by forming a ternary complex with CADH1 and EPHA4 and cleaving CADH1 at adherens junctions (By similarity). May regulate the EFNA5-EPHA3 signaling (PubMed:16239146). {ECO:0000250|UniProtKB:O35598, ECO:0000269|PubMed:11477090, ECO:0000269|PubMed:11786905, ECO:0000269|PubMed:12475894, ECO:0000269|PubMed:16239146, ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:19114711, ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:21288900, ECO:0000269|PubMed:24990881, ECO:0000269|PubMed:26686862, ECO:0000269|PubMed:26876177, ECO:0000269|PubMed:29224781}.; (Microbial infection) Promotes the cytotoxic activity of S.aureus hly by binding to the toxin at zonula adherens and promoting formation of toxin pores. {ECO:0000269|PubMed:20624979, ECO:0000269|PubMed:30463011}.","6":"-5.11485308","7":"-33.837046539","8":"Undefined","9":"PM,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"O14672"},{"1":"ABCD4 PXMP1L","2":"ABCD4_HUMAN","3":"unknown","4":"Lysosomal cobalamin transporter ABCD4 (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69)","5":"Lysosomal transporter that plays a role in the lysosomal release of vitamin B12 into the cytosol (PubMed:22922874). Targeted by LMBRD1 lysosomal chaperone from the endoplasmic reticulum to the lysosomal membrane (PubMed:27456980). Then forms a complex with lysosomal chaperone LMBRD1 and cytosolic MMACHC to transport cobalamin across the lysosomal membrane (PubMed:25535791). {ECO:0000269|PubMed:22922874, ECO:0000269|PubMed:27456980, ECO:0000303|PubMed:25535791}.","6":"4.91731302","7":"-37.386563815","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O14678"},{"1":"KMT2D ALR MLL2 MLL4","2":"KMT2D_HUMAN","3":"unknown","4":"Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)","5":"Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.","6":"-15.88122440","7":"29.999663250","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O14686"},{"1":"TRDMT1 DNMT2","2":"TRDMT_HUMAN","3":"unknown","4":"tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog HsaIIP) (DNA MTase homolog HsaIIP) (M.HsaIIP) (PuMet)","5":"Specifically methylates cytosine 38 in the anticodon loop of tRNA(Asp). {ECO:0000269|PubMed:16424344}.","6":"4.94318210","7":"7.670261643","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14717"},{"1":"APAF1 KIAA0413","2":"APAF_HUMAN","3":"unknown","4":"Apoptotic protease-activating factor 1 (APAF-1)","5":"Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. Isoform 6 is less effective in inducing apoptosis. {ECO:0000269|PubMed:10393175, ECO:0000269|PubMed:12804598}.","6":"32.77738193","7":"18.770139530","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14727"},{"1":"ACOT8 ACTEIII PTE1","2":"ACOT8_HUMAN","3":"unknown","4":"Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.1) (EC 3.1.2.11) (EC 3.1.2.2) (EC 3.1.2.3) (EC 3.1.2.5) (Choloyl-coenzyme A thioesterase) (EC 3.1.2.27) (HIV-Nef-associated acyl-CoA thioesterase) (Peroxisomal acyl-CoA thioesterase 2) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) (Thioesterase II) (hACTE-III) (hACTEIII) (hTE)","5":"Acyl-coenzyme A (acyl-CoA) thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH (PubMed:9299485, PubMed:9153233, PubMed:15194431). Acyl-coenzyme A thioesterase 8/ACOT8 display no strong substrate specificity with respect to the carboxylic acid moiety of Acyl-CoAs (By similarity). Hydrolyzes medium length (C2 to C20) straight-chain, saturated and unsaturated acyl-CoAS but is inactive towards substrates with longer aliphatic chains (PubMed:9299485, PubMed:9153233). Moreover, it catalyzes the hydrolysis of CoA esters of bile acids, such as choloyl-CoA and chenodeoxycholoyl-CoA and competes with bile acid CoA:amino acid N-acyltransferase (BAAT) (By similarity). ACOT8 is also able to hydrolyze CoA esters of dicarboxylic acids (By similarity). It is involved in the metabolic regulation of peroxisome proliferation (PubMed:15194431). {ECO:0000250|UniProtKB:P58137, ECO:0000269|PubMed:15194431, ECO:0000269|PubMed:9153233, ECO:0000269|PubMed:9299485}.; (Microbial infection) May mediate Nef-induced down-regulation of CD4 cell-surface expression (PubMed:9153233). {ECO:0000269|PubMed:9153233}.","6":"-23.55286936","7":"-14.338076142","8":"Undefined","9":"PEROXISOME,PEROXISOME,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O14734"},{"1":"PDCD5 TFAR19","2":"PDCD5_HUMAN","3":"unknown","4":"Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19)","5":"May function in the process of apoptosis.","6":"15.60224360","7":"-8.695626236","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14737"},{"1":"PRMT5 HRMT1L5 IBP72 JBP1 SKB1","2":"ANM5_HUMAN","3":"unknown","4":"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]","5":"Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA (PubMed:10531356, PubMed:11152681, PubMed:11747828, PubMed:12411503, PubMed:15737618, PubMed:17709427, PubMed:20159986, PubMed:20810653, PubMed:21258366, PubMed:21917714, PubMed:22269951, PubMed:21081503). Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles (PubMed:12411503, PubMed:11747828, PubMed:17709427). Methylates SUPT5H and may regulate its transcriptional elongation properties (PubMed:12718890). Mono- and dimethylates arginine residues of myelin basic protein (MBP) in vitro. May play a role in cytokine-activated transduction pathways. Negatively regulates cyclin E1 promoter activity and cellular proliferation. Methylates histone H2A and H4 'Arg-3' during germ cell development (By similarity). Methylates histone H3 'Arg-8', which may repress transcription (By similarity). Methylates the Piwi proteins (PIWIL1, PIWIL2 and PIWIL4), methylation of Piwi proteins being required for the interaction with Tudor domain-containing proteins and subsequent localization to the meiotic nuage (By similarity). Methylates RPS10. Attenuates EGF signaling through the MAPK1/MAPK3 pathway acting at 2 levels. First, monomethylates EGFR; this enhances EGFR 'Tyr-1197' phosphorylation and PTPN6 recruitment, eventually leading to reduced SOS1 phosphorylation (PubMed:21917714, PubMed:21258366). Second, methylates RAF1 and probably BRAF, hence destabilizing these 2 signaling proteins and reducing their catalytic activity (PubMed:21917714). Required for induction of E-selectin and VCAM-1, on the endothelial cells surface at sites of inflammation. Methylates HOXA9 (PubMed:22269951). Methylates and regulates SRGAP2 which is involved in cell migration and differentiation (PubMed:20810653). Acts as a transcriptional corepressor in CRY1-mediated repression of the core circadian component PER1 by regulating the H4R3 dimethylation at the PER1 promoter (By similarity). Methylates GM130/GOLGA2, regulating Golgi ribbon formation (PubMed:20421892). Methylates H4R3 in genes involved in glioblastomagenesis in a CHTOP- and/or TET1-dependent manner (PubMed:25284789). Symmetrically methylates POLR2A, a modification that allows the recruitment to POLR2A of proteins including SMN1/SMN2 and SETX. This is required for resolving RNA-DNA hybrids created by RNA polymerase II, that form R-loop in transcription terminal regions, an important step in proper transcription termination (PubMed:26700805). Along with LYAR, binds the promoter of gamma-globin HBG1/HBG2 and represses its expression (PubMed:25092918). Symmetrically methylates NCL (PubMed:21081503). Methylates TP53; methylation might possibly affect TP53 target gene specificity (PubMed:19011621). Involved in spliceosome maturation and mRNA splicing in prophase I spermatocytes through the catalysis of the symmetrical arginine dimethylation of SNRPB (small nuclear ribonucleoprotein-associated protein) and the interaction with tudor domain-containing protein TDRD6 (By similarity). {ECO:0000250|UniProtKB:Q8CIG8, ECO:0000269|PubMed:10531356, ECO:0000269|PubMed:11152681, ECO:0000269|PubMed:11747828, ECO:0000269|PubMed:12411503, ECO:0000269|PubMed:12718890, ECO:0000269|PubMed:15737618, ECO:0000269|PubMed:17709427, ECO:0000269|PubMed:19011621, ECO:0000269|PubMed:20159986, ECO:0000269|PubMed:20421892, ECO:0000269|PubMed:20810653, ECO:0000269|PubMed:21081503, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:21917714, ECO:0000269|PubMed:22269951, ECO:0000269|PubMed:25092918, ECO:0000269|PubMed:25284789, ECO:0000269|PubMed:26700805}.","6":"13.63883362","7":"36.032650273","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14744"},{"1":"SLC9A3R1 NHERF NHERF1","2":"NHRF1_HUMAN","3":"unknown","4":"Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)","5":"Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized ADRB2. Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling. May participate in HTR4 targeting to microvilli (By similarity). Involved in the regulation of phosphate reabsorption in the renal proximal tubules. Involved in sperm capacitation. May participate in the regulation of the chloride and bicarbonate homeostasis in spermatozoa. {ECO:0000250, ECO:0000269|PubMed:10499588, ECO:0000269|PubMed:18784102, ECO:0000269|PubMed:9096337, ECO:0000269|PubMed:9430655}.","6":"2.42161209","7":"-29.659818397","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"O14745"},{"1":"CHEK1 CHK1","2":"CHK1_HUMAN","3":"unknown","4":"Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1)","5":"Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047). This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047). Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047). Binds to and phosphorylates CDC25A, CDC25B and CDC25C (PubMed:9278511, PubMed:12676583, PubMed:14681206, PubMed:12676925, PubMed:12759351, PubMed:19734889, PubMed:14559997). Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C (PubMed:9278511). Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A (PubMed:9278511, PubMed:12676583, PubMed:14681206, PubMed:12676925, PubMed:12759351, PubMed:19734889). Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A (PubMed:9278511, PubMed:19734889, PubMed:20090422). Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression (PubMed:9278511). Also phosphorylates NEK6 (PubMed:18728393). Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination (PubMed:15665856). Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation (PubMed:10673501, PubMed:15659650, PubMed:16511572). Also promotes repair of DNA cross-links through phosphorylation of FANCE (PubMed:17296736). Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A (PubMed:12660173, PubMed:12955071). This may enhance chromatin assembly both in the presence or absence of DNA damage (PubMed:12660173, PubMed:12955071). May also play a role in replication fork maintenance through regulation of PCNA (PubMed:18451105). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity). Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest (PubMed:17380128). Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (PubMed:31316063). Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (PubMed:33108758). {ECO:0000250|UniProtKB:O35280, ECO:0000269|PubMed:10673501, ECO:0000269|PubMed:11535615, ECO:0000269|PubMed:12399544, ECO:0000269|PubMed:12446774, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676925, ECO:0000269|PubMed:12759351, ECO:0000269|PubMed:12955071, ECO:0000269|PubMed:14559997, ECO:0000269|PubMed:14681206, ECO:0000269|PubMed:14988723, ECO:0000269|PubMed:15311285, ECO:0000269|PubMed:15650047, ECO:0000269|PubMed:15659650, ECO:0000269|PubMed:15665856, ECO:0000269|PubMed:16511572, ECO:0000269|PubMed:17296736, ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:18451105, ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:19734889, ECO:0000269|PubMed:20090422, ECO:0000269|PubMed:31316063, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:9278511}.; [Isoform 2]: Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition. {ECO:0000269|PubMed:22184239}.","6":"29.75690090","7":"0.276540584","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14757"},{"1":"TPP1 CLN2 GIG1 UNQ267/PRO304","2":"TPP1_HUMAN","3":"LYSOSOME","4":"Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)","5":"Lysosomal serine protease with tripeptidyl-peptidase I activity (PubMed:11054422, PubMed:19038966, PubMed:19038967). May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases (PubMed:11054422, PubMed:19038966, PubMed:19038967). Requires substrates with an unsubstituted N-terminus (PubMed:19038966). {ECO:0000269|PubMed:11054422, ECO:0000269|PubMed:19038966, ECO:0000269|PubMed:19038967}.","6":"10.88603199","7":"-42.735169121","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O14773"},{"1":"TCERG1 CA150 TAF2S","2":"TCRG1_HUMAN","3":"unknown","4":"Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)","5":"Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner. Necessary for TAT-dependent activation of the human immunodeficiency virus type 1 (HIV-1) promoter. {ECO:0000269|PubMed:11604498, ECO:0000269|PubMed:9315662}.","6":"25.92899071","7":"18.024059728","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14776"},{"1":"NDC80 HEC HEC1 KNTC2","2":"NDC80_HUMAN","3":"unknown","4":"Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)","5":"Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity (PubMed:9315664, PubMed:12351790, PubMed:14654001, PubMed:14699129, PubMed:15062103, PubMed:15235793, PubMed:15239953, PubMed:15548592, PubMed:16732327). Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore (PubMed:15548592). The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules (PubMed:23085020). Plays a role in chromosome congression and is essential for the end-on attachment of the kinetochores to spindle microtubules (PubMed:25743205, PubMed:23891108). {ECO:0000269|PubMed:12351790, ECO:0000269|PubMed:14654001, ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:15062103, ECO:0000269|PubMed:15235793, ECO:0000269|PubMed:15239953, ECO:0000269|PubMed:15548592, ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:23085020, ECO:0000269|PubMed:23891108, ECO:0000269|PubMed:25743205, ECO:0000269|PubMed:9315664}.","6":"18.01206886","7":"7.074932609","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14777"},{"1":"NRP1 NRP VEGF165R","2":"NRP1_HUMAN","3":"PM","4":"Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304)","5":"Cell-surface receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. Mediates the chemorepulsant activity of semaphorins (PubMed:9288753, PubMed:9529250, PubMed:10688880). Recognizes a C-end rule (CendR) motif R/KXXR/K on its ligands which causes cellular internalization and vascular leakage (PubMed:19805273). It binds to semaphorin 3A, the PLGF-2 isoform of PGF, the VEGF165 isoform of VEGFA and VEGFB (PubMed:9288753, PubMed:9529250, PubMed:10688880, PubMed:19805273). Coexpression with KDR results in increased VEGF165 binding to KDR as well as increased chemotaxis. Regulates VEGF-induced angiogenesis. Binding to VEGFA initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). Regulates mitochondrial iron transport via interaction with ABCB8/MITOSUR (PubMed:30623799). {ECO:0000250|UniProtKB:P97333, ECO:0000269|PubMed:10688880, ECO:0000269|PubMed:19805273, ECO:0000269|PubMed:30623799, ECO:0000269|PubMed:9288753, ECO:0000269|PubMed:9529250}.; [Isoform 2]: Binds VEGF-165 and may inhibit its binding to cells (PubMed:10748121, PubMed:26503042). May induce apoptosis by sequestering VEGF-165 (PubMed:10748121). May bind as well various members of the semaphorin family. Its expression has an averse effect on blood vessel number and integrity. {ECO:0000269|PubMed:10748121, ECO:0000269|PubMed:26503042}.; (Microbial infection) Acts as a host factor for human coronavirus SARS-CoV-2 infection. Recognizes and binds to CendR motif RRAR on SARS-CoV-2 spike protein S1 which enhances SARS-CoV-2 infection. {ECO:0000269|PubMed:33082293, ECO:0000269|PubMed:33082294}.","6":"-0.57117379","7":"-35.928638919","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O14786"},{"1":"TNPO2","2":"TNPO2_HUMAN","3":"unknown","4":"Transportin-2 (Karyopherin beta-2b)","5":"Probably functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). {ECO:0000250}.","6":"39.58166163","7":"5.228934022","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O14787"},{"1":"POLR3A","2":"RPC1_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic core component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Forms the polymerase active center together with the second largest subunit. A single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol III. A bridging helix emanates from RPC1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol III by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition (By similarity). Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway. {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370}.","6":"11.54061644","7":"37.233968655","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14802"},{"1":"PSMA7 HSPC","2":"PSA7_HUMAN","3":"PROTEIN COMPLEX","4":"Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)","5":"Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Inhibits the transactivation function of HIF-1A under both normoxic and hypoxia-mimicking conditions. The interaction with EMAP2 increases the proteasome-mediated HIF-1A degradation under the hypoxic conditions. Plays a role in hepatitis C virus internal ribosome entry site-mediated translation. Mediates nuclear translocation of the androgen receptor (AR) and thereby enhances androgen-mediated transactivation. Promotes MAVS degradation and thereby negatively regulates MAVS-mediated innate immune response. {ECO:0000269|PubMed:11389899, ECO:0000269|PubMed:11713272, ECO:0000269|PubMed:12119296, ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:19442227, ECO:0000269|PubMed:19734229, ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.","6":"13.22775884","7":"34.817934835","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O14818"},{"1":"SCAMP3 C1orf3 PROPIN1","2":"SCAM3_HUMAN","3":"unknown","4":"Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3)","5":"Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface.","6":"22.07893776","7":"-34.469045524","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O14828"},{"1":"OPLAH","2":"OPLA_HUMAN","3":"unknown","4":"5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)","5":"Catalyzes the cleavage of 5-oxo-L-proline to form L-glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate.","6":"46.21427485","7":"-0.905871769","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O14841"},{"1":"BACH1","2":"BACH1_HUMAN","3":"unknown","4":"Transcription regulator protein BACH1 (BTB and CNC homolog 1) (HA2303)","5":"Transcriptional regulator that acts as repressor or activator, depending on the context. Binds to NF-E2 DNA binding sites. Plays important roles in coordinating transcription activation and repression by MAFK (By similarity). Together with MAF, represses the transcription of genes under the control of the NFE2L2 oxidative stress pathway (PubMed:24035498). {ECO:0000250|UniProtKB:P97302, ECO:0000269|PubMed:24035498}.","6":"-3.90928748","7":"27.161090813","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O14867"},{"1":"GEMIN2 SIP1","2":"GEMI2_HUMAN","3":"unknown","4":"Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1)","5":"The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:9323129}.","6":"7.12657559","7":"37.533147922","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14893"},{"1":"GIPC1 C19orf3 GIPC RGS19IP1","2":"GIPC1_HUMAN","3":"unknown","4":"PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2)","5":"May be involved in G protein-linked signaling.","6":"6.33468021","7":"-18.374211109","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14908"},{"1":"IKBKB IKKB","2":"IKKB_HUMAN","3":"unknown","4":"Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)","5":"Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:30337470). Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation. Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:20410276). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NCOA3, BCL10 and IRS1 (PubMed:17213322). Within the nucleus, acts as an adapter protein for NFKBIA degradation in UV-induced NF-kappa-B activation (PubMed:11297557). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418). {ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:11297557, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17213322, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:20410276, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20797629, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:30337470}.","6":"36.32742414","7":"17.619055277","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14920"},{"1":"TIMM23 TIM23","2":"TIM23_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial import inner membrane translocase subunit Tim23","5":"Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane. {ECO:0000305|PubMed:10339406}.","6":"-35.22105096","7":"-11.229646079","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O14925"},{"1":"HAT1 KAT1","2":"HAT1_HUMAN","3":"unknown","4":"Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)","5":"Histone acetyltransferase that plays a role in different biological processes including cell cycle progression, glucose metabolism, histone production or DNA damage repair (PubMed:31278053, PubMed:20953179, PubMed:23653357, PubMed:32081014). Coordinates histone production and acetylation via H4 promoter binding (PubMed:31278053). Acetylates histone H4 at 'Lys-5' (H4K5ac) and 'Lys-12' (H4K12ac) and, to a lesser extent, histone H2A at 'Lys-5' (H2AK5ac) (PubMed:22615379, PubMed:11585814). Drives H4 production by chromatin binding to support chromatin replication and acetylation. Since transcription of H4 genes is tightly coupled to S-phase, plays an important role in S-phase entry and progression (PubMed:31278053). Promotes homologous recombination in DNA repair by facilitating histone turnover and incorporation of acetylated H3.3 at sites of double-strand breaks (PubMed:23653357). In addition, acetylates other substrates such as chromatin-related proteins (PubMed:32081014). Acetylates also RSAD2 which mediates the interaction of ubiquitin ligase UBE4A with RSAD2 leading to RSAD2 ubiquitination and subsequent degradation (PubMed:31812350). {ECO:0000269|PubMed:11585814, ECO:0000269|PubMed:20953179, ECO:0000269|PubMed:22615379, ECO:0000269|PubMed:23653357, ECO:0000269|PubMed:31278053, ECO:0000269|PubMed:31812350, ECO:0000269|PubMed:32081014}.; (Microbial infection) Contributes to hepatitis B virus (HBV) replication by acetylating histone H4 at the sites of 'Lys-5' and 'Lys-12' on the covalently closed circular DNA (cccDNA) minichromosome leading to its accumulation within the host cell. {ECO:0000269|PubMed:31695772}.","6":"-0.85480852","7":"22.566600500","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14929"},{"1":"CASK LIN2","2":"CSKP_HUMAN","3":"unknown","4":"Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)","5":"Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TBR1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1. Component of the LIN-10-LIN-2-LIN-7 complex, which associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). {ECO:0000250|UniProtKB:O70589}.","6":"-8.89100405","7":"-23.400094303","8":"ER","9":"ER,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"O14936"},{"1":"MYL12B MRLC2 MYLC2B","2":"ML12B_HUMAN","3":"unknown","4":"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)","5":"Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Phosphorylation triggers actin polymerization in vascular smooth muscle. Implicated in cytokinesis, receptor capping, and cell locomotion. {ECO:0000269|PubMed:10965042}.","6":"-10.75352099","7":"15.853718565","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O14950"},{"1":"HGS HRS","2":"HGS_HUMAN","3":"unknown","4":"Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)","5":"Involved in intracellular signal transduction mediated by cytokines and growth factors. When associated with STAM, it suppresses DNA signaling upon stimulation by IL-2 and GM-CSF. Could be a direct effector of PI3-kinase in vesicular pathway via early endosomes and may regulate trafficking to early and late endosomes by recruiting clathrin. May concentrate ubiquitinated receptors within clathrin-coated regions. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with STAM (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes. May contribute to the efficient recruitment of SMADs to the activin receptor complex. Involved in receptor recycling via its association with the CART complex, a multiprotein complex required for efficient transferrin receptor recycling but not for EGFR degradation.","6":"6.15536857","7":"-16.707828452","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14964"},{"1":"AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6","2":"AURKA_HUMAN","3":"unknown","4":"Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)","5":"Mitotic serine/threonine kinase that contributes to the regulation of cell cycle progression (PubMed:26246606, PubMed:12390251, PubMed:18615013, PubMed:11039908, PubMed:17125279, PubMed:17360485). Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis (PubMed:26246606, PubMed:14523000). Required for normal spindle positioning during mitosis and for the localization of NUMA1 and DCTN1 to the cell cortex during metaphase (PubMed:27335426). Required for initial activation of CDK1 at centrosomes (PubMed:13678582, PubMed:15128871). Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2 (PubMed:18056443, PubMed:15128871, PubMed:14702041, PubMed:11551964, PubMed:15147269, PubMed:15987997, PubMed:17604723, PubMed:18615013). Regulates KIF2A tubulin depolymerase activity (PubMed:19351716). Important for microtubule formation and/or stabilization (PubMed:18056443). Required for normal axon formation (PubMed:19812038). Plays a role in microtubule remodeling during neurite extension (PubMed:19668197). Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and destabilizing p53/TP53 (PubMed:14702041). Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (PubMed:11551964). Necessary for proper cilia disassembly prior to mitosis (PubMed:17604723, PubMed:20643351). Regulates protein levels of the anti-apoptosis protein BIRC5 by suppressing the expression of the SCF(FBXL7) E3 ubiquitin-protein ligase substrate adapter FBXL7 through the phosphorylation of the transcription factor FOXP1 (PubMed:28218735). {ECO:0000269|PubMed:11039908, ECO:0000269|PubMed:11551964, ECO:0000269|PubMed:12390251, ECO:0000269|PubMed:13678582, ECO:0000269|PubMed:14523000, ECO:0000269|PubMed:14702041, ECO:0000269|PubMed:15128871, ECO:0000269|PubMed:15147269, ECO:0000269|PubMed:15987997, ECO:0000269|PubMed:17125279, ECO:0000269|PubMed:17360485, ECO:0000269|PubMed:17604723, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19351716, ECO:0000269|PubMed:19668197, ECO:0000269|PubMed:19812038, ECO:0000269|PubMed:20643351, ECO:0000269|PubMed:26246606, ECO:0000269|PubMed:27335426, ECO:0000269|PubMed:28218735}.","6":"8.71859364","7":"3.788031482","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O14965"},{"1":"RAB29 RAB7L1","2":"RAB7L_HUMAN","3":"unknown","4":"Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29)","5":"The small GTPases Rab are key regulators in vesicle trafficking (PubMed:24788816). Essential for maintaining the integrity of the endosome-trans-Golgi network structure (By similarity). Together with LRRK2, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose 6 phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner (PubMed:24788816). Recruits LRRK2 to the Golgi complex and stimulates LRRK2 kinase activity (PubMed:29212815). Regulates neuronal process morphology in the intact central nervous system (CNS) (By similarity). May play a role in the formation of typhoid toxin transport intermediates during Salmonella enterica serovar Typhi (S.Typhi) epithelial cell infection (PubMed:22042847). {ECO:0000250|UniProtKB:Q63481, ECO:0000269|PubMed:22042847, ECO:0000269|PubMed:24788816, ECO:0000269|PubMed:29212815}.","6":"-17.02423686","7":"-18.194981632","8":"Undefined","9":"ER,ER,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O14966"},{"1":"PPP1R12A MBS MYPT1","2":"MYPT1_HUMAN","3":"unknown","4":"Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)","5":"Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. {ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:20354225}.","6":"-8.92855633","7":"10.520178174","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O14974"},{"1":"GAK","2":"GAK_HUMAN","3":"unknown","4":"Cyclin-G-associated kinase (EC 2.7.11.1)","5":"Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1. {ECO:0000269|PubMed:10625686}.","6":"19.73101503","7":"17.509421224","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14976"},{"1":"HNRNPDL HNRPDL JKTBP","2":"HNRDL_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)","5":"Acts as a transcriptional regulator. Promotes transcription repression. Promotes transcription activation in differentiated myotubes (By similarity). Binds to double- and single-stranded DNA sequences. Binds to the transcription suppressor CATR sequence of the COX5B promoter (By similarity). Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Binds both to nuclear and cytoplasmic poly(A) mRNAs. Binds to poly(G) and poly(A), but not to poly(U) or poly(C) RNA homopolymers. Binds to the 5'-ACUAGC-3' RNA consensus sequence. {ECO:0000250, ECO:0000269|PubMed:9538234}.","6":"30.68101316","7":"-3.029347576","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14979"},{"1":"XPO1 CRM1","2":"XPO1_HUMAN","3":"unknown","4":"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","5":"Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich nuclear export signal (NES) and of RNAs. In the nucleus, in association with RANBP3, binds cooperatively to the NES on its target protein and to the GTPase RAN in its active GTP-bound form (Ran-GTP). Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the cargo from the export receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Involved in U3 snoRNA transport from Cajal bodies to nucleoli. Binds to late precursor U3 snoRNA bearing a TMG cap. {ECO:0000269|PubMed:15574332, ECO:0000269|PubMed:20921223, ECO:0000269|PubMed:9311922, ECO:0000269|PubMed:9323133}.; (Microbial infection) Mediates the export of unspliced or incompletely spliced RNAs out of the nucleus from different viruses including HIV-1, HTLV-1 and influenza A. Interacts with, and mediates the nuclear export of HIV-1 Rev and HTLV-1 Rex proteins. Involved in HTLV-1 Rex multimerization. {ECO:0000269|PubMed:14612415, ECO:0000269|PubMed:9837918}.","6":"39.52858174","7":"6.397250933","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O14980"},{"1":"BTAF1 TAF172","2":"BTAF1_HUMAN","3":"unknown","4":"TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)","5":"Regulates transcription in association with TATA binding protein (TBP). Removes TBP from the TATA box in an ATP-dependent manner.","6":"32.31387286","7":"19.364383068","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O14981"},{"1":"ARHGEF10 KIAA0294","2":"ARHGA_HUMAN","3":"unknown","4":"Rho guanine nucleotide exchange factor 10","5":"May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}.","6":"-3.20204391","7":"26.345743181","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15013"},{"1":"ZNF609 KIAA0295","2":"ZN609_HUMAN","3":"unknown","4":"Zinc finger protein 609","5":"Transcription factor, which activates RAG1, and possibly RAG2, transcription. Through the regulation of RAG1/2 expression, may regulate thymocyte maturation. Along with NIPBL and the multiprotein complex Integrator, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others. {ECO:0000250|UniProtKB:Q8BZ47}.; [Isoform 2]: Involved in the regulation of myoblast proliferation during myogenesis. {ECO:0000269|PubMed:28344082}.","6":"0.66863801","7":"32.001261633","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15014"},{"1":"SPTBN2 KIAA0302 SCA5","2":"SPTN2_HUMAN","3":"unknown","4":"Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)","5":"Probably plays an important role in neuronal membrane skeleton.","6":"-9.24000881","7":"-13.519483654","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15020"},{"1":"SEC16A KIAA0310 SEC16 SEC16L","2":"SC16A_HUMAN","3":"unknown","4":"Protein transport protein Sec16A (SEC16 homolog A) (p250)","5":"Acts as a molecular scaffold that plays a key role in the organization of the endoplasmic reticulum exit sites (ERES), also known as transitional endoplasmic reticulum (tER). SAR1A-GTP-dependent assembly of SEC16A on the ER membrane forms an organized scaffold defining an ERES. Required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus (PubMed:17192411, PubMed:17005010, PubMed:17428803, PubMed:21768384, PubMed:22355596). Mediates the recruitment of MIA3/TANGO to ERES (PubMed:28442536). Regulates both conventional (ER/Golgi-dependent) and GORASP2-mediated unconventional (ER/Golgi-independent) trafficking of CFTR to cell membrane (PubMed:28067262). Positively regulates the protein stability of E3 ubiquitin-protein ligases RNF152 and RNF183 and the ER localization of RNF183 (PubMed:29300766). Acts as a RAB10 effector in the regulation of insulin-induced SLC2A4/GLUT4 glucose transporter-enriched vesicles delivery to the cell membrane in adipocytes (By similarity). {ECO:0000250|UniProtKB:E9QAT4, ECO:0000269|PubMed:17005010, ECO:0000269|PubMed:17192411, ECO:0000269|PubMed:17428803, ECO:0000269|PubMed:21768384, ECO:0000269|PubMed:22355596, ECO:0000269|PubMed:28067262, ECO:0000269|PubMed:28442536, ECO:0000269|PubMed:29300766}.","6":"21.91754975","7":"32.965587155","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15027"},{"1":"PLXNB2 KIAA0315","2":"PLXB2_HUMAN","3":"PM","4":"Plexin-B2 (MM1)","5":"Cell surface receptor for SEMA4C, SEMA4D and SEMA4G that plays an important role in cell-cell signaling (By similarity). Plays a role in glutamatergic synapse development and is required for SEMA4A-mediated excitatory synapse development (By similarity). Binding to class 4 semaphorins promotes downstream activation of RHOA and phosphorylation of ERBB2 at 'Tyr-1248' (By similarity). Required for normal differentiation and migration of neuronal cells during brain corticogenesis and for normal embryonic brain development (By similarity). Regulates the migration of cerebellar granule cells in the developing brain (By similarity). Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton (PubMed:12183458). Plays a role in axon guidance, invasive growth and cell migration (PubMed:15184888). May modulate the activity of RAC1 and CDC42 (By similarity). {ECO:0000250|UniProtKB:B2RXS4, ECO:0000269|PubMed:12183458, ECO:0000269|PubMed:15184888}.","6":"-1.72608934","7":"-39.452423161","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15031"},{"1":"U2SURP KIAA0332 SR140","2":"SR140_HUMAN","3":"unknown","4":"U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)","5":"NA","6":"-1.94281420","7":"30.376325574","8":"Undefined","9":"PROTEIN COMPLEX,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15042"},{"1":"SETD1A KIAA0339 KMT2F SET1 SET1A","2":"SET1A_HUMAN","3":"unknown","4":"Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.354) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)","5":"Histone methyltransferase that specifically methylates 'Lys-4' of histone H3, when part of the SET1 histone methyltransferase (HMT) complex, but not if the neighboring 'Lys-9' residue is already methylated. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. The non-overlapping localization with SETD1B suggests that SETD1A and SETD1B make non-redundant contributions to the epigenetic control of chromatin structure and gene expression (PubMed:12670868). May play a role in synaptic function and the development of neurons (PubMed:31197650). {ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:31197650}.","6":"-21.87950616","7":"12.836194729","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15047"},{"1":"SYNJ2 KIAA0348","2":"SYNJ2_HUMAN","3":"unknown","4":"Synaptojanin-2 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2)","5":"Inositol 5-phosphatase which may be involved in distinct membrane trafficking and signal transduction pathways. May mediate the inhibitory effect of Rac1 on endocytosis.","6":"17.46937990","7":"15.766917374","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15056"},{"1":"KIF3B KIAA0359","2":"KIF3B_HUMAN","3":"unknown","4":"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]","5":"Microtubule-based molecular motor that transport intracellular cargos, such as vesicles, organelles and protein complexes. Uses ATP hydrolysis to generate force to bind and move along the microtubule (By similarity). Plays a role in cilia formation (PubMed:32386558). Involved in photoreceptor integrity and opsin trafficking in rod photoreceptors (PubMed:32386558). Transports vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit GRIN2A into neuronal dendrites (By similarity). {ECO:0000250|UniProtKB:Q61771, ECO:0000269|PubMed:32386558}.","6":"11.54795851","7":"28.354882809","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15066"},{"1":"PFAS KIAA0361","2":"PUR4_HUMAN","3":"unknown","4":"Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)","5":"Phosphoribosylformylglycinamidine synthase involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate (By similarity). {ECO:0000250}.","6":"43.02459689","7":"2.068516073","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O15067"},{"1":"CEP290 BBS14 KIAA0373 NPHP6","2":"CE290_HUMAN","3":"unknown","4":"Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2)","5":"Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110 (PubMed:18694559). May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs). Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1 (PubMed:24421332). Required for the correct localization of ciliary and phototransduction proteins in retinal photoreceptor cells; may play a role in ciliary transport processes (By similarity). Required for efficient recruitment of RAB8A to primary cilium (PubMed:17705300). In the ciliary transition zone is part of the tectonic-like complex which is required for tissue-specific ciliogenesis and may regulate ciliary membrane composition (By similarity). Involved in regulation of the BBSome complex integrity, specifically for presence of BBS2, BBS5 and BBS8/TTC8 in the complex, and in ciliary targeting of selected BBSome cargos. May play a role in controlling entry of the BBSome complex to cilia possibly implicating IQCB1/NPHP5 (PubMed:25552655). Activates ATF4-mediated transcription (PubMed:16682973). {ECO:0000250|UniProtKB:Q6A078, ECO:0000269|PubMed:16682973, ECO:0000269|PubMed:17705300, ECO:0000269|PubMed:18694559, ECO:0000269|PubMed:24421332, ECO:0000269|PubMed:25552655}.","6":"13.29735840","7":"-8.801640347","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15078"},{"1":"ANKRD28 KIAA0379","2":"ANR28_HUMAN","3":"unknown","4":"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)","5":"Putative regulatory subunit of protein phosphatase 6 (PP6) that may be involved in the recognition of phosphoprotein substrates. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. Selectively inhibits the phosphatase activity of PPP1C. Targets PPP1C to modulate HNRPK phosphorylation. {ECO:0000269|PubMed:16564677, ECO:0000269|PubMed:18186651}.","6":"-1.49175980","7":"35.808939733","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15084"},{"1":"ARHGEF11 KIAA0380","2":"ARHGB_HUMAN","3":"unknown","4":"Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF)","5":"May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. Involved in neurotrophin-induced neurite outgrowth. {ECO:0000269|PubMed:21670212}.","6":"-11.64042834","7":"-8.721638980","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15085"},{"1":"PRORP KIAA0391 MRPP3","2":"MRPP3_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit)","5":"Catalytic ribonuclease component of mitochondrial ribonuclease P, a complex composed of TRMT10C/MRPP1, HSD17B10/MRPP2 and PRORP/MRPP3, which cleaves tRNA molecules in their 5'-ends (PubMed:18984158, PubMed:25953853). The presence of TRMT10C/MRPP1, HSD17B10/MRPP2 is required to catalyze tRNA molecules in their 5'-ends (PubMed:25953853). {ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:25953853}.","6":"-32.12120582","7":"-10.150452016","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15091"},{"1":"CHUK IKKA TCF16","2":"IKKA_HUMAN","3":"unknown","4":"Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16)","5":"Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:12789342, PubMed:15084260, PubMed:17434128, PubMed:20434986, PubMed:20501937, PubMed:21765415). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). {ECO:0000250|UniProtKB:Q60680, ECO:0000269|PubMed:12789342, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17434128, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20501937, ECO:0000269|PubMed:21765415}.","6":"37.74849147","7":"16.767334260","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15111"},{"1":"LSM1 CASM","2":"LSM1_HUMAN","3":"unknown","4":"U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm)","5":"Plays a role in the degradation of histone mRNAs, the only eukaryotic mRNAs that are not polyadenylated (PubMed:18172165). Probably also part of an LSm subunits-containing complex involved in the general process of mRNA degradation (By similarity). {ECO:0000250|UniProtKB:P47017, ECO:0000269|PubMed:18172165}.","6":"17.80989080","7":"22.425681845","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15116"},{"1":"NPC1","2":"NPC1_HUMAN","3":"unknown","4":"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","5":"Intracellular cholesterol transporter which acts in concert with NPC2 and plays an important role in the egress of cholesterol from the endosomal/lysosomal compartment (PubMed:9211849, PubMed:9927649, PubMed:10821832, PubMed:18772377, PubMed:27238017, PubMed:12554680). Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol-binding pocket in the N-terminal domain of NPC1 (PubMed:9211849, PubMed:9927649, PubMed:18772377, PubMed:19563754, PubMed:27238017, PubMed:28784760). Cholesterol binds to NPC1 with the hydroxyl group buried in the binding pocket (PubMed:19563754). Binds oxysterol with higher affinity than cholesterol. May play a role in vesicular trafficking in glia, a process that may be crucial for maintaining the structural and functional integrity of nerve terminals (Probable). {ECO:0000269|PubMed:10821832, ECO:0000269|PubMed:12554680, ECO:0000269|PubMed:18772377, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:28784760, ECO:0000269|PubMed:9211849, ECO:0000269|PubMed:9927649, ECO:0000305}.; (Microbial infection) Acts as an endosomal entry receptor for ebolavirus. {ECO:0000269|PubMed:21866103, ECO:0000269|PubMed:25855742, ECO:0000269|PubMed:32855215}.","6":"4.91672901","7":"-40.251360424","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O15118"},{"1":"SCAMP1 SCAMP","2":"SCAM1_HUMAN","3":"unknown","4":"Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)","5":"Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface.","6":"16.37139528","7":"-35.695236543","8":"GOLGI","9":"GOLGI,GOLGI,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15126"},{"1":"SCAMP2","2":"SCAM2_HUMAN","3":"unknown","4":"Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2)","5":"Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface.","6":"20.32744357","7":"-34.965608654","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O15127"},{"1":"ARPC1B ARC41","2":"ARC1B_HUMAN","3":"unknown","4":"Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)","5":"Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:11741539, PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:11741539, PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:11741539, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}.","6":"24.28678175","7":"5.895656270","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15143"},{"1":"ARPC2 ARC34 PRO2446","2":"ARPC2_HUMAN","3":"unknown","4":"Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)","5":"Actin-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). Seems to contact the mother actin filament (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}.","6":"24.46819148","7":"4.267179912","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15144"},{"1":"ARPC3 ARC21","2":"ARPC3_HUMAN","3":"unknown","4":"Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)","5":"Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}.","6":"24.23211281","7":"5.958894762","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15145"},{"1":"POLR1C POLR1E","2":"RPAC1_HUMAN","3":"unknown","4":"DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPA39) (RPC40)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and small RNAs, such as 5S rRNA and tRNAs, respectively. RPAC1 is part of the Pol core element with the central large cleft and probably a clamp element that moves to open and close the cleft (By similarity). {ECO:0000250|UniProtKB:P07703, ECO:0000305|PubMed:26151409}.","6":"-1.85881255","7":"28.070418040","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15160"},{"1":"TRIM24 RNF82 TIF1 TIF1A","2":"TIF1A_HUMAN","3":"unknown","4":"Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)","5":"Transcriptional coactivator that interacts with numerous nuclear receptors and coactivators and modulates the transcription of target genes. Interacts with chromatin depending on histone H3 modifications, having the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac). Has E3 protein-ubiquitin ligase activity. Promotes ubiquitination and proteasomal degradation of p53/TP53. Plays a role in the regulation of cell proliferation and apoptosis, at least in part via its effects on p53/TP53 levels. Up-regulates ligand-dependent transcription activation by AR, GCR/NR3C1, thyroid hormone receptor (TR) and ESR1. Modulates transcription activation by retinoic acid (RA) receptors, including RARA. Plays a role in regulating retinoic acid-dependent proliferation of hepatocytes (By similarity). {ECO:0000250, ECO:0000269|PubMed:16322096, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:21164480}.","6":"-0.85438579","7":"30.021674224","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15164"},{"1":"PGRMC2 DG6 PMBP","2":"PGRC2_HUMAN","3":"unknown","4":"Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6)","5":"Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). May serve as a universal non-classical progesterone receptor in the uterus (Probable). Intracellular heme chaperone required for delivery of labile, or signaling heme, to the nucleus (By similarity). Plays a role in adipocyte function and systemic glucose homeostasis (PubMed:28111073). In brown fat, which has a high demand for heme, delivery of labile heme in the nucleus regulates the activity of heme-responsive transcriptional repressors such as NR1D1 and BACH1 (By similarity). {ECO:0000250|UniProtKB:Q80UU9, ECO:0000269|PubMed:28111073, ECO:0000305|PubMed:28396637}.","6":"-11.08536268","7":"-31.580603432","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O15173"},{"1":"WDR46 BING4 C6orf11 FP221","2":"WDR46_HUMAN","3":"unknown","4":"WD repeat-containing protein 46 (WD repeat-containing protein BING4)","5":"Scaffold component of the nucleolar structure. Required for localization of DDX21 and NCL to the granular compartment of the nucleolus. {ECO:0000269|PubMed:23848194}.","6":"-38.28956515","7":"20.240017171","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15213"},{"1":"NKRF ITBA4 NRF","2":"NKRF_HUMAN","3":"unknown","4":"NF-kappa-B-repressing factor (NFkB-repressing factor) (Protein ITBA4) (Transcription factor NRF)","5":"Interacts with a specific negative regulatory element (NRE) 5'-AATTCCTCTGA-3' to mediate transcriptional repression of certain NK-kappa-B responsive genes. Involved in the constitutive silencing of the interferon beta promoter, independently of the virus-induced signals, and in the inhibition of the basal and cytokine-induced iNOS promoter activity. Also involved in the regulation of IL-8 transcription. {ECO:0000269|PubMed:12381793}.","6":"-21.88679738","7":"18.144384060","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15226"},{"1":"GNPAT DAPAT DHAPAT","2":"GNPAT_HUMAN","3":"PEROXISOME","4":"Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)","5":"Dihydroxyacetonephosphate acyltransferase involved in plasmalogen biosynthesis. {ECO:0000269|PubMed:15687349}.","6":"-22.51537305","7":"-16.649154693","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15228"},{"1":"ZNF185","2":"ZN185_HUMAN","3":"unknown","4":"Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A)","5":"May be involved in the regulation of cellular proliferation and/or differentiation.","6":"0.22740404","7":"-15.968218727","8":"Undefined","9":"Undefined,NUCLEOPLASM-2,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O15231"},{"1":"CASC3 MLN51","2":"CASC3_HUMAN","3":"unknown","4":"Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz)","5":"Required for pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:29301961). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA-helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homomer. {ECO:0000269|PubMed:17375189, ECO:0000269|PubMed:17652158, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961}.","6":"15.93640892","7":"16.705668143","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15234"},{"1":"MRPS12 RPMS12 RPSM12","2":"RT12_HUMAN","3":"unknown","4":"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Mitochondrial small ribosomal subunit protein uS12m)","5":"NA","6":"-41.76617247","7":"-1.745326728","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O15235"},{"1":"ACOX3 BRCOX PRCOX","2":"ACOX3_HUMAN","3":"PEROXISOME","4":"Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)","5":"Oxidizes the CoA-esters of 2-methyl-branched fatty acids. {ECO:0000250|UniProtKB:Q63448}.","6":"-23.01228660","7":"-17.267749576","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15254"},{"1":"RER1","2":"RER1_HUMAN","3":"unknown","4":"Protein RER1","5":"Involved in the retrieval of endoplasmic reticulum membrane proteins from the early Golgi compartment. {ECO:0000250}.","6":"9.52229298","7":"-38.956210170","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O15258"},{"1":"ATXN7 SCA7","2":"ATX7_HUMAN","3":"unknown","4":"Ataxin-7 (Spinocerebellar ataxia type 7 protein)","5":"Acts as component of the STAGA transcription coactivator-HAT complex. Mediates the interaction of STAGA complex with the CRX and is involved in CRX-dependent gene activation. Necessary for microtubule cytoskeleton stabilization. {ECO:0000269|PubMed:22100762}.","6":"5.42214990","7":"19.763924772","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15265"},{"1":"SPTLC1 LCB1","2":"SPTC1_HUMAN","3":"ER","4":"Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1)","5":"Serine palmitoyltransferase (SPT) (PubMed:19416851). The heterodimer formed with SPTLC2 or SPTLC3 constitutes the catalytic core (PubMed:19416851). The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference (PubMed:19416851). The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA (PubMed:19416851). The SPTLC1-SPTLC2-SPTSSB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference (PubMed:19416851). Required for adipocyte cell viability and metabolic homeostasis (By similarity). {ECO:0000250|UniProtKB:O35704, ECO:0000269|PubMed:19416851}.","6":"-7.95153462","7":"-38.946350958","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15269"},{"1":"SPTLC2 KIAA0526 LCB2","2":"SPTC2_HUMAN","3":"ER","4":"Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)","5":"Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate. Plays an important role in de novo sphyngolipid biosynthesis which is crucial for adipogenesis (By similarity). {ECO:0000250|UniProtKB:P97363, ECO:0000269|PubMed:19416851, ECO:0000269|PubMed:19648650, ECO:0000269|PubMed:20920666}.","6":"-4.77109118","7":"-39.815244743","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15270"},{"1":"OGT","2":"OGT1_HUMAN","3":"unknown","4":"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)","5":"Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc) (PubMed:26678539, PubMed:23103939, PubMed:21240259, PubMed:21285374, PubMed:15361863). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, EZH2, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1. Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing (PubMed:21285374). Probably by glycosylating KMT2E/MLL5, stabilizes KMT2E/MLL5 by preventing its ubiquitination (PubMed:26678539). Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling (By similarity). Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity (PubMed:22923583). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. Plays a key role in chromatin structure by mediating O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3) (PubMed:22121020, PubMed:23353889). As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). O-GlcNAcylation of 'Ser-75' of EZH2 increases its stability, and facilitating the formation of H3K27me3 by the PRC2/EED-EZH2 complex (PubMed:24474760). Regulates circadian oscillation of the clock genes and glucose homeostasis in the liver. Stabilizes clock proteins ARNTL/BMAL1 and CLOCK through O-glycosylation, which prevents their ubiquitination and subsequent degradation. Promotes the CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2 and CRY1/2 (PubMed:12150998, PubMed:19451179, PubMed:20018868, PubMed:20200153, PubMed:21285374, PubMed:15361863). O-glycosylates HCFC1 and regulates its proteolytic processing and transcriptional activity (PubMed:21285374, PubMed:28584052, PubMed:28302723). Regulates mitochondrial motility in neurons by mediating glycosylation of TRAK1 (By similarity). Glycosylates HOXA1 (By similarity). O-glycosylates FNIP1 (PubMed:30699359). {ECO:0000250|UniProtKB:P56558, ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:19451179, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20018868, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:22121020, ECO:0000269|PubMed:22923583, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:24474760, ECO:0000269|PubMed:26678539, ECO:0000269|PubMed:28302723, ECO:0000269|PubMed:28584052, ECO:0000269|PubMed:30699359}.; [Isoform 2]: the mitochondrial isoform (mOGT) is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line. {ECO:0000269|PubMed:20824293}.","6":"32.43011309","7":"10.617003751","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15294"},{"1":"PPM1D WIP1","2":"PPM1D_HUMAN","3":"unknown","4":"Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)","5":"Involved in the negative regulation of p53 expression (PubMed:23242139). Required for the relief of p53-dependent checkpoint mediated cell cycle arrest. Binds to and dephosphorylates 'Ser-15' of TP53 and 'Ser-345' of CHEK1 which contributes to the functional inactivation of these proteins (PubMed:15870257, PubMed:16311512). Mediates MAPK14 dephosphorylation and inactivation (PubMed:21283629). Is also an important regulator of global heterochromatin silencing and critical in maintaining genome integrity (By similarity). {ECO:0000250|UniProtKB:Q9QZ67, ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:16311512, ECO:0000269|PubMed:21283629, ECO:0000269|PubMed:23242139}.","6":"-22.27244559","7":"19.549914721","8":"NUCLEUS","9":"Undefined,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15297"},{"1":"PMM2","2":"PMM2_HUMAN","3":"unknown","4":"Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8)","5":"Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. {ECO:0000250|UniProtKB:Q92871}.","6":"30.25100089","7":"-0.376741595","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15305"},{"1":"TM9SF1","2":"TM9S1_HUMAN","3":"unknown","4":"Transmembrane 9 superfamily member 1 (MP70 protein family member) (hMP70)","5":"Plays an essential role in autophagy. {ECO:0000269|PubMed:19029833}.","6":"14.41923197","7":"-37.692170697","8":"GOLGI","9":"GOLGI,GOLGI,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15321"},{"1":"INPP4B","2":"INP4B_HUMAN","3":"unknown","4":"Inositol polyphosphate 4-phosphatase type II (Type II inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)","5":"Catalyzes the hydrolysis of the 4-position phosphate of phosphatidylinositol 3,4-bisphosphate, inositol 1,3,4-trisphosphate and inositol 3,4-trisphosphate (PubMed:24070612, PubMed:24591580). Plays a role in the late stages of macropinocytosis by dephosphorylating phosphatidylinositol 3,4-bisphosphate in membrane ruffles (PubMed:24591580). The lipid phosphatase activity is critical for tumor suppressor function. Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival (PubMed:19647222, PubMed:24070612). {ECO:0000269|PubMed:19647222, ECO:0000269|PubMed:24070612, ECO:0000269|PubMed:24591580}.","6":"19.10931398","7":"15.170422576","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15327"},{"1":"HMGB3 HMG2A HMG4","2":"HMGB3_HUMAN","3":"unknown","4":"High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4)","5":"Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor (By similarity). Negatively regulates B-cell and myeloid cell differentiation. In hematopoietic stem cells may regulate the balance between self-renewal and differentiation. Involved in negative regulation of canonical Wnt signaling (By similarity). {ECO:0000250|UniProtKB:O54879, ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P40618}.","6":"-5.41220776","7":"0.607217796","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15347"},{"1":"PPM1G PPM1C","2":"PPM1G_HUMAN","3":"unknown","4":"Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma)","5":"NA","6":"-15.37067292","7":"3.374060424","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15355"},{"1":"INPPL1 SHIP2","2":"SHIP2_HUMAN","3":"unknown","4":"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)","5":"Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Plays a central role in regulation of PI3K-dependent insulin signaling, although the precise molecular mechanisms and signaling pathways remain unclear. While overexpression reduces both insulin-stimulated MAP kinase and Akt activation, its absence does not affect insulin signaling or GLUT4 trafficking. Confers resistance to dietary obesity. May act by regulating AKT2, but not AKT1, phosphorylation at the plasma membrane. Part of a signaling pathway that regulates actin cytoskeleton remodeling. Required for the maintenance and dynamic remodeling of actin structures as well as in endocytosis, having a major impact on ligand-induced EGFR internalization and degradation. Participates in regulation of cortical and submembraneous actin by hydrolyzing PtdIns(3,4,5)P3 thereby regulating membrane ruffling (PubMed:21624956). Regulates cell adhesion and cell spreading. Required for HGF-mediated lamellipodium formation, cell scattering and spreading. Acts as a negative regulator of EPHA2 receptor endocytosis by inhibiting via PI3K-dependent Rac1 activation. Acts as a regulator of neuritogenesis by regulating PtdIns(3,4,5)P3 level and is required to form an initial protrusive pattern, and later, maintain proper neurite outgrowth. Acts as a negative regulator of the FC-gamma-RIIA receptor (FCGR2A). Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Involved in EGF signaling pathway. Upon stimulation by EGF, it is recruited by EGFR and dephosphorylates PtdIns(3,4,5)P3. Plays a negative role in regulating the PI3K-PKB pathway, possibly by inhibiting PKB activity. Down-regulates Fc-gamma-R-mediated phagocytosis in macrophages independently of INPP5D/SHIP1. In macrophages, down-regulates NF-kappa-B-dependent gene transcription by regulating macrophage colony-stimulating factor (M-CSF)-induced signaling. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6. Involved in endochondral ossification. {ECO:0000269|PubMed:11349134, ECO:0000269|PubMed:11739414, ECO:0000269|PubMed:12235291, ECO:0000269|PubMed:12676785, ECO:0000269|PubMed:12690104, ECO:0000269|PubMed:15668240, ECO:0000269|PubMed:16824732, ECO:0000269|PubMed:17135240, ECO:0000269|PubMed:21624956, ECO:0000269|PubMed:23273569, ECO:0000269|PubMed:9660833}.","6":"21.37139996","7":"32.430852371","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15357"},{"1":"EIF3D EIF3S7","2":"EIF3D_HUMAN","3":"PROTEIN COMPLEX","4":"Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)","5":"mRNA cap-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, a complex required for several steps in the initiation of protein synthesis of a specialized repertoire of mRNAs (PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:18599441, PubMed:25849773). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). In the eIF-3 complex, EIF3D specifically recognizes and binds the 7-methylguanosine cap of a subset of mRNAs (PubMed:27462815). {ECO:0000269|PubMed:18599441, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}.","6":"14.65111612","7":"37.110352577","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15371"},{"1":"EIF3H EIF3S3","2":"EIF3H_HUMAN","3":"PROTEIN COMPLEX","4":"Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)","5":"Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03007, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.","6":"14.66214983","7":"37.569654513","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15372"},{"1":"HDAC3","2":"HDAC3_HUMAN","3":"unknown","4":"Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45)","5":"Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Participates in the BCL6 transcriptional repressor activity by deacetylating the H3 'Lys-27' (H3K27) on enhancer elements, antagonizing EP300 acetyltransferase activity and repressing proximal gene expression. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required to repress transcription of the POU1F1 transcription factor. Acts as a molecular chaperone for shuttling phosphorylated NR2C1 to PML bodies for sumoylation (PubMed:21444723, PubMed:23911289). Contributes, together with XBP1 isoform 1, to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to endothelial cell (EC) survival under disturbed flow/oxidative stress (PubMed:25190803). Regulates both the transcriptional activation and repression phases of the circadian clock in a deacetylase activity-independent manner (By similarity). During the activation phase, promotes the accumulation of ubiquitinated ARNTL/BMAL1 at the E-boxes and during the repression phase, blocks FBXL3-mediated CRY1/2 ubiquitination and promotes the interaction of CRY1 and ARNTL/BMAL1 (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding (PubMed:28167758). In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response (PubMed:28167758). Interacts with SETD5 (By similarity). {ECO:0000250|UniProtKB:O88895, ECO:0000269|PubMed:21444723, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:25190803, ECO:0000269|PubMed:28167758}.","6":"18.89067135","7":"31.292906906","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15379"},{"1":"NVL NVL2","2":"NVL_HUMAN","3":"unknown","4":"Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","5":"Participates in the assembly of the telomerase holoenzyme and effecting of telomerase activity via its interaction with TERT (PubMed:22226966). Involved in both early and late stages of the pre-rRNA processing pathways (PubMed:26166824). Spatiotemporally regulates 60S ribosomal subunit biogenesis in the nucleolus (PubMed:15469983, PubMed:16782053, PubMed:29107693, PubMed:26456651). Catalyzes the release of specific assembly factors, such as WDR74, from pre-60S ribosomal particles through the ATPase activity (PubMed:29107693, PubMed:26456651, PubMed:28416111). {ECO:0000269|PubMed:15469983, ECO:0000269|PubMed:16782053, ECO:0000269|PubMed:22226966, ECO:0000269|PubMed:26166824, ECO:0000269|PubMed:26456651, ECO:0000269|PubMed:28416111, ECO:0000269|PubMed:29107693}.","6":"-31.48235154","7":"15.622515412","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15381"},{"1":"BCAT2 BCATM BCT2 ECA40","2":"BCAT2_HUMAN","3":"MITOCHONDRIA","4":"Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42) (Placental protein 18) (PP18)","5":"Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine (PubMed:25653144). May also function as a transporter of branched chain alpha-keto acids. {ECO:0000269|PubMed:25653144}.","6":"-42.67124587","7":"-10.486011520","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15382"},{"1":"BIRC5 API4 IAP4","2":"BIRC5_HUMAN","3":"unknown","4":"Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin)","5":"Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:9859993, PubMed:21364656, PubMed:20627126, PubMed:25778398, PubMed:28218735). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (PubMed:16322459). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules (PubMed:20826784). Involved in the recruitment of CPC to centromeres during early mitosis via association with histone H3 phosphorylated at 'Thr-3' (H3pT3) during mitosis (PubMed:20929775). The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules (PubMed:18591255). May counteract a default induction of apoptosis in G2/M phase (PubMed:9859993). The acetylated form represses STAT3 transactivation of target gene promoters (PubMed:20826784). May play a role in neoplasia (PubMed:10626797). Inhibitor of CASP3 and CASP7 (PubMed:21536684). Essential for the maintenance of mitochondrial integrity and function (PubMed:25778398). Isoform 2 and isoform 3 do not appear to play vital roles in mitosis (PubMed:12773388, PubMed:16291752). Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform (PubMed:10626797). {ECO:0000269|PubMed:10626797, ECO:0000269|PubMed:12773388, ECO:0000269|PubMed:16291752, ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:20627126, ECO:0000269|PubMed:20826784, ECO:0000269|PubMed:20929775, ECO:0000269|PubMed:21364656, ECO:0000269|PubMed:21536684, ECO:0000269|PubMed:25778398, ECO:0000269|PubMed:28218735, ECO:0000269|PubMed:9859993}.","6":"-22.80527128","7":"14.740887398","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O15392"},{"1":"IPO8 RANBP8","2":"IPO8_HUMAN","3":"unknown","4":"Importin-8 (Imp8) (Ran-binding protein 8) (RanBP8)","5":"Seems to function in nuclear protein import, either by acting as autonomous nuclear transport receptor or as an adapter-like protein in association with the importin-beta subunit KPNB1. Acting autonomously, is thought to serve itself as receptor for nuclear localization signals (NLS) and to promote translocation of import substrates through the nuclear pore complex (NPC) by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro mediates the nuclear import of SRP19. {ECO:0000269|PubMed:11682607, ECO:0000269|PubMed:9214382}.","6":"34.30390074","7":"14.476624301","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15397"},{"1":"STX7","2":"STX7_HUMAN","3":"unknown","4":"Syntaxin-7","5":"May be involved in protein trafficking from the plasma membrane to the early endosome (EE) as well as in homotypic fusion of endocytic organelles. Mediates the endocytic trafficking from early endosomes to late endosomes and lysosomes.","6":"16.47326618","7":"-37.845973401","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O15400"},{"1":"ABCC4 MOATB MRP4","2":"MRP4_HUMAN","3":"unknown","4":"ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","5":"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds and xenobiotics from cells. Transports a range of endogenous molecules that have a key role in cellular communication and signaling, including cyclic nucleotides such as cyclic AMP (cAMP) and cyclic GMP (cGMP), bile acids, steroid conjugates, urate, and prostaglandins (PubMed:11856762, PubMed:12883481, PubMed:12523936, PubMed:12835412, PubMed:15364914, PubMed:15454390, PubMed:16282361, PubMed:17959747, PubMed:18300232, PubMed:26721430). Mediates the ATP-dependent efflux of glutathione conjugates such as leukotriene C4 (LTC4) and leukotriene B4 (LTB4) too. The presence of GSH is necessary for the ATP-dependent transport of LTB4, whereas GSH is not required for the transport of LTC4 (PubMed:17959747). Mediates the cotransport of bile acids with reduced glutathione (GSH) (PubMed:12883481, PubMed:12523936, PubMed:16282361). Transports a wide range of drugs and their metabolites, including anticancer, antiviral and antibiotics molecules (PubMed:11856762, PubMed:12105214, PubMed:15454390, PubMed:18300232, PubMed:17344354). Confers resistance to anticancer agents such as methotrexate (PubMed:11106685). {ECO:0000269|PubMed:11106685, ECO:0000269|PubMed:11856762, ECO:0000269|PubMed:12105214, ECO:0000269|PubMed:12523936, ECO:0000269|PubMed:12835412, ECO:0000269|PubMed:12883481, ECO:0000269|PubMed:15364914, ECO:0000269|PubMed:15454390, ECO:0000269|PubMed:16282361, ECO:0000269|PubMed:17344354, ECO:0000269|PubMed:17959747, ECO:0000269|PubMed:18300232, ECO:0000269|PubMed:26721430}.","6":"-28.62655866","7":"-17.571831143","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15439"},{"1":"POLR1G ASE1 CAST CD3EAP PAF49","2":"RPA34_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein) (ASE-1) (CD3-epsilon-associated protein) (CD3E-associated protein) (DNA-directed RNA polymerase I subunit G) (RNA polymerase I-associated factor PAF49)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Isoform 1 is involved in UBTF-activated transcription, presumably at a step following PIC formation.; Isoform 2 has been described as a component of preformed T-cell receptor (TCR) complex.","6":"-13.89127804","7":"17.360998588","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15446"},{"1":"P4HA2 UNQ290/PRO330","2":"P4HA2_HUMAN","3":"ER","4":"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)","5":"Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins.","6":"-24.61048571","7":"-17.998143283","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O15460"},{"1":"MAGEB2","2":"MAGB2_HUMAN","3":"unknown","4":"Melanoma-associated antigen B2 (Cancer/testis antigen 3.2) (CT3.2) (DSS-AHC critical interval MAGE superfamily 6) (DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen)","5":"May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.","6":"30.94781010","7":"-20.169477504","8":"RIBOSOME","9":"RIBOSOME,RIBOSOME,RIBOSOME","10":"Highly confident","11":"2","12":"1,3","_rn_":"O15479"},{"1":"MAGEB4","2":"MAGB4_HUMAN","3":"unknown","4":"Melanoma-associated antigen B4 (MAGE-B4 antigen)","5":"NA","6":"2.49126141","7":"10.535412176","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15481"},{"1":"CAPN5 NCL3","2":"CAN5_HUMAN","3":"unknown","4":"Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3)","5":"Calcium-regulated non-lysosomal thiol-protease. {ECO:0000250}.","6":"-20.96914447","7":"-28.679832785","8":"MITOCHONDRIA","9":"Undefined,MITOCHONDRIA,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15484"},{"1":"YKT6","2":"YKT6_HUMAN","3":"unknown","4":"Synaptobrevin homolog YKT6 (EC 2.3.1.-)","5":"Vesicular soluble NSF attachment protein receptor (v-SNARE) mediating vesicle docking and fusion to a specific acceptor cellular compartment. Functions in endoplasmic reticulum to Golgi transport; as part of a SNARE complex composed of GOSR1, GOSR2 and STX5. Functions in early/recycling endosome to TGN transport; as part of a SNARE complex composed of BET1L, GOSR1 and STX5. Has a S-palmitoyl transferase activity. {ECO:0000269|PubMed:15215310, ECO:0000269|PubMed:9211930}.","6":"15.50940940","7":"-9.557531451","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15498"},{"1":"NUP42 CG1 NUPL2","2":"NUP42_HUMAN","3":"unknown","4":"Nucleoporin NUP42 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1) (Nucleoporin-42) (Nucleoporin-like protein 2)","5":"Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. {ECO:0000269|PubMed:10610322, ECO:0000269|PubMed:16000379}.; (Microbial infection) In case of infection by HIV-1, it may participate in the docking of viral Vpr at the nuclear envelope. {ECO:0000269|PubMed:12228227}.","6":"-13.15999512","7":"17.018403521","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15504"},{"1":"ARPC5 ARC16","2":"ARPC5_HUMAN","3":"unknown","4":"Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC)","5":"Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}.","6":"25.16651396","7":"5.880079833","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O15511"},{"1":"POLR2D","2":"RPB4_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB4 is part of a subcomplex with RPB7 that binds to a pocket formed by RPB1, RPB2 and RPB6 at the base of the clamp element. The RBP4-RPB7 subcomplex seems to lock the clamp via RPB7 in the closed conformation thus preventing double-stranded DNA to enter the active site cleft. The RPB4-RPB7 subcomplex binds single-stranded DNA and RNA (By similarity). {ECO:0000250, ECO:0000269|PubMed:9852112}.","6":"-9.99079099","7":"26.677570180","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15514"},{"1":"CLOCK BHLHE8 KIAA0334","2":"CLOCK_HUMAN","3":"unknown","4":"Circadian locomoter output cycles protein kaput (hCLOCK) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 8) (bHLHe8)","5":"Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. Regulates the circadian expression of ICAM1, VCAM1, CCL2, THPO and MPL and also acts as an enhancer of the transactivation potential of NF-kappaB. Plays an important role in the homeostatic regulation of sleep. The CLOCK-ARNTL/BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The CLOCK-ARNTL2/BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. The preferred binding motif for the CLOCK-ARNTL/BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking Ala residue in addition to the canonical 6-nucleotide E-box sequence (PubMed:23229515). CLOCK specifically binds to the half-site 5'-CAC-3', while ARNTL binds to the half-site 5'-GTGA-3' (PubMed:23229515). The CLOCK-ARNTL/BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3' (PubMed:23229515). CLOCK has an intrinsic acetyltransferase activity, which enables circadian chromatin remodeling by acetylating histones and nonhistone proteins, including its own partner ARNTL/BMAL1. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) via the acetylation of multiple lysine residues located in its hinge region (PubMed:21980503). The acetyltransferase activity of CLOCK is as important as its transcription activity in circadian control. Acetylates metabolic enzymes IMPDH2 and NDUFA9 in a circadian manner. Facilitated by BMAL1, rhythmically interacts and acetylates argininosuccinate synthase 1 (ASS1) leading to enzymatic inhibition of ASS1 as well as the circadian oscillation of arginine biosynthesis and subsequent ureagenesis (PubMed:28985504). Drives the circadian rhythm of blood pressure through transcriptional activation of ATP1B1 (By similarity). {ECO:0000250|UniProtKB:O08785, ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:18587630, ECO:0000269|PubMed:21659603, ECO:0000269|PubMed:21980503, ECO:0000269|PubMed:22284746, ECO:0000269|PubMed:23229515, ECO:0000269|PubMed:23785138, ECO:0000269|PubMed:24005054, ECO:0000269|PubMed:28985504}.","6":"6.12260600","7":"22.462835519","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O15516"},{"1":"PDPK1 PDK1","2":"PDPK1_HUMAN","3":"unknown","4":"3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)","5":"Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive. {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10480933, ECO:0000269|PubMed:10995762, ECO:0000269|PubMed:12167717, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:14604990, ECO:0000269|PubMed:16207722, ECO:0000269|PubMed:16251192, ECO:0000269|PubMed:17327236, ECO:0000269|PubMed:17371830, ECO:0000269|PubMed:18835241, ECO:0000269|PubMed:9094314, ECO:0000269|PubMed:9445476, ECO:0000269|PubMed:9707564, ECO:0000269|PubMed:9768361}.","6":"16.93872488","7":"-1.099222686","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O15530"},{"1":"RNF113A RNF113 ZNF183","2":"R113A_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183)","5":"Required for pre-mRNA splicing as component of the spliceosome (PubMed:29361316, PubMed:29360106). E3 ubiquitin-protein ligase that catalyzes the transfer of ubiquitin onto target proteins (PubMed:28978524, PubMed:29144457). Catalyzes polyubiquitination of SNRNP200/BRR2 with non-canonical 'Lys-63'-linked polyubiquitin chains (PubMed:29144457). Plays a role in DNA repair via its role in the synthesis of 'Lys-63'-linked polyubiquitin chains that recruit ALKBH3 and the ASCC complex to sites of DNA damage by alkylating agents (PubMed:29144457). Ubiquitinates CXCR4, leading to its degradation, and thereby contributes to the termination of CXCR4 signaling (PubMed:28978524). {ECO:0000269|PubMed:28978524, ECO:0000269|PubMed:29144457, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.","6":"-6.24866809","7":"11.335044077","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O15541"},{"1":"DHX15 DBP1 DDX15","2":"DHX15_HUMAN","3":"unknown","4":"Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)","5":"Pre-mRNA processing factor involved in disassembly of spliceosomes after the release of mature mRNA. In cooperation with TFIP11 seem to be involved in the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns. {ECO:0000269|PubMed:19103666}.","6":"13.55179718","7":"22.296939184","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43143"},{"1":"RNMT KIAA0398","2":"MCES_HUMAN","3":"unknown","4":"mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase) (hCMT1) (hMet) (hcm1p)","5":"Catalytic subunit of the mRNA-capping methyltransferase RNMT:RAMAC complex that methylates the N7 position of the added guanosine to the 5'-cap structure of mRNAs (PubMed:9790902, PubMed:9705270, PubMed:10347220, PubMed:11114884, PubMed:22099306, PubMed:27422871). Binds RNA containing 5'-terminal GpppC (PubMed:11114884). {ECO:0000269|PubMed:10347220, ECO:0000269|PubMed:11114884, ECO:0000269|PubMed:22099306, ECO:0000269|PubMed:27422871, ECO:0000269|PubMed:9705270, ECO:0000269|PubMed:9790902}.","6":"32.59289881","7":"11.683673952","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43148"},{"1":"ZZEF1 KIAA0399","2":"ZZEF1_HUMAN","3":"unknown","4":"Zinc finger ZZ-type and EF-hand domain-containing protein 1","5":"NA","6":"-5.39973860","7":"40.179107511","8":"Undefined","9":"NUCLEOPLASM-2,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43149"},{"1":"TTI1 KIAA0406 SMG10","2":"TTI1_HUMAN","3":"unknown","4":"TELO2-interacting protein 1 homolog (Protein SMG10)","5":"Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. {ECO:0000269|PubMed:20427287, ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650}.","6":"33.54543162","7":"15.873355342","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43156"},{"1":"RRP8 KIAA0409 NML hucep-1","2":"RRP8_HUMAN","3":"unknown","4":"Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1) (Nucleomethylin)","5":"Essential component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. In the complex, RRP8 binds to H3K9me2 and probably acts as a methyltransferase. Its substrates are however unknown. {ECO:0000269|PubMed:18485871}.","6":"-39.09860968","7":"22.713496930","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O43159"},{"1":"PJA2 KIAA0438 RNF131","2":"PJA2_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase Praja-2 (Praja2) (EC 2.3.2.27) (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)","5":"Has E2-dependent E3 ubiquitin-protein ligase activity. Responsible for ubiquitination of cAMP-dependent protein kinase type I and type II-alpha/beta regulatory subunits and for targeting them for proteasomal degradation. Essential for PKA-mediated long-term memory processes. Through the ubiquitination of MFHAS1, positively regulates the TLR2 signaling pathway that leads to the activation of the downstream p38 and JNK MAP kinases and promotes the polarization of macrophages toward the pro-inflammatory M1 phenotype (PubMed:28471450). {ECO:0000269|PubMed:12036302, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:28471450}.","6":"-4.37193051","7":"18.421767689","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43164"},{"1":"SIPA1L1 E6TP1 KIAA0440","2":"SI1L1_HUMAN","3":"unknown","4":"Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1)","5":"Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}.","6":"-23.08524704","7":"-10.735304017","8":"Undefined","9":"PEROXISOME,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43166"},{"1":"CYB5B CYB5M OMB5","2":"CYB5B_HUMAN","3":"unknown","4":"Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)","5":"Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases. {ECO:0000250}.","6":"1.88977207","7":"-45.114558366","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43169"},{"1":"PRPF4 PRP4","2":"PRP4_HUMAN","3":"NUCLEOPLASM-2","4":"U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)","5":"Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). {ECO:0000269|PubMed:25383878, ECO:0000269|PubMed:28781166}.","6":"-4.34502790","7":"31.478491612","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43172"},{"1":"PHGDH PGDH3","2":"SERA_HUMAN","3":"unknown","4":"D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37)","5":"Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of (S)-malate to oxaloacetate. {ECO:0000269|PubMed:11751922, ECO:0000269|PubMed:25406093}.","6":"26.89384651","7":"15.421726819","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43175"},{"1":"NDUFS4","2":"NDUS4_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:11181577, ECO:0000269|PubMed:12611891, ECO:0000269|PubMed:9463323}.","6":"-37.97594708","7":"-16.299306804","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43181"},{"1":"DYNC1LI2 DNCLI2 LIC2","2":"DC1L2_HUMAN","3":"unknown","4":"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)","5":"Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes.","6":"9.61604613","7":"30.524147919","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43237"},{"1":"PSMD3","2":"PSMD3_HUMAN","3":"PROTEIN COMPLEX","4":"26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)","5":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. {ECO:0000269|PubMed:1317798}.","6":"-5.17727769","7":"39.735141314","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43242"},{"1":"RBFOX2 FOX2 HRNBP2 RBM9 RTA","2":"RFOX2_HUMAN","3":"unknown","4":"RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity)","5":"RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Prevents binding of U2AF2 to the 3'-splice site. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis (By similarity). RNA-binding protein that seems to act as a coregulatory factor of ER-alpha. {ECO:0000250, ECO:0000269|PubMed:11875103}.","6":"35.07372333","7":"-1.933185968","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O43251"},{"1":"PAPSS1 ATPSK1 PAPSS","2":"PAPS1_HUMAN","3":"unknown","4":"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","5":"Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate-activation pathway (PubMed:9576487, PubMed:9668121, PubMed:9648242, PubMed:14747722). Required for normal biosynthesis of sulfated L-selectin ligands in endothelial cells (PubMed:9576487). {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121}.","6":"39.08157005","7":"9.592113636","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43252"},{"1":"ZW10","2":"ZW10_HUMAN","3":"unknown","4":"Centromere/kinetochore protein zw10 homolog","5":"Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. Required for the assembly of the dynein-dynactin and MAD1-MAD2 complexes onto kinetochores. Its function related to the spindle assembly machinery is proposed to depend on its association in the mitotic RZZ complex (PubMed:11590237, PubMed:15485811, PubMed:15824131). Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the interphase NRZ complex which is believed to play a role in SNARE assembly at the ER (PubMed:15029241). {ECO:0000269|PubMed:11590237, ECO:0000269|PubMed:15029241, ECO:0000269|PubMed:15094189, ECO:0000269|PubMed:15485811, ECO:0000269|PubMed:15824131, ECO:0000305}.","6":"2.63276197","7":"-13.724378043","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43264"},{"1":"SART1","2":"SNUT1_HUMAN","3":"unknown","4":"U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)","5":"Plays a role in mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the spliceosome. May also bind to DNA. {ECO:0000269|PubMed:11350945}.","6":"-15.24105945","7":"8.967340823","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43290"},{"1":"GPAA1 GAA1","2":"GPAA1_HUMAN","3":"ER","4":"Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1)","5":"Essential for GPI-anchoring of precursor proteins but not for GPI synthesis. Acts before or during formation of the carbonyl intermediate. {ECO:0000269|PubMed:29100095, ECO:0000269|PubMed:9468317}.","6":"-9.47281644","7":"-30.144453247","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43292"},{"1":"DAPK3 ZIPK","2":"DAPK3_HUMAN","3":"unknown","4":"Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase)","5":"Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A; the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Phosphorylates MYL12B in non-muscle cells leading to reorganization of actin cytoskeleton. Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Overexpression leads to condensation of actin stress fibers into thick bundles. Involved in actin filament focal adhesion dynamics. The function in both reorganization of actin cytoskeleton and focal adhesion dissolution is modulated by RhoD. Positively regulates canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, RPL13A association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Involved in regulation of cell cycle progression and cell proliferation. May be a tumor suppressor. {ECO:0000269|PubMed:10356987, ECO:0000269|PubMed:11384979, ECO:0000269|PubMed:11781833, ECO:0000269|PubMed:12917339, ECO:0000269|PubMed:15096528, ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:16219639, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18084323, ECO:0000269|PubMed:18995835, ECO:0000269|PubMed:21169990, ECO:0000269|PubMed:21408167, ECO:0000269|PubMed:21454679, ECO:0000269|PubMed:21487036, ECO:0000269|PubMed:23454120}.","6":"-22.90543828","7":"-11.124928036","8":"Undefined","9":"PEROXISOME,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43293"},{"1":"TGFB1I1 ARA55","2":"TGFI1_HUMAN","3":"unknown","4":"Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5)","5":"Functions as a molecular adapter coordinating multiple protein-protein interactions at the focal adhesion complex and in the nucleus. Links various intracellular signaling modules to plasma membrane receptors and regulates the Wnt and TGFB signaling pathways. May also regulate SLC6A3 and SLC6A4 targeting to the plasma membrane hence regulating their activity. In the nucleus, functions as a nuclear receptor coactivator regulating glucocorticoid, androgen, mineralocorticoid and progesterone receptor transcriptional activity. May play a role in the processes of cell growth, proliferation, migration, differentiation and senescence. May have a zinc-dependent DNA-binding activity. {ECO:0000269|PubMed:10075738, ECO:0000269|PubMed:11463817, ECO:0000269|PubMed:11856738, ECO:0000269|PubMed:12177201, ECO:0000269|PubMed:12445807, ECO:0000269|PubMed:12700349, ECO:0000269|PubMed:15211577, ECO:0000269|PubMed:15561701, ECO:0000269|PubMed:16141357, ECO:0000269|PubMed:16624805, ECO:0000269|PubMed:16803896, ECO:0000269|PubMed:16849583, ECO:0000269|PubMed:17166536, ECO:0000269|PubMed:17233630, ECO:0000269|PubMed:9032249}.","6":"25.70211967","7":"5.443436435","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43294"},{"1":"AP5Z1 KIAA0415 SPG48","2":"AP5Z1_HUMAN","3":"unknown","4":"AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5)","5":"As part of AP-5, a probable fifth adaptor protein complex it may be involved in endosomal transport. According to PubMed:20613862 it is a putative helicase required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20613862, ECO:0000269|PubMed:22022230}.","6":"7.08898446","7":"-12.252118172","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43299"},{"1":"HSPA12A KIAA0417","2":"HS12A_HUMAN","3":"unknown","4":"Heat shock 70 kDa protein 12A","5":"Adapter protein for SORL1, but not SORT1. Delays SORL1 internalization and affects SORL1 subcellular localization. {ECO:0000269|PubMed:30679749}.","6":"3.58460951","7":"-22.939065232","8":"PM","9":"Undefined,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"O43301"},{"1":"CCP110 CEP110 CP110 KIAA0419","2":"CP110_HUMAN","3":"unknown","4":"Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110)","5":"Necessary for centrosome duplication at different stages of procentriole formation. Acts as a key negative regulator of ciliogenesis in collaboration with CEP97 by capping the mother centriole thereby preventing cilia formation (PubMed:17719545 PubMed:17681131, PubMed:23486064). Also involved in promoting ciliogenesis. May play a role in the assembly of the mother centriole subdistal appendages (SDA) thereby effecting the fusion of recycling endosomes to basal bodies during cilia formation (By similarity). Required for correct spindle formation and has a role in regulating cytokinesis and genome stability via cooperation with CALM1 and CETN2 (PubMed:16760425). {ECO:0000250|UniProtKB:Q7TSH4, ECO:0000269|PubMed:12361598, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:23486064}.","6":"-8.17480235","7":"17.582715072","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43303"},{"1":"ADCY6 KIAA0422","2":"ADCY6_HUMAN","3":"unknown","4":"Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)","5":"Catalyzes the formation of the signaling molecule cAMP downstream of G protein-coupled receptors (PubMed:17916776, PubMed:17110384). Functions in signaling cascades downstream of beta-adrenergic receptors in the heart and in vascular smooth muscle cells (PubMed:17916776). Functions in signaling cascades downstream of the vasopressin receptor in the kidney and has a role in renal water reabsorption. Functions in signaling cascades downstream of PTH1R and plays a role in regulating renal phosphate excretion. Functions in signaling cascades downstream of the VIP and SCT receptors in pancreas and contributes to the regulation of pancreatic amylase and fluid secretion (By similarity). Signaling mediates cAMP-dependent activation of protein kinase PKA. This promotes increased phosphorylation of various proteins, including AKT. Plays a role in regulating cardiac sarcoplasmic reticulum Ca(2+) uptake and storage, and is required for normal heart ventricular contractibility. May contribute to normal heart function (By similarity). Mediates vasodilatation after activation of beta-adrenergic receptors by isoproterenol (PubMed:17916776). Contributes to bone cell responses to mechanical stimuli (By similarity). {ECO:0000250|UniProtKB:Q01341, ECO:0000250|UniProtKB:Q03343, ECO:0000269|PubMed:17110384, ECO:0000269|PubMed:17916776}.","6":"-14.09535913","7":"-36.469987255","8":"Undefined","9":"PM,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O43306"},{"1":"CTIF KIAA0427","2":"CTIF_HUMAN","3":"unknown","4":"CBP80/20-dependent translation initiation factor","5":"Specifically required for the pioneer round of mRNA translation mediated by the cap-binding complex (CBC), that takes place during or right after mRNA export via the nuclear pore complex (NPC). Acts via its interaction with the NCBP1/CBP80 component of the CBC complex and recruits the 40S small subunit of the ribosome via eIF3. In contrast, it is not involved in steady state translation, that takes place when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. Also required for nonsense-mediated mRNA decay (NMD), the pioneer round of mRNA translation mediated by the cap-binding complex playing a central role in nonsense-mediated mRNA decay (NMD). {ECO:0000269|PubMed:19648179}.","6":"14.93020019","7":"9.801801164","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43310"},{"1":"PPIP5K2 HISPPD1 KIAA0433 VIP2","2":"VIP2_HUMAN","3":"unknown","4":"Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2)","5":"Bifunctional inositol kinase that acts in concert with the IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate group-containing inositol pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis-diphosphoinositol tetrakisphosphate, (PP)2-InsP4 (PubMed:17690096, PubMed:17702752, PubMed:21222653, PubMed:29590114). PP-InsP5 and (PP)2-InsP4, also respectively called InsP7 and InsP8, regulate a variety of cellular processes, including apoptosis, vesicle trafficking, cytoskeletal dynamics, exocytosis, insulin signaling and neutrophil activation (PubMed:17690096, PubMed:17702752, PubMed:21222653, PubMed:29590114). Phosphorylates inositol hexakisphosphate (InsP6) at positions 1 or 3 to produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce (PP)2-InsP4 (PubMed:17690096, PubMed:17702752). Alternatively, phosphorylates at position 1 or 3 PP-InsP5, produced by IP6Ks from InsP6, to produce (PP)2-InsP4 (PubMed:17690096, PubMed:17702752). Required for normal hearing (PubMed:29590114). {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653, ECO:0000269|PubMed:29590114}.","6":"30.21737242","7":"18.301784828","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43314"},{"1":"MAP3K7 TAK1","2":"M3K7_HUMAN","3":"unknown","4":"Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1)","5":"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity. Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.","6":"15.50413172","7":"2.257190291","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43318"},{"1":"EEF1E1 AIMP3 P18","2":"MCA3_HUMAN","3":"PROTEIN COMPLEX","4":"Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18)","5":"Positive modulator of ATM response to DNA damage. {ECO:0000250|UniProtKB:Q9D1M4}.","6":"14.98312708","7":"38.817938862","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43324"},{"1":"MSI1","2":"MSI1H_HUMAN","3":"unknown","4":"RNA-binding protein Musashi homolog 1 (Musashi-1)","5":"RNA binding protein that regulates the expression of target mRNAs at the translation level. Regulates expression of the NOTCH1 antagonist NUMB. Binds RNA containing the sequence 5'-GUUAGUUAGUUAGUU-3' and other sequences containing the pattern 5'-[GA]U(1-3)AGU-3'. May play a role in the proliferation and maintenance of stem cells in the central nervous system (By similarity). {ECO:0000250}.","6":"34.41666948","7":"-1.873373438","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43347"},{"1":"RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092","2":"RIPK2_HUMAN","3":"unknown","4":"Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)","5":"Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Once recruited, RIPK2 autophosphorylates and undergoes 'Lys-63'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3. The polyubiquitinated protein mediates the recruitment of MAP3K7/TAK1 to IKBKG/NEMO and induces 'Lys-63'-linked polyubiquitination of IKBKG/NEMO and subsequent activation of IKBKB/IKKB. In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Plays also a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation. Plays a role in the inactivation of RHOA in response to NGFR signaling (PubMed:26646181). {ECO:0000269|PubMed:14638696, ECO:0000269|PubMed:17054981, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:21123652, ECO:0000269|PubMed:21887730, ECO:0000269|PubMed:26646181}.","6":"27.45031555","7":"5.100457912","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43353"},{"1":"WDR62 C19orf14","2":"WDR62_HUMAN","3":"unknown","4":"WD repeat-containing protein 62","5":"Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20890278, PubMed:20729831). Plays a role in mother-centriole-dependent centriole duplication; the function seems also to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}.","6":"-1.37263300","7":"35.762827231","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43379"},{"1":"HNRNPR HNRPR","2":"HNRPR_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoprotein R (hnRNP R)","5":"Component of ribonucleosomes, which are complexes of at least 20 other different heterogeneous nuclear ribonucleoproteins (hnRNP). hnRNP play an important role in processing of precursor mRNA in the nucleus.","6":"-17.21846316","7":"20.962399455","8":"Undefined","9":"NUCLEOPLASM-2,Undefined,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O43390"},{"1":"PRPF3 HPRP3 PRP3","2":"PRPF3_HUMAN","3":"unknown","4":"U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3) (hPrp3) (U4/U6 snRNP 90 kDa protein)","5":"Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). {ECO:0000269|PubMed:26912367, ECO:0000269|PubMed:28781166, ECO:0000305|PubMed:20595234}.","6":"-5.32364891","7":"31.140016238","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43395"},{"1":"TXNL1 TRP32 TXL TXNL","2":"TXNL1_HUMAN","3":"unknown","4":"Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)","5":"Active thioredoxin with a redox potential of about -250 mV. {ECO:0000269|PubMed:19349277}.","6":"7.47742231","7":"9.324184853","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43396"},{"1":"TPD52L2","2":"TPD54_HUMAN","3":"unknown","4":"Tumor protein D54 (hD54) (Tumor protein D52-like 2)","5":"NA","6":"22.74619480","7":"-33.915441018","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O43399"},{"1":"EMC8 C16orf2 C16orf4 COX4AL COX4NB FAM158B NOC4","2":"EMC8_HUMAN","3":"unknown","4":"ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B)","5":"Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins (PubMed:30415835, PubMed:29809151, PubMed:29242231, PubMed:32459176, PubMed:32439656). Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues (PubMed:30415835, PubMed:29809151, PubMed:29242231). Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices (PubMed:30415835, PubMed:29809151). It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes (PubMed:29809151, PubMed:29242231). By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors (PubMed:30415835). By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes (Probable). {ECO:0000269|PubMed:29242231, ECO:0000269|PubMed:29809151, ECO:0000269|PubMed:30415835, ECO:0000269|PubMed:32439656, ECO:0000269|PubMed:32459176, ECO:0000305}.","6":"-18.80308476","7":"-22.607975547","8":"ER","9":"ER,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O43402"},{"1":"FIBP","2":"FIBP_HUMAN","3":"unknown","4":"Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)","5":"May be involved in mitogenic function of FGF1. May mediate with IER2 FGF-signaling in the establishment of laterality in the embryo (By similarity). {ECO:0000250|UniProtKB:Q6T938, ECO:0000269|PubMed:9806903}.","6":"4.15567417","7":"-39.274420664","8":"Undefined","9":"PM,Undefined,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O43427"},{"1":"EIF4G3","2":"IF4G3_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","5":"Probable component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome. Thought to be a functional homolog of EIF4G1. {ECO:0000269|PubMed:9418880}.","6":"-1.63481140","7":"25.378049396","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43432"},{"1":"PPIH CYP20 CYPH","2":"PPIH_HUMAN","3":"unknown","4":"Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP)","5":"PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:20676357). Participates in pre-mRNA splicing. May play a role in the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome. May act as a chaperone. {ECO:0000269|PubMed:11823439, ECO:0000269|PubMed:12875835, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:9570313}.","6":"20.54447850","7":"-1.070357174","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43447"},{"1":"SUV39H1 KMT1A SUV39H","2":"SUV91_HUMAN","3":"unknown","4":"Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1)","5":"Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate. Also weakly methylates histone H1 (in vitro). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as repression of MYOD1-stimulated differentiation, regulation of the control switch for exiting the cell cycle and entering differentiation, repression by the PML-RARA fusion protein, BMP-induced repression, repression of switch recombination to IgA and regulation of telomere length. Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation. {ECO:0000269|PubMed:14765126, ECO:0000269|PubMed:16449642, ECO:0000269|PubMed:16818776, ECO:0000269|PubMed:16858404, ECO:0000269|PubMed:18004385, ECO:0000269|PubMed:18485871}.","6":"-39.36263068","7":"20.653907870","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O43463"},{"1":"HTRA2 OMI PRSS25","2":"HTRA2_HUMAN","3":"unknown","4":"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)","5":"Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. {ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:19502560}.","6":"-33.89855724","7":"-14.564594065","8":"Undefined","9":"MITOCHONDRIA,MITOCHONDRIA,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O43464"},{"1":"AKR7A2 AFAR AFAR1 AKR7","2":"ARK72_HUMAN","3":"unknown","4":"Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase)","5":"Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. {ECO:0000269|PubMed:17591773, ECO:0000269|PubMed:9576847}.","6":"31.78946762","7":"1.968721834","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43488"},{"1":"EPB41L2","2":"E41L2_HUMAN","3":"unknown","4":"Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G)","5":"Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}.","6":"1.46207983","7":"-33.808822114","8":"Undefined","9":"Undefined,ER,PM","10":"NA","11":"NA","12":"NA","_rn_":"O43491"},{"1":"TGOLN2 TGN46 TGN51","2":"TGON2_HUMAN","3":"unknown","4":"Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2)","5":"May be involved in regulating membrane traffic to and from trans-Golgi network.","6":"22.46760103","7":"-34.546411858","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O43493"},{"1":"RAD51C RAD51L2","2":"RA51C_HUMAN","3":"unknown","4":"DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2)","5":"Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Part of the RAD21 paralog protein complexes BCDX2 and CX3 which act at different stages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 seems to act downstream of BRCA2 recruitment and upstream of RAD51 recruitment; CX3 seems to act downstream of RAD51 recruitment; both complexes bind predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. Involved in RAD51 foci formation in response to DNA damage suggesting an involvement in early stages of HR probably in the invasion step. Has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHEK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Participates in branch migration and HJ resolution and thus is important for processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex. Part of a PALB2-scaffolded HR complex containing BRCA2 and which is thought to play a role in DNA repair by HR. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis. {ECO:0000269|PubMed:14716019, ECO:0000269|PubMed:16215984, ECO:0000269|PubMed:16395335, ECO:0000269|PubMed:19451272, ECO:0000269|PubMed:19783859, ECO:0000269|PubMed:20413593, ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}.","6":"19.65505355","7":"7.493083856","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43502"},{"1":"LAMTOR5 HBXIP XIP","2":"LTOR5_HUMAN","3":"unknown","4":"Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein) (HBV X-interacting protein) (HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5)","5":"As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator functions as a guanine nucleotide exchange factor activating the small GTPases Rag. Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated. When complexed to BIRC5, interferes with apoptosome assembly, preventing recruitment of pro-caspase-9 to oligomerized APAF1, thereby selectively suppressing apoptosis initiated via the mitochondrial/cytochrome c pathway. Down-regulates hepatitis B virus (HBV) replication. {ECO:0000269|PubMed:12773388, ECO:0000269|PubMed:22980980}.","6":"-12.11749035","7":"-26.755143105","8":"Undefined","9":"PM,MITOCHONDRIA,ER","10":"NA","11":"NA","12":"NA","_rn_":"O43504"},{"1":"B4GAT1 B3GNT1 B3GNT6","2":"B4GA1_HUMAN","3":"GOLGI","4":"Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)","5":"Beta-1,4-glucuronyltransferase involved in O-mannosylation of alpha-dystroglycan (DAG1). Transfers a glucuronic acid (GlcA) residue onto a xylose (Xyl) acceptor to produce the glucuronyl-beta-1,4-xylose-beta disaccharide primer, which is further elongated by LARGE1, during synthesis of phosphorylated O-mannosyl glycan (PubMed:25279699, PubMed:25279697). Phosphorylated O-mannosyl glycan is a carbohydrate is a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity (PubMed:25279699, PubMed:25279697). Required for axon guidance; via its function in O-mannosylation of alpha-dystroglycan (DAG1) (By similarity). {ECO:0000250|UniProtKB:Q8BWP8, ECO:0000269|PubMed:19587235, ECO:0000269|PubMed:23359570, ECO:0000269|PubMed:25279697, ECO:0000269|PubMed:25279699}.","6":"13.48753194","7":"-38.253192919","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43505"},{"1":"DENR DRP1 H14","2":"DENR_HUMAN","3":"unknown","4":"Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3)","5":"May be involved in the translation of target mRNAs by scanning and recognition of the initiation codon. Involved in translation initiation; promotes recruitmnet of aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. Plays a role in the modulation of the translational profile of a subset of cancer-related mRNAs when recruited to the translational initiation complex by the oncogene MCTS1. {ECO:0000269|PubMed:16982740, ECO:0000269|PubMed:17878526, ECO:0000269|PubMed:20713520}.","6":"-5.90371075","7":"1.297629768","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43583"},{"1":"XPOT","2":"XPOT_HUMAN","3":"unknown","4":"Exportin-T (Exportin(tRNA)) (tRNA exportin)","5":"Mediates the nuclear export of aminoacylated tRNAs. In the nucleus binds to tRNA and to the GTPase Ran in its active GTP-bound form. Docking of this trimeric complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the tRNA from the export receptor. XPOT then return to the nuclear compartment and mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. {ECO:0000269|PubMed:12138183, ECO:0000269|PubMed:9512417, ECO:0000269|PubMed:9660920}.","6":"40.19032959","7":"7.987900193","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43592"},{"1":"DNPH1 C6orf108 RCL","2":"DNPH1_HUMAN","3":"unknown","4":"2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL)","5":"Catalyzes the cleavage of the N-glycosidic bond of deoxyribonucleoside 5'-monophosphates to yield deoxyribose 5-phosphate and a purine or pyrimidine base. Deoxyribonucleoside 5'-monophosphates containing purine bases are preferred to those containing pyrimidine bases. {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:24260472, ECO:0000269|PubMed:25108359}.","6":"17.83626018","7":"-3.171815508","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43598"},{"1":"TIMM44 MIMT44 TIM44","2":"TIM44_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial import inner membrane translocase subunit TIM44","5":"Essential component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner (By similarity). Recruits mitochondrial HSP70 to drive protein translocation into the matrix using ATP as an energy source (By similarity). {ECO:0000250|UniProtKB:O35857, ECO:0000250|UniProtKB:Q01852}.","6":"-34.51224360","7":"-11.995668906","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43615"},{"1":"TRAPPC3 BET3 CDABP0066","2":"TPPC3_HUMAN","3":"unknown","4":"Trafficking protein particle complex subunit 3 (BET3 homolog)","5":"May play a role in vesicular transport from endoplasmic reticulum to Golgi.","6":"13.77354745","7":"8.128908644","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43617"},{"1":"CHMP2A BC2 CHMP2","2":"CHM2A_HUMAN","3":"unknown","4":"Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1)","5":"Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (PubMed:21310966). Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase (PubMed:26040712). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. {ECO:0000269|PubMed:21310966, ECO:0000269|PubMed:26040712, ECO:0000305}.; (Microbial infection) The ESCRT machinery functions in topologically equivalent membrane fission events, such as the budding of enveloped viruses (HIV-1 and other lentiviruses). Involved in HIV-1 p6- and p9-dependent virus release. {ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844}.","6":"3.37160197","7":"-18.066726123","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43633"},{"1":"NCK2 GRB4","2":"NCK2_HUMAN","3":"unknown","4":"Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta)","5":"Adapter protein which associates with tyrosine-phosphorylated growth factor receptors or their cellular substrates. Maintains low levels of EIF2S1 phosphorylation by promoting its dephosphorylation by PP1. Plays a role in ELK1-dependent transcriptional activation in response to activated Ras signaling. {ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:16835242}.","6":"6.21794561","7":"-17.805633068","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43639"},{"1":"TSPAN6 TM4SF6 UNQ767/PRO1560","2":"TSN6_HUMAN","3":"unknown","4":"Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6)","5":"NA","6":"8.02667040","7":"-35.323413968","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43657"},{"1":"PLRG1","2":"PLRG1_HUMAN","3":"unknown","4":"Pleiotropic regulator 1","5":"Involved in pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:28076346). Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing (PubMed:11101529, PubMed:11544257). {ECO:0000269|PubMed:11101529, ECO:0000269|PubMed:11544257, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.","6":"-9.92128269","7":"23.523816328","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43660"},{"1":"PRC1","2":"PRC1_HUMAN","3":"unknown","4":"Protein regulator of cytokinesis 1","5":"Key regulator of cytokinesis that cross-links antiparrallel microtubules at an average distance of 35 nM. Essential for controlling the spatiotemporal formation of the midzone and successful cytokinesis. Required for KIF14 localization to the central spindle and midbody. Required to recruit PLK1 to the spindle. Stimulates PLK1 phosphorylation of RACGAP1 to allow recruitment of ECT2 to the central spindle. Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression (PubMed:17409436). {ECO:0000269|PubMed:12082078, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:17409436, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:20691902, ECO:0000269|PubMed:9885575}.","6":"4.02320259","7":"0.350628003","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43663"},{"1":"RGS10","2":"RGS10_HUMAN","3":"unknown","4":"Regulator of G-protein signaling 10 (RGS10)","5":"Regulates G protein-coupled receptor signaling cascades, including signaling downstream of the muscarinic acetylcholine receptor CHRM2. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:8774883, PubMed:10608901, PubMed:9353196, PubMed:11443111, PubMed:18434541). Modulates the activity of potassium channels that are activated in response to CHRM2 signaling (PubMed:11443111). Activity on GNAZ is inhibited by palmitoylation of the G-protein (PubMed:9353196). {ECO:0000269|PubMed:10608901, ECO:0000269|PubMed:11443111, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:8774883, ECO:0000269|PubMed:9353196}.","6":"11.41992644","7":"-3.771445411","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43665"},{"1":"ZNF207 BUGZ","2":"ZN207_HUMAN","3":"NUCLEOPLASM-1","4":"BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207)","5":"Kinetochore- and microtubule-binding protein that plays a key role in spindle assembly (PubMed:24462186, PubMed:24462187, PubMed:26388440). ZNF207/BuGZ is mainly composed of disordered low-complexity regions and undergoes phase transition or coacervation to form temperature-dependent liquid droplets. Coacervation promotes microtubule bundling and concentrates tubulin, promoting microtubule polymerization and assembly of spindle and spindle matrix by concentrating its building blocks (PubMed:26388440). Also acts as a regulator of mitotic chromosome alignment by mediating the stability and kinetochore loading of BUB3 (PubMed:24462186, PubMed:24462187). Mechanisms by which BUB3 is protected are unclear: according to a first report, ZNF207/BuGZ may act by blocking ubiquitination and proteasomal degradation of BUB3 (PubMed:24462186). According to another report, the stabilization is independent of the proteasome (PubMed:24462187). {ECO:0000269|PubMed:24462186, ECO:0000269|PubMed:24462187, ECO:0000269|PubMed:26388440}.","6":"43.62855106","7":"2.033205475","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43670"},{"1":"NDUFB5","2":"NDUB5_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-34.14470263","7":"-5.891805759","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43674"},{"1":"GET3 ARSA ASNA1 TRC40","2":"GET3_HUMAN","3":"unknown","4":"ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)","5":"ATPase required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum. Recognizes and selectively binds the transmembrane domain of TA proteins in the cytosol. This complex then targets to the endoplasmic reticulum by membrane-bound receptors GET1/WRB and CAMLG/GET2, where the tail-anchored protein is released for insertion. This process is regulated by ATP binding and hydrolysis. ATP binding drives the homodimer towards the closed dimer state, facilitating recognition of newly synthesized TA membrane proteins. ATP hydrolysis is required for insertion. Subsequently, the homodimer reverts towards the open dimer state, lowering its affinity for the GET1-CAMLG receptor, and returning it to the cytosol to initiate a new round of targeting. May be involved in insulin signaling. {ECO:0000255|HAMAP-Rule:MF_03112, ECO:0000269|PubMed:17382883, ECO:0000269|PubMed:18477612, ECO:0000269|PubMed:23041287, ECO:0000269|PubMed:25535373}.","6":"-11.32684066","7":"-0.908611618","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43681"},{"1":"BUB1 BUB1L","2":"BUB1_HUMAN","3":"unknown","4":"Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A)","5":"Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936}.","6":"18.21294239","7":"15.855637141","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43683"},{"1":"BUB3","2":"BUB3_HUMAN","3":"unknown","4":"Mitotic checkpoint protein BUB3","5":"Has a dual function in spindle-assembly checkpoint signaling and in promoting the establishment of correct kinetochore-microtubule (K-MT) attachments. Promotes the formation of stable end-on bipolar attachments. Necessary for kinetochore localization of BUB1. Regulates chromosome segregation during oocyte meiosis. The BUB1/BUB3 complex plays a role in the inhibition of anaphase-promoting complex or cyclosome (APC/C) when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:18199686}.","6":"35.42957101","7":"-1.978958216","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O43684"},{"1":"PLPP2 LPP2 PPAP2C","2":"PLPP2_HUMAN","3":"unknown","4":"Phospholipid phosphatase 2 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c)","5":"Magnesium-independent phospholipid phosphatase that catalyzes the dephosphorylation of a variety of glycerolipid and sphingolipid phosphate esters including phosphatidate/PA, lysophosphatidate/LPA, sphingosine 1-phosphate/S1P and ceramide 1-phosphate/C1P (PubMed:9705349, PubMed:9607309, PubMed:16467304). Has no apparent extracellular phosphatase activity and therefore most probably acts intracellularly (PubMed:16467304). Also acts on N-oleoyl ethanolamine phosphate/N-(9Z-octadecenoyl)-ethanolamine phosphate, a potential physiological compound (PubMed:9607309). Through dephosphorylation of these bioactive lipid mediators produces new bioactive compounds and may regulate signal transduction in different cellular processes (Probable). Indirectly regulates, for instance, cell cycle G1/S phase transition through its phospholipid phosphatase activity (By similarity). {ECO:0000250|UniProtKB:Q8K593, ECO:0000269|PubMed:16467304, ECO:0000269|PubMed:9607309, ECO:0000269|PubMed:9705349, ECO:0000305|PubMed:16467304}.","6":"10.10755373","7":"-40.840368656","8":"Undefined","9":"LYSOSOME,GOLGI,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O43688"},{"1":"ACTN4","2":"ACTN4_HUMAN","3":"unknown","4":"Alpha-actinin-4 (Non-muscle alpha-actinin 4)","5":"F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (PubMed:15772161). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (By similarity). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA (PubMed:22351778). {ECO:0000250|UniProtKB:P57780, ECO:0000269|PubMed:15772161, ECO:0000269|PubMed:22351778, ECO:0000305|PubMed:9508771}.","6":"-7.63038031","7":"-11.795647030","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43707"},{"1":"GSTZ1 MAAI","2":"MAAI_HUMAN","3":"unknown","4":"Maleylacetoacetate isomerase (MAAI) (EC 5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (EC 2.5.1.18)","5":"Bifunctional enzyme showing minimal glutathione-conjugating activity with ethacrynic acid and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Has also low glutathione peroxidase activity with T-butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid. {ECO:0000269|PubMed:10739172}.","6":"-22.75789668","7":"-9.610179908","8":"MITOCHONDRIA","9":"Undefined,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43708"},{"1":"BUD23 MERM1 WBSCR22 HUSSY-03 PP3381","2":"BUD23_HUMAN","3":"unknown","4":"Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)","5":"S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the N(7) position of a guanine in 18S rRNA (PubMed:25851604). Requires the methyltransferase adapter protein TRM112 for full rRNA methyltransferase activity (PubMed:25851604). Involved in the pre-rRNA processing steps leading to small-subunit rRNA production independently of its RNA-modifying catalytic activity (PubMed:25851604). Important for biogenesis end export of the 40S ribosomal subunit independent on its methyltransferase activity (PubMed:24086612). Locus-specific steroid receptor coactivator. Potentiates transactivation by glucocorticoid (NR3C1), mineralocorticoid (NR3C2), androgen (AR) and progesterone (PGR) receptors (PubMed:24488492). Required for the maintenance of open chromatin at the TSC22D3/GILZ locus to facilitate NR3C1 loading on the response elements (PubMed:24488492). Required for maintenance of dimethylation on histone H3 'Lys-79' (H3K79me2), although direct histone methyltransferase activity is not observed in vitro (PubMed:24488492). {ECO:0000250, ECO:0000269|PubMed:24086612, ECO:0000269|PubMed:24488492, ECO:0000269|PubMed:25851604}.","6":"21.47880094","7":"-1.763499173","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43709"},{"1":"GATC 15E1.2","2":"GATC_HUMAN","3":"MITOCHONDRIA","4":"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-) (Protein 15E1.2)","5":"Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). {ECO:0000255|HAMAP-Rule:MF_03149, ECO:0000269|PubMed:19805282}.","6":"-42.14055503","7":"3.109101510","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43716"},{"1":"HTATSF1","2":"HTSF1_HUMAN","3":"unknown","4":"HIV Tat-specific factor 1 (Tat-SF1)","5":"Functions as a general transcription factor playing a role in the process of transcriptional elongation. May mediate the reciprocal stimulatory effect of splicing on transcriptional elongation. In case of infection by HIV-1, it is up-regulated by the HIV-1 proteins NEF and gp120, acts as a cofactor required for the Tat-enhanced transcription of the virus. {ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10913173, ECO:0000269|PubMed:11420046, ECO:0000269|PubMed:11780068, ECO:0000269|PubMed:15905670, ECO:0000269|PubMed:8849451, ECO:0000269|PubMed:9765201}.","6":"-16.13148045","7":"5.136480192","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43719"},{"1":"AP1G1 ADTG CLAPG1","2":"AP1G1_HUMAN","3":"unknown","4":"AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)","5":"Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. In association with AFTPH/aftiphilin in the aftiphilin/p200/gamma-synergin complex, involved in the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes (PubMed:15758025). {ECO:0000269|PubMed:15758025}.","6":"13.25809222","7":"-27.222904807","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43747"},{"1":"STX6","2":"STX6_HUMAN","3":"unknown","4":"Syntaxin-6","5":"Involved in intracellular vesicle trafficking.","6":"20.91364159","7":"-34.767548811","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O43752"},{"1":"SGTA SGT SGT1","2":"SGTA_HUMAN","3":"CYTOSOL","4":"Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP)","5":"Co-chaperone that binds misfolded and hydrophobic patches-containing client proteins in the cytosol. Mediates their targeting to the endoplasmic reticulum but also regulates their sorting to the proteasome when targeting fails (PubMed:28104892). Functions in tail-anchored/type II transmembrane proteins membrane insertion constituting with ASNA1 and the BAG6 complex a targeting module (PubMed:28104892). Functions upstream of the BAG6 complex and ASNA1, binding more rapidly the transmembrane domain of newly synthesized proteins (PubMed:28104892, PubMed:25535373). It is also involved in the regulation of the endoplasmic reticulum-associated misfolded protein catabolic process via its interaction with BAG6: collaborates with the BAG6 complex to maintain hydrophobic substrates in non-ubiquitinated states (PubMed:23129660, PubMed:25179605). Competes with RNF126 for interaction with BAG6, preventing the ubiquitination of client proteins associated with the BAG6 complex (PubMed:27193484). Binds directly to HSC70 and HSP70 and regulates their ATPase activity (PubMed:18759457). {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:27193484, ECO:0000269|PubMed:28104892}.; (Microbial infection) In case of infection by polyomavirus, involved in the virus endoplasmic reticulum membrane penetration and infection via interaction with DNAJB12, DNAJB14 and HSPA8/Hsc70 (PubMed:24675744). {ECO:0000269|PubMed:24675744}.","6":"-1.76840369","7":"6.097624226","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43765"},{"1":"LIAS LAS HUSSY-01","2":"LIAS_HUMAN","3":"unknown","4":"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)","5":"Catalyzes the radical-mediated insertion of two sulfur atoms into the C-6 and C-8 positions of the octanoyl moiety bound to the lipoyl domains of lipoate-dependent enzymes, thereby converting the octanoylated domains into lipoylated derivatives. {ECO:0000255|HAMAP-Rule:MF_03123}.","6":"-30.32822574","7":"-6.140251313","8":"MITOCHONDRIA","9":"MITOCHONDRIA,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43766"},{"1":"ENSA","2":"ENSA_HUMAN","3":"unknown","4":"Alpha-endosulfine (ARPP-19e)","5":"Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-67 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase (By similarity). Also acts as a stimulator of insulin secretion by interacting with sulfonylurea receptor (ABCC8), thereby preventing sulfonylurea from binding to its receptor and reducing K(ATP) channel currents. {ECO:0000250, ECO:0000269|PubMed:9653196}.","6":"-5.33270099","7":"2.745066813","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O43768"},{"1":"NARS1 NARS NRS","2":"SYNC_HUMAN","3":"unknown","4":"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1)","5":"Catalyzes the attachment of asparagine to tRNA(Asn) in a two-step reaction: asparagine is first activated by ATP to form Asn-AMP and then transferred to the acceptor end of tRNA(Asn) (PubMed:9421509). In addition to its essential role in protein synthesis, acts as a signaling molecule that induced migration of CCR3-expressing cells (PubMed:30171954, PubMed:12235211). {ECO:0000269|PubMed:12235211, ECO:0000269|PubMed:30171954, ECO:0000269|PubMed:9421509}.","6":"31.70616917","7":"15.323266387","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43776"},{"1":"MYO1B","2":"MYO1B_HUMAN","3":"unknown","4":"Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa)","5":"Motor protein that may participate in process critical to neuronal development and function such as cell migration, neurite outgrowth and vesicular transport. {ECO:0000250}.","6":"0.50277309","7":"-29.560769018","8":"Undefined","9":"PM,ER,PM","10":"NA","11":"NA","12":"NA","_rn_":"O43795"},{"1":"NUDT21 CFIM25 CPSF25 CPSF5","2":"CPSF5_HUMAN","3":"unknown","4":"Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit) (CPSF 25 kDa subunit) (Cleavage factor Im complex 25 kDa subunit) (CFIm25) (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Nudix hydrolase 21) (Pre-mRNA cleavage factor Im 68 kDa subunit)","5":"Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs (PubMed:9659921, PubMed:8626397, PubMed:14690600, PubMed:15937220, PubMed:17024186, PubMed:17098938, PubMed:29276085). CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals) (PubMed:9659921, PubMed:8626397, PubMed:14690600, PubMed:17024186). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation (PubMed:17098938, PubMed:23187700, PubMed:29276085). The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs (PubMed:17098938, PubMed:20695905, PubMed:29276085). NUDT21/CPSF5 activates indirectly the mRNA 3'-processing machinery by recruiting CPSF6 and/or CPSF7 (PubMed:29276085). Binds to 5'-UGUA-3' elements localized upstream of pA signals that act as enhancers of pre-mRNA 3'-end processing (PubMed:8626397, PubMed:14690600, PubMed:15169763, PubMed:17024186, PubMed:22813749, PubMed:20479262). The homodimer mediates simultaneous sequence-specific recognition of two 5'-UGUA-3' elements within the pre-mRNA (PubMed:20479262, PubMed:21295486). Plays a role in somatic cell fate transitions and pluripotency by regulating widespread changes in gene expression through an APA-dependent function (By similarity). Binds to chromatin (By similarity). Binds to, but does not hydrolyze mono- and di-adenosine nucleotides (PubMed:18445629). {ECO:0000250|UniProtKB:Q9CQF3, ECO:0000269|PubMed:14690600, ECO:0000269|PubMed:15169763, ECO:0000269|PubMed:15937220, ECO:0000269|PubMed:17024186, ECO:0000269|PubMed:17098938, ECO:0000269|PubMed:18445629, ECO:0000269|PubMed:20479262, ECO:0000269|PubMed:20695905, ECO:0000269|PubMed:21295486, ECO:0000269|PubMed:22813749, ECO:0000269|PubMed:23187700, ECO:0000269|PubMed:29276085, ECO:0000269|PubMed:8626397, ECO:0000269|PubMed:9659921}.","6":"45.57795869","7":"-1.324406870","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O43809"},{"1":"LANCL1 GPR69A","2":"LANC1_HUMAN","3":"unknown","4":"Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)","5":"Functions as glutathione transferase. Catalyzes conjugation of the glutathione (GSH) to artificial substrates 1-chloro-2,4-dinitrobenzene (CDNB) and p-nitrophenyl acetate. Mitigates neuronal oxidative stress during normal postnatal development and in response to oxidative stresses probably through GSH antioxidant defense mechanism (By similarity). May play a role in EPS8 signaling. Binds glutathione (PubMed:19528316). {ECO:0000250|UniProtKB:O89112, ECO:0000269|PubMed:19528316}.","6":"22.48293414","7":"-8.526701105","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43813"},{"1":"STRN","2":"STRN_HUMAN","3":"unknown","4":"Striatin","5":"Calmodulin-binding protein which may function as scaffolding or signaling protein and may play a role in dendritic Ca(2+) signaling.","6":"-9.91734993","7":"7.019476662","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43815"},{"1":"RRP9 RNU3IP2 U355K","2":"U3IP2_HUMAN","3":"NUCLEUS","4":"U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K)","5":"Component of a nucleolar small nuclear ribonucleoprotein particle (snoRNP) thought to participate in the processing and modification of pre-ribosomal RNA (pre-rRNA). {ECO:0000269|PubMed:26867678}.","6":"-28.47461253","7":"14.124334682","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43818"},{"1":"SCO2","2":"SCO2_HUMAN","3":"MITOCHONDRIA","4":"Protein SCO2 homolog, mitochondrial","5":"Copper metallochaperone essential for the synthesis and maturation of cytochrome c oxidase subunit II (MT-CO2/COX2). Involved in transporting copper to the Cu(A) site on MT-CO2/COX2 (PubMed:15229189, PubMed:17189203). Also acts as a thiol-disulfide oxidoreductase to regulate the redox state of the cysteines in SCO1 during maturation of MT-CO2/COX2 (PubMed:19336478). {ECO:0000269|PubMed:15229189, ECO:0000269|PubMed:17189203, ECO:0000269|PubMed:19336478}.","6":"-34.63400510","7":"-9.603121924","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43819"},{"1":"AKAP8 AKAP95","2":"AKAP8_HUMAN","3":"unknown","4":"A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95)","5":"Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II) (PubMed:9473338). Acts as an anchor for a PKA-signaling complex onto mitotic chromosomes, which is required for maintenance of chromosomes in a condensed form throughout mitosis. Recruits condensin complex subunit NCAPD2 to chromosomes required for chromatin condensation; the function appears to be independent from PKA-anchoring (PubMed:10601332, PubMed:10791967, PubMed:11964380). May help to deliver cyclin D/E to CDK4 to facilitate cell cycle progression (PubMed:14641107). Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function may act redundantly with AKAP8L (PubMed:16980585). Involved in nuclear retention of RPS6KA1 upon ERK activation thus inducing cell proliferation (PubMed:22130794). May be involved in regulation of DNA replication by acting as scaffold for MCM2 (PubMed:12740381). Enhances HMT activity of the KMT2 family MLL4/WBP7 complex and is involved in transcriptional regulation. In a teratocarcinoma cell line is involved in retinoic acid-mediated induction of developmental genes implicating H3 'Lys-4' methylation (PubMed:23995757). May be involved in recruitment of active CASP3 to the nucleus in apoptotic cells (PubMed:16227597). May act as a carrier protein of GJA1 for its transport to the nucleus (PubMed:26880274). May play a repressive role in the regulation of rDNA transcription. Preferentially binds GC-rich DNA in vitro. In cells, associates with ribosomal RNA (rRNA) chromatin, preferentially with rRNA promoter and transcribed regions (PubMed:26683827). Involved in modulation of Toll-like receptor signaling. Required for the cAMP-dependent suppression of TNF-alpha in early stages of LPS-induced macrophage activation; the function probably implicates targeting of PKA to NFKB1 (By similarity). {ECO:0000250|UniProtKB:Q63014, ECO:0000250|UniProtKB:Q9DBR0, ECO:0000269|PubMed:10601332, ECO:0000269|PubMed:10791967, ECO:0000269|PubMed:11964380, ECO:0000269|PubMed:16980585, ECO:0000269|PubMed:22130794, ECO:0000269|PubMed:26683827, ECO:0000269|PubMed:26880274, ECO:0000305|PubMed:14641107, ECO:0000305|PubMed:9473338}.","6":"17.41975066","7":"26.980808743","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43823"},{"1":"GTPBP6 PGPL","2":"GTPB6_HUMAN","3":"unknown","4":"Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like)","5":"NA","6":"-23.36492440","7":"-12.497925263","8":"Undefined","9":"PEROXISOME,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43824"},{"1":"IDH3B","2":"IDH3B_HUMAN","3":"MITOCHONDRIA","4":"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)","5":"Plays a structural role to facilitate the assembly and ensure the full activity of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers. {ECO:0000269|PubMed:28139779}.","6":"-42.02857347","7":"-10.330358136","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43837"},{"1":"NRDC NRD1","2":"NRDC_HUMAN","3":"CYTOSOL","4":"Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)","5":"Cleaves peptide substrates on the N-terminus of arginine residues in dibasic pairs.","6":"1.95488801","7":"26.598922327","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O43847"},{"1":"CALU","2":"CALU_HUMAN","3":"unknown","4":"Calumenin (Crocalbin) (IEF SSP 9302)","5":"Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity). {ECO:0000250}.","6":"-16.49360613","7":"-29.866975608","8":"Undefined","9":"ER,PEROXISOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43852"},{"1":"EDIL3 DEL1","2":"EDIL3_HUMAN","3":"unknown","4":"EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","5":"Promotes adhesion of endothelial cells through interaction with the alpha-v/beta-3 integrin receptor. Inhibits formation of vascular-like structures. May be involved in regulation of vascular morphogenesis of remodeling in embryonic development.","6":"15.09701976","7":"-37.701509369","8":"GOLGI","9":"GOLGI,GOLGI,Undefined","10":"Candidate","11":"2","12":"1,2","_rn_":"O43854"},{"1":"AHCYL1 DCAL IRBIT XPVKONA","2":"SAHH2_HUMAN","3":"unknown","4":"S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2)","5":"Multifaceted cellular regulator which coordinates several essential cellular functions including regulation of epithelial HCO3(-) and fluid secretion, mRNA processing and DNA replication. Regulates ITPR1 sensitivity to inositol 1,4,5-trisphosphate, competing for the common binding site and acting as endogenous 'pseudoligand' whose inhibitory activity can be modulated by its phosphorylation status. Promotes the formation of contact points between the endoplasmic reticulum (ER) and mitochondria, facilitating transfer of Ca(2+) from the ER to mitochondria (PubMed:27995898). Under normal cellular conditions, functions cooperatively with BCL2L10 to limit ITPR1-mediated Ca(2+) release but, under apoptotic stress conditions, dephosphorylated which promotes dissociation of both AHCYL1 and BCL2L10 from mitochondria-associated endoplasmic reticulum membranes, inhibits BCL2L10 interaction with ITPR1 and leads to increased Ca(2+) transfer to mitochondria which promotes apoptosis (PubMed:27995898). In the pancreatic and salivary ducts, at resting state, attenuates inositol 1,4,5-trisphosphate-induced calcium release by interacting with ITPR1 (PubMed:16793548). When extracellular stimuli induce ITPR1 phosphorylation or inositol 1,4,5-trisphosphate production, dissociates from ITPR1 to interact with CFTR and SLC26A6, mediating their synergistic activation by calcium and cAMP that stimulates the epithelial secretion of electrolytes and fluid (By similarity). Also activates basolateral SLC4A4 isoform 1 to coordinate fluid and HCO3(-) secretion (PubMed:16769890). Inhibits the effect of STK39 on SLC4A4 and CFTR by recruiting PP1 phosphatase which activates SLC4A4, SLC26A6 and CFTR through dephosphorylation (By similarity). Mediates the induction of SLC9A3 surface expression produced by Angiotensin-2 (PubMed:20584908). Depending on the cell type, activates SLC9A3 in response to calcium or reverses SLC9A3R2-dependent calcium inhibition (PubMed:18829453). May modulate the polyadenylation state of specific mRNAs, both by controlling the subcellular location of FIP1L1 and by inhibiting PAPOLA activity, in response to a stimulus that alters its phosphorylation state (PubMed:19224921). Acts as a (dATP)-dependent inhibitor of ribonucleotide reductase large subunit RRM1, controlling the endogenous dNTP pool and ensuring normal cell cycle progression (PubMed:25237103). In vitro does not exhibit any S-adenosyl-L-homocysteine hydrolase activity (By similarity). {ECO:0000250|UniProtKB:B5DFN2, ECO:0000250|UniProtKB:Q80SW1, ECO:0000269|PubMed:16769890, ECO:0000269|PubMed:16793548, ECO:0000269|PubMed:18829453, ECO:0000269|PubMed:19224921, ECO:0000269|PubMed:20584908, ECO:0000269|PubMed:25237103, ECO:0000269|PubMed:27995898}.","6":"35.19964004","7":"8.947233231","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O43865"},{"1":"KIF1C KIAA0706","2":"KIF1C_HUMAN","3":"unknown","4":"Kinesin-like protein KIF1C","5":"Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility. {ECO:0000269|PubMed:9685376}.","6":"18.60944133","7":"16.862171015","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O43896"},{"1":"EXTL3 EXTL1L EXTR1 KIAA0519","2":"EXTL3_HUMAN","3":"unknown","4":"Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3)","5":"Glycosyltransferase which regulates the biosynthesis of heparan sulfate (HS). Important for both skeletal development and hematopoiesis, through the formation of HS proteoglycans (HSPGs) (PubMed:28132690, PubMed:28148688). Required for the function of REG3A in regulating keratinocyte proliferation and differentiation (PubMed:22727489). {ECO:0000269|PubMed:22727489, ECO:0000269|PubMed:28132690, ECO:0000269|PubMed:28148688}.","6":"0.80031177","7":"-42.256434328","8":"Undefined","9":"PM,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O43909"},{"1":"ORC5 ORC5L","2":"ORC5_HUMAN","3":"unknown","4":"Origin recognition complex subunit 5","5":"Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. {ECO:0000269|PubMed:31160578}.","6":"13.12338247","7":"22.656191604","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43913"},{"1":"NDUFS5","2":"NDUS5_HUMAN","3":"unknown","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-41.85051266","7":"2.695252734","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O43920"},{"1":"ORC4 ORC4L","2":"ORC4_HUMAN","3":"unknown","4":"Origin recognition complex subunit 4","5":"Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3. {ECO:0000269|PubMed:22427655}.","6":"13.28880989","7":"22.466294550","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O43929"},{"1":"RAD21 HR21 KIAA0078 NXP1 SCC1","2":"RAD21_HUMAN","3":"unknown","4":"Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)]","5":"[Double-strand-break repair protein rad21 homolog]: As a member of the cohesin complex, involved in sister chromatid cohesion from the time of DNA replication in S phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative DNA repair, and the prevention of inappropriate recombination between repetitive regions (PubMed:11509732). The cohesin complex may also play a role in spindle pole assembly during mitosis (PubMed:11590136). In interphase, cohesins may function in the control of gene expression by binding to numerous sites within the genome (By similarity). May control RUNX1 gene expression (Probable). Binds to and represses APOB gene promoter (PubMed:25575569). May play a role in embryonic gut development, possibly through the regulation of enteric neuron development (By similarity). {ECO:0000250|UniProtKB:Q61550, ECO:0000250|UniProtKB:Q6TEL1, ECO:0000269|PubMed:11509732, ECO:0000269|PubMed:11590136, ECO:0000269|PubMed:25575569, ECO:0000305|PubMed:25575569}.; [64-kDa C-terminal product]: May promote apoptosis. {ECO:0000269|PubMed:11875078, ECO:0000269|PubMed:12417729}.","6":"-15.55307589","7":"26.580821100","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60216"},{"1":"TIMM8A DDP DDP1 TIM8A","2":"TIM8A_HUMAN","3":"unknown","4":"Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein)","5":"Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins. Probably necessary for normal neurologic development. {ECO:0000269|PubMed:11489896, ECO:0000269|PubMed:15254020}.","6":"-39.71499406","7":"3.131344826","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60220"},{"1":"DHX16 DBP2 DDX16 KIAA0577 PRP2","2":"DHX16_HUMAN","3":"unknown","4":"Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16)","5":"Required for pre-mRNA splicing as component of the spliceosome (PubMed:20423332, PubMed:20841358, PubMed:25296192, PubMed:29360106). Contributes to pre-mRNA splicing after spliceosome formation and prior to the first transesterification reaction. {ECO:0000269|PubMed:20423332, ECO:0000269|PubMed:20841358, ECO:0000269|PubMed:25296192, ECO:0000269|PubMed:29360106}.","6":"20.19465737","7":"23.873799515","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60231"},{"1":"ZNRD2 SSSCA1","2":"ZNRD2_HUMAN","3":"unknown","4":"Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2)","5":"Might play a role in mitosis. Antigenic molecule. Could be a centromere-associated protein. May induce anti-centromere antibodies. {ECO:0000305|PubMed:9486406}.","6":"14.64320619","7":"38.336324639","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60232"},{"1":"MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170","2":"MED14_HUMAN","3":"unknown","4":"Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150)","5":"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:15340088, ECO:0000269|PubMed:15625066, ECO:0000269|PubMed:16595664}.","6":"23.72045946","7":"34.659276215","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60244"},{"1":"PRPSAP2","2":"KPRB_HUMAN","3":"unknown","4":"Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41)","5":"Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis.","6":"19.76152028","7":"36.533461501","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60256"},{"1":"SMARCA5 SNF2H WCRF135","2":"SMCA5_HUMAN","3":"unknown","4":"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)","5":"Helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity. Complexes containing SMARCA5 are capable of forming ordered nucleosome arrays on chromatin; this may require intact histone H4 tails. Also required for replication of pericentric heterochromatin in S-phase specifically in conjunction with BAZ1A. Probably plays a role in repression of polI dependent transcription of the rDNA locus, through the recruitment of the SIN3/HDAC1 corepressor complex to the rDNA promoter. Essential component of the WICH complex, a chromatin remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure. The WICH complex regulates the transcription of various genes, has a role in RNA polymerase I and RNA polymerase III transcription, mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes. Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. {ECO:0000269|PubMed:10880450, ECO:0000269|PubMed:11980720, ECO:0000269|PubMed:12198550, ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:12972596, ECO:0000269|PubMed:15543136, ECO:0000269|PubMed:16603771}.","6":"-35.35806732","7":"16.089980755","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O60264"},{"1":"SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6","2":"JIP4_HUMAN","3":"unknown","4":"C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)","5":"The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:14743216). Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex (PubMed:29146937). Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity). {ECO:0000250|UniProtKB:Q58A65, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:29146937}.","6":"-17.57974296","7":"8.745272614","8":"Undefined","9":"NUCLEUS,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60271"},{"1":"KIF5C KIAA0531 NKHC2","2":"KIF5C_HUMAN","3":"unknown","4":"Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2)","5":"Involved in synaptic transmission (PubMed:24812067). Mediates dendritic trafficking of mRNAs (By similarity). Kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. Required for anterograde axonal transportation of MAPK8IP3/JIP3 which is essential for MAPK8IP3/JIP3 function in axon elongation (By similarity). {ECO:0000250|UniProtKB:P28738, ECO:0000250|UniProtKB:P56536, ECO:0000269|PubMed:24812067}.","6":"10.24835247","7":"18.355908277","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60282"},{"1":"URB1 C21orf108 KIAA0539 NOP254 NPA1","2":"NPA1P_HUMAN","3":"unknown","4":"Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog)","5":"NA","6":"-36.37983166","7":"18.491563994","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O60287"},{"1":"MGRN1 KIAA0544 RNF156","2":"MGRN1_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)","5":"E3 ubiquitin-protein ligase. Mediates monoubiquitination at multiple sites of TSG101 in the presence of UBE2D1, but not of UBE2G1, nor UBE2H. Plays a role in the regulation of endosome-to-lysosome trafficking. Impairs MC1R- and MC4R-signaling by competing with GNAS-binding to MCRs and inhibiting agonist-induced cAMP production. Does not inhibit ADRB2-signaling. Does not promote MC1R ubiquitination. Acts also as a negative regulator of hedgehog signaling (By similarity). {ECO:0000250|UniProtKB:Q9D074, ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:19703557, ECO:0000269|PubMed:19737927}.","6":"-10.12144949","7":"-32.761951425","8":"Undefined","9":"PM,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"O60291"},{"1":"ZFC3H1 CCDC131 KIAA0546 PSRC2","2":"ZC3H1_HUMAN","3":"unknown","4":"Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","5":"Subunit of the trimeric poly(A) tail exosome targeting (PAXT) complex, a complex that directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor MTREX, which links to RNA-binding protein adapters. {ECO:0000269|PubMed:27871484}.","6":"6.45569367","7":"18.783897270","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60293"},{"1":"LCMT2 KIAA0547 TYW4","2":"TYW4_HUMAN","3":"unknown","4":"tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)","5":"Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA (By similarity). May methylate the carboxyl group of leucine residues to form alpha-leucine ester residues. {ECO:0000250}.","6":"24.22535827","7":"4.253729462","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60294"},{"1":"AQR KIAA0560","2":"AQR_HUMAN","3":"unknown","4":"RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160)","5":"Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:25599396, PubMed:28502770, PubMed:28076346). Intron-binding spliceosomal protein required to link pre-mRNA splicing and snoRNP (small nucleolar ribonucleoprotein) biogenesis (PubMed:16949364). Plays a key role in position-dependent assembly of intron-encoded box C/D small snoRNP, splicing being required for snoRNP assembly (PubMed:16949364). May act by helping the folding of the snoRNA sequence. Binds to intron of pre-mRNAs in a sequence-independent manner, contacting the region between snoRNA and the branchpoint of introns (40 nucleotides upstream of the branchpoint) during the late stages of splicing (PubMed:16949364). Has ATP-dependent RNA helicase activity and can unwind double-stranded RNA molecules with a 3' overhang (in vitro) (PubMed:25599396). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:16949364, ECO:0000269|PubMed:25599396, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.","6":"-12.69032704","7":"28.597818001","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60306"},{"1":"OPA1 KIAA0567","2":"OPA1_HUMAN","3":"MITOCHONDRIA","4":"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1]","5":"Dynamin-related GTPase that is essential for normal mitochondrial morphology by regulating the equilibrium between mitochondrial fusion and mitochondrial fission (PubMed:16778770, PubMed:17709429, PubMed:20185555, PubMed:24616225, PubMed:28746876). Coexpression of isoform 1 with shorter alternative products is required for optimal activity in promoting mitochondrial fusion (PubMed:17709429). Binds lipid membranes enriched in negatively charged phospholipids, such as cardiolipin, and promotes membrane tubulation (PubMed:20185555). The intrinsic GTPase activity is low, and is strongly increased by interaction with lipid membranes (PubMed:20185555). Plays a role in remodeling cristae and the release of cytochrome c during apoptosis (By similarity). Proteolytic processing in response to intrinsic apoptotic signals may lead to disassembly of OPA1 oligomers and release of the caspase activator cytochrome C (CYCS) into the mitochondrial intermembrane space (By similarity). Plays a role in mitochondrial genome maintenance (PubMed:20974897, PubMed:18158317). {ECO:0000250|UniProtKB:P58281, ECO:0000269|PubMed:16778770, ECO:0000269|PubMed:17709429, ECO:0000269|PubMed:18158317, ECO:0000269|PubMed:20185555, ECO:0000269|PubMed:20974897, ECO:0000269|PubMed:24616225, ECO:0000269|PubMed:28746876}.; [Dynamin-like 120 kDa protein, form S1]: Inactive form produced by cleavage at S1 position by OMA1 following stress conditions that induce loss of mitochondrial membrane potential, leading to negative regulation of mitochondrial fusion. {ECO:0000269|PubMed:20038677}.; Isoforms that contain the alternative exon 4b (present in isoform 4 and isoform 5) are required for mitochondrial genome maintenance, possibly by anchoring the mitochondrial nucleoids to the inner mitochondrial membrane. {ECO:0000269|PubMed:20974897}.","6":"-37.71759873","7":"-7.517510412","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60313"},{"1":"MCM3AP GANP KIAA0572 MAP80","2":"GANP_HUMAN","3":"unknown","4":"Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (MCM3AP) (EC 2.3.1.-) (MCM3 acetyltransferase)","5":"[Isoform GANP]: As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores (PubMed:20005110, PubMed:20384790, PubMed:23591820, PubMed:22307388). Through the acetylation of histones, affects the assembly of nucleosomes at immunoglobulin variable region genes and promotes the recruitment and positioning of transcription complex to favor DNA cytosine deaminase AICDA/AID targeting, hence promoting somatic hypermutations (PubMed:23652018). {ECO:0000269|PubMed:20005110, ECO:0000269|PubMed:20384790, ECO:0000269|PubMed:22307388, ECO:0000269|PubMed:23591820, ECO:0000269|PubMed:23652018}.; [Isoform MCM3AP]: Binds to and acetylates the replication protein MCM3. Plays a role in the initiation of DNA replication and participates in controls that ensure that DNA replication initiates only once per cell cycle (PubMed:11258703, PubMed:12226073). Through the acetylation of histones, affects the assembly of nucleosomes at immunoglobulin variable region genes and promotes the recruitment and positioning of transcription complex to favor DNA cytosine deaminase AICDA/AID targeting, hence promoting somatic hypermutations (PubMed:23652018). {ECO:0000269|PubMed:11258703, ECO:0000269|PubMed:12226073, ECO:0000269|PubMed:23652018}.","6":"0.81072293","7":"31.164660188","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60318"},{"1":"KIF1B KIAA0591 KIAA1448","2":"KIF1B_HUMAN","3":"unknown","4":"Kinesin-like protein KIF1B (Klp)","5":"Motor for anterograde transport of mitochondria. Has a microtubule plus end-directed motility. Isoform 2 is required for induction of neuronal apoptosis. {ECO:0000269|PubMed:18334619}.; Isoform 1 mediates the transport of synaptic vesicles in neuronal cells. {ECO:0000250|UniProtKB:O88658}.","6":"10.22779159","7":"19.076466508","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60333"},{"1":"KDM1A AOF2 KDM1 KIAA0601 LSD1","2":"KDM1A_HUMAN","3":"unknown","4":"Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)","5":"Histone demethylase that can demethylate both 'Lys-4' (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context (PubMed:15620353, PubMed:15811342, PubMed:16140033, PubMed:16079794, PubMed:16079795, PubMed:16223729). Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed (PubMed:15620353, PubMed:15811342, PubMed:16079794, PubMed:21300290). Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me (PubMed:15620353, PubMed:20389281, PubMed:21300290, PubMed:23721412). May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity (PubMed:16140033, PubMed:16079794, PubMed:16885027, PubMed:21300290, PubMed:23721412). Also acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in AR-containing complexes, which mediates phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A (PubMed:16079795). Demethylates di-methylated 'Lys-370' of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation. Demethylates and stabilizes the DNA methylase DNMT1. Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Effector of SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7 (PubMed:20389281). {ECO:0000269|PubMed:12032298, ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342, ECO:0000269|PubMed:16079794, ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:16140033, ECO:0000269|PubMed:16223729, ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:20389281, ECO:0000269|PubMed:20562920, ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412}.","6":"6.12759353","7":"29.560878773","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60341"},{"1":"TBC1D4 AS160 KIAA0603","2":"TBCD4_HUMAN","3":"unknown","4":"TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160)","5":"May act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake. {ECO:0000269|PubMed:15971998, ECO:0000269|PubMed:18771725, ECO:0000269|PubMed:22908308}.","6":"-4.52121150","7":"33.203177694","8":"Undefined","9":"NUCLEOPLASM-2,PROTEIN COMPLEX,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60343"},{"1":"FZD6","2":"FZD6_HUMAN","3":"unknown","4":"Frizzled-6 (Fz-6) (hFz6)","5":"Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Together with FZD3, is involved in the neural tube closure and plays a role in the regulation of the establishment of planar cell polarity (PCP), particularly in the orientation of asymmetric bundles of stereocilia on the apical faces of a subset of auditory and vestibular sensory cells located in the inner ear (By similarity). {ECO:0000250|UniProtKB:Q61089}.","6":"-20.26253828","7":"-24.808521495","8":"ER","9":"ER,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60353"},{"1":"FADS1 FADSD5","2":"FADS1_HUMAN","3":"unknown","4":"Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1)","5":"[Isoform 1]: Acts as a front-end fatty acyl-coenzyme A (CoA) desaturase that introduces a cis double bond at carbon 5 located between a preexisting double bond and the carboxyl end of the fatty acyl chain. Involved in biosynthesis of highly unsaturated fatty acids (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3) precursors. Specifically, desaturates dihomo-gamma-linoleoate (DGLA) (20:3n-6) and eicosatetraenoate (ETA) (20:4n-3) to generate arachidonate (AA) (20:4n-6) and eicosapentaenoate (EPA) (20:5n-3), respectively (PubMed:10601301, PubMed:10769175). As a rate limiting enzyme for DGLA (20:3n-6) and AA (20:4n-6)-derived eicosanoid biosynthesis, controls the metabolism of inflammatory lipids like prostaglandin E2, critical for efficient acute inflammatory response and maintenance of epithelium homeostasis. Contributes to membrane phospholipid biosynthesis by providing AA (20:4n-6) as a major acyl chain esterified into phospholipids. In particular, regulates phosphatidylinositol-4,5-bisphosphate levels, modulating inflammatory cytokine production in T-cells (By similarity). Also desaturates (11E)-octadecenoate (trans-vaccenoate)(18:1n-9), a metabolite in the biohydrogenation pathway of LA (18:2n-6) (By similarity). {ECO:0000250|UniProtKB:Q920L1, ECO:0000250|UniProtKB:Q920R3, ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175}.; [Isoform 2]: Does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity. {ECO:0000250|UniProtKB:A4UVI1}.","6":"-9.70262601","7":"-32.771210406","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60427"},{"1":"GSDME DFNA5 ICERE1","2":"GSDME_HUMAN","3":"unknown","4":"Gasdermin-E (Inversely correlated with estrogen receptor expression 1) (ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal (GSDME-NT); Gasdermin-E, C-terminal (GSDME-CT)]","5":"[Gasdermin-E]: Precursor of a pore-forming protein that converts non-inflammatory apoptosis to pyroptosis (PubMed:27281216, PubMed:28459430). This form constitutes the precursor of the pore-forming protein: upon cleavage, the released N-terminal moiety (Gasdermin-E, N-terminal) binds to membranes and forms pores, triggering pyroptosis (PubMed:28459430). {ECO:0000269|PubMed:27281216, ECO:0000269|PubMed:28459430}.; [Gasdermin-E, N-terminal]: Pore-forming protein produced by cleavage by CASP3 or granzyme B (GZMB), which converts non-inflammatory apoptosis to pyroptosis or promotes granzyme-mediated pyroptosis, respectively (PubMed:27281216, PubMed:28459430, PubMed:32188940). After cleavage, moves to the plasma membrane, homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed:28459430, PubMed:32188940). Binds to inner leaflet lipids, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate (PubMed:28459430). Cleavage by CASP3 switches CASP3-mediated apoptosis induced by TNF or danger signals, such as chemotherapy drugs, to pyroptosis (PubMed:27281216, PubMed:28459430, PubMed:32188940). Mediates secondary necrosis downstream of the mitochondrial apoptotic pathway and CASP3 activation as well as in response to viral agents (PubMed:28045099). Exhibits bactericidal activity (PubMed:27281216). Cleavage by GZMB promotes tumor suppressor activity by triggering robust anti-tumor immunity (PubMed:21522185, PubMed:32188940). Suppresses tumors by mediating granzyme-mediated pyroptosis in target cells of natural killer (NK) cells: cleavage by granzyme B (GZMB), delivered to target cells from NK-cells, triggers pyroptosis of tumor cells and tumor suppression (PubMed:32188940, PubMed:31953257). May play a role in the p53/TP53-regulated cellular response to DNA damage (PubMed:16897187). {ECO:0000269|PubMed:16897187, ECO:0000269|PubMed:21522185, ECO:0000269|PubMed:27281216, ECO:0000269|PubMed:28045099, ECO:0000269|PubMed:28459430, ECO:0000269|PubMed:31953257, ECO:0000269|PubMed:32188940}.","6":"-0.42441660","7":"4.490995920","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60443"},{"1":"MAN1A2 MAN1B","2":"MA1A2_HUMAN","3":"GOLGI","4":"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)","5":"Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2).","6":"11.66111473","7":"-40.008665676","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60476"},{"1":"ACSL4 ACS4 FACL4 LACS4","2":"ACSL4_HUMAN","3":"unknown","4":"Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)","5":"Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:24269233, PubMed:22633490, PubMed:21242590). Preferentially activates arachidonate and eicosapentaenoate as substrates (PubMed:21242590). Preferentially activates 8,9-EET > 14,15-EET > 5,6-EET > 11,12-EET. Modulates glucose-stimulated insulin secretion by regulating the levels of unesterified EETs (By similarity). Modulates prostaglandin E2 secretion (PubMed:21242590). {ECO:0000250|UniProtKB:O35547, ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}.","6":"1.04282085","7":"-20.447686701","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60488"},{"1":"SNX3","2":"SNX3_HUMAN","3":"unknown","4":"Sorting nexin-3 (Protein SDP3)","5":"Phosphoinositide-binding protein required for multivesicular body formation. Specifically binds phosphatidylinositol 3-phosphate (PtdIns(P3)). Also can bind phosphatidylinositol 4-phosphate (PtdIns(P4)), phosphatidylinositol 5-phosphate (PtdIns(P5)) and phosphatidylinositol 3,5-biphosphate (PtdIns(3,5)P2) (By similarity). Plays a role in protein transport between cellular compartments. Together with RAB7A facilitates endosome membrane association of the retromer cargo-selective subcomplex (CSC/VPS). May in part act as component of the SNX3-retromer complex which mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway (PubMed:21725319, PubMed:24344282, PubMed:30213940). Promotes stability and cell surface expression of epithelial sodium channel (ENAC) subunits SCNN1A and SCNN1G (By similarity). Not involved in EGFR degradation. Involved in the regulation of phagocytosis in dendritic cells possibly by regulating EEA1 recruitment to the nascent phagosomes (PubMed:23237080). Involved in iron homeostasis through regulation of endocytic recycling of the transferrin receptor TFRC presumably by delivering the transferrin:transferrin receptor complex to recycling endosomes; the function may involve the CSC retromer subcomplex (By similarity). In the case of Salmonella enterica infection plays arole in maturation of the Salmonella-containing vacuole (SCV) and promotes recruitment of LAMP1 to SCVs (PubMed:20482551). {ECO:0000250|UniProtKB:O70492, ECO:0000269|PubMed:11433298, ECO:0000269|PubMed:18767904, ECO:0000269|PubMed:21725319, ECO:0000269|PubMed:23237080, ECO:0000269|PubMed:24344282, ECO:0000305|PubMed:21725319}.","6":"10.25478520","7":"-22.076939233","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60493"},{"1":"STX10 SYN10","2":"STX10_HUMAN","3":"unknown","4":"Syntaxin-10 (Syn10)","5":"SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}.","6":"20.72364673","7":"-34.702193993","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O60499"},{"1":"OGA HEXC KIAA0679 MEA5 MGEA5","2":"OGA_HUMAN","3":"unknown","4":"Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT)","5":"[Isoform 1]: Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) (PubMed:11148210). Does not bind acetyl-CoA and does not have histone acetyltransferase activity (PubMed:24088714). {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:20673219, ECO:0000269|PubMed:22365600, ECO:0000269|PubMed:24088714}.; [Isoform 3]: Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro), but has about six times lower specific activity than isoform 1. {ECO:0000269|PubMed:20673219}.","6":"-17.10688555","7":"8.561388331","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60502"},{"1":"SORBS3 SCAM1","2":"VINEX_HUMAN","3":"unknown","4":"Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3)","5":"Vinexin alpha isoform promotes up-regulation of actin stress fiber formation. Vinexin beta isoform plays a role in cell spreading and enhances the activation of JNK/SAPK in response to EGF stimulation by using its third SH3 domain.","6":"23.87661871","7":"-6.664301955","8":"CYTOSOL","9":"CYTOSOL,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60504"},{"1":"SYNCRIP HNRPQ NSAP1","2":"HNRPQ_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)","5":"Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD-mediated complex that promotes MYC mRNA stability. Isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences. Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 3 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation; seems not to be essential for GAIT complex function. {ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:11134005, ECO:0000269|PubMed:11352648, ECO:0000269|PubMed:11574476, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23071094}.","6":"1.69462664","7":"19.403741040","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60506"},{"1":"TPST1","2":"TPST1_HUMAN","3":"GOLGI","4":"Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1)","5":"Catalyzes the O-sulfation of tyrosine residues within acidic motifs of polypeptides, using 3'-phosphoadenylyl sulfate (PAPS) as cosubstrate. {ECO:0000269|PubMed:28821720, ECO:0000269|PubMed:9501187, ECO:0000269|PubMed:9733778}.","6":"8.86236914","7":"-36.042187248","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60507"},{"1":"CDC40 EHB3 PRP17 PRPF17","2":"PRP17_HUMAN","3":"NUCLEUS","4":"Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)","5":"Required for pre-mRNA splicing as component of the activated spliceosome. {ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9830021}.","6":"-22.16492948","7":"19.971095828","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60508"},{"1":"B4GALT4 UNQ552/PRO1109","2":"B4GT4_HUMAN","3":"GOLGI","4":"Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)","5":"Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. {ECO:0000269|PubMed:9792633}.","6":"18.11283855","7":"-35.408787986","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60513"},{"1":"RANBP6","2":"RNBP6_HUMAN","3":"unknown","4":"Ran-binding protein 6 (RanBP6)","5":"May function in nuclear protein import as nuclear transport receptor.","6":"-7.18206475","7":"-13.219755409","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60518"},{"1":"NEMF SDCCAG1","2":"NEMF_HUMAN","3":"unknown","4":"Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1)","5":"Component of the ribosome quality control complex (RQC), a ribosome-associated complex that mediates ubiquitination and extraction of incompletely synthesized nascent chains for proteasomal degradation. NEMF is responsible for selective recognition of stalled 60S subunits by recognizing an exposed, nascent chain-conjugated tRNA moiety. NEMF is important for the stable association of LTN1 to the complex (PubMed:25578875). May indirectly play a role in nuclear export (PubMed:16103875). {ECO:0000269|PubMed:16103875, ECO:0000269|PubMed:25578875}.","6":"4.45654612","7":"18.111405916","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60524"},{"1":"GMDS","2":"GMDS_HUMAN","3":"unknown","4":"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","5":"Catalyzes the conversion of GDP-D-mannose to GDP-4-dehydro-6-deoxy-D-mannose.","6":"35.01965741","7":"2.835591445","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60547"},{"1":"NMT2","2":"NMT2_HUMAN","3":"unknown","4":"Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase)","5":"Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:9506952}.","6":"7.17458727","7":"15.308273982","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60551"},{"1":"CCNT1","2":"CCNT1_HUMAN","3":"unknown","4":"Cyclin-T1 (CycT1) (Cyclin-T)","5":"Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II). {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377}.; (Microbial infection) In case of HIV or SIV infections, binds to the transactivation domain of the viral nuclear transcriptional activator, Tat, thereby increasing Tat's affinity for the transactivating response RNA element (TAR RNA). Serves as an essential cofactor for Tat, by promoting RNA Pol II activation, allowing transcription of viral genes. {ECO:0000269|PubMed:10329125, ECO:0000269|PubMed:10329126}.","6":"4.36006050","7":"29.906665966","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60563"},{"1":"BUB1B BUBR1 MAD3L SSK1","2":"BUB1B_HUMAN","3":"unknown","4":"Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1)","5":"Essential component of the mitotic checkpoint. Required for normal mitosis progression. The mitotic checkpoint delays anaphase until all chromosomes are properly attached to the mitotic spindle. One of its checkpoint functions is to inhibit the activity of the anaphase-promoting complex/cyclosome (APC/C) by blocking the binding of CDC20 to APC/C, independently of its kinase activity. The other is to monitor kinetochore activities that depend on the kinetochore motor CENPE. Required for kinetochore localization of CENPE. Negatively regulates PLK1 activity in interphase cells and suppresses centrosome amplification. Also implicated in triggering apoptosis in polyploid cells that exit aberrantly from mitotic arrest. May play a role for tumor suppression. {ECO:0000269|PubMed:10477750, ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:14706340, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:19411850, ECO:0000269|PubMed:19503101}.","6":"15.28535051","7":"17.001902359","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60566"},{"1":"PLOD3","2":"PLOD3_HUMAN","3":"ER","4":"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]","5":"Multifunctional enzyme that catalyzes a series of essential post-translational modifications on Lys residues in procollagen (PubMed:11956192, PubMed:12475640, PubMed:18298658, PubMed:30089812, PubMed:18834968). Plays a redundant role in catalyzing the formation of hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:9582318, PubMed:9724729, PubMed:11956192, PubMed:12475640, PubMed:18298658, PubMed:30089812, PubMed:18834968). Plays a redundant role in catalyzing the transfer of galactose onto hydroxylysine groups, giving rise to galactosyl 5-hydroxylysine (PubMed:12475640, PubMed:18298658, PubMed:30089812, PubMed:18834968). Has an essential role by catalyzing the subsequent transfer of glucose moieties, giving rise to 1,2-glucosylgalactosyl-5-hydroxylysine residues (PubMed:10934207, PubMed:11896059, PubMed:11956192, PubMed:12475640, PubMed:18298658, PubMed:30089812, PubMed:18834968). Catalyzes hydroxylation and glycosylation of Lys residues in the MBL1 collagen-like domain, giving rise to hydroxylysine and 1,2-glucosylgalactosyl-5-hydroxylysine residues (PubMed:25419660). Essential for normal biosynthesis and secretion of type IV collagens (PubMed:18834968) (Probable). Essential for normal formation of basement membranes (By similarity). {ECO:0000250|UniProtKB:Q9R0E1, ECO:0000269|PubMed:10934207, ECO:0000269|PubMed:11896059, ECO:0000269|PubMed:11956192, ECO:0000269|PubMed:12475640, ECO:0000269|PubMed:18298658, ECO:0000269|PubMed:18834968, ECO:0000269|PubMed:25419660, ECO:0000269|PubMed:30089812, ECO:0000269|PubMed:9582318, ECO:0000269|PubMed:9724729, ECO:0000305}.","6":"-24.92117600","7":"-16.388871036","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60568"},{"1":"EIF4E2 EIF4EL3","2":"IF4E2_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3)","5":"Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation (PubMed:17368478, PubMed:25624349, PubMed:9582349). Acts as a repressor of translation initiation (PubMed:22751931). In contrast to EIF4E, it is unable to bind eIF4G (EIF4G1, EIF4G2 or EIF4G3), suggesting that it acts by competing with EIF4E and block assembly of eIF4F at the cap (By similarity). In P-bodies, component of a complex that promotes miRNA-mediated translational repression (PubMed:28487484). {ECO:0000250|UniProtKB:Q8BMB3, ECO:0000269|PubMed:17368478, ECO:0000269|PubMed:22751931, ECO:0000269|PubMed:25624349, ECO:0000269|PubMed:28487484, ECO:0000269|PubMed:9582349}.","6":"33.70049163","7":"11.633473461","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60573"},{"1":"DIAPH1 DIAP1","2":"DIAP1_HUMAN","3":"unknown","4":"Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1)","5":"Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers (By similarity). Binds to the barbed end of the actin filament and slows down actin polymerization and depolymerization (By similarity). Required for cytokinesis, and transcriptional activation of the serum response factor (By similarity). DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics (By similarity). Functions as a scaffold protein for MAPRE1 and APC to stabilize microtubules and promote cell migration (By similarity). Has neurite outgrowth promoting activity. Acts in a Rho-dependent manner to recruit PFY1 to the membrane (By similarity). In hear cells, it may play a role in the regulation of actin polymerization in hair cells (PubMed:20937854, PubMed:21834987, PubMed:26912466). The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex (PubMed:20937854, PubMed:21834987). It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity (PubMed:20937854, PubMed:21834987). In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization (PubMed:20937854, PubMed:21834987). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape (PubMed:20937854, PubMed:21834987). Plays a role in brain development (PubMed:24781755). Also acts as an actin nucleation and elongation factor in the nucleus by promoting nuclear actin polymerization inside the nucleus to drive serum-dependent SRF-MRTFA activity (By similarity). {ECO:0000250|UniProtKB:O08808, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:24781755, ECO:0000269|PubMed:26912466}.","6":"-6.65047223","7":"20.139008967","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60610"},{"1":"SELENOF SEP15","2":"SEP15_HUMAN","3":"unknown","4":"Selenoprotein F (15 kDa selenoprotein)","5":"May be involved in redox reactions associated with the formation of disulfide bonds (By similarity). May contribute to the quality control of protein folding in the endoplasmic reticulum (PubMed:24415556). May regulate protein folding by enhancing the catalytic activity of UGGT1/UGCGL1 and UGGT2/UGCGL2 (PubMed:24415556). {ECO:0000250|UniProtKB:Q923V8, ECO:0000269|PubMed:24415556}.","6":"-22.66591965","7":"-13.759280097","8":"Undefined","9":"PEROXISOME,PEROXISOME,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O60613"},{"1":"EXOC3 SEC6 SEC6L1","2":"EXOC3_HUMAN","3":"unknown","4":"Exocyst complex component 3 (Exocyst complex component Sec6)","5":"Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.","6":"2.03929717","7":"-13.277275328","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60645"},{"1":"PLIN3 M6PRBP1 TIP47","2":"PLIN3_HUMAN","3":"unknown","4":"Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17)","5":"Required for the transport of mannose 6-phosphate receptors (MPR) from endosomes to the trans-Golgi network. {ECO:0000269|PubMed:9590177}.","6":"-7.55508806","7":"-1.969496216","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60664"},{"1":"RAD1 REC1","2":"RAD1_HUMAN","3":"unknown","4":"Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)","5":"Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair (PubMed:10846170, PubMed:10884395). The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex (PubMed:12578958). Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER) (PubMed:15871698). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates (PubMed:15314187, PubMed:15556996, PubMed:15871698). The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase (PubMed:21659603). Isoform 1 possesses 3'->5' double stranded DNA exonuclease activity (PubMed:9660799). {ECO:0000269|PubMed:10846170, ECO:0000269|PubMed:10884395, ECO:0000269|PubMed:12578958, ECO:0000269|PubMed:15314187, ECO:0000269|PubMed:15556996, ECO:0000269|PubMed:15871698, ECO:0000269|PubMed:21659603, ECO:0000269|PubMed:9660799}.","6":"-3.18236245","7":"10.235830695","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60671"},{"1":"PRMT3 HRMT1L3","2":"ANM3_HUMAN","3":"unknown","4":"Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)","5":"Methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues in some proteins.","6":"39.40076787","7":"8.284746098","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60678"},{"1":"KPNA6 IPOA7","2":"IMA7_HUMAN","3":"unknown","4":"Importin subunit alpha-7 (Karyopherin subunit alpha-6)","5":"Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. {ECO:0000269|PubMed:10523667}.","6":"1.50432755","7":"17.585286673","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60684"},{"1":"UGDH","2":"UGDH_HUMAN","3":"unknown","4":"UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)","5":"Catalyzes the formation of UDP-alpha-D-glucuronate, a constituent of complex glycosaminoglycans (PubMed:21961565, PubMed:21502315, PubMed:23106432, PubMed:22123821, PubMed:25478983, PubMed:27966912, PubMed:30420606, PubMed:30457329). Required for the biosynthesis of chondroitin sulfate and heparan sulfate. Required for embryonic development via its role in the biosynthesis of glycosaminoglycans (By similarity). Required for proper brain and neuronal development (PubMed:32001716). {ECO:0000250|UniProtKB:O70475, ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21961565, ECO:0000269|PubMed:22123821, ECO:0000269|PubMed:23106432, ECO:0000269|PubMed:25478983, ECO:0000269|PubMed:27966912, ECO:0000269|PubMed:30420606, ECO:0000269|PubMed:30457329, ECO:0000269|PubMed:32001716}.","6":"40.23876788","7":"5.494067264","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O60701"},{"1":"TPST2","2":"TPST2_HUMAN","3":"unknown","4":"Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2)","5":"Catalyzes the O-sulfation of tyrosine residues within acidic motifs of polypeptides, using 3'-phosphoadenylyl sulfate (PAPS) as cosubstrate. {ECO:0000269|PubMed:9733778}.","6":"7.08652993","7":"-37.501645852","8":"Undefined","9":"GOLGI,MITOCHONDRIA,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60704"},{"1":"CTNND1 KIAA0384","2":"CTND1_HUMAN","3":"unknown","4":"Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas))","5":"Key regulator of cell-cell adhesion that associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability (PubMed:14610055, PubMed:20371349). Beside cell-cell adhesion, regulates gene transcription through several transcription factors including ZBTB33/Kaiso2 and GLIS2, and the activity of Rho family GTPases and downstream cytoskeletal dynamics (PubMed:10207085, PubMed:20371349). Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors (PubMed:17344476). {ECO:0000269|PubMed:10207085, ECO:0000269|PubMed:14610055, ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:20371349}.","6":"-20.22763014","7":"-30.541039286","8":"Undefined","9":"ER,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O60716"},{"1":"MAGEC1","2":"MAGC1_HUMAN","3":"unknown","4":"Melanoma-associated antigen C1 (Cancer/testis antigen 7.1) (CT7.1) (MAGE-C1 antigen)","5":"NA","6":"-9.54834759","7":"5.020111391","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60732"},{"1":"SNX2 TRG9","2":"SNX2_HUMAN","3":"unknown","4":"Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9)","5":"Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) (PubMed:16179610). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex (PubMed:17101778). The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC) (Probable). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity (PubMed:23085988). Required for retrograde endosome-to-TGN transport of TGN38 (PubMed:20138391). Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN (PubMed:20604901). {ECO:0000269|PubMed:16179610, ECO:0000269|PubMed:17101778, ECO:0000269|PubMed:20138391, ECO:0000269|PubMed:20604901, ECO:0000269|PubMed:23085988, ECO:0000303|PubMed:16179610}.","6":"10.15759935","7":"-23.018238876","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Highly confident","11":"2","12":"1,3","_rn_":"O60749"},{"1":"DPM1","2":"DPM1_HUMAN","3":"ER","4":"Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)","5":"Transfers mannose from GDP-mannose to dolichol monophosphate to form dolichol phosphate mannose (Dol-P-Man) which is the mannosyl donor in pathways leading to N-glycosylation, glycosyl phosphatidylinositol membrane anchoring, and O-mannosylation of proteins; catalytic subunit of the dolichol-phosphate mannose (DPM) synthase complex.","6":"2.13379522","7":"-44.247355514","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60762"},{"1":"USO1 VDP","2":"USO1_HUMAN","3":"unknown","4":"General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein)","5":"General vesicular transport factor required for intercisternal transport in the Golgi stack; it is required for transcytotic fusion and/or subsequent binding of the vesicles to the target membrane. May well act as a vesicular anchor by interacting with the target membrane and holding the vesicular and target membranes in proximity. {ECO:0000250|UniProtKB:P41542}.","6":"-5.48457567","7":"21.432781768","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60763"},{"1":"TOM1","2":"TOM1_HUMAN","3":"unknown","4":"Target of Myb protein 1","5":"May be involved in intracellular trafficking. Probable association with membranes.","6":"8.58465855","7":"-21.218729703","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Highly confident","11":"2","12":"1,3","_rn_":"O60784"},{"1":"PFKFB2","2":"F262_HUMAN","3":"unknown","4":"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]","5":"Synthesis and degradation of fructose 2,6-bisphosphate.","6":"22.59063221","7":"23.477308223","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60825"},{"1":"CCDC22 CXorf37 JM1","2":"CCD22_HUMAN","3":"unknown","4":"Coiled-coil domain-containing protein 22","5":"Involved in regulation of NF-kappa-B signaling. Promotes ubiquitination of I-kappa-B-kinase subunit IKBKB and its subsequent proteasomal degradation leading to NF-kappa-B activation; the function may involve association with COMMD8 and a CUL1-dependent E3 ubiquitin ligase complex. May down-regulate NF-kappa-B activity via association with COMMD1 and involving a CUL2-dependent E3 ubiquitin ligase complex. Regulates the cellular localization of COMM domain-containing proteins, such as COMMD1 and COMMD10 (PubMed:23563313). Component of the CCC complex, which is involved in the regulation of endosomal recycling of surface proteins, including integrins, signaling receptor and channels. The CCC complex associates with SNX17, retriever and WASH complexes to prevent lysosomal degradation and promote cell surface recycling of numerous cargos such as integrins ITGA5:ITGB1 (PubMed:28892079, PubMed:25355947). Plays a role in copper ion homeostasis. Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes (PubMed:25355947). {ECO:0000269|PubMed:23563313, ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079}.; (Microbial infection) The CCC complex, in collaboration with the heterotrimeric retriever complex, mediates the exit of human papillomavirus to the cell surface. {ECO:0000269|PubMed:28892079}.","6":"21.39959798","7":"32.743405107","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60826"},{"1":"PQBP1 NPW38 JM26","2":"PQBP1_HUMAN","3":"unknown","4":"Polyglutamine-binding protein 1 (PQBP-1) (38 kDa nuclear protein containing a WW domain) (Npw38) (Polyglutamine tract-binding protein 1)","5":"Intrinsically disordered protein that acts as a scaffold, and which is involved in different processes, such as pre-mRNA splicing, transcription regulation, innate immunity and neuron development (PubMed:10198427, PubMed:10332029, PubMed:12062018, PubMed:20410308, PubMed:23512658). Interacts with splicing-related factors via the intrinsically disordered region and regulates alternative splicing of target pre-mRNA species (PubMed:10332029, PubMed:12062018, PubMed:23512658, PubMed:20410308). May suppress the ability of POU3F2 to transactivate the DRD1 gene in a POU3F2 dependent manner. Can activate transcription directly or via association with the transcription machinery (PubMed:10198427). May be involved in ATXN1 mutant-induced cell death (PubMed:12062018). The interaction with ATXN1 mutant reduces levels of phosphorylated RNA polymerase II large subunit (PubMed:12062018). Involved in the assembly of cytoplasmic stress granule, possibly by participating in the transport of neuronal RNA granules (PubMed:21933836). Also acts as an innate immune sensor of infection by retroviruses, such as HIV, by detecting the presence of reverse-transcribed DNA in the cytosol (PubMed:26046437). Directly binds retroviral reverse-transcribed DNA in the cytosol and interacts with CGAS, leading to activate the cGAS-STING signaling pathway, triggering type-I interferon production (PubMed:26046437). {ECO:0000269|PubMed:10198427, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:20410308, ECO:0000269|PubMed:21933836, ECO:0000269|PubMed:23512658, ECO:0000269|PubMed:26046437}.","6":"0.13249760","7":"7.433372126","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60828"},{"1":"TIMM17B TIM17B JM3","2":"TI17B_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial import inner membrane translocase subunit Tim17-B","5":"Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane.","6":"-36.46090300","7":"2.604777562","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60830"},{"1":"DKC1 NOLA4","2":"DKC1_HUMAN","3":"unknown","4":"H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)","5":"[Isoform 1]: Catalytic subunit of H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA (PubMed:25219674). This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1 (PubMed:25219674). Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. Required for ribosome biogenesis and telomere maintenance (PubMed:19179534, PubMed:25219674). Also required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (PubMed:19179534). {ECO:0000269|PubMed:19179534, ECO:0000269|PubMed:25219674}.; [Isoform 3]: Promotes cell to cell and cell to substratum adhesion, increases the cell proliferation rate and leads to cytokeratin hyper-expression. {ECO:0000269|PubMed:21820037}.","6":"-28.46349256","7":"13.262719169","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O60832"},{"1":"EIF5B IF2 KIAA0741","2":"IF2P_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)","5":"Plays a role in translation initiation. Translational GTPase that catalyzes the joining of the 40S and 60S subunits to form the 80S initiation complex with the initiator methionine-tRNA in the P-site base paired to the start codon. GTP binding and hydrolysis induces conformational changes in the enzyme that renders it active for productive interactions with the ribosome. The release of the enzyme after formation of the initiation complex is a prerequisite to form elongation-competent ribosomes. {ECO:0000250|UniProtKB:P39730}.","6":"-15.04578764","7":"2.097969631","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60841"},{"1":"EDF1","2":"EDF1_HUMAN","3":"unknown","4":"Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1)","5":"Transcriptional coactivator stimulating NR5A1 and ligand-dependent NR1H3/LXRA and PPARG transcriptional activities. Enhances the DNA-binding activity of ATF1, ATF2, CREB1 and NR5A1. Regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. May function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism. {ECO:0000269|PubMed:10567391, ECO:0000269|PubMed:12040021, ECO:0000269|PubMed:15112053, ECO:0000269|PubMed:9813014}.","6":"-0.59917118","7":"-2.809782426","8":"Undefined","9":"Undefined,CYTOSOL,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O60869"},{"1":"KIN BTCD KIN17","2":"KIN17_HUMAN","3":"unknown","4":"DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)","5":"Involved in DNA replication and the cellular response to DNA damage. May participate in DNA replication factories and create a bridge between DNA replication and repair mediated by high molecular weight complexes. May play a role in illegitimate recombination and regulation of gene expression. May participate in mRNA processing. Binds, in vitro, to double-stranded DNA. Also shown to bind preferentially to curved DNA in vitro and in vivo (By similarity). Binds via its C-terminal domain to RNA in vitro. {ECO:0000250|UniProtKB:Q8K339, ECO:0000269|PubMed:11880372, ECO:0000269|PubMed:12359749, ECO:0000269|PubMed:12754299, ECO:0000269|PubMed:12853634, ECO:0000269|PubMed:15831485, ECO:0000269|PubMed:17045609}.","6":"-13.07880765","7":"10.966522897","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60870"},{"1":"DIAPH2 DIA","2":"DIAP2_HUMAN","3":"unknown","4":"Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","5":"Could be involved in oogenesis. Involved in the regulation of endosome dynamics. Implicated in a novel signal transduction pathway, in which isoform 3 and CSK are sequentially activated by RHOD to regulate the motility of early endosomes through interactions with the actin cytoskeleton. {ECO:0000269|PubMed:12577064}.","6":"11.72462677","7":"18.801297006","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60879"},{"1":"DNAJA2 CPR3 HIRIP4","2":"DNJA2_HUMAN","3":"unknown","4":"DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)","5":"Co-chaperone of Hsc70. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro) (PubMed:24318877). {ECO:0000269|PubMed:24318877}.","6":"18.15888346","7":"7.251320900","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60884"},{"1":"BRD4 HUNK1","2":"BRD4_HUMAN","3":"unknown","4":"Bromodomain-containing protein 4 (Protein HUNK1)","5":"Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation. Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure (PubMed:23589332, PubMed:23317504, PubMed:22334664). During interphase, plays a key role in regulating the transcription of signal-inducible genes by associating with the P-TEFb complex and recruiting it to promoters. Also recruits P-TEFb complex to distal enhancers, so called anti-pause enhancers in collaboration with JMJD6. BRD4 and JMJD6 are required to form the transcriptionally active P-TEFb complex by displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from P-TEFb, thereby transforming it into an active form that can then phosphorylate the C-terminal domain (CTD) of RNA polymerase II (PubMed:23589332, PubMed:19596240, PubMed:16109377, PubMed:16109376, PubMed:24360279). Promotes phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II (PubMed:23086925). According to a report, directly acts as an atypical protein kinase and mediates phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II; these data however need additional evidences in vivo (PubMed:22509028). In addition to acetylated histones, also recognizes and binds acetylated RELA, leading to further recruitment of the P-TEFb complex and subsequent activation of NF-kappa-B (PubMed:19103749). Also acts as a regulator of p53/TP53-mediated transcription: following phosphorylation by CK2, recruited to p53/TP53 specific target promoters (PubMed:23317504). {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:19103749, ECO:0000269|PubMed:19596240, ECO:0000269|PubMed:22334664, ECO:0000269|PubMed:22509028, ECO:0000269|PubMed:23086925, ECO:0000269|PubMed:23317504, ECO:0000269|PubMed:23589332, ECO:0000269|PubMed:24360279}.; [Isoform B]: Acts as a chromatin insulator in the DNA damage response pathway. Inhibits DNA damage response signaling by recruiting the condensin-2 complex to acetylated histones, leading to chromatin structure remodeling, insulating the region from DNA damage response by limiting spreading of histone H2AX/H2A.x phosphorylation. {ECO:0000269|PubMed:23728299}.","6":"-10.90605957","7":"25.056105277","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60885"},{"1":"CUTA ACHAP C6orf82","2":"CUTA_HUMAN","3":"unknown","4":"Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor)","5":"May form part of a complex of membrane proteins attached to acetylcholinesterase (AChE).","6":"-15.23013238","7":"8.383285529","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60888"},{"1":"TBL1X TBL1","2":"TBL1X_HUMAN","3":"unknown","4":"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)","5":"F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units (PubMed:14980219). Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of corepressor complexes that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of transcription repressor complexes, thereby allowing cofactor exchange (PubMed:21240272). {ECO:0000269|PubMed:14980219, ECO:0000269|PubMed:21240272}.","6":"17.54176990","7":"17.513288987","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O60907"},{"1":"CTSV CATL2 CTSL2 CTSU UNQ268/PRO305","2":"CATL2_HUMAN","3":"LYSOSOME","4":"Cathepsin L2 (EC 3.4.22.43) (Cathepsin U) (Cathepsin V)","5":"Cysteine protease. May have an important role in corneal physiology. {ECO:0000269|PubMed:10029531, ECO:0000269|PubMed:9727401}.","6":"3.54029381","7":"-36.282340269","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O60911"},{"1":"HUS1","2":"HUS1_HUMAN","3":"unknown","4":"Checkpoint protein HUS1 (hHUS1)","5":"Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair. The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex. Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates. The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase. {ECO:0000269|PubMed:21659603}.","6":"-1.62430389","7":"22.877360684","8":"NUCLEOPLASM-2","9":"Undefined,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O60921"},{"1":"NBN NBS NBS1 P95","2":"NBN_HUMAN","3":"unknown","4":"Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1)","5":"Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. Forms a complex with RBBP8 to link DNA double-strand break sensing to resection. Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex. {ECO:0000269|PubMed:10888888, ECO:0000269|PubMed:15616588, ECO:0000269|PubMed:19759395, ECO:0000269|PubMed:23762398, ECO:0000269|PubMed:9705271}.","6":"0.21983376","7":"30.366047241","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O60934"},{"1":"RNGTT CAP1A","2":"MCE1_HUMAN","3":"unknown","4":"mRNA-capping enzyme (HCAP1) (HCE) [Includes: Polynucleotide 5'-triphosphatase (EC 3.1.3.33) (mRNA 5'-triphosphatase) (TPase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]","5":"Bifunctional mRNA-capping enzyme exhibiting RNA 5'-triphosphatase activity in the N-terminal part and mRNA guanylyltransferase activity in the C-terminal part. Catalyzes the first two steps of cap formation: by removing the gamma-phosphate from the 5'-triphosphate end of nascent mRNA to yield a diphosphate end, and by transferring the gmp moiety of GTP to the 5'-diphosphate terminus. {ECO:0000269|PubMed:21636784, ECO:0000269|PubMed:9473487, ECO:0000269|PubMed:9512541}.","6":"28.22936653","7":"6.090589855","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O60942"},{"1":"ABCB7 ABC7","2":"ABCB7_HUMAN","3":"MITOCHONDRIA","4":"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)","5":"Exports glutathione-coordinated iron-sulfur clusters such as [2Fe-2S]-(GS)4 cluster from the mitochondria to the cytosol in an ATP dependent manner allowing the assembly of the cytosolic iron-sulfur (Fe/S) cluster-containing proteins, in turns participates in iron homeostasis (PubMed:33157103, PubMed:17192393, PubMed:10196363). Moreover through a functional complex formed of ABCB7, FECH and ABCB10, also plays a role in the cellular iron homeostasis, mitochondrial function and heme biosynthesis (PubMed:30765471). In cardiomyocytes, regulates cellular iron homeostasis and cellular reactive oxygen species (ROS) levels through its interaction with COX4I1 (By similarity). May also play a role in hematopoiesis (By similarity). {ECO:0000250|UniProtKB:Q61102, ECO:0000250|UniProtKB:Q704E8, ECO:0000269|PubMed:10196363, ECO:0000269|PubMed:17192393, ECO:0000269|PubMed:30765471, ECO:0000269|PubMed:33157103}.","6":"-31.54760208","7":"-11.649723407","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75027"},{"1":"SRGAP2 ARHGAP34 FNBP2 KIAA0456 SRGAP2A","2":"SRGP2_HUMAN","3":"unknown","4":"SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34)","5":"RAC1 GTPase activating protein (GAP) that binds and deforms membranes, and regulates actin dynamics to regulate cell migration and differentiation. Plays an important role in different aspects of neuronal morphogenesis and migration mainly during development of the cerebral cortex. This includes the biogenesis of neurites, where it is required for both axons and dendrites outgrowth, and the maturation of the dendritic spines. Also stimulates the branching of the leading process and negatively regulates neuron radial migration in the cerebral cortex. Its interaction and inhibition by SRGAP2C reduces the rate of spine maturation, alters dendritic spine morphology and density and indirectly increases neuronal migration. It may have implications for cognition, learning and memory. In non-neuronal cells, it may also play a role in cell migration by regulating the formation of lamellipodia and filopodia. {ECO:0000269|PubMed:20810653, ECO:0000269|PubMed:21148482, ECO:0000269|PubMed:22559944}.","6":"-0.09502942","7":"-13.335178785","8":"RIBOSOME","9":"Undefined,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O75044"},{"1":"IGSF3 EWI3 KIAA0466","2":"IGSF3_HUMAN","3":"unknown","4":"Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3)","5":"NA","6":"-0.40208901","7":"-36.246028302","8":"Undefined","9":"LYSOSOME,LYSOSOME,ER","10":"NA","11":"NA","12":"NA","_rn_":"O75054"},{"1":"FAM20B KIAA0475","2":"XYLK_HUMAN","3":"GOLGI","4":"Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase)","5":"Responsible for the 2-O-phosphorylation of xylose in the glycosaminoglycan-protein linkage region of proteoglycans thereby regulating the amount of mature GAG chains. Sulfated glycosaminoglycans (GAGs), including heparan sulfate and chondroitin sulfate, are synthesized on the so-called common GAG-protein linkage region (GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser) of core proteins, which is formed by the stepwise addition of monosaccharide residues by the respective specific glycosyltransferases. Xylose 2-O-phosphorylation may influence the catalytic activity of B3GAT3 (GlcAT-I) which completes the precursor tetrasaccharide of GAG-protein linkage regions on which the repeating disaccharide region is synthesized. {ECO:0000269|PubMed:19473117, ECO:0000269|PubMed:24425863}.","6":"14.87816442","7":"-40.148938582","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75063"},{"1":"WDR1","2":"WDR1_HUMAN","3":"unknown","4":"WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1)","5":"Induces disassembly of actin filaments in conjunction with ADF/cofilin family proteins (PubMed:15629458, PubMed:27557945, PubMed:29751004). Enhances cofilin-mediated actin severing (By similarity). Involved in cytokinesis. Involved in chemotactic cell migration by restricting lamellipodial membrane protrusions (PubMed:18494608). Involved in myocardium sarcomere organization. Required for cardiomyocyte growth and maintenance (By similarity). Involved in megakaryocyte maturation and platelet shedding. Required for the establishment of planar cell polarity (PCP) during follicular epithelium development and for cell shape changes during PCP; the function seems to implicate cooperation with CFL1 and/or DSTN/ADF. Involved in the generation/maintenance of cortical tension (By similarity). Involved in assembly and maintenance of epithelial apical cell junctions and plays a role in the organization of the perijunctional actomyosin belt (PubMed:25792565). {ECO:0000250|UniProtKB:O88342, ECO:0000250|UniProtKB:Q9W7F2, ECO:0000269|PubMed:15629458, ECO:0000269|PubMed:18494608, ECO:0000269|PubMed:25792565, ECO:0000269|PubMed:27557945, ECO:0000269|PubMed:29751004}.","6":"15.21789975","7":"-4.367787995","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75083"},{"1":"N4BP1 KIAA0615","2":"N4BP1_HUMAN","3":"unknown","4":"NEDD4-binding protein 1 (N4BP1) (EC 3.1.-.-)","5":"Potent suppressor of cytokine production that acts as a regulator of innate immune signaling and inflammation. Acts as a key negative regulator of select cytokine and chemokine responses elicited by TRIF-independent Toll-like receptors (TLRs), thereby limiting inflammatory cytokine responses to minor insults. In response to more threatening pathogens, cleaved by CASP8 downstream of TLR3 or TLR4, leading to its inactivation, thereby allowing production of inflammatory cytokines (By similarity). Acts as a restriction factor against some viruses, such as HIV-1: restricts HIV-1 replication by binding to HIV-1 mRNAs and mediating their degradation via its ribonuclease activity (PubMed:31133753). Also acts as an inhibitor of the E3 ubiquitin-protein ligase ITCH: acts by interacting with the second WW domain of ITCH, leading to compete with ITCH's substrates and impairing ubiquitination of substrates (By similarity). {ECO:0000250|UniProtKB:Q6A037, ECO:0000269|PubMed:31133753}.","6":"12.87722275","7":"11.912235318","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75113"},{"1":"ROCK2 KIAA0619","2":"ROCK2_HUMAN","3":"unknown","4":"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)","5":"Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation. {ECO:0000269|PubMed:10579722, ECO:0000269|PubMed:15699075, ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21147781}.","6":"5.47735682","7":"1.543169303","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75116"},{"1":"CLASP2 KIAA0627","2":"CLAP2_HUMAN","3":"unknown","4":"CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2)","5":"Microtubule plus-end tracking protein that promotes the stabilization of dynamic microtubules (PubMed:26003921). Involved in the nucleation of noncentrosomal microtubules originating from the trans-Golgi network (TGN). Required for the polarization of the cytoplasmic microtubule arrays in migrating cells towards the leading edge of the cell. May act at the cell cortex to enhance the frequency of rescue of depolymerizing microtubules by attaching their plus-ends to cortical platforms composed of ERC1 and PHLDB2 (PubMed:16824950). This cortical microtubule stabilizing activity is regulated at least in part by phosphatidylinositol 3-kinase signaling. Also performs a similar stabilizing function at the kinetochore which is essential for the bipolar alignment of chromosomes on the mitotic spindle (PubMed:16866869, PubMed:16914514). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. {ECO:0000269|PubMed:11290329, ECO:0000269|PubMed:15631994, ECO:0000269|PubMed:16824950, ECO:0000269|PubMed:16866869, ECO:0000269|PubMed:16914514, ECO:0000269|PubMed:17543864, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:26003921}.","6":"4.97342463","7":"2.641805439","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75122"},{"1":"PTCD1 KIAA0632","2":"PTCD1_HUMAN","3":"MITOCHONDRIA","4":"Pentatricopeptide repeat-containing protein 1, mitochondrial","5":"Mitochondrial protein implicated in negative regulation of leucine tRNA levels, as well as negative regulation of mitochondria-encoded proteins and COX activity. Affects also the 3'-processing of mitochondrial tRNAs. {ECO:0000269|PubMed:21857155}.","6":"-39.98671860","7":"-8.579382293","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75127"},{"1":"CPNE3 CPN3 KIAA0636","2":"CPNE3_HUMAN","3":"unknown","4":"Copine-3 (Copine III)","5":"Calcium-dependent phospholipid-binding protein that plays a role in ERBB2-mediated tumor cell migration in response to growth factor heregulin stimulation (PubMed:20010870). {ECO:0000269|PubMed:20010870}.","6":"7.85574915","7":"-14.500984534","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75131"},{"1":"ATG13 KIAA0652","2":"ATG13_HUMAN","3":"unknown","4":"Autophagy-related protein 13","5":"Autophagy factor required for autophagosome formation and mitophagy. Target of the TOR kinase signaling pathway that regulates autophagy through the control of the phosphorylation status of ATG13 and ULK1, and the regulation of the ATG13-ULK1-RB1CC1 complex. Through its regulation of ULK1 activity, plays a role in the regulation of the kinase activity of mTORC1 and cell proliferation. {ECO:0000269|PubMed:18936157, ECO:0000269|PubMed:19211835, ECO:0000269|PubMed:19225151, ECO:0000269|PubMed:19287211, ECO:0000269|PubMed:21795849, ECO:0000269|PubMed:21855797}.","6":"-7.30340239","7":"9.678414601","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75143"},{"1":"HIP1R HIP12 KIAA0655","2":"HIP1R_HUMAN","3":"unknown","4":"Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12)","5":"Component of clathrin-coated pits and vesicles, that may link the endocytic machinery to the actin cytoskeleton. Binds 3-phosphoinositides (via ENTH domain). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis. {ECO:0000269|PubMed:11889126, ECO:0000269|PubMed:14732715}.","6":"35.59250333","7":"11.742027072","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75146"},{"1":"OBSL1 KIAA0657","2":"OBSL1_HUMAN","3":"unknown","4":"Obscurin-like protein 1","5":"Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Acts as a regulator of the Cul7-RING(FBXW8) ubiquitin-protein ligase, playing a critical role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain. Required to localize CUL7 to the Golgi apparatus in neurons. {ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.","6":"4.52737406","7":"1.939242965","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75147"},{"1":"RNF40 BRE1B KIAA0661","2":"BRE1B_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (95 kDa retinoblastoma-associated protein) (RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)","5":"Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543}.","6":"18.48063944","7":"28.746389712","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75150"},{"1":"PHF2 CENP-35 KIAA0662","2":"PHF2_HUMAN","3":"unknown","4":"Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2)","5":"Lysine demethylase that demethylates both histones and non-histone proteins. Enzymatically inactive by itself, and becomes active following phosphorylation by PKA: forms a complex with ARID5B and mediates demethylation of methylated ARID5B. Demethylation of ARID5B leads to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated 'Lys-9' of histone H3 (H3K9me2), followed by transcription activation of target genes. The PHF2-ARID5B complex acts as a coactivator of HNF4A in liver. PHF2 is recruited to trimethylated 'Lys-4' of histone H3 (H3K4me3) at rDNA promoters and promotes expression of rDNA. {ECO:0000269|PubMed:20129925, ECO:0000269|PubMed:21167174, ECO:0000269|PubMed:21532585}.","6":"-36.93078455","7":"16.477692399","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75151"},{"1":"ZC3H11A KIAA0663 ZC3HDC11A","2":"ZC11A_HUMAN","3":"unknown","4":"Zinc finger CCCH domain-containing protein 11A","5":"RNA-binding protein that interacts with purine-rich sequences and is involved in nuclear mRNA export; probably mediated by association with the TREX complex. {ECO:0000269|PubMed:22928037, ECO:0000269|PubMed:29610341}.; (Microbial infection) Plays a role in efficient growth of several nuclear-replicating viruses such as HIV-1, influenza virus or herpes simplex virus 1/HHV-1. Required for efficient viral mRNA Export. {ECO:0000269|PubMed:29610341}.","6":"-23.55108182","7":"14.051595442","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75152"},{"1":"CLUH KIAA0664","2":"CLU_HUMAN","3":"unknown","4":"Clustered mitochondria protein homolog","5":"mRNA-binding protein involved in proper cytoplasmic distribution of mitochondria. Specifically binds mRNAs of nuclear-encoded mitochondrial proteins in the cytoplasm and regulates transport or translation of these transcripts close to mitochondria, playing a role in mitochondrial biogenesis. {ECO:0000255|HAMAP-Rule:MF_03013, ECO:0000269|PubMed:25349259}.","6":"20.01077048","7":"27.568534388","8":"Undefined","9":"PROTEIN COMPLEX,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75153"},{"1":"TSC22D2 KIAA0669 TILZ4","2":"T22D2_HUMAN","3":"unknown","4":"TSC22 domain family protein 2 (TSC22-related-inducible leucine zipper protein 4)","5":"NA","6":"-16.29365095","7":"10.065127248","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75157"},{"1":"DNAJC13 KIAA0678 RME8","2":"DJC13_HUMAN","3":"unknown","4":"DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)","5":"Involved in membrane trafficking through early endosomes, such as the early endosome to recycling endosome transport implicated in the recycling of transferrin and the early endosome to late endosome transport implicated in degradation of EGF and EGFR (PubMed:18256511, PubMed:18307993). Involved in the regulation of endosomal membrane tubulation and regulates th dynamics of SNX1 on the endosomal membrane; via association with WASHC2 may link the WASH complex to the retromer SNX-BAR subcomplex (PubMed:24643499). {ECO:0000269|PubMed:18256511, ECO:0000269|PubMed:18307993, ECO:0000269|PubMed:24643499}.","6":"20.71549528","7":"-34.342744711","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O75165"},{"1":"PPP6R2 KIAA0685 PP6R2 SAPS2","2":"PP6R2_HUMAN","3":"unknown","4":"Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2)","5":"Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. {ECO:0000269|PubMed:16769727}.","6":"9.61872802","7":"31.978842529","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75170"},{"1":"CNOT3 KIAA0691 LENG2 NOT3","2":"CNOT3_HUMAN","3":"unknown","4":"CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2)","5":"Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. May be involved in metabolic regulation; may be involved in recruitment of the CCR4-NOT complex to deadenylation target mRNAs involved in energy metabolism. Involved in mitotic progression and regulation of the spindle assembly checkpoint by regulating the stability of MAD1L1 mRNA. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may involve histone deacetylases. Involved in the maintenance of embryonic stem (ES) cell identity. {ECO:0000269|PubMed:14707134, ECO:0000269|PubMed:22342980, ECO:0000269|PubMed:22367759}.","6":"13.50179176","7":"16.209392919","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75175"},{"1":"ANKRD17 GTAR KIAA0697","2":"ANR17_HUMAN","3":"unknown","4":"Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)","5":"Could play pivotal roles in cell cycle and DNA regulation (PubMed:19150984). Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways (PubMed:22328336). Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too (PubMed:23711367). Target of enterovirus 71 which is the major etiological agent of HFMD (hand, foot and mouth disease) (PubMed:17276651). Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (By similarity). {ECO:0000250|UniProtKB:Q99NH0, ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984, ECO:0000269|PubMed:22328336, ECO:0000269|PubMed:23711367}.","6":"24.45820797","7":"30.649417823","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75179"},{"1":"SIN3B KIAA0700","2":"SIN3B_HUMAN","3":"unknown","4":"Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","5":"Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression. {ECO:0000250|UniProtKB:Q62141}.","6":"-16.89911969","7":"23.467444126","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75182"},{"1":"DNAJB6 HSJ2 MRJ MSJ1","2":"DNJB6_HUMAN","3":"unknown","4":"DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1)","5":"Plays an indispensable role in the organization of KRT8/KRT18 filaments. Acts as an endogenous molecular chaperone for neuronal proteins including huntingtin. Suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins. Isoform B but not isoform A inhibits huntingtin aggregation. Has a stimulatory effect on the ATPase activity of HSP70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of HSP70. Also reduces cellular toxicity and caspase-3 activity. {ECO:0000269|PubMed:10954706, ECO:0000269|PubMed:11896048, ECO:0000269|PubMed:20159555, ECO:0000269|PubMed:22366786, ECO:0000269|PubMed:28233300}.","6":"3.70281840","7":"-0.228339590","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75190"},{"1":"XYLB","2":"XYLB_HUMAN","3":"unknown","4":"Xylulose kinase (Xylulokinase) (EC 2.7.1.17)","5":"Phosphorylates D-xylulose to produce D-xylulose 5-phosphate, a molecule that may play an important role in the regulation of glucose metabolism and lipogenesis. {ECO:0000269|PubMed:23179721}.","6":"32.15052254","7":"7.618300397","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75191"},{"1":"COQ9 C16orf49 HSPC326 PSEC0129","2":"COQ9_HUMAN","3":"MITOCHONDRIA","4":"Ubiquinone biosynthesis protein COQ9, mitochondrial","5":"Lipid-binding protein involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration. Binds a phospholipid of at least 10 carbons in each acyl group. May be required to present its bound-lipid to COQ7. {ECO:0000269|PubMed:25339443}.","6":"-36.49733456","7":"-19.229497760","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75208"},{"1":"GGCT C7orf24 CRF21","2":"GGCT_HUMAN","3":"unknown","4":"Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21)","5":"Catalyzes the formation of 5-oxoproline from gamma-glutamyl dipeptides and may play a significant role in glutathione homeostasis. Induces release of cytochrome c from mitochondria with resultant induction of apoptosis. {ECO:0000269|PubMed:16765912, ECO:0000269|PubMed:18515354}.","6":"-5.81278156","7":"0.060321793","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75223"},{"1":"NDUFS7","2":"NDUS7_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)","5":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:17275378). Essential for the catalytic activity of complex I (PubMed:17275378). {ECO:0000269|PubMed:17275378}.","6":"-42.61124991","7":"-11.493087161","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75251"},{"1":"NDUFS2","2":"NDUS2_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)","5":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:30922174, PubMed:22036843). Essential for the catalytic activity of complex I (PubMed:30922174, PubMed:22036843). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature which plays a key role in acute pulmonary oxygen-sensing and hypoxic pulmonary vasoconstriction (PubMed:30922174). Plays an important role in carotid body sensing of hypoxia (By similarity). Essential for glia-like neural stem and progenitor cell proliferation, differentiation and subsequent oligodendrocyte or neuronal maturation (By similarity). {ECO:0000250|UniProtKB:Q91WD5, ECO:0000269|PubMed:22036843, ECO:0000269|PubMed:30922174}.","6":"-39.13395364","7":"-5.161116509","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75306"},{"1":"ZPR1 ZNF259","2":"ZPR1_HUMAN","3":"unknown","4":"Zinc finger protein ZPR1 (Zinc finger protein 259)","5":"Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death. {ECO:0000269|PubMed:11283611, ECO:0000269|PubMed:17068332, ECO:0000269|PubMed:22422766}.","6":"-2.08176776","7":"5.529874565","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75312"},{"1":"DUSP11 PIR1","2":"DUS11_HUMAN","3":"unknown","4":"RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1)","5":"Possesses RNA 5'-triphosphatase and diphosphatase activities, but displays a poor protein-tyrosine phosphatase activity. In addition, has phosphatase activity with ATP, ADP and O-methylfluorescein phosphate (in vitro). Binds to RNA. May participate in nuclear mRNA metabolism. {ECO:0000269|PubMed:10347225, ECO:0000269|PubMed:24447265, ECO:0000269|PubMed:9685386}.","6":"-11.57662579","7":"17.847754992","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75319"},{"1":"NIPSNAP2 GBAS","2":"NIPS2_HUMAN","3":"unknown","4":"Protein NipSnap homolog 2 (NipSnap2) (Glioblastoma-amplified sequence)","5":"May act as a positive regulator of L-type calcium channels. {ECO:0000250|UniProtKB:O55126}.","6":"-43.19686343","7":"-10.366201387","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O75323"},{"1":"SEMA7A CD108 SEMAL","2":"SEM7A_HUMAN","3":"unknown","4":"Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108)","5":"Plays an important role in integrin-mediated signaling and functions both in regulating cell migration and immune responses. Promotes formation of focal adhesion complexes, activation of the protein kinase PTK2/FAK1 and subsequent phosphorylation of MAPK1 and MAPK3. Promotes production of proinflammatory cytokines by monocytes and macrophages. Plays an important role in modulating inflammation and T-cell-mediated immune responses. Promotes axon growth in the embryonic olfactory bulb. Promotes attachment, spreading and dendrite outgrowth in melanocytes. {ECO:0000269|PubMed:12879062, ECO:0000269|PubMed:17377534, ECO:0000269|PubMed:17671519}.","6":"4.03490007","7":"-40.408164088","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O75326"},{"1":"HMMR IHABP RHAMM","2":"HMMR_HUMAN","3":"unknown","4":"Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168)","5":"Receptor for hyaluronic acid (HA) (By similarity). Involved in cell motility (By similarity). When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular-regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity). {ECO:0000250|UniProtKB:Q00547}.","6":"2.94556960","7":"23.286190491","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75330"},{"1":"PDCD6 ALG2","2":"PDCD6_HUMAN","3":"unknown","4":"Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)","5":"Calcium sensor that plays a key role in processes such as endoplasmic reticulum (ER)-Golgi vesicular transport, endosomal biogenesis or membrane repair. Acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium: calcium-binding triggers exposure of apolar surface, promoting interaction with different sets of proteins thanks to 3 different hydrophobic pockets, leading to translocation to membranes (PubMed:20691033, PubMed:25667979). Involved in ER-Golgi transport by promoting the association between PDCD6IP and TSG101, thereby bridging together the ESCRT-III and ESCRT-I complexes (PubMed:19520058). Together with PEF1, acts as calcium-dependent adapter for the BCR(KLHL12) complex, a complex involved in ER-Golgi transport by regulating the size of COPII coats (PubMed:27716508). In response to cytosolic calcium increase, the heterodimer formed with PEF1 interacts with, and bridges together the BCR(KLHL12) complex and SEC31 (SEC31A or SEC31B), promoting monoubiquitination of SEC31 and subsequent collagen export, which is required for neural crest specification (PubMed:27716508). Involved in the regulation of the distribution and function of MCOLN1 in the endosomal pathway (PubMed:19864416). Promotes localization and polymerization of TFG at endoplasmic reticulum exit site (PubMed:27813252). Required for T-cell receptor-, Fas-, and glucocorticoid-induced apoptosis (By similarity). May mediate Ca(2+)-regulated signals along the death pathway: interaction with DAPK1 can accelerate apoptotic cell death by increasing caspase-3 activity (PubMed:16132846). Its role in apoptosis may however be indirect, as suggested by knockout experiments (By similarity). May inhibit KDR/VEGFR2-dependent angiogenesis; the function involves inhibition of VEGF-induced phosphorylation of the Akt signaling pathway (PubMed:21893193). In case of infection by HIV-1 virus, indirectly inhibits HIV-1 production by affecting viral Gag expression and distribution (PubMed:27784779). {ECO:0000250|UniProtKB:P12815, ECO:0000269|PubMed:16132846, ECO:0000269|PubMed:19520058, ECO:0000269|PubMed:19864416, ECO:0000269|PubMed:20691033, ECO:0000269|PubMed:21893193, ECO:0000269|PubMed:25667979, ECO:0000269|PubMed:27716508, ECO:0000269|PubMed:27784779, ECO:0000269|PubMed:27813252}.; [Isoform 2]: Has a lower Ca(2+) affinity than isoform 1 (By similarity). {ECO:0000250|UniProtKB:P12815}.","6":"38.21101517","7":"-2.541437564","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O75340"},{"1":"TBCA","2":"TBCA_HUMAN","3":"unknown","4":"Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA)","5":"Tubulin-folding protein; involved in the early step of the tubulin folding pathway.","6":"-5.74141800","7":"0.005150704","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75347"},{"1":"ATP6V1G1 ATP6G ATP6G1 ATP6J","2":"VATG1_HUMAN","3":"unknown","4":"V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16)","5":"Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:32001091). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). {ECO:0000269|PubMed:28296633, ECO:0000303|PubMed:32001091}.","6":"5.80961205","7":"-12.013271430","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75348"},{"1":"VPS4B SKD1 VPS42 MIG1","2":"VPS4B_HUMAN","3":"unknown","4":"Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)","5":"Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). {ECO:0000269|PubMed:11563910, ECO:0000269|PubMed:18687924, ECO:0000269|PubMed:22660413}.; (Microbial infection) In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). {ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:16193069, ECO:0000269|PubMed:18606141}.","6":"19.82075923","7":"-2.975897537","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75351"},{"1":"ENTPD6 CD39L2 IL6ST2","2":"ENTP6_HUMAN","3":"unknown","4":"Ectonucleoside triphosphate diphosphohydrolase 6 (NTPDase 6) (EC 3.6.1.6) (CD39 antigen-like 2)","5":"Catalyzes the hydrolysis of nucleoside triphosphates and diphosphates in a calcium- or magnesium-dependent manner. Has a strong preference for nucleoside diphosphates, preferentially hydrolyzes GDP, IDP, and UDP, with slower hydrolysis of CDP, ITP, GTP, CTP, ADP, and UTP and virtually no hydrolysis of ATP (PubMed:10948193, PubMed:14529283, PubMed:11041856). The membrane bound form might support glycosylation reactions in the Golgi apparatus and, when released from cells, might catalyze the hydrolysis of extracellular nucleotides (PubMed:10948193, PubMed:14529283, PubMed:11041856). {ECO:0000269|PubMed:10948193, ECO:0000269|PubMed:11041856, ECO:0000269|PubMed:14529283}.","6":"16.71627499","7":"-38.014281624","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O75354"},{"1":"ENTPD5 CD39L4 PCPH","2":"ENTP5_HUMAN","3":"ER","4":"Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)","5":"Uridine diphosphatase (UDPase) that promotes protein N-glycosylation and ATP level regulation. UDP hydrolysis promotes protein N-glycosylation and folding in the endoplasmic reticulum, as well as elevated ATP consumption in the cytosol via an ATP hydrolysis cycle. Together with CMPK1 and AK1, constitutes an ATP hydrolysis cycle that converts ATP to AMP and results in a compensatory increase in aerobic glycolysis. The nucleotide hydrolyzing preference is GDP > IDP > UDP, but not any other nucleoside di-, mono- or triphosphates, nor thiamine pyrophosphate. Plays a key role in the AKT1-PTEN signaling pathway by promoting glycolysis in proliferating cells in response to phosphoinositide 3-kinase (PI3K) signaling. {ECO:0000269|PubMed:10400613}.","6":"-17.47067730","7":"-18.110179942","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75356"},{"1":"ZNF217 ZABC1","2":"ZN217_HUMAN","3":"unknown","4":"Zinc finger protein 217","5":"Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:16203743, ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:17259635, ECO:0000269|PubMed:18625718}.","6":"19.06186875","7":"30.399244072","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75362"},{"1":"MACROH2A1 H2AFY","2":"H2AY_HUMAN","3":"unknown","4":"Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205)","5":"Variant histone H2A which replaces conventional H2A in a subset of nucleosomes where it represses transcription (PubMed:12718888, PubMed:15621527, PubMed:16428466). Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Involved in stable X chromosome inactivation (PubMed:15897469). Inhibits the binding of transcription factors, including NF-kappa-B, and interferes with the activity of remodeling SWI/SNF complexes (PubMed:12718888, PubMed:16428466). Inhibits histone acetylation by EP300 and recruits class I HDACs, which induces a hypoacetylated state of chromatin (PubMed:16428466, PubMed:16107708). {ECO:0000269|PubMed:12718888, ECO:0000269|PubMed:15621527, ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:16107708, ECO:0000269|PubMed:16428466}.; [Isoform 1]: Binds ADP-ribose and O-acetyl-ADP-ribose, and may be involved in ADP-ribose-mediated chromatin modulation (PubMed:15902274). Increases the expression of genes involved in redox metabolism, including SOD3 (PubMed:23022728). {ECO:0000269|PubMed:15902274, ECO:0000269|PubMed:23022728}.; [Isoform 2]: Represses SOD3 gene expression. {ECO:0000269|PubMed:23022728}.","6":"-41.11134138","7":"23.487253279","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75367"},{"1":"SH3BGRL","2":"SH3L1_HUMAN","3":"unknown","4":"SH3 domain-binding glutamic acid-rich-like protein","5":"NA","6":"-6.40656500","7":"-0.630243615","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75368"},{"1":"FLNB FLN1L FLN3 TABP TAP","2":"FLNB_HUMAN","3":"unknown","4":"Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP)","5":"Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Various interactions and localizations of isoforms affect myotube morphology and myogenesis. Isoform 6 accelerates muscle differentiation in vitro.","6":"-9.47683817","7":"-8.831766604","8":"Undefined","9":"Undefined,NUCLEOPLASM-2,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O75369"},{"1":"NDUFS6","2":"NDUS6_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-37.70509193","7":"0.532240103","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75380"},{"1":"PEX14","2":"PEX14_HUMAN","3":"PEROXISOME","4":"Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14)","5":"Peroxisome membrane protein that is an essential component of the peroxisomal import machinery. Functions as a docking factor for the predominantly cytoplasmic PTS1 receptor (PEX5). Plays a key role for peroxisome movement through a direct interaction with tubulin. {ECO:0000269|PubMed:21525035, ECO:0000269|PubMed:9653144}.","6":"-25.16249246","7":"-18.751883449","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75381"},{"1":"TRIM3 BERP RNF22 RNF97","2":"TRIM3_HUMAN","3":"unknown","4":"Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)","5":"Probably involved in vesicular trafficking via its association with the CART complex (PubMed:15772161). The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (PubMed:15772161). Positively regulates motility of microtubule-dependent motor protein KIF21B (By similarity). {ECO:0000250|UniProtKB:Q9R1R2, ECO:0000269|PubMed:15772161}.","6":"33.13781131","7":"3.919396235","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75382"},{"1":"CS","2":"CISY_HUMAN","3":"MITOCHONDRIA","4":"Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)","5":"NA","6":"-35.98272127","7":"-17.561565961","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75390"},{"1":"SPAG7","2":"SPAG7_HUMAN","3":"unknown","4":"Sperm-associated antigen 7","5":"NA","6":"11.72436991","7":"-5.941169120","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75391"},{"1":"SEC22B SEC22L1","2":"SC22B_HUMAN","3":"unknown","4":"Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1)","5":"SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. {ECO:0000269|PubMed:15272311}.","6":"-12.31159837","7":"-26.562430742","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O75396"},{"1":"PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225","2":"PR40A_HUMAN","3":"unknown","4":"Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)","5":"Binds to WASL/N-WASP and suppresses its translocation from the nucleus to the cytoplasm, thereby inhibiting its cytoplasmic function (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. May play a role in cytokinesis. May be involved in pre-mRNA splicing. {ECO:0000250, ECO:0000269|PubMed:21834987}.","6":"-28.95730970","7":"18.731208720","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75400"},{"1":"TACC1 KIAA1103","2":"TACC1_HUMAN","3":"unknown","4":"Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1)","5":"Involved in transcription regulation induced by nuclear receptors, including in T3 thyroid hormone and all-trans retinoic acid pathways (PubMed:20078863). Might promote the nuclear localization of the receptors (PubMed:20078863). Likely involved in the processes that promote cell division prior to the formation of differentiated tissues. {ECO:0000269|PubMed:20078863}.","6":"-0.01042100","7":"-21.803242312","8":"PM","9":"PM,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75410"},{"1":"NME6","2":"NDK6_HUMAN","3":"unknown","4":"Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6) (Inhibitor of p53-induced apoptosis-alpha) (IPIA-alpha) (nm23-H6)","5":"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Inhibitor of p53-induced apoptosis.","6":"-35.45044962","7":"-18.431294079","8":"Undefined","9":"MITOCHONDRIA,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O75414"},{"1":"CDC45 CDC45L CDC45L2 UNQ374/PRO710","2":"CDC45_HUMAN","3":"unknown","4":"Cell division control protein 45 homolog (PORC-PI-1)","5":"Required for initiation of chromosomal DNA replication.","6":"23.18172049","7":"13.200293546","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75419"},{"1":"GIGYF1 CDS2 PERQ1 PP3360","2":"GGYF1_HUMAN","3":"unknown","4":"GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1)","5":"May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling. May increase IGF1 receptor phosphorylation under IGF1 stimulation as well as phosphorylation of IRS1 and SHC1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:12771153}.","6":"29.59798179","7":"18.506197363","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75420"},{"1":"LRCH4 LRN LRRN1 LRRN4","2":"LRCH4_HUMAN","3":"unknown","4":"Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein)","5":"NA","6":"10.24499072","7":"-38.054634691","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O75427"},{"1":"MTX2","2":"MTX2_HUMAN","3":"unknown","4":"Metaxin-2 (Mitochondrial outer membrane import complex protein 2)","5":"Involved in transport of proteins into the mitochondrion. {ECO:0000269|PubMed:10381257}.","6":"-34.80893151","7":"1.006896648","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O75431"},{"1":"VPS26A VPS26","2":"VP26A_HUMAN","3":"unknown","4":"Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26)","5":"Acts as component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway. The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins (Probable). The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5 (Probable). Required for retrograde transport of lysosomal enzyme receptor IGF2R (PubMed:15078902, PubMed:15078903). Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA) (PubMed:15247922). Required for the endosomal localization of WASHC2A (indicative for the WASH complex) (PubMed:22070227). Required for the endosomal localization of TBC1D5 (PubMed:20923837). Mediates retromer cargo recognition of SORL1 and is involved in trafficking of SORL1 implicated in sorting and processing of APP (PubMed:22279231). Involved in retromer-independent lysosomal sorting of F2R (PubMed:16407403). Involved in recycling of ADRB2 (PubMed:21602791). Enhances the affinity of SNX27 for PDZ-binding motifs in cargo proteins (By similarity). {ECO:0000250|UniProtKB:P40336, ECO:0000269|PubMed:15078902, ECO:0000269|PubMed:15078903, ECO:0000269|PubMed:15247922, ECO:0000269|PubMed:16407403, ECO:0000269|PubMed:22070227, ECO:0000269|PubMed:22279231, ECO:0000303|PubMed:20923837, ECO:0000303|PubMed:21602791, ECO:0000303|PubMed:21725319, ECO:0000303|PubMed:23563491, ECO:0000305}.","6":"11.48421111","7":"-22.070956693","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75436"},{"1":"PMPCB MPPB","2":"MPPB_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) (P-52)","5":"Catalytic subunit of the essential mitochondrial processing protease (MPP), which cleaves the mitochondrial sequence off newly imported precursors proteins (PubMed:29576218) (Probable). Preferentially, cleaves after an arginine at position P2 (By similarity). Required for PINK1 turnover by coupling PINK1 mitochondrial import and cleavage, which results in subsequent PINK1 proteolysis (PubMed:22354088). {ECO:0000250|UniProtKB:Q03346, ECO:0000269|PubMed:22354088, ECO:0000269|PubMed:29576218, ECO:0000305|PubMed:22354088}.","6":"-38.77758547","7":"-5.333522993","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75439"},{"1":"SAP30","2":"SAP30_HUMAN","3":"NUCLEUS","4":"Histone deacetylase complex subunit SAP30 (30 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP30) (Sin3-associated polypeptide p30)","5":"Involved in the functional recruitment of the Sin3-histone deacetylase complex (HDAC) to a specific subset of N-CoR corepressor complexes. Capable of transcription repression by N-CoR. Active in deacetylating core histone octamers (when in a complex) but inactive in deacetylating nucleosomal histones. {ECO:0000250|UniProtKB:O88574, ECO:0000269|PubMed:9651585}.","6":"-21.01292636","7":"22.750609639","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75446"},{"1":"MED24 ARC100 CRSP4 DRIP100 KIAA0130 THRAP4 TRAP100","2":"MED24_HUMAN","3":"unknown","4":"Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component) (ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4) (CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component) (Trap100) (hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component) (DRIP100)","5":"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:12218053, ECO:0000269|PubMed:16595664}.","6":"36.48662294","7":"17.280266429","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75448"},{"1":"PSIP1 DFS70 LEDGF PSIP2","2":"PSIP1_HUMAN","3":"unknown","4":"PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52)","5":"Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration. {ECO:0000269|PubMed:15642333}.","6":"-21.51889315","7":"7.126730799","8":"NUCLEUS","9":"Undefined,Undefined,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75475"},{"1":"ERLIN1 C10orf69 KE04 KEO4 SPFH1","2":"ERLN1_HUMAN","3":"ER","4":"Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1)","5":"Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. Binds cholesterol and may promote ER retention of the SCAP-SREBF complex (PubMed:24217618). {ECO:0000269|PubMed:19240031, ECO:0000269|PubMed:24217618}.; (Microbial infection) Required early in hepatitis C virus (HCV) infection to initiate RNA replication, and later in the infection to support infectious virus production. {ECO:0000269|PubMed:31810281}.","6":"-12.75630389","7":"-25.383368861","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75477"},{"1":"NDUFS3","2":"NDUS3_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)","5":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14729820, PubMed:30140060). Essential for the catalytic activity and assembly of complex I (PubMed:14729820, PubMed:24028823, PubMed:30140060). {ECO:0000269|PubMed:14729820, ECO:0000269|PubMed:24028823, ECO:0000269|PubMed:30140060}.","6":"-38.21309682","7":"-3.954658659","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75489"},{"1":"SRSF10 FUSIP1 FUSIP2 SFRS13A TASR","2":"SRS10_HUMAN","3":"unknown","4":"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)","5":"Splicing factor that in its dephosphorylated form acts as a general repressor of pre-mRNA splicing (PubMed:11684676, PubMed:12419250, PubMed:14765198). Seems to interfere with the U1 snRNP 5'-splice recognition of SNRNP70 (PubMed:14765198). Required for splicing repression in M-phase cells and after heat shock (PubMed:14765198). Also acts as a splicing factor that specifically promotes exon skipping during alternative splicing (PubMed:26876937). Interaction with YTHDC1, a RNA-binding protein that recognizes and binds N6-methyladenosine (m6A)-containing RNAs, prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May be involved in regulation of alternative splicing in neurons, with isoform 1 acting as a positive and isoform 3 as a negative regulator (PubMed:12419250). {ECO:0000269|PubMed:11684676, ECO:0000269|PubMed:12419250, ECO:0000269|PubMed:14765198, ECO:0000269|PubMed:26876937}.","6":"-34.30200306","7":"21.723684146","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75494"},{"1":"CLN5","2":"CLN5_HUMAN","3":"unknown","4":"Ceroid-lipofuscinosis neuronal protein 5 (Protein CLN5) [Cleaved into: Ceroid-lipofuscinosis neuronal protein 5, secreted form]","5":"Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane (PubMed:22431521). {ECO:0000269|PubMed:22431521}.","6":"12.04071996","7":"-41.873451844","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75503"},{"1":"HSBP1 HSF1BP","2":"HSBP1_HUMAN","3":"unknown","4":"Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13)","5":"Negative regulator of the heat shock response. Negatively affects HSF1 DNA-binding activity. May have a role in the suppression of the activation of the stress response during the aging process.","6":"-13.10684090","7":"20.050266275","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75506"},{"1":"ECI2 DRS1 HCA88 PECI","2":"ECI2_HUMAN","3":"unknown","4":"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)","5":"Able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species. Has a preference for 3-trans substrates. {ECO:0000269|PubMed:10419495}.","6":"-32.85211414","7":"1.824591041","8":"Undefined","9":"PEROXISOME,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O75521"},{"1":"TADA3 ADA3 TADA3L","2":"TADA3_HUMAN","3":"unknown","4":"Transcriptional adapter 3 (ADA3 homolog) (hADA3) (STAF54) (Transcriptional adapter 3-like) (ADA3-like protein)","5":"Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex. Also known as a coactivator for p53/TP53-dependent transcriptional activation. Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. {ECO:0000269|PubMed:11707411, ECO:0000269|PubMed:19103755}.","6":"0.75399386","7":"12.418204098","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75528"},{"1":"TAF5L PAF65B","2":"TAF5L_HUMAN","3":"unknown","4":"TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (TAF5L) (PCAF-associated factor 65 beta) (PAF65-beta)","5":"Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex (Probable). With TAF6L, acts as an epigenetic regulator essential for somatic reprogramming. Regulates target genes through H3K9ac deposition and MYC recruitment which trigger MYC regulatory network to orchestrate gene expression programs to control embryonic stem cell state (By similarity). {ECO:0000250|UniProtKB:Q91WQ5, ECO:0000305|PubMed:9674419}.","6":"7.80842694","7":"34.360757446","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75529"},{"1":"EED","2":"EED_HUMAN","3":"unknown","4":"Polycomb protein EED (hEED) (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1) (WAIT-1)","5":"Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. Also recognizes 'Lys-26' trimethylated histone H1 with the effect of inhibiting PRC2 complex methyltransferase activity on nucleosomal histone H3 'Lys-27', whereas H3 'Lys-27' recognition has the opposite effect, enabling the propagation of this repressive mark. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A. {ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:14532106, ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:15231737, ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16357870, ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:20974918, ECO:0000269|PubMed:28229514, ECO:0000269|PubMed:9584199}.","6":"-6.53352675","7":"24.651798879","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75530"},{"1":"BANF1 BAF BCRG1","2":"BAF_HUMAN","3":"unknown","4":"Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]","5":"Plays fundamental roles in nuclear assembly, chromatin organization, gene expression and gonad development. May potently compress chromatin structure and be involved in membrane recruitment and chromatin decondensation during nuclear assembly. Contains 2 non-specific dsDNA-binding sites which may promote DNA cross-bridging. {ECO:0000269|PubMed:12163470}.; (Microbial infection) Exploited by retroviruses for inhibiting self-destructing autointegration of retroviral DNA, thereby promoting integration of viral DNA into the host chromosome. EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. {ECO:0000269|PubMed:11005805, ECO:0000269|PubMed:16680152}.; (Microbial infection) In case of poxvirus infection, has an antiviral activity by blocking viral DNA replication. {ECO:0000269|PubMed:18005698}.","6":"-15.43443974","7":"8.530750108","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75531"},{"1":"SF3B1 SAP155","2":"SF3B1_HUMAN","3":"unknown","4":"Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)","5":"Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). Together with other U2 snRNP complex components may also play a role in the selective processing of microRNAs (miRNAs) from the long primary miRNA transcript, pri-miR-17-92 (By similarity). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron (PubMed:15146077). {ECO:0000250|UniProtKB:Q99NB9, ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:27720643}.","6":"-16.23579617","7":"27.676275366","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75533"},{"1":"CSDE1 D1S155E KIAA0885 NRU UNR","2":"CSDE1_HUMAN","3":"unknown","4":"Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR)","5":"RNA-binding protein involved in translationally coupled mRNA turnover (PubMed:11051545, PubMed:15314026). Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain (PubMed:11051545, PubMed:15314026). Required for efficient formation of stress granules (PubMed:29395067). {ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:15314026, ECO:0000269|PubMed:29395067}.; (Microbial infection) Required for internal initiation of translation of human rhinovirus RNA. {ECO:0000269|PubMed:10049359}.","6":"20.28150951","7":"23.349186508","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75534"},{"1":"WBP4 FBP21 FNBP21","2":"WBP4_HUMAN","3":"unknown","4":"WW domain-binding protein 4 (WBP-4) (Formin-binding protein 21) (WW domain-containing-binding protein 4)","5":"Involved in pre-mRNA splicing as a component of the spliceosome (PubMed:9724750, PubMed:19592703, PubMed:28781166). May play a role in cross-intron bridging of U1 and U2 snRNPs in the mammalian A complex (PubMed:9724750). {ECO:0000269|PubMed:19592703, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:9724750}.","6":"-0.89357140","7":"13.625555621","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75554"},{"1":"PRKRA PACT RAX HSD-14 HSD14","2":"PRKRA_HUMAN","3":"unknown","4":"Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)","5":"Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53 association and sumoylation and phosphorylation of p53/TP53 at 'Lys-386' at 'Ser-392' respectively and enhances its activity in a EIF2AK2/PKR-dependent manner (By similarity). {ECO:0000250, ECO:0000269|PubMed:10336432, ECO:0000269|PubMed:11238927, ECO:0000269|PubMed:16424907, ECO:0000269|PubMed:16982605, ECO:0000269|PubMed:17452327, ECO:0000269|PubMed:9687506}.","6":"30.73532573","7":"-20.130451139","8":"RIBOSOME","9":"RIBOSOME,RIBOSOME,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O75569"},{"1":"LRP6","2":"LRP6_HUMAN","3":"unknown","4":"Low-density lipoprotein receptor-related protein 6 (LRP-6)","5":"Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation (By similarity). {ECO:0000250, ECO:0000269|PubMed:11357136, ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:15778503, ECO:0000269|PubMed:16341017, ECO:0000269|PubMed:16513652, ECO:0000269|PubMed:17326769, ECO:0000269|PubMed:17400545, ECO:0000269|PubMed:19107203, ECO:0000269|PubMed:19293931, ECO:0000269|PubMed:19801552}.","6":"-9.62186451","7":"-24.080554737","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O75581"},{"1":"MED6 ARC33","2":"MED6_HUMAN","3":"unknown","4":"Mediator of RNA polymerase II transcription subunit 6 (Activator-recruited cofactor 33 kDa component) (ARC33) (Mediator complex subunit 6) (hMed6) (Renal carcinoma antigen NY-REN-28)","5":"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.","6":"26.43753902","7":"34.206918335","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75586"},{"1":"MYCBP2 KIAA0916 PAM","2":"MYCB2_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc)","5":"Atypical E3 ubiquitin-protein ligase which specifically mediates ubiquitination of threonine and serine residues on target proteins, instead of ubiquitinating lysine residues (PubMed:29643511). Shows esterification activity towards both threonine and serine, with a preference for threonine, and acts via two essential catalytic cysteine residues that relay ubiquitin to its substrate via thioester intermediates (PubMed:29643511). Interacts with the E2 enzymes UBE2D1, UBE2D3, UBE2E1 and UBE2L3 (PubMed:18308511, PubMed:29643511). Plays a key role in neural development, probably by mediating ubiquitination of threonine residues on target proteins (Probable). Involved in different processes such as regulation of neurite outgrowth, synaptic growth, synaptogenesis and axon degeneration (By similarity). Required for the formation of major central nervous system axon tracts (By similarity). Required for proper axon growth by regulating axon navigation and axon branching: acts by regulating the subcellular location and stability of MAP3K12/DLK (By similarity). Required for proper localization of retinogeniculate projections but not for eye-specific segregation (By similarity). Regulates axon guidance in the olfactory system (By similarity). Involved in Wallerian axon degeneration, an evolutionarily conserved process that drives the loss of damaged axons: acts by promoting destabilization of NMNAT2, probably via ubiquitination of NMNAT2 (By similarity). Catalyzes ubiquitination of threonine and/or serine residues on NMNAT2, consequences of threonine and/or serine ubiquitination are however unknown (PubMed:29643511). Regulates the internalization of TRPV1 in peripheral sensory neurons (By similarity). Mediates ubiquitination and subsequent proteasomal degradation of TSC2/tuberin (PubMed:18308511, PubMed:27278822). Independently of the E3 ubiquitin-protein ligase activity, also acts as a guanosine exchange factor (GEF) for RAN in neurons of dorsal root ganglia (PubMed:26304119). May function as a facilitator or regulator of transcriptional activation by MYC (PubMed:9689053). Acts in concert with HUWE1 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). {ECO:0000250|UniProtKB:Q7TPH6, ECO:0000269|PubMed:18308511, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26304119, ECO:0000269|PubMed:27278822, ECO:0000269|PubMed:29643511, ECO:0000269|PubMed:9689053}.","6":"7.24666918","7":"37.592157016","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75592"},{"1":"NPM3","2":"NPM3_HUMAN","3":"unknown","4":"Nucleoplasmin-3","5":"Plays a role in the regulation of diverse cellular processes such as ribosome biogenesis, chromatin remodeling or protein chaperoning (PubMed:22362753, PubMed:20073534). Modulates the histone chaperone function and the RNA-binding activity of nucleolar phosphoprotein B23/NPM (PubMed:22362753). Efficiently mediates chromatin remodeling when included in a pentamer containing NPM3 and NPM (PubMed:15596447). {ECO:0000269|PubMed:15596447, ECO:0000269|PubMed:20073534, ECO:0000269|PubMed:22362753}.","6":"-20.87472053","7":"10.626668745","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75607"},{"1":"LYPLA1 APT1 LPL1","2":"LYPA1_HUMAN","3":"unknown","4":"Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)","5":"Acts as a acyl-protein thioesterase (PubMed:19439193, PubMed:20418879). Hydrolyzes fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins or HRAS (PubMed:20418879). Has depalmitoylating activity toward KCNMA1 (PubMed:22399288). Could also depalmitoylate ADRB2 (PubMed:27481942). Acts as a lysophospholipase and hydrolyzes lysophosphatidylcholine (lyso-PC) (PubMed:19439193). Also hydrolyzes lysophosphatidylethanolamine (lyso-PE), lysophosphatidylinositol (lyso-PI) and lysophosphatidylserine (lyso-PS) (By similarity). Has much higher thioesterase activity than lysophospholipase activity (PubMed:19439193). Contributes to the production of lysophosphatidic acid (LPA) during blood coagulation by recognizing and cleaving plasma phospholipids to generate lysophospholipids which in turn act as substrates for ENPP2 to produce LPA (PubMed:21393252). {ECO:0000250|UniProtKB:P70470, ECO:0000269|PubMed:19439193, ECO:0000269|PubMed:20418879, ECO:0000269|PubMed:21393252, ECO:0000269|PubMed:22399288, ECO:0000269|PubMed:27481942}.","6":"-3.71938459","7":"-10.776636733","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75608"},{"1":"ERAL1 HERA","2":"ERAL1_HUMAN","3":"MITOCHONDRIA","4":"GTPase Era, mitochondrial (H-ERA) (hERA) (Conserved ERA-like GTPase) (CEGA) (ERA-W) (ERA-like protein 1)","5":"Probable GTPase that plays a role in the mitochondrial ribosomal small subunit assembly. Specifically binds the 12S mitochondrial rRNA (12S mt-rRNA) to a 33 nucleotide section delineating the 3' terminal stem-loop region. May act as a chaperone that protects the 12S mt-rRNA on the 28S mitoribosomal subunit during ribosomal small subunit assembly. {ECO:0000269|PubMed:20430825, ECO:0000269|PubMed:20604745, ECO:0000269|PubMed:28449065}.","6":"-38.54265751","7":"-4.956143083","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75616"},{"1":"SNRNP200 ASCC3L1 HELIC2 KIAA0788","2":"U520_HUMAN","3":"unknown","4":"U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)","5":"Plays role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:28502770, PubMed:28781166, PubMed:29361316, PubMed:30315277, PubMed:29360106, PubMed:29301961, PubMed:30728453, PubMed:30705154). Involved in spliceosome assembly, activation and disassembly. Mediates changes in the dynamic network of RNA-RNA interactions in the spliceosome. Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome. {ECO:0000269|PubMed:16723661, ECO:0000269|PubMed:23045696, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30315277, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:30728453, ECO:0000269|PubMed:8670905, ECO:0000269|PubMed:9539711}.","6":"-16.47327918","7":"26.765380050","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75643"},{"1":"TRMU MTU1 TRMT1","2":"MTU1_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14) (MTO2 homolog)","5":"Catalyzes the 2-thiolation of uridine at the wobble position (U34) of mitochondrial tRNA(Lys), tRNA(Glu) and tRNA(Gln). Required for the formation of 5-taurinomethyl-2-thiouridine (tm5s2U) of mitochondrial tRNA(Lys), tRNA(Glu), and tRNA(Gln) at the wobble position. ATP is required to activate the C2 atom of the wobble base. {ECO:0000269|PubMed:15509579, ECO:0000269|PubMed:15944150, ECO:0000269|PubMed:16826519}.","6":"-29.17619133","7":"-5.105545404","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75648"},{"1":"TIPRL","2":"TIPRL_HUMAN","3":"CYTOSOL","4":"TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP)","5":"May be a allosteric regulator of serine/threonine-protein phosphatase 2A (PP2A). Isoform 1 inhibits catalytic activity of the PP2A(D) core complex in vitro. The PP2A(C):TIPRL complex does not show phosphatase activity. Acts as negative regulator of serine/threonine-protein phosphatase 4 probably by inhibiting the formation of the active PPP4C:PPP4R2 complex; the function is proposed to implicate it in DNA damage response by promoting H2AX phosphorylated on Ser-140 (gamma-H2AX). May play a role in the regulation of ATM/ATR signaling pathway controlling DNA replication and repair. {ECO:0000269|PubMed:17384681, ECO:0000269|PubMed:26717153}.","6":"20.76766742","7":"-4.525468441","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75663"},{"1":"SURF6 SURF-6","2":"SURF6_HUMAN","3":"unknown","4":"Surfeit locus protein 6","5":"Binds to both DNA and RNA in vitro, with a stronger binding capacity for RNA. May represent a nucleolar constitutive protein involved in ribosomal biosynthesis or assembly (By similarity). {ECO:0000250}.","6":"-33.57894892","7":"17.213524878","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75683"},{"1":"PPM1B PP2CB","2":"PPM1B_HUMAN","3":"unknown","4":"Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)","5":"Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at 'Ser-172'. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.","6":"12.12574447","7":"9.504008868","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75688"},{"1":"UTP20 DRIM","2":"UTP20_HUMAN","3":"unknown","4":"Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)","5":"Involved in 18S pre-rRNA processing. Associates with U3 snoRNA. {ECO:0000269|PubMed:17498821}.","6":"-39.74912440","7":"21.240231805","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O75691"},{"1":"NUP155 KIAA0791","2":"NU155_HUMAN","3":"unknown","4":"Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)","5":"Essential component of nuclear pore complex. Could be essessential for embryogenesis. Nucleoporins may be involved both in binding and translocating proteins during nucleocytoplasmic transport. {ECO:0000250|UniProtKB:Q99P88}.","6":"35.42545019","7":"7.463881997","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75694"},{"1":"RP2","2":"XRP2_HUMAN","3":"unknown","4":"Protein XRP2","5":"Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:18376416, ECO:0000269|PubMed:20106869, ECO:0000269|PubMed:22085962}.","6":"-3.35049845","7":"-40.613521069","8":"PM","9":"PM,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"O75695"},{"1":"WDHD1 AND1","2":"WDHD1_HUMAN","3":"unknown","4":"WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)","5":"Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. {ECO:0000269|PubMed:19805216}.","6":"-1.63384075","7":"33.706023262","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75717"},{"1":"CRTAP CASP","2":"CRTAP_HUMAN","3":"unknown","4":"Cartilage-associated protein","5":"Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues. {ECO:0000269|PubMed:17055431}.","6":"-25.25624525","7":"-18.218511230","8":"PEROXISOME","9":"PEROXISOME,Undefined,PEROXISOME","10":"Candidate","11":"2","12":"1,3","_rn_":"O75718"},{"1":"SLC25A12 ARALAR1","2":"CMC1_HUMAN","3":"unknown","4":"Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12)","5":"Mitochondrial and calcium-binding carrier that catalyzes the calcium-dependent exchange of cytoplasmic glutamate with mitochondrial aspartate across the mitochondrial inner membrane (PubMed:11566871, PubMed:25410934). May have a function in the urea cycle (PubMed:11566871). {ECO:0000269|PubMed:11566871, ECO:0000269|PubMed:25410934}.","6":"-36.14130389","7":"-7.469796627","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O75746"},{"1":"PALM KIAA0270","2":"PALM_HUMAN","3":"PM","4":"Paralemmin-1 (Paralemmin)","5":"Involved in plasma membrane dynamics and cell process formation. Isoform 1 and isoform 2 are necessary for axonal and dendritic filopodia induction, for dendritic spine maturation and synapse formation in a palmitoylation-dependent manner. {ECO:0000269|PubMed:14978216}.","6":"-0.71949329","7":"-41.912759684","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75781"},{"1":"ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072","2":"RENR_HUMAN","3":"PM","4":"Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment]","5":"Multifunctional protein which functions as a renin, prorenin cellular receptor and is involved in the assembly of the lysosomal proton-transporting V-type ATPase (v-ATPase) and the acidification of the endo-lysosomal system (PubMed:12045255, PubMed:29127204, PubMed:30374053, PubMed:32276428). May mediate renin-dependent cellular responses by activating ERK1 and ERK2 (PubMed:12045255). By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, may also play a role in the renin-angiotensin system (RAS) (PubMed:12045255). Through its function in V-type ATPase (v-ATPase) assembly and acidification of the lysosome it regulates protein degradation and may control different signaling pathways important for proper brain development, synapse morphology and synaptic transmission (By similarity). {ECO:0000250|UniProtKB:Q9CYN9, ECO:0000269|PubMed:12045255, ECO:0000269|PubMed:29127204, ECO:0000269|PubMed:30374053, ECO:0000269|PubMed:32276428}.","6":"-6.82507980","7":"-40.831381666","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75787"},{"1":"RNASEH2A RNASEHI RNHIA","2":"RNH2A_HUMAN","3":"unknown","4":"Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)","5":"Catalytic subunit of RNase HII, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging-strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}.","6":"6.46889683","7":"13.711791224","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75792"},{"1":"CDC123 C10orf7 D123","2":"CD123_HUMAN","3":"unknown","4":"Cell division cycle protein 123 homolog (Protein D123) (HT-1080) (PZ32)","5":"Required for S phase entry of the cell cycle. {ECO:0000250}.","6":"-1.89544002","7":"3.918317956","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75794"},{"1":"RPP40 RNASEP1","2":"RPP40_HUMAN","3":"unknown","4":"Ribonuclease P protein subunit p40 (RNaseP protein p40) (EC 3.1.26.5) (RNase P subunit 1)","5":"Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends (PubMed:9630247, PubMed:30454648). Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences (PubMed:28115465). {ECO:0000269|PubMed:28115465, ECO:0000269|PubMed:30454648, ECO:0000269|PubMed:9630247}.","6":"-19.99019800","7":"21.470460334","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75818"},{"1":"EIF3G EIF3S4","2":"EIF3G_HUMAN","3":"PROTEIN COMPLEX","4":"Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)","5":"RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). This subunit can bind 18S rRNA. {ECO:0000255|HAMAP-Rule:MF_03006, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}.","6":"14.65141540","7":"37.656752877","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75821"},{"1":"EIF3J EIF3S1 PRO0391","2":"EIF3J_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35)","5":"Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.","6":"-4.89768781","7":"-1.351989093","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75822"},{"1":"PSMD10","2":"PSD10_HUMAN","3":"unknown","4":"26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK))","5":"Acts as a chaperone during the assembly of the 26S proteasome, specifically of the PA700/19S regulatory complex (RC). In the initial step of the base subcomplex assembly is part of an intermediate PSMD10:PSMC4:PSMC5:PAAF1 module which probably assembles with a PSMD5:PSMC2:PSMC1:PSMD2 module. Independently of the proteasome, regulates EGF-induced AKT activation through inhibition of the RHOA/ROCK/PTEN pathway, leading to prolonged AKT activation. Plays an important role in RAS-induced tumorigenesis.; Acts as an proto-oncoprotein by being involved in negative regulation of tumor suppressors RB1 and p53/TP53. Overexpression is leading to phosphorylation of RB1 and proteasomal degradation of RB1. Regulates CDK4-mediated phosphorylation of RB1 by competing with CDKN2A for binding with CDK4. Facilitates binding of MDM2 to p53/TP53 and the mono- and polyubiquitination of p53/TP53 by MDM2 suggesting a function in targeting the TP53:MDM2 complex to the 26S proteasome. Involved in p53-independent apoptosis. Involved in regulation of NF-kappa-B by retaining it in the cytoplasm. Binds to the NF-kappa-B component RELA and accelerates its XPO1/CRM1-mediated nuclear export.","6":"-3.17800947","7":"36.947699436","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O75832"},{"1":"AP1G2","2":"AP1G2_HUMAN","3":"unknown","4":"AP-1 complex subunit gamma-like 2 (Gamma2-adaptin) (G2ad)","5":"May function in protein sorting in late endosomes or multivesucular bodies (MVBs). {ECO:0000269|PubMed:9733768}.; (Microbial infection) Involved in MVB-assisted maturation of hepatitis B virus (HBV). {ECO:0000269|PubMed:16867982, ECO:0000269|PubMed:17553870}.","6":"2.67848788","7":"-3.239050274","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75843"},{"1":"ZMPSTE24 FACE1 STE24","2":"FACE1_HUMAN","3":"unknown","4":"CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)","5":"Proteolytically removes the C-terminal three residues of farnesylated proteins. Acts on lamin A/C.","6":"-4.45808961","7":"-41.001002552","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75844"},{"1":"IDH1 PICD","2":"IDHC_HUMAN","3":"unknown","4":"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","5":"NA","6":"31.93061670","7":"9.698328194","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75874"},{"1":"GATB PET112 PET112L HSPC199","2":"GATB_HUMAN","3":"MITOCHONDRIA","4":"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog)","5":"Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). {ECO:0000255|HAMAP-Rule:MF_03147, ECO:0000269|PubMed:19805282}.","6":"-38.16759762","7":"-5.574087954","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75879"},{"1":"ATRN KIAA0548 MGCA","2":"ATRN_HUMAN","3":"PM","4":"Attractin (DPPT-L) (Mahogany homolog)","5":"Involved in the initial immune cell clustering during inflammatory response and may regulate chemotactic activity of chemokines. May play a role in melanocortin signaling pathways that regulate energy homeostasis and hair color. Low-affinity receptor for agouti (By similarity). Has a critical role in normal myelination in the central nervous system (By similarity). {ECO:0000250, ECO:0000269|PubMed:9736737}.","6":"-9.65364664","7":"-33.260351074","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75882"},{"1":"RBBP9 BOG RBBP10","2":"RBBP9_HUMAN","3":"unknown","4":"Serine hydrolase RBBP9 (EC 3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9)","5":"Serine hydrolase whose substrates have not been identified yet (PubMed:19329999, PubMed:20080647). May negatively regulate basal or autocrine TGF-beta signaling by suppressing SMAD2-SMAD3 phosphorylation (PubMed:20080647). May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta through interaction with RB1 and the subsequent displacement of E2F1 (PubMed:9697699). {ECO:0000269|PubMed:19329999, ECO:0000269|PubMed:20080647, ECO:0000269|PubMed:9697699}.","6":"10.57341185","7":"7.836844838","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75884"},{"1":"STAM2 HBP","2":"STAM2_HUMAN","3":"unknown","4":"Signal transducing adapter molecule 2 (STAM-2) (Hrs-binding protein)","5":"Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes (By similarity). {ECO:0000250}.","6":"6.53381215","7":"-16.275041965","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75886"},{"1":"DGAT1 AGRP1 DGAT","2":"DGAT1_HUMAN","3":"unknown","4":"Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase)","5":"Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates (PubMed:16214399, PubMed:18768481, PubMed:28420705, PubMed:9756920, PubMed:32433611, PubMed:32433610). Highly expressed in epithelial cells of the small intestine and its activity is essential for the absorption of dietary fats (PubMed:18768481). In liver, plays a role in esterifying exogenous fatty acids to glycerol, and is required to synthesize fat for storage (PubMed:16214399). Also present in female mammary glands, where it produces fat in the milk (By similarity). May be involved in VLDL (very low density lipoprotein) assembly (PubMed:18768481). In contrast to DGAT2 it is not essential for survival (By similarity). Functions as the major acyl-CoA retinol acyltransferase (ARAT) in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity leading to skin and hair disorders (PubMed:16214399). Exhibits additional acyltransferase activities, includin acyl CoA:monoacylglycerol acyltransferase (MGAT), wax monoester and wax diester synthases (By similarity). Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) (PubMed:28420705). {ECO:0000250|UniProtKB:Q8MK44, ECO:0000250|UniProtKB:Q9Z2A7, ECO:0000269|PubMed:16214399, ECO:0000269|PubMed:18768481, ECO:0000269|PubMed:28420705, ECO:0000269|PubMed:32433610, ECO:0000269|PubMed:32433611, ECO:0000269|PubMed:9756920}.","6":"-10.24706322","7":"-41.357827711","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"O75907"},{"1":"CCNK CPR4","2":"CCNK_HUMAN","3":"unknown","4":"Cyclin-K","5":"Regulatory subunit of cyclin-dependent kinases that mediates activation of target kinases. Plays a role in transcriptional regulation via its role in regulating the phosphorylation of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A). {ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:9632813}.","6":"-4.66965032","7":"25.715915321","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75909"},{"1":"DYSF FER1L1","2":"DYSF_HUMAN","3":"unknown","4":"Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)","5":"Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). {ECO:0000250}.","6":"-12.30668685","7":"-34.943950956","8":"Undefined","9":"Undefined,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O75923"},{"1":"BCAS2 DAM1","2":"SPF27_HUMAN","3":"unknown","4":"Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27)","5":"Required for pre-mRNA splicing as component of the activated spliceosome (PubMed:28502770, PubMed:28076346, PubMed:29360106, PubMed:29301961, PubMed:30705154). Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR). {ECO:0000269|PubMed:20176811, ECO:0000269|PubMed:24332808, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:30705154}.","6":"-10.49115342","7":"21.547776171","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75934"},{"1":"DCTN3 DCTN22","2":"DCTN3_HUMAN","3":"unknown","4":"Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22)","5":"Together with dynein may be involved in spindle assembly and cytokinesis. {ECO:0000269|PubMed:9722614}.","6":"-6.33220551","7":"38.813471209","8":"Undefined","9":"NUCLEOPLASM-2,PROTEIN COMPLEX,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75935"},{"1":"DNAJC8 SPF31 HSPC315 HSPC331","2":"DNJC8_HUMAN","3":"unknown","4":"DnaJ homolog subfamily C member 8 (Splicing protein spf31)","5":"Suppresses polyglutamine (polyQ) aggregation of ATXN3 in neuronal cells (PubMed:27133716). {ECO:0000269|PubMed:27133716}.","6":"15.93697526","7":"-8.294576086","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O75937"},{"1":"SMNDC1 SMNR SPF30","2":"SPF30_HUMAN","3":"unknown","4":"Survival of motor neuron-related-splicing factor 30 (30 kDa splicing factor SMNrp) (SMN-related protein) (Survival motor neuron domain-containing protein 1)","5":"Necessary for spliceosome assembly. Overexpression causes apoptosis. {ECO:0000269|PubMed:11331295, ECO:0000269|PubMed:11331595, ECO:0000269|PubMed:9817934}.","6":"-5.23397331","7":"1.100797732","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O75940"},{"1":"ATP5PD ATP5H My032","2":"ATP5H_HUMAN","3":"MITOCHONDRIA","4":"ATP synthase subunit d, mitochondrial (ATPase subunit d) (ATP synthase peripheral stalk subunit d)","5":"Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements.","6":"-41.35529512","7":"1.868794095","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75947"},{"1":"DNAJB5 HSC40","2":"DNJB5_HUMAN","3":"unknown","4":"DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-2) (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40)","5":"NA","6":"21.66882900","7":"16.566141842","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75953"},{"1":"FLOT1","2":"FLOT1_HUMAN","3":"unknown","4":"Flotillin-1","5":"May act as a scaffolding protein within caveolar membranes, functionally participating in formation of caveolae or caveolae-like vesicles.","6":"-0.70357560","7":"-42.823586800","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75955"},{"1":"TRIO","2":"TRIO_HUMAN","3":"unknown","4":"Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)","5":"Guanine nucleotide exchange factor (GEF) for RHOA and RAC1 GTPases (PubMed:8643598, PubMed:22155786, PubMed:27418539). Involved in coordinating actin remodeling, which is necessary for cell migration and growth (PubMed:10341202, PubMed:22155786). Plays a key role in the regulation of neurite outgrowth and lamellipodia formation (PubMed:32109419). In developing hippocampal neurons, limits dendrite formation, without affecting the establishment of axon polarity. Once dendrites are formed, involved in the control of synaptic function by regulating the endocytosis of AMPA-selective glutamate receptors (AMPARs) at CA1 excitatory synapses (By similarity). May act as a regulator of adipogenesis (By similarity). {ECO:0000250|UniProtKB:F1M0Z1, ECO:0000269|PubMed:10341202, ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419, ECO:0000269|PubMed:8643598}.","6":"8.58704766","7":"-0.137760867","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O75962"},{"1":"ATP5MG ATP5L","2":"ATP5L_HUMAN","3":"MITOCHONDRIA","4":"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)","5":"Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane.","6":"-39.87674311","7":"3.312701455","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O75964"},{"1":"CPD","2":"CBPD_HUMAN","3":"unknown","4":"Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)","5":"NA","6":"19.61033349","7":"-34.973258297","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"O75976"},{"1":"GLRX3 PICOT TXNL2 HUSSY-22","2":"GLRX3_HUMAN","3":"unknown","4":"Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2)","5":"Together with BOLA2, acts as a cytosolic iron-sulfur (Fe-S) cluster assembly factor that facilitates [2Fe-2S] cluster insertion into a subset of cytosolic proteins (PubMed:26613676, PubMed:27519415). Acts as a critical negative regulator of cardiac hypertrophy and a positive inotropic regulator (By similarity). Required for hemoglobin maturation (PubMed:23615448). Does not possess any thyoredoxin activity since it lacks the conserved motif that is essential for catalytic activity. {ECO:0000250|UniProtKB:Q9CQM9, ECO:0000269|PubMed:23615448, ECO:0000269|PubMed:26613676, ECO:0000269|PubMed:27519415}.","6":"11.90028669","7":"-5.975446474","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O76003"},{"1":"RSL1D1 CATX11 CSIG PBK1 L12","2":"RL1D1_HUMAN","3":"NUCLEUS","4":"Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1)","5":"Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage. {ECO:0000269|PubMed:18678645, ECO:0000269|PubMed:22419112}.","6":"-38.36919067","7":"21.073252638","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O76021"},{"1":"WFS1","2":"WFS1_HUMAN","3":"unknown","4":"Wolframin","5":"Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store (PubMed:16989814). Negatively regulates the ER stress response and positively regulates the stability of V-ATPase subunits ATP6V1A and ATP1B1 by preventing their degradation through an unknown proteasome-independent mechanism (PubMed:23035048). {ECO:0000269|PubMed:16989814, ECO:0000269|PubMed:23035048}.","6":"-10.83555351","7":"-31.778065156","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O76024"},{"1":"CLPX","2":"CLPX_HUMAN","3":"MITOCHONDRIA","4":"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial","5":"ATP-dependent specificity component of the Clp protease complex. Hydrolyzes ATP (PubMed:28874591). Targets specific substrates for degradation by the Clp complex (PubMed:11923310, PubMed:22710082). Can perform chaperone functions in the absence of CLPP. Enhances the DNA-binding activity of TFAM and is required for maintaining a normal mitochondrial nucleoid structure (PubMed:22841477). ATP-dependent unfoldase that stimulates the incorporation of the pyridoxal phosphate cofactor into 5-aminolevulinate synthase, thereby activating 5-aminolevulinate (ALA) synthesis, the first step in heme biosynthesis (PubMed:28874591). Important for efficient erythropoiesis through upregulation of heme biosynthesis (PubMed:25957689, PubMed:28874591). {ECO:0000269|PubMed:11923310, ECO:0000269|PubMed:22710082, ECO:0000269|PubMed:22841477, ECO:0000269|PubMed:25957689, ECO:0000269|PubMed:28874591}.","6":"-38.52543451","7":"-7.004142639","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O76031"},{"1":"SEC14L2 C22orf6 KIAA1186 KIAA1658","2":"S14L2_HUMAN","3":"unknown","4":"SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (hTAP) (Squalene transfer protein) (Supernatant protein factor) (SPF)","5":"Carrier protein. Binds to some hydrophobic molecules and promotes their transfer between the different cellular sites. Binds with high affinity to alpha-tocopherol. Also binds with a weaker affinity to other tocopherols and to tocotrienols. May have a transcriptional activatory activity via its association with alpha-tocopherol. Probably recognizes and binds some squalene structure, suggesting that it may regulate cholesterol biosynthesis by increasing the transfer of squalene to a metabolic active pool in the cell.","6":"27.57302164","7":"-0.100431555","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O76054"},{"1":"CIAO1 CIA1 WDR39","2":"CIAO1_HUMAN","3":"unknown","4":"Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39)","5":"Key component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins (PubMed:17937914, PubMed:23891004). As a CIA complex component, interacts specifically with CIAO2A or CIAO2B and MMS19 to assist different branches of iron-sulfur protein assembly, depending of its interactors. The complex CIAO1:CIAO2B:MMS19 binds to and facilitates the assembly of most cytosolic-nuclear Fe/S proteins. CIAO1:CIAO2A specifically matures ACO1 and stabilizes IREB2 (PubMed:23891004). Seems to specifically modulate the transactivation activity of WT1 (PubMed:9556563). As part of the mitotic spindle-associated MMXD complex it may play a role in chromosome segregation (PubMed:20797633). {ECO:0000255|HAMAP-Rule:MF_03037, ECO:0000269|PubMed:17937914, ECO:0000269|PubMed:20797633, ECO:0000269|PubMed:23891004, ECO:0000269|PubMed:9556563}.","6":"10.51027996","7":"9.936898847","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O76071"},{"1":"SRP72","2":"SRP72_HUMAN","3":"unknown","4":"Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","5":"Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. Binds the 7S RNA only in presence of SRP68. This ribonucleoprotein complex might interact directly with the docking protein in the ER membrane and possibly participate in the elongation arrest function.","6":"19.56639606","7":"31.951511843","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O76094"},{"1":"DDAH1 DDAH","2":"DDAH1_HUMAN","3":"unknown","4":"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)","5":"Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. Has therefore a role in the regulation of nitric oxide generation.","6":"7.91881080","7":"-20.279522728","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94760"},{"1":"RECQL4 RECQ4","2":"RECQ4_HUMAN","3":"unknown","4":"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)","5":"DNA-dependent ATPase. May modulate chromosome segregation. {ECO:0000269|PubMed:15317757}.","6":"13.20249541","7":"2.961187078","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94761"},{"1":"RECQL5 RECQ5","2":"RECQ5_HUMAN","3":"unknown","4":"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)","5":"Isoform beta is a DNA helicase that plays an important role in DNA replication, transcription and repair. Inhibits elongation of stalled transcripts at DNA damage sites by binding to the RNA polymerase II subunit POLR2A and blocking the TCEA1 binding site. Required for mitotic chromosome separation after cross-over events and cell cycle progress. Required for efficient DNA repair, including repair of inter-strand cross-links. Stimulates DNA decatenation mediated by TOP2A. Prevents sister chromatid exchange and homologous recombination. {ECO:0000269|PubMed:20231364, ECO:0000269|PubMed:20348101, ECO:0000269|PubMed:20643585, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22973052, ECO:0000269|PubMed:23715498, ECO:0000269|PubMed:23748380}.","6":"-8.02209718","7":"13.137574086","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94762"},{"1":"URI1 C19orf2 NNX3 PPP1R19 RMP URI","2":"RMP_HUMAN","3":"unknown","4":"Unconventional prefoldin RPB5 interactor 1 (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein)","5":"Involved in gene transcription regulation. Acts as a transcriptional repressor in concert with the corepressor UXT to regulate androgen receptor (AR) transcription. May act as a tumor suppressor to repress AR-mediated gene transcription and to inhibit anchorage-independent growth in prostate cancer cells. Required for cell survival in ovarian cancer cells. Together with UXT, associates with chromatin to the NKX3-1 promoter region. Antagonizes transcriptional modulation via hepatitis B virus X protein.; Plays a central role in maintaining S6K1 signaling and BAD phosphorylation under normal growth conditions thereby protecting cells from potential deleterious effects of sustained S6K1 signaling. The URI1-PPP1CC complex acts as a central component of a negative feedback mechanism that counteracts excessive S6K1 survival signaling to BAD in response to growth factors. Mediates inhibition of PPP1CC phosphatase activity in mitochondria. Coordinates the regulation of nutrient-sensitive gene expression availability in a mTOR-dependent manner. Seems to be a scaffolding protein able to assemble a prefoldin-like complex that contains PFDs and proteins with roles in transcription and ubiquitination.","6":"-14.85765525","7":"27.876272865","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O94763"},{"1":"B3GAT3","2":"B3GA3_HUMAN","3":"GOLGI","4":"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)","5":"Glycosaminoglycans biosynthesis (PubMed:25893793). Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-glucuronic acid (UDP-GlcUA) to the common linkage region trisaccharide Gal-beta-1,3-Gal-beta-1,4-Xyl covalently bound to a Ser residue at the glycosaminylglycan attachment site of proteoglycans. Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins. Shows strict specificity for Gal-beta-1,3-Gal-beta-1,4-Xyl, exhibiting negligible incorporation into other galactoside substrates including Galbeta1-3Gal beta1-O-benzyl, Galbeta1-4GlcNAc and Galbeta1-4Glc. Stimulates 2-phosphoxylose phosphatase activity of PXYLP1 in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA) during completion of linkage region formation (PubMed:24425863). {ECO:0000269|PubMed:24425863, ECO:0000269|PubMed:25893793}.","6":"9.93700627","7":"-40.766251126","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O94766"},{"1":"MTA2 MTA1L1 PID","2":"MTA2_HUMAN","3":"unknown","4":"Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)","5":"May be involved in the regulation of gene expression as repressor and activator. The repression might be related to covalent modification of histone proteins.","6":"-6.20414553","7":"37.931152283","8":"Undefined","9":"NUCLEOPLASM-2,PROTEIN COMPLEX,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O94776"},{"1":"USP1","2":"UBP1_HUMAN","3":"unknown","4":"Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1)","5":"Negative regulator of DNA damage repair which specifically deubiquitinates monoubiquitinated FANCD2 (PubMed:15694335). Also involved in PCNA-mediated translesion synthesis (TLS) by deubiquitinating monoubiquitinated PCNA (PubMed:16531995). Has almost no deubiquitinating activity by itself and requires the interaction with WDR48 to have a high activity (PubMed:18082604, PubMed:26388029). {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995, ECO:0000269|PubMed:18082604, ECO:0000269|PubMed:26388029}.","6":"-2.34749586","7":"23.541296002","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94782"},{"1":"STK10 LOK","2":"STK10_HUMAN","3":"unknown","4":"Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase)","5":"Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo. {ECO:0000269|PubMed:11903060, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:19255442}.","6":"3.25553605","7":"0.959194281","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94804"},{"1":"GFPT2","2":"GFPT2_HUMAN","3":"unknown","4":"Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)","5":"Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins.","6":"35.12285093","7":"16.766285156","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O94808"},{"1":"LTN1 C21orf10 C21orf98 KIAA0714 RNF160 ZNF294 HSPC087","2":"LTN1_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294)","5":"E3 ubiquitin-protein ligase component of the ribosome quality control complex (RQC), a ribosome-associated complex that mediates ubiquitination and extraction of incompletely synthesized nascent chains for proteasomal degradation (PubMed:23685075, PubMed:25132172, PubMed:25578875). Ubiquitination leads to VCP/p97 recruitment for extraction and degradation of the incomplete translation product (By similarity). {ECO:0000250|UniProtKB:Q04781, ECO:0000269|PubMed:23685075, ECO:0000269|PubMed:25132172, ECO:0000269|PubMed:25578875}.","6":"14.62089810","7":"24.552793335","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94822"},{"1":"TOMM70 KIAA0719 TOM70 TOMM70A","2":"TOM70_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70)","5":"Acts as receptor of the preprotein translocase complex of the outer mitochondrial membrane (TOM complex). Recognizes and mediates the translocation of mitochondrial preproteins from the cytosol into the mitochondria in a chaperone dependent manner (PubMed:12526792). Mediates TBK1 and IRF3 activation induced by MAVS in response to Sendai virus infection and promotes host antiviral responses during virus infection (PubMed:20628368, PubMed:25609812). Upon Sendai virus infection, recruits HSP90AA1:IRF3:BAX in mitochondrion and the complex induces apoptosis (PubMed:25609812). {ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:25609812}.","6":"-33.75072227","7":"-13.954523655","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O94826"},{"1":"IPO13 KIAA0724 RANBP13","2":"IPO13_HUMAN","3":"unknown","4":"Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13)","5":"Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of UBC9, the RBM8A/MAGOH complex, PAX6 and probably other members of the paired homeobox family. Also mediates nuclear export of eIF-1A, and the cytoplasmic release of eIF-1A is triggered by the loading of import substrates onto IPO13. {ECO:0000250, ECO:0000269|PubMed:11447110, ECO:0000269|PubMed:15143176}.","6":"38.99233374","7":"5.741582727","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O94829"},{"1":"MYO1D KIAA0727","2":"MYO1D_HUMAN","3":"unknown","4":"Unconventional myosin-Id","5":"Unconventional myosin that functions as actin-based motor protein with ATPase activity (By similarity). Plays a role in endosomal protein trafficking, and especially in the transfer of cargo proteins from early to recycling endosomes (By similarity). Required for normal planar cell polarity in ciliated tracheal cells, for normal rotational polarity of cilia, and for coordinated, unidirectional ciliary movement in the trachea. Required for normal, polarized cilia organization in brain ependymal epithelial cells (By similarity). {ECO:0000250|UniProtKB:F1PRN2, ECO:0000250|UniProtKB:Q63357}.","6":"-8.06960945","7":"-23.538139683","8":"Undefined","9":"PM,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"O94832"},{"1":"TOX4 C14orf92 KIAA0737","2":"TOX4_HUMAN","3":"unknown","4":"TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1)","5":"Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. {ECO:0000269|PubMed:20516061}.","6":"-5.44281658","7":"29.394927827","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O94842"},{"1":"MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2","2":"MICA2_HUMAN","3":"unknown","4":"[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2)","5":"Nuclear monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization (PubMed:24440334). In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2) (By similarity). Acts as a key regulator of the SRF signaling pathway elicited by nerve growth factor and serum: mediates oxidation and subsequent depolymerization of nuclear actin, leading to increase MKL1/MRTF-A presence in the nucleus and promote SRF:MKL1/MRTF-A-dependent gene transcription. Does not activate SRF:MKL1/MRTF-A through RhoA (PubMed:24440334). {ECO:0000250|UniProtKB:Q8TDZ2, ECO:0000269|PubMed:24440334}.","6":"-19.52705811","7":"-30.679722227","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O94851"},{"1":"KIAA0754","2":"K0754_HUMAN","3":"unknown","4":"Uncharacterized protein KIAA0754","5":"NA","6":"-22.74230369","7":"-23.021443279","8":"Undefined","9":"ER,PM,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O94854"},{"1":"SEC24D KIAA0755","2":"SC24D_HUMAN","3":"unknown","4":"Protein transport protein Sec24D (SEC24-related protein D)","5":"Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:17499046, PubMed:20427317, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24C may have a different specificity compared to SEC24A and SEC24B (PubMed:17499046, PubMed:20427317, PubMed:18843296). May more specifically package GPI-anchored proteins through the cargo receptor TMED10 (PubMed:20427317). May also be specific for IxM motif-containing cargos like the SNAREs GOSR2 and STX5 (PubMed:18843296). {ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296, ECO:0000269|PubMed:20427317}.","6":"41.67506968","7":"0.409381378","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O94855"},{"1":"NFASC KIAA0756","2":"NFASC_HUMAN","3":"PM","4":"Neurofascin","5":"Cell adhesion, ankyrin-binding protein which may be involved in neurite extension, axonal guidance, synaptogenesis, myelination and neuron-glial cell interactions. {ECO:0000250}.","6":"-18.97654896","7":"-34.390189137","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O94856"},{"1":"SUPT7L KIAA0764","2":"ST65G_HUMAN","3":"unknown","4":"STAGA complex 65 subunit gamma (Adenocarcinoma antigen ART1) (SPTF-associated factor 65 gamma) (STAF65gamma) (Suppressor of Ty 7-like)","5":"NA","6":"13.58510884","7":"29.213350140","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94864"},{"1":"UFL1 KIAA0776 MAXER NLBP RCAD","2":"UFL1_HUMAN","3":"unknown","4":"E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)","5":"E3 protein ligase that mediates ufmylation, the covalent attachment of the ubiquitin-like modifier UFM1 to lysine residues on target proteins, and which plays a key role in reticulophagy (also called ER-phagy) induced in response to endoplasmic reticulum stress (PubMed:20018847, PubMed:20164180, PubMed:20228063, PubMed:25219498, PubMed:32160526). In response to endoplasmic reticulum stress, recruited to the endoplasmic reticulum membrane by DDRGK1, and mediates ufmylation of proteins such as RPN1 and RPL26/uL24, thereby promoting reticulophagy of endoplasmic reticulum sheets (PubMed:32160526). Ufmylation-dependent reticulophagy inhibits the unfolded protein response (UPR) via ERN1/IRE1-alpha (PubMed:23152784, PubMed:32160526). Ufmylation in response to endoplasmic reticulum stress is essential for processes such as hematopoiesis, blood vessel morphogenesis or inflammatory response (PubMed:32050156). Regulates inflammation in response to endoplasmic reticulum stress by promoting reticulophagy, leading to inhibit the activity of the NF-kappa-B transcription factor (By similarity). Mediates ufmylation of DDRGK1 and CDK5RAP3; the role of these modifications is however unclear: as both DDRGK1 and CDK5RAP3 act as substrate adapters for ufmylation, it is uncertain whether ufmylation of these proteins is a collateral effect or is required for ufmylation (PubMed:20531390, PubMed:20018847). Catalyzes ufmylation of various subunits of the ribosomal complex or associated components, such as RPS3/uS3, RPS20/uS10, RPL10/uL16, RPL26/uL24 and EIF6 (By similarity). Anchors CDK5RAP3 in the cytoplasm, preventing its translocation to the nucleus which allows expression of the CCND1 cyclin and progression of cells through the G1/S transition (PubMed:20531390). Also involved in the response to DNA damage: recruited to double-strand break sites following DNA damage and mediates monoufmylation of histone H4 (PubMed:30886146). Catalyzes ufmylation of TRIP4, thereby playing a role in nuclear receptor-mediated transcription (PubMed:25219498). Required for hematopoietic stem cell function and hematopoiesis (By similarity). Required for cardiac homeostasis (By similarity). {ECO:0000250|UniProtKB:A1A4I9, ECO:0000250|UniProtKB:Q8CCJ3, ECO:0000269|PubMed:20018847, ECO:0000269|PubMed:20164180, ECO:0000269|PubMed:20228063, ECO:0000269|PubMed:20531390, ECO:0000269|PubMed:23152784, ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:30886146, ECO:0000269|PubMed:32050156, ECO:0000269|PubMed:32160526}.","6":"-12.94919888","7":"-30.465448068","8":"ER","9":"Undefined,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94874"},{"1":"PHF14 KIAA0783","2":"PHF14_HUMAN","3":"unknown","4":"PHD finger protein 14","5":"NA","6":"-23.93847381","7":"15.170066078","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O94880"},{"1":"FARP2 KIAA0793 PLEKHC3","2":"FARP2_HUMAN","3":"unknown","4":"FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain-including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2) (Pleckstrin homology domain-containing family C member 3) (PH domain-containing family C member 3)","5":"Functions as guanine nucleotide exchange factor that activates RAC1. May have relatively low activity. Plays a role in the response to class 3 semaphorins and remodeling of the actin cytoskeleton. Plays a role in TNFSF11-mediated osteoclast differentiation, especially in podosome rearrangement and reorganization of the actin cytoskeleton. Regulates the activation of ITGB3, integrin signaling and cell adhesion (By similarity). {ECO:0000250}.","6":"-11.98705882","7":"-20.826106663","8":"Undefined","9":"ER,ER,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O94887"},{"1":"UBXN7 KIAA0794 UBXD7","2":"UBXN7_HUMAN","3":"unknown","4":"UBX domain-containing protein 7","5":"Ubiquitin-binding adapter that links a subset of NEDD8-associated cullin ring ligases (CRLs) to the segregase VCP/p97, to regulate turnover of their ubiquitination substrates. {ECO:0000269|PubMed:22537386}.","6":"-0.81671418","7":"11.278563133","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94888"},{"1":"SUN1 KIAA0810 UNC84A","2":"SUN1_HUMAN","3":"unknown","4":"SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)","5":"As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton (PubMed:18039933, PubMed:18396275). The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning (By similarity). Required for interkinetic nuclear migration (INM) and essential for nucleokinesis and centrosome-nucleus coupling during radial neuronal migration in the cerebral cortex and during glial migration (By similarity). Involved in telomere attachment to nuclear envelope in the prophase of meiosis implicating a SUN1/2:KASH5 LINC complex in which SUN1 and SUN2 seem to act at least partial redundantly (By similarity). Required for gametogenesis and involved in selective gene expression of coding and non-coding RNAs needed for gametogenesis (By similarity). Helps to define the distribution of nuclear pore complexes (NPCs) (By similarity). Required for efficient localization of SYNE4 in the nuclear envelope (By similarity). May be involved in nuclear remodeling during sperm head formation in spermatogenenis (By similarity). May play a role in DNA repair by suppressing non-homologous end joining repair to facilitate the repair of DNA cross-links (PubMed:24375709). {ECO:0000250|UniProtKB:Q9D666, ECO:0000269|PubMed:18039933, ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:24375709}.","6":"-35.29170314","7":"14.691547178","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O94901"},{"1":"PLPBP PROSC","2":"PLPHP_HUMAN","3":"unknown","4":"Pyridoxal phosphate homeostasis protein (PLP homeostasis protein) (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein)","5":"Pyridoxal 5'-phosphate (PLP)-binding protein, which may be involved in intracellular homeostatic regulation of pyridoxal 5'-phosphate (PLP), the active form of vitamin B6. {ECO:0000255|HAMAP-Rule:MF_03225, ECO:0000269|PubMed:27912044}.","6":"4.66131781","7":"1.348812926","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94903"},{"1":"ERLIN2 C8orf2 SPFH2 UNQ2441/PRO5003/PRO9924","2":"ERLN2_HUMAN","3":"ER","4":"Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2)","5":"Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1 (PubMed:19240031, PubMed:17502376). Promotes sterol-accelerated ERAD of HMGCR probably implicating an AMFR/gp78-containing ubiquitin ligase complex (PubMed:21343306). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. May promote ER retention of the SCAP-SREBF complex (PubMed:24217618). {ECO:0000269|PubMed:17502376, ECO:0000269|PubMed:19240031, ECO:0000269|PubMed:21343306, ECO:0000269|PubMed:24217618}.","6":"-10.63603989","7":"-31.002087375","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O94905"},{"1":"PRPF6 C20orf14","2":"PRP6_HUMAN","3":"unknown","4":"Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)","5":"Involved in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:28781166, PubMed:21549338). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but does not affect estrogen-induced transactivation. {ECO:0000269|PubMed:12039962, ECO:0000269|PubMed:21549338, ECO:0000269|PubMed:28781166}.","6":"-20.18199992","7":"26.119981872","8":"Undefined","9":"NUCLEOPLASM-2,Undefined,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O94906"},{"1":"PCF11 KIAA0824","2":"PCF11_HUMAN","3":"unknown","4":"Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)","5":"Component of pre-mRNA cleavage complex II.","6":"19.11061887","7":"17.083847210","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94913"},{"1":"FRYL AF4P12 KIAA0826","2":"FRYL_HUMAN","3":"unknown","4":"Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein)","5":"Plays a key role in maintaining the integrity of polarized cell extensions during morphogenesis, regulates the actin cytoskeleton and plays a key role in patterning sensory neuron dendritic fields by promoting avoidance between homologous dendrites as well as by limiting dendritic branching (By similarity). May function as a transcriptional activator. {ECO:0000250, ECO:0000269|PubMed:16061630}.","6":"-18.51670490","7":"24.201389383","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94915"},{"1":"NFAT5 KIAA0827 TONEBP","2":"NFAT5_HUMAN","3":"unknown","4":"Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP)","5":"Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Binds the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). {ECO:0000269|PubMed:10051678, ECO:0000269|PubMed:10377394, ECO:0000269|PubMed:22266867}.","6":"4.00130508","7":"21.506918575","8":"Undefined","9":"PROTEIN COMPLEX,NUCLEOPLASM-2,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94916"},{"1":"ENDOD1 KIAA0830","2":"ENDD1_HUMAN","3":"unknown","4":"Endonuclease domain-containing 1 protein (EC 3.1.30.-)","5":"May act as a DNase and a RNase. {ECO:0000305}.","6":"0.20095864","7":"-36.306410456","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94919"},{"1":"CDK14 KIAA0834 PFTK1","2":"CDK14_HUMAN","3":"unknown","4":"Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1)","5":"Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport. {ECO:0000269|PubMed:16461467, ECO:0000269|PubMed:17517622, ECO:0000269|PubMed:19524571, ECO:0000269|PubMed:20059949}.","6":"11.37051556","7":"11.402756732","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94921"},{"1":"GLCE KIAA0836","2":"GLCE_HUMAN","3":"GOLGI","4":"D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","5":"Converts D-glucuronic acid residues adjacent to N-sulfate sugar residues to L-iduronic acid residues, both in maturing heparan sulfate (HS) and heparin chains. This is important for further modifications that determine the specificity of interactions between these glycosaminoglycans and proteins. {ECO:0000269|PubMed:20118238, ECO:0000269|PubMed:22528493, ECO:0000269|PubMed:30872481}.","6":"10.68967563","7":"-37.694135585","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O94923"},{"1":"GLS GLS1 KIAA0838","2":"GLSK_HUMAN","3":"unknown","4":"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]","5":"Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate, the main excitatory neurotransmitter in the brain (PubMed:30575854, PubMed:30239721, PubMed:30970188). {ECO:0000269|PubMed:30239721, ECO:0000269|PubMed:30575854, ECO:0000269|PubMed:30970188}.; [Isoform 2]: Lacks catalytic activity. {ECO:0000269|PubMed:11015561}.","6":"-40.49314139","7":"-11.891599647","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94925"},{"1":"HAUS5 KIAA0841","2":"HAUS5_HUMAN","3":"unknown","4":"HAUS augmin-like complex subunit 5","5":"Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. {ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}.","6":"18.47202886","7":"12.518689778","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94927"},{"1":"USP19 KIAA0891 ZMYND9","2":"UBP19_HUMAN","3":"unknown","4":"Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)","5":"Deubiquitinating enzyme that regulates the degradation of various proteins. Deubiquitinates and prevents proteasomal degradation of RNF123 which in turn stimulates CDKN1B ubiquitin-dependent degradation thereby playing a role in cell proliferation. Involved in decreased protein synthesis in atrophying skeletal muscle. Modulates transcription of major myofibrillar proteins. Also involved in turnover of endoplasmic-reticulum-associated degradation (ERAD) substrates. Regulates the stability of BIRC2/c-IAP1 and BIRC3/c-IAP2 by preventing their ubiquitination. Required for cells to mount an appropriate response to hypoxia and rescues HIF1A from degradation in a non-catalytic manner. Plays an important role in 17 beta-estradiol (E2)-inhibited myogenesis. Decreases the levels of ubiquitinated proteins during skeletal muscle formation and acts to repress myogenesis. Exhibits a preference towards 'Lys-63'-linked ubiquitin chains. {ECO:0000269|PubMed:19465887, ECO:0000269|PubMed:21849505, ECO:0000269|PubMed:22128162, ECO:0000269|PubMed:22689415}.","6":"2.65381639","7":"-9.503918074","8":"Undefined","9":"CYTOSOL,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O94966"},{"1":"WDR47 KIAA0893","2":"WDR47_HUMAN","3":"unknown","4":"WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)","5":"NA","6":"7.87436178","7":"0.439084937","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94967"},{"1":"TRIM37 KIAA0898 MUL POB1","2":"TRI37_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)","5":"E3 ubiquitin-protein ligase required to prevent centriole reduplication (PubMed:15885686, PubMed:23769972). Probably acts by ubiquitinating positive regulators of centriole reduplication (PubMed:23769972). Mediates monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub), a specific tag for epigenetic transcriptional repression: associates with some Polycomb group (PcG) multiprotein PRC2-like complex and mediates repression of target genes (PubMed:25470042). Has anti-HIV activity (PubMed:24317724). {ECO:0000269|PubMed:15885686, ECO:0000269|PubMed:23769972, ECO:0000269|PubMed:24317724, ECO:0000269|PubMed:25470042}.","6":"-5.98669837","7":"17.807576414","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94972"},{"1":"AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899","2":"AP2A2_HUMAN","3":"unknown","4":"AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)","5":"Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity). {ECO:0000250, ECO:0000269|PubMed:12960147, ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:19033387, ECO:0000269|PubMed:23676497}.","6":"1.97754439","7":"-13.611115486","8":"RIBOSOME","9":"Undefined,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O94973"},{"1":"SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334","2":"SC31A_HUMAN","3":"unknown","4":"Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein)","5":"Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER) (PubMed:10788476). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules (By similarity). {ECO:0000250|UniProtKB:Q9Z2Q1, ECO:0000269|PubMed:10788476}.","6":"42.86830234","7":"1.652314215","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O94979"},{"1":"CEP152 KIAA0912","2":"CE152_HUMAN","3":"unknown","4":"Centrosomal protein of 152 kDa (Cep152)","5":"Necessary for centrosome duplication; the function seems also to involve CEP63, CDK5RAP2 and WDR62 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). Acts as a molecular scaffold facilitating the interaction of PLK4 and CENPJ, 2 molecules involved in centriole formation (PubMed:21059844, PubMed:20852615). Proposed to snatch PLK4 away from PLK4:CEP92 complexes in early G1 daughter centriole and to reposition PLK4 at the outer boundary of a newly forming CEP152 ring structure (PubMed:24997597). Also plays a key role in deuterosome-mediated centriole amplification in multiciliated that can generate more than 100 centrioles (By similarity). Overexpression of CEP152 can drive amplification of centrioles (PubMed:20852615). {ECO:0000250|UniProtKB:A2AUM9, ECO:0000250|UniProtKB:Q498G2, ECO:0000269|PubMed:20852615, ECO:0000269|PubMed:21059844, ECO:0000269|PubMed:21131973}.","6":"-10.05790392","7":"-10.213483527","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O94986"},{"1":"HEXIM1 CLP1 EDG1 HIS1 MAQ1","2":"HEXI1_HUMAN","3":"unknown","4":"Protein HEXIM1 (Cardiac lineage protein 1) (Estrogen down-regulated gene 1 protein) (Hexamethylene bis-acetamide-inducible protein 1) (Menage a quatre protein 1)","5":"Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor (PubMed:14580347, PubMed:15713661, PubMed:15201869). Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:12832472, PubMed:14580347, PubMed:15713661, PubMed:15201869). May also regulate NF-kappa-B, ESR1, NR3C1 and CIITA-dependent transcriptional activity (PubMed:15940264, PubMed:15941832, PubMed:17088550). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). {ECO:0000269|PubMed:12581153, ECO:0000269|PubMed:12832472, ECO:0000269|PubMed:14580347, ECO:0000269|PubMed:15201869, ECO:0000269|PubMed:15713661, ECO:0000269|PubMed:15940264, ECO:0000269|PubMed:15941832, ECO:0000269|PubMed:17088550, ECO:0000269|PubMed:28712728}.","6":"1.26266754","7":"29.103884588","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O94992"},{"1":"CCNB2","2":"CCNB2_HUMAN","3":"unknown","4":"G2/mitotic-specific cyclin-B2","5":"Essential for the control of the cell cycle at the G2/M (mitosis) transition.","6":"6.51786568","7":"-4.852935170","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95067"},{"1":"UBR5 EDD EDD1 HYD KIAA0896","2":"UBR5_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)","5":"E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation (By similarity). Involved in maturation and/or transcriptional regulation of mRNA by activating CDK9 by polyubiquitination. May play a role in control of cell cycle progression. May have tumor suppressor function. Regulates DNA topoisomerase II binding protein (TopBP1) in the DNA damage response. Plays an essential role in extraembryonic development. Ubiquitinates acetylated PCK1. Also acts as a regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes. {ECO:0000250, ECO:0000269|PubMed:21127351, ECO:0000269|PubMed:21726808, ECO:0000269|PubMed:22884692}.","6":"-4.77473396","7":"39.958481665","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95071"},{"1":"AGFG2 HRBL RABR","2":"AGFG2_HUMAN","3":"unknown","4":"Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related) (RAB-R)","5":"NA","6":"33.93857917","7":"-0.526466739","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95081"},{"1":"SCAF4 KIAA1172 SFRS15","2":"SCAF4_HUMAN","3":"NUCLEOPLASM-1","4":"SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)","5":"Anti-terminator protein required to prevent early mRNA termination during transcription (PubMed:31104839). Together with SCAF8, acts by suppressing the use of early, alternative poly(A) sites, thereby preventing the accumulation of non-functional truncated proteins (PubMed:31104839). Mechanistically, associates with the phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit (POLR2A), and subsequently binds nascent RNA upstream of early polyadenylation sites to prevent premature mRNA transcript cleavage and polyadenylation (PubMed:31104839). Independently of SCAF8, also acts as a suppressor of transcriptional readthrough (PubMed:31104839). {ECO:0000269|PubMed:31104839}.","6":"25.63400320","7":"18.429075451","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95104"},{"1":"NDUFB6","2":"NDUB6_HUMAN","3":"unknown","4":"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-34.37832179","7":"1.656799304","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O95139"},{"1":"MFN2 CPRP1 KIAA0214","2":"MFN2_HUMAN","3":"unknown","4":"Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2)","5":"Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion (PubMed:11181170, PubMed:11950885, PubMed:26214738, PubMed:28114303). Mitochondria are highly dynamic organelles, and their morphology is determined by the equilibrium between mitochondrial fusion and fission events (PubMed:28114303). Overexpression induces the formation of mitochondrial networks (PubMed:28114303). Membrane clustering requires GTPase activity and may involve a major rearrangement of the coiled coil domains (Probable). Plays a central role in mitochondrial metabolism and may be associated with obesity and/or apoptosis processes (By similarity). Plays an important role in the regulation of vascular smooth muscle cell proliferation (By similarity). Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) (PubMed:23620051). Is required for PRKN recruitment to dysfunctional mitochondria (PubMed:23620051). Involved in the control of unfolded protein response (UPR) upon ER stress including activation of apoptosis and autophagy during ER stress (By similarity). Acts as an upstream regulator of EIF2AK3 and suppresses EIF2AK3 activation under basal conditions (By similarity). {ECO:0000250|UniProtKB:Q80U63, ECO:0000250|UniProtKB:Q8R500, ECO:0000269|PubMed:11181170, ECO:0000269|PubMed:11950885, ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:26085578, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:28114303, ECO:0000305}.","6":"-41.97236635","7":"-7.288471143","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O95140"},{"1":"UBE4B HDNB1 KIAA0684 UFD2","2":"UBE4B_HUMAN","3":"unknown","4":"Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)","5":"Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases (By similarity). May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase (By similarity). May regulate myosin assembly in striated muscles together with STUB1 and VCP/p97 by targeting myosin chaperone UNC45B for proteasomal degradation (PubMed:17369820). {ECO:0000250|UniProtKB:P54860, ECO:0000250|UniProtKB:Q9ES00, ECO:0000269|PubMed:17369820}.","6":"16.12129670","7":"26.416322047","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95155"},{"1":"ZFPL1","2":"ZFPL1_HUMAN","3":"unknown","4":"Zinc finger protein-like 1 (Zinc finger protein MCG4)","5":"Required for cis-Golgi integrity and efficient ER to Golgi transport. Involved in the maintenance of the integrity of the cis-Golgi, possibly via its interaction with GOLGA2/GM130. {ECO:0000269|PubMed:18323775}.","6":"9.28975280","7":"-43.001592610","8":"Undefined","9":"LYSOSOME,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95159"},{"1":"ELP1 IKAP IKBKAP","2":"ELP1_HUMAN","3":"unknown","4":"Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150)","5":"Component of the RNA polymerase II elongator complex, a multiprotein complex associated with the RNA polymerase II (Pol II) holoenzyme, and which is involved in transcriptional elongation (PubMed:11714725, PubMed:11818576). The elongator complex catalyzes formation of carboxymethyluridine in the wobble base at position 34 in tRNAs (PubMed:29332244). Involved in neurogenesis (By similarity). Regulates the migration and branching of projection neurons in the developing cerebral cortex, through a process depending on alpha-tubulin acetylation (By similarity). May act as a scaffold protein that may assemble active IKK-MAP3K14 complexes (IKKA, IKKB and MAP3K14/NIK) (PubMed:9751059). {ECO:0000250|UniProtKB:Q7TT37, ECO:0000269|PubMed:11714725, ECO:0000269|PubMed:11818576, ECO:0000269|PubMed:9751059, ECO:0000303|PubMed:29332244}.","6":"36.05902094","7":"16.669886294","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95163"},{"1":"NDUFB8","2":"NDUB8_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-35.99495552","7":"-17.294060522","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95169"},{"1":"NDUFA7","2":"NDUA7_HUMAN","3":"unknown","4":"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-41.93162917","7":"3.831799228","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O95182"},{"1":"RTN3 ASYIP NSPL2","2":"RTN3_HUMAN","3":"unknown","4":"Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII)","5":"May be involved in membrane trafficking in the early secretory pathway. Inhibits BACE1 activity and amyloid precursor protein processing. May induce caspase-8 cascade and apoptosis. May favor BCL2 translocation to the mitochondria upon endoplasmic reticulum stress. In case of enteroviruses infection, RTN3 may be involved in the viral replication or pathogenesis. Induces the formation of endoplasmic reticulum tubules (PubMed:25612671). {ECO:0000269|PubMed:15286784, ECO:0000269|PubMed:16054885, ECO:0000269|PubMed:17031492, ECO:0000269|PubMed:17191123, ECO:0000269|PubMed:25612671}.","6":"9.44621100","7":"-36.371973912","8":"Undefined","9":"GOLGI,LYSOSOME,PM","10":"NA","11":"NA","12":"NA","_rn_":"O95197"},{"1":"LETM1","2":"LETM1_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1)","5":"Mitochondrial proton/calcium antiporter that mediates proton-dependent calcium efflux from mitochondrion (PubMed:19797662). Crucial for the maintenance of mitochondrial tubular networks and for the assembly of the supercomplexes of the respiratory chain (PubMed:18628306). Required for the maintenance of the tubular shape and cristae organization (PubMed:18628306). In contrast to SLC8B1/NCLX, does not constitute the major factor for mitochondrial calcium extrusion (PubMed:24898248). {ECO:0000269|PubMed:18628306, ECO:0000269|PubMed:19797662, ECO:0000269|PubMed:24898248}.","6":"-35.63626140","7":"-14.728862247","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95202"},{"1":"EPN2 KIAA1065","2":"EPN2_HUMAN","3":"unknown","4":"Epsin-2 (EPS-15-interacting protein 2)","5":"Plays a role in the formation of clathrin-coated invaginations and endocytosis. {ECO:0000269|PubMed:10567358}.","6":"-0.08972986","7":"-21.272076830","8":"PM","9":"PM,Undefined,Undefined","10":"Candidate","11":"2","12":"1,3","_rn_":"O95208"},{"1":"STBD1 GENX-3414","2":"STBD1_HUMAN","3":"unknown","4":"Starch-binding domain-containing protein 1 (Genethonin-1) (Glycophagy cargo receptor STBD1)","5":"Acts as a cargo receptor for glycogen. Delivers its cargo to an autophagic pathway called glycophagy, resulting in the transport of glycogen to lysosomes. {ECO:0000269|PubMed:20810658, ECO:0000269|PubMed:21893048, ECO:0000269|PubMed:24837458}.","6":"-5.95812928","7":"-41.711050456","8":"PM","9":"PM,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95210"},{"1":"ZRANB2 ZIS ZNF265","2":"ZRAB2_HUMAN","3":"unknown","4":"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)","5":"Splice factor required for alternative splicing of TRA2B/SFRS10 transcripts. May interfere with constitutive 5'-splice site selection. {ECO:0000269|PubMed:11448987}.","6":"-15.22037431","7":"6.477278144","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95218"},{"1":"SNX4","2":"SNX4_HUMAN","3":"unknown","4":"Sorting nexin-4","5":"Involved in the regulation of endocytosis and in several stages of intracellular trafficking (PubMed:12668730). Plays a role in recycling endocytosed transferrin receptor and prevent its degradation. {ECO:0000269|PubMed:12668730, ECO:0000269|PubMed:17994011}.","6":"13.60778734","7":"-27.111346986","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95219"},{"1":"ZWINT","2":"ZWINT_HUMAN","3":"unknown","4":"ZW10 interactor (ZW10-interacting protein 1) (Zwint-1)","5":"Part of the MIS12 complex, which is required for kinetochore formation and spindle checkpoint activity. Required to target ZW10 to the kinetochore at prometaphase. {ECO:0000269|PubMed:15094189, ECO:0000269|PubMed:15485811, ECO:0000269|PubMed:15824131, ECO:0000269|PubMed:16732327}.","6":"-1.82699026","7":"-1.348643372","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95229"},{"1":"LUC7L3 CREAP1 CROP O48","2":"LC7L3_HUMAN","3":"NUCLEUS","4":"Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1)","5":"Binds cAMP regulatory element DNA sequence. May play a role in RNA splicing. {ECO:0000269|PubMed:16462885}.","6":"-20.11202624","7":"13.142548664","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95232"},{"1":"KIF20A MKLP2 RAB6KIFL","2":"KI20A_HUMAN","3":"unknown","4":"Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6)","5":"Mitotic kinesin required for chromosome passenger complex (CPC)-mediated cytokinesis. Following phosphorylation by PLK1, involved in recruitment of PLK1 to the central spindle. Interacts with guanosine triphosphate (GTP)-bound forms of RAB6A and RAB6B. May act as a motor required for the retrograde RAB6 regulated transport of Golgi membranes and associated vesicles along microtubules. Has a microtubule plus end-directed motility. {ECO:0000269|PubMed:12939256}.","6":"-13.31676272","7":"22.043345725","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95235"},{"1":"KIF4A KIF4","2":"KIF4A_HUMAN","3":"unknown","4":"Chromosome-associated kinesin KIF4A (Chromokinesin-A)","5":"Iron-sulfur (Fe-S) cluster binding motor protein that has a role in chromosome segregation during mitosis (PubMed:29848660). Translocates PRC1 to the plus ends of interdigitating spindle microtubules during the metaphase to anaphase transition, an essential step for the formation of an organized central spindle midzone and midbody and for successful cytokinesis (PubMed:15297875, PubMed:15625105). May play a role in mitotic chromosomal positioning and bipolar spindle stabilization (By similarity). {ECO:0000250|UniProtKB:P33174, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:29848660}.","6":"1.89710257","7":"30.376874182","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95239"},{"1":"SBF1 MTMR5","2":"MTMR5_HUMAN","3":"unknown","4":"Myotubularin-related protein 5 (Inactive phosphatidylinositol 3-phosphatase 5) (SET-binding factor 1) (Sbf1)","5":"Acts as an adapter for the phosphatase MTMR2 to regulate MTMR2 catalytic activity and subcellular location (PubMed:12668758). May function as a guanine nucleotide exchange factor (GEF) activating RAB28 (PubMed:20937701). Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form (PubMed:20937701). Inhibits myoblast differentiation in vitro and induces oncogenic transformation in fibroblasts (PubMed:9537414). {ECO:0000269|PubMed:12668758, ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:9537414}.","6":"6.50906180","7":"-13.726278053","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95248"},{"1":"KAT7 HBO1 HBOa MYST2","2":"KAT7_HUMAN","3":"unknown","4":"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)","5":"Catalytic subunit of histone acetyltransferase HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby regulating various processes, such as gene transcription, protein ubiquitination, immune regulation, stem cell pluripotent and self-renewal maintenance and embryonic development (PubMed:16387653, PubMed:21753189, PubMed:24065767, PubMed:26620551, PubMed:31767635, PubMed:31827282). Some complexes also catalyze acetylation of histone H4 at 'Lys-5', 'Lys-8' and 'Lys-12' (H4K5ac, H4K8ac and H4K12ac, respectively), regulating DNA replication initiation, regulating DNA replication initiation (PubMed:10438470, PubMed:19187766, PubMed:20129055, PubMed:24065767). Specificity of the HBO1 complexes is determined by the scaffold subunit: complexes containing BRPF scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1 specificity towards H3K14ac, while complexes containing JADE (JADE1, JADE2 and JADE3) scaffold direct KAT7/HBO1 specificity towards histone H4 (PubMed:19187766, PubMed:20129055, PubMed:24065767, PubMed:26620551). H3K14ac promotes transcriptional elongation by facilitating the processivity of RNA polymerase II (PubMed:31827282). Acts as a key regulator of hematopoiesis by forming a complex with BRD1/BRPF2, directing KAT7/HBO1 specificity towards H3K14ac and promoting erythroid differentiation (PubMed:21753189). H3K14ac is also required for T-cell development (By similarity). KAT7/HBO1-mediated acetylation facilitates two consecutive steps, licensing and activation, in DNA replication initiation: H3K14ac facilitates the activation of replication origins, and histone H4 acetylation (H4K5ac, H4K8ac and H4K12ac) facilitates chromatin loading of MCM complexes, promoting DNA replication licensing (PubMed:10438470, PubMed:11278932, PubMed:18832067, PubMed:19187766, PubMed:20129055, PubMed:21856198, PubMed:24065767, PubMed:26620551). Acts as a positive regulator of centromeric CENPA assembly: recruited to centromeres and mediates histone acetylation, thereby preventing centromere inactivation mediated by SUV39H1, possibly by increasing histone turnover/exchange (PubMed:27270040). Involved in nucleotide excision repair: phosphorylation by ATR in response to ultraviolet irradiation promotes its localization to DNA damage sites, where it mediates histone acetylation to facilitate recruitment of XPC at the damaged DNA sites (PubMed:28719581). Acts as an inhibitor of NF-kappa-B independently of its histone acetyltransferase activity (PubMed:16997280). {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:16997280, ECO:0000269|PubMed:18832067, ECO:0000269|PubMed:19187766, ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:21753189, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551, ECO:0000269|PubMed:27270040, ECO:0000269|PubMed:28719581, ECO:0000269|PubMed:31767635, ECO:0000269|PubMed:31827282}.; Plays a central role in the maintenance of leukemia stem cells in acute myeloid leukemia (AML) (PubMed:31827282). Acts by mediating acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby facilitating the processivity of RNA polymerase II to maintain the high expression of key genes, such as HOXA9 and HOXA10 that help to sustain the functional properties of leukemia stem cells (PubMed:31827282). {ECO:0000269|PubMed:31827282}.","6":"-23.56222564","7":"17.414321719","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O95251"},{"1":"ATE1","2":"ATE1_HUMAN","3":"unknown","4":"Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)","5":"Involved in the post-translational conjugation of arginine to the N-terminal aspartate or glutamate of a protein. This arginylation is required for degradation of the protein via the ubiquitin pathway. Does not arginylate cysteine residues (By similarity). {ECO:0000250}.","6":"20.72525139","7":"23.338349611","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95260"},{"1":"CCNDBP1 DIP1 GCIP HHM","2":"CCDB1_HUMAN","3":"unknown","4":"Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)","5":"May negatively regulate cell cycle progression. May act at least in part via inhibition of the cyclin-D1/CDK4 complex, thereby preventing phosphorylation of RB1 and blocking E2F-dependent transcription. {ECO:0000269|PubMed:10801854}.","6":"-12.93728140","7":"4.478455482","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95273"},{"1":"VAPB UNQ484/PRO983","2":"VAPB_HUMAN","3":"unknown","4":"Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C)","5":"Participates in the endoplasmic reticulum unfolded protein response (UPR) by inducing ERN1/IRE1 activity. Involved in cellular calcium homeostasis regulation. {ECO:0000269|PubMed:16891305, ECO:0000269|PubMed:20940299, ECO:0000269|PubMed:22131369}.","6":"-9.63713035","7":"-39.768952802","8":"PM","9":"Undefined,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"O95292"},{"1":"SNAPIN BLOC1S7 SNAP25BP SNAPAP","2":"SNAPN_HUMAN","3":"unknown","4":"SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein)","5":"Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in intracellular vesicle trafficking and synaptic vesicle recycling. May modulate a step between vesicle priming, fusion and calcium-dependent neurotransmitter release through its ability to potentiate the interaction of synaptotagmin with the SNAREs and the plasma-membrane-associated protein SNAP25. Its phosphorylation state influences exocytotic protein interactions and may regulate synaptic vesicle exocytosis. May also have a role in the mechanisms of SNARE-mediated membrane fusion in non-neuronal cells (PubMed:17182842, PubMed:18167355). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor (PubMed:25898167). {ECO:0000269|PubMed:17182842, ECO:0000269|PubMed:18167355, ECO:0000269|PubMed:25898167}.","6":"11.92498367","7":"-22.261095394","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95295"},{"1":"MPZL1 PZR UNQ849/PRO1787","2":"MPZL1_HUMAN","3":"unknown","4":"Myelin protein zero-like protein 1 (Protein zero-related)","5":"Cell surface receptor, which is involved in signal transduction processes. Recruits PTPN11/SHP-2 to the cell membrane and is a putative substrate of PTPN11/SHP-2. Is a major receptor for concanavalin-A (ConA) and is involved in cellular signaling induced by ConA, which probably includes Src family tyrosine-protein kinases. Isoform 3 seems to have a dominant negative role; it blocks tyrosine phosphorylation of MPZL1 induced by ConA. Isoform 1, but not isoform 2 and isoform 3, may be involved in regulation of integrin-mediated cell motility. {ECO:0000269|PubMed:11751924, ECO:0000269|PubMed:12410637}.","6":"-5.20658877","7":"-42.236493383","8":"PM","9":"PM,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95297"},{"1":"NDUFA10","2":"NDUAA_HUMAN","3":"MITOCHONDRIA","4":"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-40.83476329","7":"-9.836836205","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95299"},{"1":"FKBP9 FKBP60 FKBP63","2":"FKBP9_HUMAN","3":"ER","4":"Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase)","5":"PPIases accelerate the folding of proteins during protein synthesis.","6":"-22.42337553","7":"-19.301663370","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95302"},{"1":"PGLS","2":"6PGL_HUMAN","3":"CYTOSOL","4":"6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)","5":"Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate.","6":"2.07346105","7":"13.019264996","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95336"},{"1":"PAPSS2 ATPSK2","2":"PAPS2_HUMAN","3":"unknown","4":"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","5":"Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate-activation pathway. May have an important role in skeletogenesis during postnatal growth (By similarity). {ECO:0000250}.","6":"39.94417638","7":"4.053069230","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95340"},{"1":"SMC2 CAPE SMC2L1 PRO0324","2":"SMC2_HUMAN","3":"unknown","4":"Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (hCAP-E) (XCAP-E homolog)","5":"Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. {ECO:0000269|PubMed:11136719}.","6":"-2.37781489","7":"36.339694708","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95347"},{"1":"ATG7 APG7L","2":"ATG7_HUMAN","3":"unknown","4":"Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein)","5":"E1-like activating enzyme involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Required for mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Modulates p53/TP53 activity to regulate cell cycle and survival during metabolic stress. Plays also a key role in the maintenance of axonal homeostasis, the prevention of axonal degeneration, the maintenance of hematopoietic stem cells, the formation of Paneth cell granules, as well as in adipose differentiation. Plays a role in regulating the liver clock and glucose metabolism by mediating the autophagic degradation of CRY1 (clock repressor) in a time-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q9D906, ECO:0000269|PubMed:11096062, ECO:0000269|PubMed:16303767, ECO:0000269|PubMed:22170151}.","6":"39.99739372","7":"6.873210223","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95352"},{"1":"TACC2","2":"TACC2_HUMAN","3":"unknown","4":"Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1)","5":"Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). May play a role in organizing centrosomal microtubules. May act as a tumor suppressor protein. May represent a tumor progression marker. {ECO:0000250, ECO:0000269|PubMed:10749935}.","6":"-10.16081425","7":"0.020429504","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95359"},{"1":"FARS2 FARS1 HSPC320","2":"SYFM_HUMAN","3":"unknown","4":"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)","5":"Is responsible for the charging of tRNA(Phe) with phenylalanine in mitochondrial translation. To a lesser extent, also catalyzes direct attachment of m-Tyr (an oxidized version of Phe) to tRNA(Phe), thereby opening the way for delivery of the misacylated tRNA to the ribosome and incorporation of ROS-damaged amino acid into proteins. {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}.","6":"-30.31838742","7":"-11.575149756","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Candidate","11":"2","12":"2,3","_rn_":"O95363"},{"1":"ZBTB7A FBI1 LRF ZBTB7 ZNF857A","2":"ZBT7A_HUMAN","3":"unknown","4":"Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (Pokemon 1) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A)","5":"Transcription factor that represses the transcription of a wide range of genes involved in cell proliferation and differentiation (PubMed:14701838, PubMed:17595526, PubMed:20812024, PubMed:25514493, PubMed:26455326, PubMed:26816381). Directly and specifically binds to the consensus sequence 5'-[GA][CA]GACCCCCCCCC-3' and represses transcription both by regulating the organization of chromatin and through the direct recruitment of transcription factors to gene regulatory regions (PubMed:12004059, PubMed:17595526, PubMed:20812024, PubMed:25514493, PubMed:26816381). Negatively regulates SMAD4 transcriptional activity in the TGF-beta signaling pathway through these two mechanisms (PubMed:25514493). That is, recruits the chromatin regulator HDAC1 to the SMAD4-DNA complex and in parallel prevents the recruitment of the transcriptional activators CREBBP and EP300 (PubMed:25514493). Collaborates with transcription factors like RELA to modify the accessibility of gene transcription regulatory regions to secondary transcription factors (By similarity). Also directly interacts with transcription factors like SP1 to prevent their binding to DNA (PubMed:12004059). Functions as an androgen receptor/AR transcriptional corepressor by recruiting NCOR1 and NCOR2 to the androgen response elements/ARE on target genes (PubMed:20812024). Thereby, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Involved in the switch between fetal and adult globin expression during erythroid cells maturation (PubMed:26816381). Through its interaction with the NuRD complex regulates chromatin at the fetal globin genes to repress their transcription (PubMed:26816381). Specifically represses the transcription of the tumor suppressor ARF isoform from the CDKN2A gene (By similarity). Efficiently abrogates E2F1-dependent CDKN2A transactivation (By similarity). Regulates chondrogenesis through the transcriptional repression of specific genes via a mechanism that also requires histone deacetylation (By similarity). Regulates cell proliferation through the transcriptional regulation of genes involved in glycolysis (PubMed:26455326). Involved in adipogenesis through the regulation of genes involved in adipocyte differentiation (PubMed:14701838). Plays a key role in the differentiation of lymphoid progenitors into B and T lineages (By similarity). Promotes differentiation towards the B lineage by inhibiting the T-cell instructive Notch signaling pathway through the specific transcriptional repression of Notch downstream target genes (By similarity). Also regulates osteoclast differentiation (By similarity). May also play a role, independently of its transcriptional activity, in double-strand break repair via classical non-homologous end joining/cNHEJ (By similarity). Recruited to double-strand break sites on damage DNA, interacts with the DNA-dependent protein kinase complex and directly regulates its stability and activity in DNA repair (By similarity). May also modulate the splicing activity of KHDRBS1 toward BCL2L1 in a mechanism which is histone deacetylase-dependent and thereby negatively regulates the pro-apoptotic effect of KHDRBS1 (PubMed:24514149). {ECO:0000250|UniProtKB:O88939, ECO:0000250|UniProtKB:Q9QZ48, ECO:0000269|PubMed:12004059, ECO:0000269|PubMed:14701838, ECO:0000269|PubMed:17595526, ECO:0000269|PubMed:20812024, ECO:0000269|PubMed:24514149, ECO:0000269|PubMed:25514493, ECO:0000269|PubMed:26455326, ECO:0000269|PubMed:26816381}.","6":"-14.67036440","7":"20.111051117","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95365"},{"1":"IPO7 RANBP7","2":"IPO7_HUMAN","3":"unknown","4":"Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)","5":"Functions in nuclear protein import, either by acting as autonomous nuclear transport receptor or as an adapter-like protein in association with the importin-beta subunit KPNB1. Acting autonomously, is thought to serve itself as receptor for nuclear localization signals (NLS) and to promote translocation of import substrates through the nuclear pore complex (NPC) by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates autonomously the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In association with KPNB1 mediates the nuclear import of H1 histone and the Ran-binding site of IPO7 is not required but synergizes with that of KPNB1 in importin/substrate complex dissociation. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. {ECO:0000269|PubMed:10228156, ECO:0000269|PubMed:9687515}.; (Microbial infection) Mediates the nuclear import of HIV-1 reverse transcription complex (RTC) integrase. Binds and mediates the nuclear import of HIV-1 Rev. {ECO:0000269|PubMed:12853482, ECO:0000269|PubMed:16704975}.","6":"38.66299292","7":"8.496146754","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95373"},{"1":"ARIH2 ARI2 TRIAD1 HT005","2":"ARI2_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein)","5":"E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3 (PubMed:16118314, PubMed:17646546, PubMed:19340006, PubMed:24076655). Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-5-RING ubiquitin ligase complex (ECS complex, also named CRL5 complex) and initiating ubiquitination of ECS substrates: associates with ECS complex and specifically mediates addition of the first ubiquitin on ECS targets (By similarity). The initial ubiquitin is then elongated (By similarity). E3 ubiquitin-protein ligase activity is activated upon binding to neddylated form of the ECS complex (PubMed:24076655). Mediates 'Lys-6', 'Lys-48'- and 'Lys-63'-linked polyubiquitination (PubMed:16118314, PubMed:17646546, PubMed:19340006). May play a role in myelopoiesis (PubMed:19340006). {ECO:0000250|UniProtKB:Q9Y4X5, ECO:0000269|PubMed:16118314, ECO:0000269|PubMed:17646546, ECO:0000269|PubMed:19340006, ECO:0000269|PubMed:24076655}.","6":"26.79935464","7":"13.084347066","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95376"},{"1":"PGM3 AGM1","2":"AGM1_HUMAN","3":"CYTOSOL","4":"Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)","5":"Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation. {ECO:0000303|PubMed:24589341, ECO:0000303|PubMed:24698316, ECO:0000303|PubMed:24931394}.","6":"20.31410843","7":"-1.513435569","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95394"},{"1":"MOCS3 UBA4","2":"MOCS3_HUMAN","3":"unknown","4":"Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase) (MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]","5":"Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of cytosolic tRNA(Lys), tRNA(Glu) and tRNA(Gln). Also essential during biosynthesis of the molybdenum cofactor. Acts by mediating the C-terminal thiocarboxylation of sulfur carriers URM1 and MOCS2A. Its N-terminus first activates URM1 and MOCS2A as acyl-adenylates (-COAMP), then the persulfide sulfur on the catalytic cysteine is transferred to URM1 and MOCS2A to form thiocarboxylation (-COSH) of their C-terminus. The reaction probably involves hydrogen sulfide that is generated from the persulfide intermediate and that acts as nucleophile towards URM1 and MOCS2A. Subsequently, a transient disulfide bond is formed. Does not use thiosulfate as sulfur donor; NFS1 probably acting as a sulfur donor for thiocarboxylation reactions. {ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:19017811}.","6":"23.79759093","7":"16.126749692","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95396"},{"1":"CD2BP2 KIAA1178","2":"CD2B2_HUMAN","3":"unknown","4":"CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K)","5":"Involved in pre-mRNA splicing as component of the U5 snRNP complex that is involved in spliceosome assembly. {ECO:0000269|PubMed:15840814}.","6":"-3.72703302","7":"29.316445747","8":"Undefined","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95400"},{"1":"SVIL","2":"SVIL_HUMAN","3":"unknown","4":"Supervillin (Archvillin) (p205/p250)","5":"[Isoform 1]: Forms a high-affinity link between the actin cytoskeleton and the membrane. Is among the first costameric proteins to assemble during myogenesis and it contributes to myogenic membrane structure and differentiation (PubMed:12711699). Appears to be involved in myosin II assembly. May modulate myosin II regulation through MLCK during cell spreading, an initial step in cell migration. May play a role in invadopodial function (PubMed:19109420). {ECO:0000269|PubMed:12711699, ECO:0000269|PubMed:19109420}.; [Isoform 2]: May be involved in modulation of focal adhesions. Supervillin-mediated down-regulation of focal adhesions involves binding to TRIP6. Plays a role in cytokinesis through KIF14 interaction (By similarity). {ECO:0000250|UniProtKB:O46385}.","6":"-23.43909345","7":"-10.611314543","8":"Undefined","9":"PEROXISOME,ER,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O95425"},{"1":"BAG4 SODD","2":"BAG4_HUMAN","3":"unknown","4":"BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains)","5":"Inhibits the chaperone activity of HSP70/HSC70 by promoting substrate release (By similarity). Prevents constitutive TNFRSF1A signaling. Negative regulator of PRKN translocation to damaged mitochondria. {ECO:0000250, ECO:0000269|PubMed:24270810}.","6":"43.43196735","7":"-0.249725977","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O95429"},{"1":"AHSA1 C14orf3 HSPC322","2":"AHSA1_HUMAN","3":"unknown","4":"Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38)","5":"Acts as a co-chaperone of HSP90AA1 (PubMed:29127155). Activates the ATPase activity of HSP90AA1 leading to increase in its chaperone activity (PubMed:29127155). Competes with the inhibitory co-chaperone FNIP1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:27353360). Competes with the inhibitory co-chaperone TSC1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:29127155). {ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155}.","6":"10.59885007","7":"-6.954231480","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95433"},{"1":"PARN DAN","2":"PARN_HUMAN","3":"unknown","4":"Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease)","5":"3'-exoribonuclease that has a preference for poly(A) tails of mRNAs, thereby efficiently degrading poly(A) tails. Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs and is also used to silence certain maternal mRNAs translationally during oocyte maturation and early embryonic development. Interacts with both the 3'-end poly(A) tail and the 5'-end cap structure during degradation, the interaction with the cap structure being required for an efficient degradation of poly(A) tails. Involved in nonsense-mediated mRNA decay, a critical process of selective degradation of mRNAs that contain premature stop codons. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly via its interaction with KHSRP. Probably mediates the removal of poly(A) tails of AREs mRNAs, which constitutes the first step of destabilization (PubMed:10882133, PubMed:11359775, PubMed:12748283, PubMed:15175153, PubMed:9736620). Also able to recognize and trim poly(A) tails of microRNAs such as MIR21 and H/ACA box snoRNAs (small nucleolar RNAs) leading to microRNAs degradation or snoRNA increased stability (PubMed:25049417, PubMed:22442037). {ECO:0000269|PubMed:10882133, ECO:0000269|PubMed:11359775, ECO:0000269|PubMed:12748283, ECO:0000269|PubMed:15175153, ECO:0000269|PubMed:22442037, ECO:0000269|PubMed:25049417, ECO:0000269|PubMed:9736620}.","6":"-16.16854702","7":"24.913026970","8":"Undefined","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O95453"},{"1":"PSMG1 C21LRP DSCR2 PAC1","2":"PSMG1_HUMAN","3":"unknown","4":"Proteasome assembly chaperone 1 (PAC-1) (Chromosome 21 leucine-rich protein) (C21-LRP) (Down syndrome critical region protein 2)","5":"Chaperone protein which promotes assembly of the 20S proteasome as part of a heterodimer with PSMG2. The PSMG1-PSMG2 heterodimer binds to the PSMA5 and PSMA7 proteasome subunits, promotes assembly of the proteasome alpha subunits into the heteroheptameric alpha ring and prevents alpha ring dimerization. {ECO:0000269|PubMed:16251969, ECO:0000269|PubMed:17707236}.","6":"31.09077903","7":"15.185094168","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95456"},{"1":"FMNL1 C17orf1 C17orf1B FMNL FRL1","2":"FMNL1_HUMAN","3":"unknown","4":"Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin)","5":"May play a role in the control of cell motility and survival of macrophages (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics and cell shape. {ECO:0000250, ECO:0000269|PubMed:21834987}.","6":"-0.80491417","7":"-19.645509151","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95466"},{"1":"SGPL1 KIAA1252","2":"SGPL1_HUMAN","3":"ER","4":"Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","5":"Cleaves phosphorylated sphingoid bases (PSBs), such as sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine. Elevates stress-induced ceramide production and apoptosis (PubMed:11018465, PubMed:14570870, PubMed:24809814, PubMed:28165339). Required for global lipid homeostasis in liver and cholesterol homeostasis in fibroblasts. Involved in the regulation of pro-inflammatory response and neutrophil trafficking. Modulates neuronal autophagy via phosphoethanolamine production which regulates accumulation of aggregate-prone proteins such as APP (By similarity). Seems to play a role in establishing neuronal contact sites and axonal maintenance (By similarity). {ECO:0000250|UniProtKB:Q8R0X7, ECO:0000250|UniProtKB:Q9V7Y2, ECO:0000269|PubMed:11018465, ECO:0000269|PubMed:14570870, ECO:0000269|PubMed:24809814, ECO:0000269|PubMed:28165339}.","6":"-13.83082456","7":"-21.398969955","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95470"},{"1":"NSA2 TINP1 HUSSY-29","2":"NSA2_HUMAN","3":"unknown","4":"Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1)","5":"Involved in the biogenesis of the 60S ribosomal subunit. May play a part in the quality control of pre-60S particles (By similarity). {ECO:0000250}.","6":"-39.15419134","7":"22.827794277","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O95478"},{"1":"H6PD GDH","2":"G6PE_HUMAN","3":"ER","4":"GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (GDH) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)]","5":"Bifunctional enzyme localized in the lumen of the endoplasmic reticulum that catalyzes the first two steps of the oxidative branch of the pentose phosphate pathway/shunt, an alternative to glycolysis and a major source of reducing power and metabolic intermediates for biosynthetic processes (By similarity). Has a hexose-6-phosphate dehydrogenase activity, with broad substrate specificity compared to glucose-6-phosphate 1-dehydrogenase/G6PD, and catalyzes the first step of the pentose phosphate pathway (PubMed:12858176, PubMed:18628520, PubMed:23132696). In addition, acts as a 6-phosphogluconolactonase and catalyzes the second step of the pentose phosphate pathway (By similarity). May have a dehydrogenase activity for alternative substrates including glucosamine 6-phosphate and glucose 6-sulfate (By similarity). The main function of this enzyme is to provide reducing equivalents such as NADPH to maintain the adequate levels of reductive cofactors in the oxidizing environment of the endoplasmic reticulum (PubMed:12858176, PubMed:18628520, PubMed:23132696). By producing NADPH that is needed by reductases of the lumen of the endoplasmic reticulum like corticosteroid 11-beta-dehydrogenase isozyme 1/HSD11B1, indirectly regulates their activity (PubMed:18628520). {ECO:0000250|UniProtKB:Q8CFX1, ECO:0000269|PubMed:12858176, ECO:0000269|PubMed:18628520, ECO:0000269|PubMed:23132696}.","6":"-18.22009677","7":"-24.764714369","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95479"},{"1":"SEC24A","2":"SC24A_HUMAN","3":"unknown","4":"Protein transport protein Sec24A (SEC24-related protein A)","5":"Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:20427317, PubMed:17499046, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24B may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes (PubMed:17499046, PubMed:18843296). {ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296, ECO:0000269|PubMed:20427317}.","6":"33.55526584","7":"1.896834048","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"O95486"},{"1":"SEC24B","2":"SC24B_HUMAN","3":"unknown","4":"Protein transport protein Sec24B (SEC24-related protein B)","5":"Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:17499046, PubMed:20427317, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24A may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes (PubMed:17499046, PubMed:18843296). {ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296, ECO:0000269|PubMed:20427317}.","6":"23.58234245","7":"-7.944235276","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95487"},{"1":"TDP2 EAP2 TTRAP AD-022","2":"TYDP2_HUMAN","3":"unknown","4":"Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase)","5":"DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 5'-phosphodiester bond, giving rise to DNA with a free 5' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase 2 (TOP2) active site tyrosine residue. The 5'-tyrosyl DNA phosphodiesterase activity can enable the repair of TOP2-induced DNA double-strand breaks/DSBs without the need for nuclease activity, creating a 'clean' DSB with 5'-phosphate termini that are ready for ligation (PubMed:27099339, PubMed:27060144). Thereby, protects the transcription of many genes involved in neurological development and maintenance from the abortive activity of TOP2. Hydrolyzes 5'-phosphoglycolates on protruding 5' ends on DSBs due to DNA damage by radiation and free radicals. Has preference for single-stranded DNA or duplex DNA with a 4 base pair overhang as substrate. Acts as a regulator of ribosome biogenesis following stress. Has also 3'-tyrosyl DNA phosphodiesterase activity, but less efficiently and much slower than TDP1. Constitutes the major if not only 5'-tyrosyl-DNA phosphodiesterase in cells. Also acts as an adapter by participating in the specific activation of MAP3K7/TAK1 in response to TGF-beta: associates with components of the TGF-beta receptor-TRAF6-TAK1 signaling module and promotes their ubiquitination dependent complex formation. Involved in non-canonical TGF-beta induced signaling routes. May also act as a negative regulator of ETS1 and may inhibit NF-kappa-B activation. {ECO:0000269|PubMed:19794497, ECO:0000269|PubMed:21030584, ECO:0000269|PubMed:21921940, ECO:0000269|PubMed:21980489, ECO:0000269|PubMed:22405347, ECO:0000269|PubMed:22822062, ECO:0000269|PubMed:24658003, ECO:0000269|PubMed:27060144, ECO:0000269|PubMed:27099339}.; (Microbial infection) Also acts as a 5'-tyrosyl-RNA phosphodiesterase following picornavirus infection: its activity is hijacked by picornavirus and acts by specifically cleaving the protein-RNA covalent linkage generated during the viral genomic RNA replication steps of a picornavirus infection, without impairing the integrity of viral RNA. {ECO:0000269|PubMed:22908287}.","6":"5.70724751","7":"6.500576931","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95551"},{"1":"ETHE1 HSCO","2":"ETHE1_HUMAN","3":"unknown","4":"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)","5":"Sulfur dioxygenase that plays an essential role in hydrogen sulfide catabolism in the mitochondrial matrix. Hydrogen sulfide (H(2)S) is first oxidized by SQRDL, giving rise to cysteine persulfide residues. ETHE1 consumes molecular oxygen to catalyze the oxidation of the persulfide, once it has been transferred to a thiophilic acceptor, such as glutathione (R-SSH). Plays an important role in metabolic homeostasis in mitochondria by metabolizing hydrogen sulfide and preventing the accumulation of supraphysiological H(2)S levels that have toxic effects, due to the inhibition of cytochrome c oxidase. First described as a protein that can shuttle between the nucleus and the cytoplasm and suppress p53-induced apoptosis by sequestering the transcription factor RELA/NFKB3 in the cytoplasm and preventing its accumulation in the nucleus (PubMed:12398897). {ECO:0000269|PubMed:12398897, ECO:0000269|PubMed:14732903, ECO:0000269|PubMed:19136963, ECO:0000269|PubMed:23144459}.","6":"-33.53730642","7":"-14.878441172","8":"Undefined","9":"MITOCHONDRIA,MITOCHONDRIA,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O95571"},{"1":"ACSL3 ACS3 FACL3 LACS3","2":"ACSL3_HUMAN","3":"unknown","4":"Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)","5":"Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:22633490). Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins) (PubMed:18003621). Has mainly an anabolic role in energy metabolism. Mediates hepatic lipogenesis. Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates. Both isoforms exhibit the same level of activity (By similarity). {ECO:0000250|UniProtKB:Q63151, ECO:0000269|PubMed:18003621, ECO:0000269|PubMed:22633490}.","6":"-9.09556864","7":"-33.722626659","8":"PM","9":"PM,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95573"},{"1":"POLR1A","2":"RPA1_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic core component of RNA polymerase I which synthesizes ribosomal RNA precursors. Forms the polymerase active center together with the second largest subunit. A single stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol I. A bridging helix emanates from RPA1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol I by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition (By similarity). {ECO:0000250|UniProtKB:P10964}.","6":"-12.65183279","7":"21.290860588","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95602"},{"1":"PCNT KIAA0402 PCNT2","2":"PCNT_HUMAN","3":"unknown","4":"Pericentrin (Kendrin) (Pericentrin-B)","5":"Integral component of the filamentous matrix of the centrosome involved in the initial establishment of organized microtubule arrays in both mitosis and meiosis. Plays a role, together with DISC1, in the microtubule network formation. Is an integral component of the pericentriolar material (PCM). May play an important role in preventing premature centrosome splitting during interphase by inhibiting NEK2 kinase activity at the centrosome. {ECO:0000269|PubMed:10823944, ECO:0000269|PubMed:11171385, ECO:0000269|PubMed:18955030, ECO:0000269|PubMed:20599736}.","6":"-10.13941829","7":"-8.001100942","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95613"},{"1":"ZBTB11","2":"ZBT11_HUMAN","3":"unknown","4":"Zinc finger and BTB domain-containing protein 11","5":"May be involved in transcriptional regulation. {ECO:0000305}.","6":"-11.35815689","7":"20.652266709","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95625"},{"1":"CNOT4 NOT4","2":"CNOT4_HUMAN","3":"unknown","4":"CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)","5":"Has E3 ubiquitin ligase activity, promoting ubiquitination and degradation of target proteins (PubMed:11823428, PubMed:22159038, PubMed:26575292). Involved in activation of the JAK/STAT pathway (PubMed:11823428, PubMed:22159038). Catalyzes ubiquitination of methylated RBM15 (PubMed:26575292). Plays a role in quality control of translation of mitochondrial outer membrane-localized mRNA (PubMed:29861391). As part of the PINK1-regulated signaling, upon mitochondria damage, ubiquitinates ABCE1 and thereby recruits autophagy receptors to the mitochondrial outer membrane to initiate mitophagy (PubMed:29861391). {ECO:0000269|PubMed:11823428, ECO:0000269|PubMed:22159038, ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:29861391}.","6":"29.14432113","7":"4.482298853","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95628"},{"1":"STAMBP AMSH","2":"STABP_HUMAN","3":"unknown","4":"STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase)","5":"Zinc metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Does not cleave 'Lys-48'-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways. {ECO:0000250, ECO:0000269|PubMed:10383417, ECO:0000269|PubMed:11483516, ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17261583, ECO:0000269|PubMed:23542699}.","6":"13.65891576","7":"-8.455607616","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95630"},{"1":"CPSF4 CPSF30 NAR NEB1","2":"CPSF4_HUMAN","3":"unknown","4":"Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog)","5":"Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. CPSF4 binds RNA polymers with a preference for poly(U). {ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:9224719}.","6":"23.76204285","7":"34.655695004","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95639"},{"1":"NFATC1 NFAT2 NFATC","2":"NFAC1_HUMAN","3":"unknown","4":"Nuclear factor of activated T-cells, cytoplasmic 1 (NF-ATc1) (NFATc1) (NFAT transcription complex cytosolic component) (NF-ATc) (NFATc)","5":"Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}.","6":"13.69868209","7":"21.303619573","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95644"},{"1":"ASMTL","2":"ASML_HUMAN","3":"unknown","4":"Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]","5":"Nucleoside triphosphate pyrophosphatase that hydrolyzes dTTP and UTP. Can also hydrolyze CTP and the modified nucleotides pseudo-UTP, 5-methyl-UTP (m(5)UTP) and 5-methyl-CTP (m(5)CTP). Has weak activity with dCTP, 8-oxo-GTP and N(4)-methyl-dCTP (PubMed:24210219). May have a dual role in cell division arrest and in preventing the incorporation of modified nucleotides into cellular nucleic acids (PubMed:24210219). In addition, the presence of the putative catalytic domain of S-adenosyl-L-methionine binding in the C-terminal region argues for a methyltransferase activity (Probable). {ECO:0000269|PubMed:24210219, ECO:0000305}.","6":"22.71628995","7":"19.974711145","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95671"},{"1":"CDS2","2":"CDS2_HUMAN","3":"unknown","4":"Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)","5":"Catalyzes the conversion of phosphatidic acid (PA) to CDP-diacylglycerol (CDP-DAG), an essential intermediate in the synthesis of phosphatidylglycerol, cardiolipin and phosphatidylinositol (PubMed:25375833). Exhibits specificity for the nature of the acyl chains at the sn-1 and sn-2 positions in the substrate, PA and the preferred acyl chain composition is 1-stearoyl-2-arachidonoyl-sn-phosphatidic acid (PubMed:25375833). Plays an important role in regulating the growth and maturation of lipid droplets which are storage organelles at the center of lipid and energy homeostasis (PubMed:26946540, PubMed:31548309). {ECO:0000269|PubMed:25375833, ECO:0000269|PubMed:26946540, ECO:0000269|PubMed:31548309}.","6":"-8.26624453","7":"-40.598004180","8":"Undefined","9":"Undefined,ER,PM","10":"NA","11":"NA","12":"NA","_rn_":"O95674"},{"1":"CEP43 FGFR1OP FOP","2":"CEP43_HUMAN","3":"unknown","4":"Centrosomal protein 43 (FGFR1 oncogene partner)","5":"Required for anchoring microtubules to the centrosomes (PubMed:16314388, PubMed:28659385). Required for ciliation (PubMed:28625565, PubMed:28659385). {ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.","6":"-15.68122555","7":"0.141722040","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Candidate","11":"2","12":"1,3","_rn_":"O95684"},{"1":"BRD1 BRL BRPF2","2":"BRD1_HUMAN","3":"unknown","4":"Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2)","5":"Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, that acts as a regulator of hematopoiesis (PubMed:16387653, PubMed:21753189, PubMed:21880731). Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac), thereby promoting erythroid differentiation (PubMed:21753189). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:21753189, ECO:0000269|PubMed:21880731}.","6":"-39.14865672","7":"17.302466283","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O95696"},{"1":"HERC2","2":"HERC2_HUMAN","3":"unknown","4":"E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)","5":"E3 ubiquitin-protein ligase that regulates ubiquitin-dependent retention of repair proteins on damaged chromosomes. Recruited to sites of DNA damage in response to ionizing radiation (IR) and facilitates the assembly of UBE2N and RNF8 promoting DNA damage-induced formation of 'Lys-63'-linked ubiquitin chains. Acts as a mediator of binding specificity between UBE2N and RNF8. Involved in the maintenance of RNF168 levels. E3 ubiquitin-protein ligase that promotes the ubiquitination and proteasomal degradation of XPA which influences the circadian oscillation of DNA excision repair activity. By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (PubMed:26692333). {ECO:0000269|PubMed:20023648, ECO:0000269|PubMed:20304803, ECO:0000269|PubMed:22508508, ECO:0000269|PubMed:26692333}.","6":"-2.17669034","7":"-19.267277674","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95714"},{"1":"SNAP29","2":"SNP29_HUMAN","3":"unknown","4":"Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)","5":"SNAREs, soluble N-ethylmaleimide-sensitive factor-attachment protein receptors, are essential proteins for fusion of cellular membranes. SNAREs localized on opposing membranes assemble to form a trans-SNARE complex, an extended, parallel four alpha-helical bundle that drives membrane fusion. SNAP29 is a SNARE involved in autophagy through the direct control of autophagosome membrane fusion with the lysososome membrane. Plays also a role in ciliogenesis by regulating membrane fusions. {ECO:0000269|PubMed:23217709, ECO:0000269|PubMed:25686250, ECO:0000269|PubMed:25686604}.","6":"5.70739330","7":"-17.753574134","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95721"},{"1":"OXSR1 KIAA1101 OSR1","2":"OXSR1_HUMAN","3":"unknown","4":"Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)","5":"Phosphorylates RELL1, RELL2 and RELT (PubMed:16389068, PubMed:28688764). Phosphorylates PAK1 (PubMed:14707132). Phosphorylates PLSCR1 in the presence of RELT (PubMed:22052202). {ECO:0000269|PubMed:14707132, ECO:0000269|PubMed:16389068, ECO:0000269|PubMed:22052202, ECO:0000269|PubMed:28688764}.","6":"-0.81204066","7":"0.303191900","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95747"},{"1":"GGPS1","2":"GGPPS_HUMAN","3":"unknown","4":"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)","5":"Catalyzes the trans-addition of the three molecules of IPP onto DMAPP to form geranylgeranyl pyrophosphate, an important precursor of carotenoids and geranylated proteins.","6":"24.79942451","7":"20.709774046","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95749"},{"1":"PTBP3 ROD1","2":"PTBP3_HUMAN","3":"unknown","4":"Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)","5":"RNA-binding protein that mediates pre-mRNA alternative splicing regulation. Plays a role in the regulation of cell proliferation, differentiation and migration. Positive regulator of EPO-dependent erythropoiesis. Participates in cell differentiation regulation by repressing tissue-specific exons. Promotes FAS exon 6 skipping. Binds RNA, preferentially to both poly(G) and poly(U). {ECO:0000269|PubMed:10207106, ECO:0000269|PubMed:18335065, ECO:0000269|PubMed:19441079, ECO:0000269|PubMed:20937273}.","6":"13.70375263","7":"9.886354442","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95758"},{"1":"LSM8","2":"LSM8_HUMAN","3":"unknown","4":"U6 snRNA-associated Sm-like protein LSm8","5":"Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex) (PubMed:28781166). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA (PubMed:10523320). {ECO:0000269|PubMed:10523320, ECO:0000269|PubMed:28781166}.","6":"-16.13669800","7":"26.423208541","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95777"},{"1":"AP2A1 ADTAA CLAPA1","2":"AP2A1_HUMAN","3":"unknown","4":"AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)","5":"Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity). {ECO:0000250, ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:19033387, ECO:0000269|PubMed:23676497}.","6":"-1.15128449","7":"-14.501293283","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95782"},{"1":"WIZ ZNF803","2":"WIZ_HUMAN","3":"unknown","4":"Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803)","5":"May link EHMT1 and EHMT2 histone methyltransferases to the CTBP corepressor machinery. May be involved in EHMT1-EHMT2 heterodimer formation and stabilization (By similarity). {ECO:0000250}.","6":"-11.40570214","7":"27.994207973","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95785"},{"1":"STAU1 STAU","2":"STAU1_HUMAN","3":"unknown","4":"Double-stranded RNA-binding protein Staufen homolog 1","5":"Binds double-stranded RNA (regardless of the sequence) and tubulin. May play a role in specific positioning of mRNAs at given sites in the cell by cross-linking cytoskeletal and RNA components, and in stimulating their translation at the site.; (Microbial infection) Plays a role in virus particles production of many viruses including of HIV-1, HERV-K, ebola virus and influenza virus. Acts by interacting with various viral proteins involved in particle budding process. {ECO:0000269|PubMed:10325410, ECO:0000269|PubMed:18498651, ECO:0000269|PubMed:23926355, ECO:0000269|PubMed:30301857}.","6":"29.66346073","7":"-17.736791757","8":"RIBOSOME","9":"RIBOSOME,RIBOSOME,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O95793"},{"1":"TTC4 My044","2":"TTC4_HUMAN","3":"unknown","4":"Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","5":"May act as a co-chaperone for HSP90AB1 (PubMed:18320024). Promotes Sendai virus (SeV)-induced host cell innate immune responses (PubMed:29251827). {ECO:0000269|PubMed:18320024, ECO:0000269|PubMed:29251827}.","6":"-4.97665728","7":"11.985335419","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95801"},{"1":"CAVIN2 SDPR","2":"CAVN2_HUMAN","3":"unknown","4":"Caveolae-associated protein 2 (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein) (Serum deprivation-response protein)","5":"Plays an important role in caveolar biogenesis and morphology. Regulates caveolae morphology by inducing membrane curvature within caveolae (PubMed:19525939). Plays a role in caveola formation in a tissue-specific manner. Required for the formation of caveolae in the lung and fat endothelia but not in the heart endothelia. Negatively regulates the size or stability of CAVIN complexes in the lung endothelial cells. May play a role in targeting PRKCA to caveolae (By similarity). {ECO:0000250|UniProtKB:Q66H98, ECO:0000269|PubMed:19525939}.","6":"-7.24984045","7":"-39.287522480","8":"Undefined","9":"PM,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95810"},{"1":"BAG2","2":"BAG2_HUMAN","3":"unknown","4":"BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2)","5":"Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release (PubMed:24318877, PubMed:9873016). {ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:9873016}.","6":"-10.89565484","7":"-21.326718017","8":"ER","9":"ER,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"O95816"},{"1":"BAG3 BIS","2":"BAG3_HUMAN","3":"unknown","4":"BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1)","5":"Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release. Nucleotide release is mediated via its binding to the nucleotide-binding domain (NBD) of HSPA8/HSC70 where as the substrate release is mediated via its binding to the substrate-binding domain (SBD) of HSPA8/HSC70 (PubMed:9873016, PubMed:27474739). Has anti-apoptotic activity (PubMed:10597216). Plays a role in the HSF1 nucleocytoplasmic transport (PubMed:26159920). {ECO:0000269|PubMed:10597216, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:26159920, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:9873016}.","6":"26.09820166","7":"16.701863530","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"O95817"},{"1":"MAP4K4 HGK KIAA0687 NIK","2":"M4K4_HUMAN","3":"unknown","4":"Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)","5":"Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:9890973}.","6":"-2.83060878","7":"-22.738212072","8":"ER","9":"Undefined,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"O95819"},{"1":"CRYZL1 4P11","2":"QORL1_HUMAN","3":"unknown","4":"Quinone oxidoreductase-like protein 1 (EC 1.-.-.-) (Protein 4P11) (Quinone oxidoreductase homolog 1) (QOH-1) (Zeta-crystallin homolog)","5":"NA","6":"20.29750754","7":"24.856849419","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95825"},{"1":"AIFM1 AIF PDCD8","2":"AIFM1_HUMAN","3":"unknown","4":"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)","5":"Functions both as NADH oxidoreductase and as regulator of apoptosis (PubMed:20362274, PubMed:23217327, PubMed:17094969). In response to apoptotic stimuli, it is released from the mitochondrion intermembrane space into the cytosol and to the nucleus, where it functions as a proapoptotic factor in a caspase-independent pathway. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e. caspase-independent fragmentation of chromosomal DNA (By similarity). Binds to DNA in a sequence-independent manner (PubMed:27178839). Interacts with EIF3G, and thereby inhibits the EIF3 machinery and protein synthesis, and activates caspase-7 to amplify apoptosis (PubMed:17094969). Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells (PubMed:19418225). In contrast, participates in normal mitochondrial metabolism. Plays an important role in the regulation of respiratory chain biogenesis by interacting with CHCHD4 and controlling CHCHD4 mitochondrial import (PubMed:26004228). {ECO:0000250|UniProtKB:Q9Z0X1, ECO:0000269|PubMed:17094969, ECO:0000269|PubMed:19418225, ECO:0000269|PubMed:20362274, ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:26004228, ECO:0000269|PubMed:27178839}.; [Isoform 4]: Has NADH oxidoreductase activity. Does not induce nuclear apoptosis. {ECO:0000269|PubMed:16644725}.; [Isoform 5]: Pro-apoptotic isoform. {ECO:0000269|PubMed:16365034}.","6":"-34.29152267","7":"-12.575175738","8":"Undefined","9":"MITOCHONDRIA,MITOCHONDRIA,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O95831"},{"1":"EML2 EMAP2 EMAPL2","2":"EMAL2_HUMAN","3":"unknown","4":"Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2)","5":"Tubulin binding protein that inhibits microtubule nucleation and growth, resulting in shorter microtubules. {ECO:0000269|PubMed:11694528}.","6":"5.11636422","7":"-0.458823052","8":"Undefined","9":"PROTEIN COMPLEX,NUCLEOPLASM-2,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"O95834"},{"1":"BPNT1","2":"BPNT1_HUMAN","3":"unknown","4":"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)","5":"Converts adenosine 3'-phosphate 5'-phosphosulfate (PAPS) to adenosine 5'-phosphosulfate (APS) and 3'(2')-phosphoadenosine 5'- phosphate (PAP) to AMP. Has 1000-fold lower activity towards inositol 1,4-bisphosphate (Ins(1,4)P2) and inositol 1,3,4-trisphosphate (Ins(1,3,4)P3), but does not hydrolyze Ins(1)P, Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6. {ECO:0000269|PubMed:10224133}.","6":"15.03000858","7":"-4.200771393","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95861"},{"1":"FADS2","2":"FADS2_HUMAN","3":"unknown","4":"Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2)","5":"Involved in the biosynthesis of highly unsaturated fatty acids (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3) precursors, acting as a fatty acyl-coenzyme A (CoA) desaturase that introduces a cis double bond at carbon 6 of the fatty acyl chain. Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleate (GLA) (18:3n-6) and stearidonate (18:4n-3), respectively (PubMed:12713571). Subsequently, in the biosynthetic pathway of HUFA n-3 series, it desaturates tetracosapentaenoate (24:5n-3) to tetracosahexaenoate (24:6n-3), which is then converted to docosahexaenoate (DHA)(22:6n-3), an important lipid for nervous system function (By similarity). Desaturates hexadecanate (palmitate) to produce 6Z-hexadecenoate (sapienate), a fatty acid unique to humans and major component of human sebum, that has been implicated in the development of acne and may have potent antibacterial activity (PubMed:12713571). It can also desaturate (11E)-octadecenoate (trans-vaccenoate, the predominant trans fatty acid in human milk) at carbon 6 generating (6Z,11E)-octadecadienoate (By similarity). In addition to Delta-6 activity, this enzyme exhibits Delta-8 activity with slight biases toward n-3 fatty acyl-CoA substrates (By similarity). {ECO:0000250|UniProtKB:B8R1K0, ECO:0000250|UniProtKB:Q9Z122, ECO:0000269|PubMed:12713571}.","6":"-5.65075901","7":"-41.517012162","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"O95864"},{"1":"DDAH2 DDAH G6A NG30","2":"DDAH2_HUMAN","3":"unknown","4":"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dimethylaminohydrolase 2) (EC 3.5.3.18) (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)","5":"Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. Has therefore a role in the regulation of nitric oxide generation. {ECO:0000269|PubMed:10493931}.","6":"5.60999649","7":"-17.913711856","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95865"},{"1":"ABHD16A BAT5 G5 NG26 PP199","2":"ABHGA_HUMAN","3":"unknown","4":"Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5)","5":"Phosphatidylserine (PS) lipase that mediates the hydrolysis of phosphatidylserine to generate lysophosphatidylserine (LPS) (By similarity). LPS constitutes a class of signaling lipids that regulates immunological and neurological processes (By similarity). Has no activity towards diacylglycerol, triacylglycerol or lysophosphatidylserine lipase (PubMed:25290914). Also has monoacylglycerol lipase activity, with preference for 1-(9Z,12Z-octadecadienoyl)-glycerol (1-LG) and 2-glyceryl-15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ(2)-G) (PubMed:25290914). {ECO:0000250|UniProtKB:Q9Z1Q2, ECO:0000269|PubMed:25290914}.","6":"-13.90405514","7":"-33.976602979","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95870"},{"1":"TXNDC12 TLP19 UNQ713/PRO1376","2":"TXD12_HUMAN","3":"ER","4":"Thioredoxin domain-containing protein 12 (EC 1.8.4.2) (Endoplasmic reticulum resident protein 18) (ER protein 18) (ERp18) (Endoplasmic reticulum resident protein 19) (ER protein 19) (ERp19) (Thioredoxin-like protein p19) (hTLP19)","5":"Possesses significant protein thiol-disulfide oxidase activity. {ECO:0000269|PubMed:12761212}.","6":"-21.23626765","7":"-17.058085622","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95881"},{"1":"TRUB2","2":"TRUB2_HUMAN","3":"unknown","4":"Mitochondrial mRNA pseudouridine synthase TRUB2 (EC 5.4.99.-)","5":"Minor enzyme contributing to the isomerization of uridine to pseudouridine (pseudouridylation) of specific mitochondrial mRNAs (mt-mRNAs) such as COXI and COXIII mt-mRNAs (PubMed:27974379). As a component of a functional protein-RNA module, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mitochondrial ribosomal RNA (16S mt-rRNA), controls 16S mt-rRNA abundance and is required for intra-mitochondrial translation (PubMed:27667664). {ECO:0000269|PubMed:27667664, ECO:0000269|PubMed:27974379}.","6":"-35.57978748","7":"-3.316685440","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"O95900"},{"1":"ECD","2":"ECD_HUMAN","3":"unknown","4":"Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)","5":"Regulator of p53/TP53 stability and function. Inhibits MDM2-mediated degradation of p53/TP53 possibly by cooperating in part with TXNIP (PubMed:16849563, PubMed:23880345). May be involved transcriptional regulation. In vitro has intrinsic transactivation activity enhanced by EP300. May be a transcriptional activator required for the expression of glycolytic genes (PubMed:19919181, PubMed:9928932). Involved in regulation of cell cycle progression. Proposed to disrupt Rb-E2F binding leading to transcriptional activation of E2F proteins (PubMed:19640839). The cell cycle -regulating function may depend on its RUVBL1-mediated association with the R2TP complex (PubMed:26711270). May play a role in regulation of pre-mRNA splicing (PubMed:24722212). {ECO:0000269|PubMed:16849563, ECO:0000269|PubMed:19640839, ECO:0000269|PubMed:19919181, ECO:0000269|PubMed:23880345, ECO:0000269|PubMed:26711270, ECO:0000305|PubMed:24722212, ECO:0000305|PubMed:9928932}.","6":"-1.63230080","7":"16.416715914","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95905"},{"1":"SYF2 CBPIN GCIPIP","2":"SYF2_HUMAN","3":"unknown","4":"Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29)","5":"Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28502770, PubMed:28076346). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.","6":"-13.18469481","7":"11.445727745","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"O95926"},{"1":"MBD3","2":"MBD3_HUMAN","3":"NUCLEOPLASM-2","4":"Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3)","5":"Acts as transcriptional repressor and plays a role in gene silencing. Does not bind to DNA by itself (PubMed:12124384). Binds to DNA with a preference for sites containing methylated CpG dinucleotides (in vitro). Binds to a lesser degree DNA containing unmethylated CpG dinucleotides (PubMed:24307175). Recruits histone deacetylases and DNA methyltransferases. {ECO:0000269|PubMed:10947852, ECO:0000269|PubMed:12124384, ECO:0000269|PubMed:18644863, ECO:0000269|PubMed:23361464, ECO:0000269|PubMed:24307175, ECO:0000269|PubMed:9774669}.","6":"-6.50230829","7":"37.827384581","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O95983"},{"1":"NUDT3 DIPP DIPP1","2":"NUDT3_HUMAN","3":"unknown","4":"Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3)","5":"Cleaves a beta-phosphate from the diphosphate groups in PP-InsP5 (diphosphoinositol pentakisphosphate) and [PP]2-InsP4 (bisdiphosphoinositol tetrakisphosphate), suggesting that it may play a role in signal transduction. InsP6 (inositol hexakisphosphate) is not a substrate. Acts as a negative regulator of the ERK1/2 pathway. Also able to catalyze the hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A being the preferred substrates. The major reaction products are ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-phosphoribose 1-diphosphate. {ECO:0000269|PubMed:9822604}.","6":"17.00922377","7":"-4.225257141","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O95989"},{"1":"BCL10 CIPER CLAP","2":"BCL10_HUMAN","3":"unknown","4":"B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10)","5":"Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation (PubMed:10187770, PubMed:10364242, PubMed:10400625, PubMed:25365219, PubMed:24074955). Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed:24074955). Recruited by activated CARD domain-containing proteins: homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex (PubMed:24074955). This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed:18287044, PubMed:27777308, PubMed:24074955). Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity (PubMed:26488816). Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR) (PubMed:18264101, PubMed:18287044, PubMed:27777308, PubMed:24074955). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK (PubMed:10187815). {ECO:0000269|PubMed:10187770, ECO:0000269|PubMed:10187815, ECO:0000269|PubMed:10364242, ECO:0000269|PubMed:10400625, ECO:0000269|PubMed:18264101, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:24074955, ECO:0000269|PubMed:25365219, ECO:0000269|PubMed:26488816, ECO:0000269|PubMed:27777308}.","6":"11.56790015","7":"-5.853598500","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O95999"},{"1":"NDUFB10","2":"NDUBA_HUMAN","3":"unknown","4":"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-36.99811708","7":"-14.493785737","8":"Undefined","9":"MITOCHONDRIA,MITOCHONDRIA,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"O96000"},{"1":"CLPTM1","2":"CLPT1_HUMAN","3":"unknown","4":"Cleft lip and palate transmembrane protein 1","5":"May play a role in T-cell development. {ECO:0000250}.","6":"-10.25425285","7":"-40.878723330","8":"Undefined","9":"PM,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O96005"},{"1":"MOCS2 MCBPE MOCO1","2":"MOC2B_HUMAN","3":"unknown","4":"Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B) (Molybdopterin-synthase large subunit) (MPT synthase large subunit)","5":"Catalytic subunit of the molybdopterin synthase complex, a complex that catalyzes the conversion of precursor Z into molybdopterin. Acts by mediating the incorporation of 2 sulfur atoms from thiocarboxylated MOCS2A into precursor Z to generate a dithiolene group. {ECO:0000255|HAMAP-Rule:MF_03052, ECO:0000269|PubMed:12732628, ECO:0000269|PubMed:15073332}.","6":"10.04646312","7":"9.801492022","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O96007"},{"1":"TOMM40 C19orf1 PEREC1 TOM40","2":"TOM40_HUMAN","3":"MITOCHONDRIA","4":"Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5)","5":"Channel-forming protein essential for import of protein precursors into mitochondria (PubMed:15644312, PubMed:31206022). Plays a role in the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) by forming a complex with BCAP31 and mediating the translocation of Complex I components from the cytosol to the mitochondria (PubMed:31206022). {ECO:0000269|PubMed:15644312, ECO:0000269|PubMed:31206022}.","6":"-29.14060730","7":"-5.268455654","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"O96008"},{"1":"PEX11B","2":"PX11B_HUMAN","3":"unknown","4":"Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta)","5":"Involved in peroxisomal proliferation (PubMed:9792670). May regulate peroxisome division by recruiting the dynamin-related GTPase DNM1L to the peroxisomal membrane (PubMed:12618434). Promotes membrane protrusion and elongation on the peroxisomal surface (PubMed:20826455). {ECO:0000269|PubMed:12618434, ECO:0000269|PubMed:20826455, ECO:0000269|PubMed:9792670}.","6":"-17.39394432","7":"-23.465086553","8":"Undefined","9":"Undefined,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"O96011"},{"1":"PAK4 KIAA1142","2":"PAK4_HUMAN","3":"unknown","4":"Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4)","5":"Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. {ECO:0000269|PubMed:11278822, ECO:0000269|PubMed:11313478, ECO:0000269|PubMed:14560027, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:20507994, ECO:0000269|PubMed:20631255, ECO:0000269|PubMed:20805321, ECO:0000269|PubMed:26607847}.","6":"22.43477862","7":"-8.665292556","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"O96013"},{"1":"CHEK2 CDS1 CHK2 RAD53","2":"CHK2_HUMAN","3":"unknown","4":"Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)","5":"Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (PubMed:25361978). {ECO:0000250|UniProtKB:Q9Z265, ECO:0000269|PubMed:10097108, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:12402044, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:17101782, ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:17715138, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:20364141, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25619829, ECO:0000269|PubMed:9836640, ECO:0000269|PubMed:9889122}.","6":"8.14070135","7":"23.146362655","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O96017"},{"1":"ACTL6A BAF53 BAF53A INO80K","2":"ACL6A_HUMAN","3":"unknown","4":"Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)","5":"Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. {ECO:0000250|UniProtKB:Q9Z2N8, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:29374058, ECO:0000303|PubMed:15196461, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.","6":"17.46753068","7":"24.426624194","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"O96019"},{"1":"NSD2 KIAA1090 MMSET TRX5 WHSC1","2":"NSD2_HUMAN","3":"unknown","4":"Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)","5":"Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (PubMed:27571355, PubMed:22099308, PubMed:19808676, PubMed:29728617). Also monomethylates nucleosomal histone H3 at 'Lys-36' (H3K36me) in vitro (PubMed:22099308). Does not trimethylate nucleosomal histone H3 at 'Lys-36' (H3K36me3) (PubMed:22099308). However, specifically trimethylates histone H3 at 'Lys-36' (H3K36me3) at euchromatic regions in embryonic stem (ES) cells (By similarity). By methylating histone H3 at 'Lys-36', involved in the regulation of gene transcription during various biological processes (PubMed:16115125, PubMed:22099308, PubMed:29728617). In ES cells, associates with developmental transcription factors such as SALL1 and represses inappropriate gene transcription mediated by histone deacetylation (By similarity). During heart development, associates with transcription factor NKX2-5 to repress transcription of NKX2-5 target genes (By similarity). Plays an essential role in adipogenesis, by regulating expression of genes involved in pre-adipocyte differentiation (PubMed:29728617). During T-cell receptor (TCR) and CD28-mediated T-cell activation, promotes the transcription of transcription factor BCL6 which is required for follicular helper T (Tfh) cell differentiation (By similarity). During B-cell development, required for the generation of the B1 lineage (By similarity). During B2 cell activation, may contribute to the control of isotype class switch recombination (CRS), splenic germinal center formation, and the humoral immune response (By similarity). Plays a role in class switch recombination of the immunoglobulin heavy chain (IgH) locus during B-cell activation (By similarity). By regulating the methylation of histone H3 at 'Lys-36' and histone H4 at 'Lys-20' at the IgH locus, involved in TP53BP1 recruitment to the IgH switch region and promotes the transcription of IgA (By similarity). {ECO:0000250|UniProtKB:Q8BVE8, ECO:0000269|PubMed:16115125, ECO:0000269|PubMed:19808676, ECO:0000269|PubMed:22099308, ECO:0000269|PubMed:27571355, ECO:0000269|PubMed:29728617}.; [Isoform 1]: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2). {ECO:0000269|PubMed:22099308}.; [Isoform 4]: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (PubMed:22099308). Methylation of histone H3 at 'Lys-27' is controversial (PubMed:18172012, PubMed:22099308). Mono-, di- or tri-methylates histone H3 at 'Lys-27' (H3K27me, H3K27me2 and H3K27me3) (PubMed:18172012). Does not methylate histone H3 at 'Lys-27' (PubMed:22099308). May act as a transcription regulator that binds DNA and suppresses IL5 transcription through HDAC recruitment (PubMed:11152655, PubMed:18172012). {ECO:0000269|PubMed:11152655, ECO:0000269|PubMed:18172012, ECO:0000269|PubMed:22099308}.","6":"-31.03377139","7":"14.339125325","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"O96028"},{"1":"LDHA PIG19","2":"LDHA_HUMAN","3":"unknown","4":"L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)","5":"NA","6":"30.43469381","7":"14.837753045","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P00338"},{"1":"DHFR","2":"DYR_HUMAN","3":"unknown","4":"Dihydrofolate reductase (EC 1.5.1.3)","5":"Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFR2. {ECO:0000269|PubMed:12096917, ECO:0000269|PubMed:21876188}.","6":"-6.32084913","7":"-0.612781010","8":"CYTOSOL","9":"CYTOSOL,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P00374"},{"1":"CYB5R3 DIA1","2":"NB5R3_HUMAN","3":"unknown","4":"NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]","5":"Desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction.","6":"-5.41362065","7":"-37.420395676","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P00387"},{"1":"GSR GLUR GRD1","2":"GSHR_HUMAN","3":"unknown","4":"Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)","5":"Maintains high levels of reduced glutathione in the cytosol.","6":"15.80054417","7":"2.060862477","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P00390"},{"1":"MT-CO2 COII COX2 COXII MTCO2","2":"COX2_HUMAN","3":"MITOCHONDRIA","4":"Cytochrome c oxidase subunit 2 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide II)","5":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix. {ECO:0000250|UniProtKB:P00410}.","6":"-39.14020602","7":"-2.398245019","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P00403"},{"1":"PNP NP","2":"PNPH_HUMAN","3":"unknown","4":"Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase)","5":"Catalyzes the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate (PubMed:9305964, PubMed:23438750). Preferentially acts on 6-oxopurine nucleosides including inosine and guanosine (PubMed:9305964). {ECO:0000269|PubMed:23438750, ECO:0000269|PubMed:9305964}.","6":"39.74699331","7":"5.109132049","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P00491"},{"1":"HPRT1 HPRT","2":"HPRT_HUMAN","3":"CYTOSOL","4":"Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)","5":"Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway.","6":"26.96543599","7":"9.743400881","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P00492"},{"1":"GOT2 KYAT4","2":"AATM_HUMAN","3":"MITOCHONDRIA","4":"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)","5":"Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). As a member of the malate-aspartate shuttle, it has a key role in the intracellular NAD(H) redox balance. Is important for metabolite exchange between mitochondria and cytosol, and for amino acid metabolism. Facilitates cellular uptake of long-chain free fatty acids. {ECO:0000269|PubMed:31422819, ECO:0000269|PubMed:9537447}.","6":"-36.35978776","7":"-12.196513851","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P00505"},{"1":"ABL1 ABL JTK7","2":"ABL1_HUMAN","3":"unknown","4":"Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)","5":"Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (PubMed:28428613). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity). {ECO:0000250|UniProtKB:P00520, ECO:0000269|PubMed:10391250, ECO:0000269|PubMed:11971963, ECO:0000269|PubMed:12379650, ECO:0000269|PubMed:12531427, ECO:0000269|PubMed:12672821, ECO:0000269|PubMed:15031292, ECO:0000269|PubMed:15556646, ECO:0000269|PubMed:15657060, ECO:0000269|PubMed:15886098, ECO:0000269|PubMed:16424036, ECO:0000269|PubMed:16678104, ECO:0000269|PubMed:16943190, ECO:0000269|PubMed:17306540, ECO:0000269|PubMed:17623672, ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:18945674, ECO:0000269|PubMed:19891780, ECO:0000269|PubMed:20357770, ECO:0000269|PubMed:20417104, ECO:0000269|PubMed:28428613, ECO:0000269|PubMed:9037071, ECO:0000269|PubMed:9144171, ECO:0000269|PubMed:9461559}.","6":"3.83201782","7":"-1.380254077","8":"Undefined","9":"CYTOSOL,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P00519"},{"1":"EGFR ERBB ERBB1 HER1","2":"EGFR_HUMAN","3":"unknown","4":"Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)","5":"Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:2790960, PubMed:10805725, PubMed:27153536). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975, PubMed:15611079, PubMed:12297049, PubMed:27153536, PubMed:20837704, PubMed:17909029). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17909029, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:7679104, ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.; Isoform 2 may act as an antagonist of EGF action.; (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.","6":"0.40570826","7":"-37.222532513","8":"Undefined","9":"LYSOSOME,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P00533"},{"1":"PGK1 PGKA MIG10 OK/SW-cl.110","2":"PGK1_HUMAN","3":"CYTOSOL","4":"Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)","5":"Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (PubMed:30323285, PubMed:7391028). In addition to its role as a glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha cofactor protein (primer recognition protein) (PubMed:2324090). May play a role in sperm motility (PubMed:26677959). {ECO:0000269|PubMed:2324090, ECO:0000269|PubMed:26677959, ECO:0000269|PubMed:30323285, ECO:0000269|PubMed:7391028}.","6":"10.84810980","7":"-3.975165370","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P00558"},{"1":"AK1","2":"KAD1_HUMAN","3":"unknown","4":"Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)","5":"Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Also displays broad nucleoside diphosphate kinase activity. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. {ECO:0000255|HAMAP-Rule:MF_03171, ECO:0000269|PubMed:23416111}.","6":"11.99563568","7":"-7.299325065","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P00568"},{"1":"ASS1 ASS","2":"ASSY_HUMAN","3":"unknown","4":"Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)","5":"One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.","6":"43.46956044","7":"1.956424738","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P00966"},{"1":"A2M CPAMD5 FWP007","2":"A2MG_HUMAN","3":"unknown","4":"Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)","5":"Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region, a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase.","6":"0.09123559","7":"-36.161469786","8":"Undefined","9":"LYSOSOME,LYSOSOME,ER","10":"NA","11":"NA","12":"NA","_rn_":"P01023"},{"1":"TIMP1 CLGI TIMP","2":"TIMP1_HUMAN","3":"unknown","4":"Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1)","5":"Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling. Mediates erythropoiesis in vitro; but, unlike IL3, it is species-specific, stimulating the growth and differentiation of only human and murine erythroid progenitors. {ECO:0000269|PubMed:1420137, ECO:0000269|PubMed:16917503, ECO:0000269|PubMed:17050530, ECO:0000269|PubMed:1730286, ECO:0000269|PubMed:20545310, ECO:0000269|PubMed:22427646, ECO:0000269|PubMed:24635319, ECO:0000269|PubMed:3839290, ECO:0000269|PubMed:3903517, ECO:0000269|PubMed:8541540, ECO:0000269|PubMed:8576151, ECO:0000269|PubMed:9065415}.","6":"11.71811006","7":"-39.030990592","8":"LYSOSOME","9":"Undefined,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P01033"},{"1":"NRAS HRAS1","2":"RASN_HUMAN","3":"unknown","4":"GTPase NRas (EC 3.6.5.2) (Transforming protein N-Ras)","5":"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:30712867}.","6":"-1.32581020","7":"-37.566639755","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P01111"},{"1":"LDLR","2":"LDLR_HUMAN","3":"unknown","4":"Low-density lipoprotein receptor (LDL receptor)","5":"Binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. {ECO:0000269|PubMed:3005267, ECO:0000269|PubMed:6091915}.; (Microbial infection) Acts as a receptor for hepatitis C virus in hepatocytes, but not through a direct interaction with viral proteins. {ECO:0000269|PubMed:10535997, ECO:0000269|PubMed:12615904}.; (Microbial infection) Acts as a receptor for Vesicular stomatitis virus. {ECO:0000269|PubMed:23589850}.; (Microbial infection) In case of HIV-1 infection, may function as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells. {ECO:0000269|PubMed:11100124}.","6":"7.92874093","7":"-35.420655238","8":"Undefined","9":"GOLGI,ER,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P01130"},{"1":"TGFB1 TGFB","2":"TGFB1_HUMAN","3":"unknown","4":"Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)]","5":"Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:2022183, PubMed:8617200, PubMed:8939931, PubMed:19750484, PubMed:22278742, PubMed:19651619). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19750484, PubMed:22278742, PubMed:19651619). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:2022183, PubMed:8617200, PubMed:8939931, PubMed:19750484, PubMed:22278742, PubMed:19651619). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}.","6":"-17.39883778","7":"-26.034840925","8":"ER","9":"ER,Undefined,ER","10":"NA","11":"NA","12":"NA","_rn_":"P01137"},{"1":"NA","2":"NA","3":"unknown","4":"NA","5":"NA","6":"-1.99870952","7":"-39.145778945","8":"Undefined","9":"PM,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P01892"},{"1":"COL1A1","2":"CO1A1_HUMAN","3":"unknown","4":"Collagen alpha-1(I) chain (Alpha-1 type I collagen)","5":"Type I collagen is a member of group I collagen (fibrillar forming collagen).","6":"-16.34368667","7":"-36.147820804","8":"Undefined","9":"ER,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P02452"},{"1":"COL4A1","2":"CO4A1_HUMAN","3":"unknown","4":"Collagen alpha-1(IV) chain [Cleaved into: Arresten]","5":"Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. {ECO:0000250|UniProtKB:P02463}.; Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. {ECO:0000269|PubMed:10811134, ECO:0000269|PubMed:18775695}.","6":"-24.77982875","7":"-17.080145002","8":"PEROXISOME","9":"PEROXISOME,PEROXISOME,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P02462"},{"1":"CRYAB CRYA2 HSPB5","2":"CRYAB_HUMAN","3":"unknown","4":"Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component)","5":"May contribute to the transparency and refractive index of the lens. Has chaperone-like activity, preventing aggregation of various proteins under a wide range of stress conditions.","6":"37.70550147","7":"4.726225690","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P02511"},{"1":"LMNA LMN1","2":"LMNA_HUMAN","3":"unknown","4":"Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)]","5":"Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:23666920, ECO:0000269|PubMed:31548606}.; Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.","6":"-18.96513242","7":"20.565607608","8":"Undefined","9":"NUCLEOPLASM-2,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P02545"},{"1":"FN1 FN","2":"FINC_HUMAN","3":"unknown","4":"Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]","5":"Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369). Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity). Participates in the regulation of type I collagen deposition by osteoblasts (By similarity). {ECO:0000250|UniProtKB:P11276, ECO:0000269|PubMed:3024962, ECO:0000269|PubMed:3593230, ECO:0000269|PubMed:3900070, ECO:0000269|PubMed:7989369}.; [Anastellin]: Binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling. {ECO:0000269|PubMed:11209058, ECO:0000269|PubMed:15665290, ECO:0000269|PubMed:19379667, ECO:0000269|PubMed:8114919}.","6":"-1.50667461","7":"-39.283956599","8":"PM","9":"PM,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"P02751"},{"1":"TFRC","2":"TFR1_HUMAN","3":"unknown","4":"Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]","5":"Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes (PubMed:26214738). Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake (PubMed:26642240). Acts as a lipid sensor that regulates mitochondrial fusion by regulating activation of the JNK pathway (PubMed:26214738). When dietary levels of stearate (C18:0) are low, promotes activation of the JNK pathway, resulting in HUWE1-mediated ubiquitination and subsequent degradation of the mitofusin MFN2 and inhibition of mitochondrial fusion (PubMed:26214738). When dietary levels of stearate (C18:0) are high, TFRC stearoylation inhibits activation of the JNK pathway and thus degradation of the mitofusin MFN2 (PubMed:26214738). {ECO:0000250, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:26642240, ECO:0000269|PubMed:3568132}.; (Microbial infection) Acts as a receptor for new-world arenaviruses: Guanarito, Junin and Machupo virus. {ECO:0000269|PubMed:17287727, ECO:0000269|PubMed:18268337}.","6":"15.51421200","7":"-36.981401805","8":"GOLGI","9":"GOLGI,GOLGI,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P02786"},{"1":"FTH1 FTH FTHL6 OK/SW-cl.84 PIG15","2":"FRIH_HUMAN","3":"unknown","4":"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]","5":"Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). {ECO:0000250}.","6":"4.21818950","7":"-29.493534929","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Confident","11":"2","12":"1,2","_rn_":"P02794"},{"1":"MT2A CES1 MT2","2":"MT2_HUMAN","3":"unknown","4":"Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II)","5":"Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.","6":"1.95309560","7":"12.943165352","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P02795"},{"1":"GBA GC GLUC","2":"GLCM_HUMAN","3":"unknown","4":"Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase)","5":"Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose (PubMed:9201993, PubMed:24211208, PubMed:15916907). Thereby, plays a central role in the degradation of complex lipids and the turnover of cellular membranes (PubMed:27378698). Through the production of ceramides, participates in the PKC-activated salvage pathway of ceramide formation (PubMed:19279011). Also plays a role in cholesterol metabolism (PubMed:24211208, PubMed:26724485). May either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol (PubMed:24211208, PubMed:26724485). The short chain saturated C8:0-GlcCer and the mono-unsaturated C18:0-GlcCer being the most effective glucose donors for that transglucosylation reaction (PubMed:24211208). Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide (PubMed:26724485). Finally, may also hydrolyze cholesteryl-beta-D-glucoside to produce D-glucose and cholesterol (PubMed:24211208, PubMed:26724485). {ECO:0000269|PubMed:15916907, ECO:0000269|PubMed:19279011, ECO:0000269|PubMed:24211208, ECO:0000269|PubMed:26724485, ECO:0000269|PubMed:27378698, ECO:0000269|PubMed:9201993}.","6":"14.50036608","7":"-39.967571813","8":"Undefined","9":"Undefined,LYSOSOME,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P04062"},{"1":"CSTB CST6 STFB","2":"CYTB_HUMAN","3":"unknown","4":"Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B)","5":"This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B.","6":"3.68010875","7":"-6.319800878","8":"Undefined","9":"CYTOSOL,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P04080"},{"1":"ANXA1 ANX1 LPC1","2":"ANXA1_HUMAN","3":"unknown","4":"Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)","5":"Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity (PubMed:8425544). Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Promotes resolution of inflammation and wound healing (PubMed:25664854). Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades (PubMed:15187149, PubMed:25664854). Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors (PubMed:15187149). Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T-cells (PubMed:17008549). Promotes the differentiation of T-cells into Th1 cells and negatively regulates differentiation into Th2 cells (PubMed:17008549). Has no effect on unstimulated T cells (PubMed:17008549). Promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration (PubMed:15187149). Negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton (PubMed:19625660). Has high affinity for Ca(2+) and can bind up to eight Ca(2+) ions (By similarity). Displays Ca(2+)-dependent binding to phospholipid membranes (PubMed:2532504, PubMed:8557678). Plays a role in the formation of phagocytic cups and phagosomes. Plays a role in phagocytosis by mediating the Ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton (By similarity). {ECO:0000250|UniProtKB:P10107, ECO:0000250|UniProtKB:P19619, ECO:0000269|PubMed:15187149, ECO:0000269|PubMed:17008549, ECO:0000269|PubMed:19625660, ECO:0000269|PubMed:2532504, ECO:0000269|PubMed:25664854, ECO:0000269|PubMed:2936963, ECO:0000269|PubMed:8425544, ECO:0000269|PubMed:8557678}.","6":"10.05343575","7":"-12.075805238","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04083"},{"1":"NR3C1 GRL","2":"GCR_HUMAN","3":"unknown","4":"Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1)","5":"Receptor for glucocorticoids (GC) (PubMed:27120390). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay (PubMed:25775514). Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity). {ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:25775514, ECO:0000269|PubMed:27120390, ECO:0000269|PubMed:9590696}.; [Isoform Alpha]: Has transcriptional activation and repression activity (PubMed:15866175, PubMed:19248771, PubMed:20484466, PubMed:23820903, PubMed:11435610, PubMed:15769988, PubMed:17635946, PubMed:19141540, PubMed:21664385). Mediates glucocorticoid-induced apoptosis (PubMed:23303127). Promotes accurate chromosome segregation during mitosis (PubMed:25847991). May act as a tumor suppressor (PubMed:25847991). May play a negative role in adipogenesis through the regulation of lipolytic and antilipogenic gene expression (By similarity). {ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:11435610, ECO:0000269|PubMed:15769988, ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:17635946, ECO:0000269|PubMed:19141540, ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:20484466, ECO:0000269|PubMed:21664385, ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903, ECO:0000269|PubMed:25847991}.; [Isoform Beta]: Acts as a dominant negative inhibitor of isoform Alpha (PubMed:7769088, PubMed:8621628, PubMed:20484466). Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed (PubMed:19248771, PubMed:26711253). Loses this transcription modulator function on its own (PubMed:20484466). Has no hormone-binding activity (PubMed:8621628). May play a role in controlling glucose metabolism by maintaining insulin sensitivity (By similarity). Reduces hepatic gluconeogenesis through down-regulation of PEPCK in an isoform Alpha-dependent manner (PubMed:26711253). Directly regulates STAT1 expression in isoform Alpha-independent manner (PubMed:26711253). {ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:20484466, ECO:0000269|PubMed:26711253, ECO:0000269|PubMed:7769088, ECO:0000269|PubMed:8621628}.; [Isoform Alpha-2]: Has lower transcriptional activation activity than isoform Alpha. Exerts a dominant negative effect on isoform Alpha trans-repression mechanism (PubMed:20484466).; [Isoform GR-P]: Increases activity of isoform Alpha. {ECO:0000269|PubMed:11358809}.; [Isoform Alpha-B]: More effective than isoform Alpha in transcriptional activation, but not repression activity. {ECO:0000269|PubMed:11435610, ECO:0000269|PubMed:15866175}.; [Isoform 10]: Has transcriptional activation activity. {ECO:0000269|PubMed:20484466}.; [Isoform Alpha-C1]: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}.; [Isoform Alpha-C2]: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}.; [Isoform Alpha-C3]: Has highest transcriptional activation activity of all isoforms created by alternative initiation (PubMed:15866175, PubMed:23820903). Has transcriptional repression activity (PubMed:23303127). Mediates glucocorticoid-induced apoptosis (PubMed:23303127, PubMed:23820903). {ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903}.; [Isoform Alpha-D1]: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}.; [Isoform Alpha-D2]: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}.; [Isoform Alpha-D3]: Has lowest transcriptional activation activity of all isoforms created by alternative initiation (PubMed:15866175, PubMed:23820903). Has transcriptional repression activity (PubMed:23303127). {ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903}.","6":"9.22833387","7":"24.008967965","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P04150"},{"1":"PRNP ALTPRP PRIP PRP","2":"PRIO_HUMAN","3":"unknown","4":"Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)","5":"Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity). {ECO:0000250|UniProtKB:P04925, ECO:0000269|PubMed:12732622, ECO:0000269|PubMed:19936054, ECO:0000269|PubMed:20564047, ECO:0000305}.","6":"13.65780885","7":"-37.518349992","8":"Undefined","9":"GOLGI,GOLGI,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P04156"},{"1":"SOD2","2":"SODM_HUMAN","3":"MITOCHONDRIA","4":"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)","5":"Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems. {ECO:0000269|PubMed:10334867}.","6":"-38.58262419","7":"-0.498267935","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P04179"},{"1":"OAT","2":"OAT_HUMAN","3":"MITOCHONDRIA","4":"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form]","5":"NA","6":"-38.07741716","7":"-14.908182924","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P04181"},{"1":"TK1","2":"KITH_HUMAN","3":"unknown","4":"Thymidine kinase, cytosolic (EC 2.7.1.21)","5":"NA","6":"43.34129674","7":"0.102087214","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P04183"},{"1":"THY1","2":"THY1_HUMAN","3":"unknown","4":"Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD antigen CD90)","5":"May play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.","6":"-10.08719292","7":"-34.926236857","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04216"},{"1":"TUBB4A TUBB4 TUBB5","2":"TBB4A_HUMAN","3":"unknown","4":"Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)","5":"Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.","6":"16.40840006","7":"26.262877077","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P04350"},{"1":"GAPDH GAPD CDABP0047 OK/SW-cl.12","2":"G3P_HUMAN","3":"unknown","4":"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)","5":"Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively (PubMed:3170585, PubMed:11724794). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate (PubMed:3170585, PubMed:11724794). Modulates the organization and assembly of the cytoskeleton (By similarity). Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes (PubMed:23071094). Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation (PubMed:23071094). Also plays a role in innate immunity by promoting TNF-induced NF-kappa-B activation and type I interferon production, via interaction with TRAF2 and TRAF3, respectively (PubMed:23332158, PubMed:27387501). Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis (By similarity). Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC (By similarity). {ECO:0000250|UniProtKB:P04797, ECO:0000269|PubMed:11724794, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:23332158, ECO:0000269|PubMed:27387501, ECO:0000269|PubMed:3170585}.","6":"29.27404915","7":"16.041663400","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P04406"},{"1":"ASL","2":"ARLY_HUMAN","3":"unknown","4":"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","5":"NA","6":"45.95900080","7":"-2.346432053","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P04424"},{"1":"ERBB2 HER2 MLN19 NEU NGL","2":"ERBB2_HUMAN","3":"unknown","4":"Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)","5":"Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.","6":"-16.06871557","7":"-36.255787992","8":"Undefined","9":"ER,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04626"},{"1":"CAPNS1 CAPN4 CAPNS","2":"CPNS1_HUMAN","3":"unknown","4":"Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)","5":"Regulatory subunit of the calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.","6":"15.99711708","7":"8.567236264","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04632"},{"1":"HSPB1 HSP27 HSP28","2":"HSPB1_HUMAN","3":"unknown","4":"Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)","5":"Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.","6":"29.30343789","7":"0.167284278","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P04792"},{"1":"TYMS TS OK/SW-cl.29","2":"TYSY_HUMAN","3":"unknown","4":"Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)","5":"Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. {ECO:0000269|PubMed:21876188}.","6":"30.54818489","7":"11.762558839","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P04818"},{"1":"RPN1","2":"RPN1_HUMAN","3":"ER","4":"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)","5":"Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. {ECO:0000250|UniProtKB:E2RQ08}.","6":"-16.36811512","7":"-23.899901928","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P04843"},{"1":"RPN2","2":"RPN2_HUMAN","3":"unknown","4":"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2)","5":"Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. {ECO:0000250|UniProtKB:F1PCT7}.","6":"-12.55526630","7":"-29.381206366","8":"ER","9":"ER,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04844"},{"1":"GNAI2 GNAI2B","2":"GNAI2_HUMAN","3":"unknown","4":"Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)","5":"Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. May play a role in cell division. {ECO:0000269|PubMed:17635935}.; [Isoform sGi2]: Regulates the cell surface density of dopamine receptors DRD2 by sequestrating them as an intracellular pool. {ECO:0000269|PubMed:17550964}.","6":"-1.80665854","7":"-42.551916820","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P04899"},{"1":"SLC4A2 AE2 EPB3L1 HKB3 MPB3L","2":"B3A2_HUMAN","3":"unknown","4":"Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2)","5":"Plasma membrane anion exchange protein of wide distribution.","6":"-22.54109399","7":"-22.674226704","8":"Undefined","9":"ER,Undefined,PEROXISOME","10":"Confident","11":"2","12":"1,3","_rn_":"P04920"},{"1":"ATP1A1","2":"AT1A1_HUMAN","3":"PM","4":"Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)","5":"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:29499166, ECO:0000269|PubMed:30388404}.","6":"-22.46803211","7":"-28.353818061","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05023"},{"1":"ATP1B1 ATP1B","2":"AT1B1_HUMAN","3":"PM","4":"Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1)","5":"This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The beta subunit regulates, through assembly of alpha/beta heterodimers, the number of sodium pumps transported to the plasma membrane. {ECO:0000269|PubMed:19694409}.; Involved in cell adhesion and establishing epithelial cell polarity. {ECO:0000269|PubMed:19694409}.","6":"-20.49385765","7":"-31.813094041","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05026"},{"1":"APP A4 AD1","2":"A4_HUMAN","3":"unknown","4":"Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]","5":"Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapes in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. {ECO:0000250, ECO:0000250|UniProtKB:P12023, ECO:0000269|PubMed:17062754, ECO:0000269|PubMed:23011729, ECO:0000269|PubMed:25122912}.; Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.; Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain. {ECO:0000250}.; The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.; N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).","6":"4.25284936","7":"-40.462070400","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P05067"},{"1":"ALDH2 ALDM","2":"ALDH2_HUMAN","3":"MITOCHONDRIA","4":"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)","5":"NA","6":"-36.36297791","7":"-2.774657216","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05091"},{"1":"ITGB3 GP3A","2":"ITB3_HUMAN","3":"PM","4":"Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)","5":"Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. Fibrinogen binding enhances SELP expression in activated platelets (By similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099). ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds to FGF2 and this binding is essential for FGF2 signaling (PubMed:28302677). ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:19578119). ITGAV:ITGB3 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). ITGAV:ITGB3 binds to IL1B and this binding is essential for IL1B signaling (PubMed:29030430). ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGAV:ITGB3 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887). In brain, plays a role in synaptic transmission and plasticity. Involved in the regulation of the serotonin neurotransmission, is required to localize to specific compartments within the synapse the serotonin receptor SLC6A4 and for an appropriate reuptake of serotonin. Controls excitatory synaptic strength by regulating GRIA2-containing AMPAR endocytosis, which affects AMPAR abundance and composition (By similarity). ITGAV:ITGB3 act as a receptor for CD40LG (PubMed:31331973). {ECO:0000250|UniProtKB:O54890, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:24789099, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:28302677, ECO:0000269|PubMed:28873464, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:31331973, ECO:0000269|PubMed:9195946, ECO:0000303|PubMed:16322781, ECO:0000303|PubMed:17635696}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Herpes virus 8/HHV-8. {ECO:0000269|PubMed:18045938}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Coxsackievirus A9. {ECO:0000269|PubMed:7519807}.; (Microbial infection) Acts as a receptor for Hantaan virus. {ECO:0000269|PubMed:9618541}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Cytomegalovirus/HHV-5. {ECO:0000269|PubMed:15834425}.; (Microbial infection) Integrin ITGA5:ITGB3 acts as a receptor for Human metapneumovirus. {ECO:0000269|PubMed:24478423}.; (Microbial infection) Integrin ITGAV:ITGB3 acts aP05556s a receptor for Human parechovirus 1. {ECO:0000269|PubMed:11160695}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus. {ECO:0000269|PubMed:23658209}.; (Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}.","6":"-3.00196499","7":"-44.326844407","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05106"},{"1":"HMGN1 HMG14","2":"HMGN1_HUMAN","3":"unknown","4":"Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1)","5":"Binds to the inner side of the nucleosomal DNA thus altering the interaction between the DNA and the histone octamer. May be involved in the process which maintains transcribable genes in a unique chromatin conformation. Inhibits the phosphorylation of nucleosomal histones H3 and H2A by RPS6KA5/MSK1 and RPS6KA3/RSK2 (By similarity). {ECO:0000250}.","6":"14.38691554","7":"-25.599806488","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P05114"},{"1":"SERPINE1 PAI1 PLANH1","2":"PAI1_HUMAN","3":"unknown","4":"Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1)","5":"Serine protease inhibitor. Inhibits TMPRSS7 (PubMed:15853774). Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase-type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots (PubMed:8481516, PubMed:9207454, PubMed:17912461). As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading (PubMed:9175705). Acts as a regulator of cell migration, independently of its role as protease inhibitor (PubMed:15001579, PubMed:9168821). It is required for stimulation of keratinocyte migration during cutaneous injury repair (PubMed:18386027). It is involved in cellular and replicative senescence (PubMed:16862142). Plays a role in alveolar type 2 cells senescence in the lung (By similarity). Is involved in the regulation of cementogenic differentiation of periodontal ligament stem cells, and regulates odontoblast differentiation and dentin formation during odontogenesis (PubMed:25808697, PubMed:27046084). {ECO:0000250|UniProtKB:P22777, ECO:0000269|PubMed:15001579, ECO:0000269|PubMed:15853774, ECO:0000269|PubMed:16862142, ECO:0000269|PubMed:17912461, ECO:0000269|PubMed:18386027, ECO:0000269|PubMed:25808697, ECO:0000269|PubMed:27046084, ECO:0000269|PubMed:8481516, ECO:0000269|PubMed:9168821, ECO:0000269|PubMed:9175705, ECO:0000269|PubMed:9207454}.","6":"8.25923726","7":"-39.381576843","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P05121"},{"1":"SLC25A5 AAC2 ANT2","2":"ADT2_HUMAN","3":"unknown","4":"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]","5":"ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell (By similarity). Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane (By similarity). In addition to its ADP:ATP antiporter activity, also involved in mitochondrial uncoupling and mitochondrial permeability transition pore (mPTP) activity (By similarity). Plays a role in mitochondrial uncoupling by acting as a proton transporter: proton transport uncouples the proton flows via the electron transport chain and ATP synthase to reduce the efficiency of ATP production and cause mitochondrial thermogenesis (By similarity). Proton transporter activity is inhibited by ADP:ATP antiporter activity, suggesting that SLC25A5/ANT2 acts as a master regulator of mitochondrial energy output by maintaining a delicate balance between ATP production (ADP:ATP antiporter activity) and thermogenesis (proton transporter activity) (By similarity). Proton transporter activity requires free fatty acids as cofactor, but does not transport it (By similarity). Probably mediates mitochondrial uncoupling in tissues that do not express UCP1 (By similarity). Also plays a key role in mPTP opening, a non-specific pore that enables free passage of the mitochondrial membranes to solutes of up to 1.5 kDa, and which contributes to cell death (PubMed:31883789). It is however unclear if SLC25A5/ANT2 constitutes a pore-forming component of mPTP or regulates it (By similarity). Acts as a regulator of mitophagy independently of ADP:ATP antiporter activity: promotes mitophagy via interaction with TIMM44, leading to inhibit the presequence translocase TIMM23, thereby promoting stabilization of PINK1 (By similarity). As part of the mitotic spindle-associated MMXD complex it may play a role in chromosome segregation (PubMed:20797633). {ECO:0000250|UniProtKB:G2QNH0, ECO:0000250|UniProtKB:P51881, ECO:0000269|PubMed:20797633, ECO:0000269|PubMed:31883789}.","6":"-42.36361963","7":"-3.104688803","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P05141"},{"1":"PCCA","2":"PCCA_HUMAN","3":"MITOCHONDRIA","4":"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","5":"This is one of the 2 subunits of the biotin-dependent propionyl-CoA carboxylase (PCC), a mitochondrial enzyme involved in the catabolism of odd chain fatty acids, branched-chain amino acids isoleucine, threonine, methionine, and valine and other metabolites (PubMed:8434582, PubMed:6765947). Propionyl-CoA carboxylase catalyzes the carboxylation of propionyl-CoA/propanoyl-CoA to D-methylmalonyl-CoA/(S)-methylmalonyl-CoA (PubMed:8434582, PubMed:6765947, PubMed:10101253). Within the holoenzyme, the alpha subunit catalyzes the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain, while the beta subunit then transfers the carboxyl group from carboxylated biotin to propionyl-CoA (By similarity). Propionyl-CoA carboxylase also significantly acts on butyryl-CoA/butanoyl-CoA, which is converted to ethylmalonyl-CoA/(2S)-ethylmalonyl-CoA at a much lower rate (PubMed:6765947). Other alternative minor substrates include (2E)-butenoyl-CoA/crotonoyl-CoA (By similarity). {ECO:0000250|UniProtKB:P0DTA4, ECO:0000250|UniProtKB:Q5LUF3, ECO:0000269|PubMed:10101253, ECO:0000269|PubMed:6765947, ECO:0000269|PubMed:8434582}.","6":"-29.83992220","7":"-2.052546343","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05165"},{"1":"PCCB","2":"PCCB_HUMAN","3":"MITOCHONDRIA","4":"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)","5":"This is one of the 2 subunits of the biotin-dependent propionyl-CoA carboxylase (PCC), a mitochondrial enzyme involved in the catabolism of odd chain fatty acids, branched-chain amino acids isoleucine, threonine, methionine, and valine and other metabolites (PubMed:6765947, PubMed:15890657). Propionyl-CoA carboxylase catalyzes the carboxylation of propionyl-CoA/propanoyl-CoA to D-methylmalonyl-CoA/(S)-methylmalonyl-CoA (PubMed:6765947, PubMed:15890657). Within the holoenzyme, the alpha subunit catalyzes the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain, while the beta subunit then transfers the carboxyl group from carboxylated biotin to propionyl-CoA (By similarity). Propionyl-CoA carboxylase also significantly acts on butyryl-CoA/butanoyl-CoA, which is converted to ethylmalonyl-CoA/(2S)-ethylmalonyl-CoA at a much lower rate (PubMed:6765947). Other alternative minor substrates include (2E)-butenoyl-CoA/crotonoyl-CoA (By similarity). {ECO:0000250|UniProtKB:P79384, ECO:0000250|UniProtKB:Q168G2, ECO:0000269|PubMed:15890657, ECO:0000269|PubMed:6765947}.","6":"-30.46891974","7":"-1.783562663","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05166"},{"1":"EIF2S1 EIF2A","2":"IF2A_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)","5":"Functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA (PubMed:16289705). This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex (PubMed:16289705). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex (PubMed:16289705). In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (PubMed:16289705). EIF2S1/eIF-2-alpha is a key component of the integrated stress response (ISR), required for adaptation to various stress: phosphorylation by metabolic-stress sensing protein kinases (EIF2AK1/HRI, EIF2AK2/PKR, EIF2AK3/PERK and EIF2AK4/GCN2) in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to an attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed:19131336, PubMed:33384352). {ECO:0000269|PubMed:16289705, ECO:0000269|PubMed:19131336, ECO:0000269|PubMed:33384352}.","6":"3.39322018","7":"10.934788798","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P05198"},{"1":"HMGN2 HMG17","2":"HMGN2_HUMAN","3":"NUCLEUS","4":"Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2)","5":"Binds to the inner side of the nucleosomal DNA thus altering the interaction between the DNA and the histone octamer. May be involved in the process which maintains transcribable genes in a unique chromatin conformation (By similarity). {ECO:0000250}.","6":"-21.03315893","7":"6.322770910","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05204"},{"1":"FGF1 FGFA","2":"FGF1_HUMAN","3":"unknown","4":"Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1)","5":"Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its binding to integrin, subsequent ternary complex formation with integrin and FGFR1, and the recruitment of PTPN11 to the complex are essential for FGF1 signaling. Induces the phosphorylation and activation of FGFR1, FRS2, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed:18441324, PubMed:20422052). Can induce angiogenesis (PubMed:23469107). {ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:20145243, ECO:0000269|PubMed:20422052, ECO:0000269|PubMed:23469107, ECO:0000269|PubMed:8663044}.","6":"0.33002468","7":"-0.581992381","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P05230"},{"1":"RPLP1 RRP1","2":"RLA1_HUMAN","3":"RIBOSOME","4":"60S acidic ribosomal protein P1 (Large ribosomal subunit protein P1)","5":"Plays an important role in the elongation step of protein synthesis.","6":"28.06244180","7":"-19.123861458","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05386"},{"1":"RPLP2 D11S2243E RPP2","2":"RLA2_HUMAN","3":"RIBOSOME","4":"60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2) (Renal carcinoma antigen NY-REN-44)","5":"Plays an important role in the elongation step of protein synthesis.","6":"29.56249148","7":"-22.601323792","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05387"},{"1":"RPLP0","2":"RLA0_HUMAN","3":"RIBOSOME","4":"60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)","5":"Ribosomal protein P0 is the functional equivalent of E.coli protein L10.","6":"28.13256543","7":"-21.196293149","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05388"},{"1":"POLR3D BN51 BN51T","2":"RPC4_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)","5":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway (By similarity). {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370}.","6":"6.85377109","7":"36.330708193","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P05423"},{"1":"SSB","2":"LA_HUMAN","3":"unknown","4":"Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B)","5":"Binds to the 3' poly(U) terminus of nascent RNA polymerase III transcripts, protecting them from exonuclease digestion and facilitating their folding and maturation (PubMed:3192525, PubMed:2470590). In case of Coxsackievirus B3 infection, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation (PubMed:12384597). {ECO:0000269|PubMed:12384597, ECO:0000269|PubMed:2470590, ECO:0000269|PubMed:3192525}.","6":"-7.81527701","7":"1.641702543","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P05455"},{"1":"ITGB1 FNRB MDF2 MSK12","2":"ITB1_HUMAN","3":"PM","4":"Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)","5":"Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. When associated with alpha-7 integrin, regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and RACK1, serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099). ITGA4:ITGB1 and ITGA5:ITGB1 bind to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling (PubMed:29030430). ITGA5:ITGB3 is a receptor for soluble CD40LG and is required for CD40/CD40LG signaling (PubMed:31331973). {ECO:0000250|UniProtKB:P09055, ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:12473654, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16256741, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:18804435, ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:24789099, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:31331973, ECO:0000269|PubMed:7523423}.; [Isoform 2]: Interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). {ECO:0000305|PubMed:2249781}.; [Isoform 5]: Isoform 5 displaces isoform 1 in striated muscles. {ECO:0000250|UniProtKB:P09055}.; (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human echoviruses 1 and 8. {ECO:0000269|PubMed:8411387}.; (Microbial infection) Acts as a receptor for Cytomegalovirus/HHV-5. {ECO:0000269|PubMed:20660204}.; (Microbial infection) Acts as a receptor for Epstein-Barr virus/HHV-4. {ECO:0000269|PubMed:17945327}.; (Microbial infection) Integrin ITGA5:ITGB1 acts as a receptor for Human parvovirus B19. {ECO:0000269|PubMed:12907437}.; (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human rotavirus. {ECO:0000269|PubMed:12941907}.; (Microbial infection) Acts as a receptor for Mammalian reovirus. {ECO:0000269|PubMed:16501085}.; (Microbial infection) In case of HIV-1 infection, integrin ITGA5:ITGB1 binding to extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}.","6":"-5.12870404","7":"-36.838320859","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P05556"},{"1":"KRT18 CYK18 PIG46","2":"K1C18_HUMAN","3":"unknown","4":"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)","5":"Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection. {ECO:0000250, ECO:0000269|PubMed:15529338, ECO:0000269|PubMed:16424149, ECO:0000269|PubMed:17213200, ECO:0000269|PubMed:7523419, ECO:0000269|PubMed:8522591, ECO:0000269|PubMed:9298992, ECO:0000269|PubMed:9524113}.","6":"0.29431849","7":"-14.891364608","8":"Undefined","9":"Undefined,NUCLEOPLASM-2,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P05783"},{"1":"COL5A2","2":"CO5A2_HUMAN","3":"unknown","4":"Collagen alpha-2(V) chain","5":"Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices (By similarity). {ECO:0000250}.","6":"-23.06938871","7":"-14.944365448","8":"Undefined","9":"Undefined,PEROXISOME,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P05997"},{"1":"UROD","2":"DCUP_HUMAN","3":"unknown","4":"Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)","5":"Catalyzes the decarboxylation of four acetate groups of uroporphyrinogen-III to yield coproporphyrinogen-III.","6":"32.07344618","7":"11.559123943","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P06132"},{"1":"GLA","2":"AGAL_HUMAN","3":"LYSOSOME","4":"Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (EC 3.2.1.47) (Melibiase) (Agalsidase)","5":"Catalyzes the hydrolysis of glycosphingolipids and participates to their degradation in the lysosome. {ECO:0000269|PubMed:10838196, ECO:0000269|PubMed:8804427}.","6":"9.69889912","7":"-42.863460282","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P06280"},{"1":"RB1","2":"RB_HUMAN","3":"unknown","4":"Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110)","5":"Tumor suppressor that is a key regulator of the G1/S transition of the cell cycle (PubMed:10499802). The hypophosphorylated form binds transcription regulators of the E2F family, preventing transcription of E2F-responsive genes (PubMed:10499802). Both physically blocks E2Fs transactivating domain and recruits chromatin-modifying enzymes that actively repress transcription (PubMed:10499802). Cyclin and CDK-dependent phosphorylation of RB1 induces its dissociation from E2Fs, thereby activating transcription of E2F responsive genes and triggering entry into S phase (PubMed:10499802). RB1 also promotes the G0-G1 transition upon phosphorylation and activation by CDK3/cyclin-C (PubMed:15084261). Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). {ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:10499802, ECO:0000269|PubMed:15084261}.; (Microbial infection) In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. {ECO:0000269|PubMed:1316611, ECO:0000269|PubMed:17974914, ECO:0000269|PubMed:18701596, ECO:0000269|PubMed:2839300, ECO:0000269|PubMed:8892909}.","6":"7.77111833","7":"22.905644238","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P06400"},{"1":"CDK1 CDC2 CDC28A CDKN1 P34CDC2","2":"CDK1_HUMAN","3":"unknown","4":"Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)","5":"Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, TPPP, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SAMHD1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration. CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis (PubMed:26549230). Regulates the amplitude of the cyclic expression of the core clock gene ARNTL/BMAL1 by phosphorylating its transcriptional repressor NR1D1, and this phosphorylation is necessary for SCF(FBXW7)-mediated ubiquitination and proteasomal degradation of NR1D1 (PubMed:27238018). Phosphorylates EML3 at 'Thr-881' which is essential for its interaction with HAUS augmin-like complex and TUBG1 (PubMed:30723163). {ECO:0000269|PubMed:16371510, ECO:0000269|PubMed:16407259, ECO:0000269|PubMed:16933150, ECO:0000269|PubMed:17459720, ECO:0000269|PubMed:18356527, ECO:0000269|PubMed:18480403, ECO:0000269|PubMed:19509060, ECO:0000269|PubMed:19917720, ECO:0000269|PubMed:20171170, ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:20395957, ECO:0000269|PubMed:20935635, ECO:0000269|PubMed:20937773, ECO:0000269|PubMed:21063390, ECO:0000269|PubMed:23355470, ECO:0000269|PubMed:23601106, ECO:0000269|PubMed:23602554, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26549230, ECO:0000269|PubMed:27238018, ECO:0000269|PubMed:30723163}.; (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. {ECO:0000269|PubMed:21516087}.","6":"28.10095722","7":"0.162558938","8":"CYTOSOL","9":"Undefined,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P06493"},{"1":"ATP5F1B ATP5B ATPMB ATPSB","2":"ATPB_HUMAN","3":"MITOCHONDRIA","4":"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)","5":"Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits.","6":"-40.94623856","7":"-11.576361508","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P06576"},{"1":"EIF4E EIF4EL1 EIF4F","2":"IF4E_HUMAN","3":"unknown","4":"Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)","5":"Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures (PubMed:16271312, PubMed:22578813). In addition to its role in translation initiation, also acts as a regulator of translation and stability in the cytoplasm (PubMed:24335285). Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression: in the complex, EIF4E mediates the binding to the mRNA cap (By similarity). Component of a multiprotein complex that sequesters and represses translation of proneurogenic factors during neurogenesis (By similarity). In P-bodies, component of a complex that mediates the storage of translationally inactive mRNAs in the cytoplasm and prevents their degradation (PubMed:24335285). May play an important role in spermatogenesis through translational regulation of stage-specific mRNAs during germ cell development (By similarity). {ECO:0000250|UniProtKB:P63073, ECO:0000250|UniProtKB:P63074, ECO:0000269|PubMed:16271312, ECO:0000269|PubMed:22578813, ECO:0000269|PubMed:24335285}.","6":"7.17297672","7":"7.936120805","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P06730"},{"1":"ENO1 ENO1L1 MBPB1 MPB1","2":"ENOA_HUMAN","3":"unknown","4":"Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)","5":"Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PubMed:29775581, PubMed:1369209). In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses (PubMed:2005901, PubMed:10802057, PubMed:12666133, PubMed:29775581). May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons (PubMed:12666133). Stimulates immunoglobulin production (PubMed:1369209). {ECO:0000269|PubMed:10802057, ECO:0000269|PubMed:12666133, ECO:0000269|PubMed:1369209, ECO:0000269|PubMed:2005901, ECO:0000269|PubMed:29775581}.; MBP1 binds to the myc promoter and acts as a transcriptional repressor. May be a tumor suppressor. {ECO:0000269|PubMed:10082554}.","6":"31.43549115","7":"11.367500112","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P06733"},{"1":"PYGL","2":"PYGL_HUMAN","3":"unknown","4":"Glycogen phosphorylase, liver form (EC 2.4.1.1)","5":"Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties.","6":"42.27805589","7":"1.751695425","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P06737"},{"1":"GPI","2":"G6PI_HUMAN","3":"unknown","4":"Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)","5":"In the cytoplasm, catalyzes the conversion of glucose-6-phosphate to fructose-6-phosphate, the second step in glycolysis, and the reverse reaction during gluconeogenesis (PubMed:28803808). Besides it's role as a glycolytic enzyme, also acts as a secreted cytokine: acts as an angiogenic factor (AMF) that stimulates endothelial cell motility (PubMed:11437381). Acts as a neurotrophic factor, neuroleukin, for spinal and sensory neurons (PubMed:3352745, PubMed:11004567). It is secreted by lectin-stimulated T-cells and induces immunoglobulin secretion (PubMed:3352745, PubMed:11004567). {ECO:0000269|PubMed:11004567, ECO:0000269|PubMed:11437381, ECO:0000269|PubMed:28803808, ECO:0000269|PubMed:3352745}.","6":"43.35602484","7":"0.407042229","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P06744"},{"1":"POLB","2":"DPOLB_HUMAN","3":"unknown","4":"DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)","5":"Repair polymerase that plays a key role in base-excision repair. Has 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity that removes the 5' sugar phosphate and also acts as a DNA polymerase that adds one nucleotide to the 3' end of the arising single-nucleotide gap. Conducts 'gap-filling' DNA synthesis in a stepwise distributive fashion rather than in a processive fashion as for other DNA polymerases. {ECO:0000269|PubMed:11805079, ECO:0000269|PubMed:21362556, ECO:0000269|PubMed:9207062, ECO:0000269|PubMed:9572863}.","6":"-1.35281415","7":"2.307631876","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P06746"},{"1":"NPM1 NPM","2":"NPM_HUMAN","3":"unknown","4":"Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)","5":"Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029). {ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:16107701, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:18809582, ECO:0000269|PubMed:19188445, ECO:0000269|PubMed:20352051, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:22002061, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25956029}.","6":"-23.76343956","7":"12.561241736","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P06748"},{"1":"TPM3","2":"TPM3_HUMAN","3":"unknown","4":"Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5)","5":"Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. {ECO:0000250|UniProtKB:P09493}.","6":"8.84367326","7":"-24.415941099","8":"PM","9":"Undefined,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P06753"},{"1":"ITGAV MSK8 VNRA VTNR","2":"ITAV_HUMAN","3":"unknown","4":"Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]","5":"The alpha-V (ITGAV) integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. They recognize the sequence R-G-D in a wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds to FGF2 and this binding is essential for FGF2 signaling (PubMed:28302677). ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:19578119). ITGAV:ITGB3 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). ITGAV:ITGB3 binds to IL1B and this binding is essential for IL1B signaling (PubMed:29030430). ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGAV:ITGB3 and ITGAV:ITGB6 act as a receptor for fibrillin-1 (FBN1) and mediate R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). Integrin alpha-V/beta-6 or alpha-V/beta-8 (ITGAV:ITGB6 or ITGAV:ITGB8) mediates R-G-D-dependent release of transforming growth factor beta-1 (TGF-beta-1) from regulatory Latency-associated peptide (LAP), thereby playing a key role in TGF-beta-1 activation (PubMed:15184403, PubMed:22278742, PubMed:28117447). ITGAV:ITGB3 act as a receptor for CD40LG (PubMed:31331973). {ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:15184403, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:28302677, ECO:0000269|PubMed:28873464, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:31331973}.; (Microbial infection) Integrin ITGAV:ITGB5 acts as a receptor for Adenovirus type C. {ECO:0000269|PubMed:20615244}.; (Microbial infection) Integrin ITGAV:ITGB5 and ITGAV:ITGB3 act as receptors for Coxsackievirus A9 and B1. {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807, ECO:0000269|PubMed:9426447}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Herpes virus 8/HHV-8. {ECO:0000269|PubMed:18045938}.; (Microbial infection) Integrin ITGAV:ITGB6 acts as a receptor for herpes simplex 1/HHV-1. {ECO:0000269|PubMed:24367260}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Human parechovirus 1. {ECO:0000269|PubMed:11160695}.; (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus. {ECO:0000269|PubMed:23658209}.; (Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}.","6":"2.28098241","7":"-40.011105651","8":"LYSOSOME","9":"LYSOSOME,Undefined,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P06756"},{"1":"HEXA","2":"HEXA_HUMAN","3":"unknown","4":"Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)","5":"Hydrolyzes the non-reducing end N-acetyl-D-hexosamine and/or sulfated N-acetyl-D-hexosamine of glycoconjugates, such as the oligosaccharide moieties from proteins and neutral glycolipids, or from certain mucopolysaccharides (PubMed:11707436, PubMed:9694901, PubMed:8672428, PubMed:8123671). The isozyme S is as active as the isozyme A on the anionic bis-sulfated glycans, the chondroitin-6-sulfate trisaccharide (C6S-3), and the dermatan sulfate pentasaccharide, and the sulfated glycosphingolipid SM2 (PubMed:11707436). The isozyme B does not hydrolyze each of these substrates, however hydrolyzes efficiently neutral oligosaccharide (PubMed:11707436). Only the isozyme A is responsible for the degradation of GM2 gangliosides in the presence of GM2A (PubMed:9694901, PubMed:8672428, PubMed:8123671). {ECO:0000269|PubMed:11707436, ECO:0000269|PubMed:8123671, ECO:0000269|PubMed:8672428, ECO:0000269|PubMed:9694901}.","6":"10.43651713","7":"-42.890500090","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P06865"},{"1":"SERPINE2 PI7 PN1","2":"GDN_HUMAN","3":"unknown","4":"Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2)","5":"Serine protease inhibitor with activity toward thrombin, trypsin, and urokinase. Promotes neurite extension by inhibiting thrombin. Binds heparin.","6":"7.12562229","7":"-37.141170929","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P07093"},{"1":"EPHX1 EPHX EPOX","2":"HYEP_HUMAN","3":"unknown","4":"Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH)","5":"Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). Plays a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids (PubMed:22798687). Metabolizes the abundant endocannabinoid 2-arachidonoylglycerol (2-AG) to free arachidonic acid (AA) and glycerol (PubMed:24958911). {ECO:0000250|UniProtKB:P07687, ECO:0000269|PubMed:22798687, ECO:0000269|PubMed:24958911}.","6":"2.90854486","7":"-42.095281882","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P07099"},{"1":"DBI","2":"ACBP_HUMAN","3":"unknown","4":"Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP)","5":"Binds medium- and long-chain acyl-CoA esters with very high affinity and may function as an intracellular carrier of acyl-CoA esters. It is also able to displace diazepam from the benzodiazepine (BZD) recognition site located on the GABA type A receptor. It is therefore possible that this protein also acts as a neuropeptide to modulate the action of the GABA receptor.","6":"2.69075774","7":"20.095185535","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07108"},{"1":"LDHB","2":"LDHB_HUMAN","3":"CYTOSOL","4":"L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)","5":"NA","6":"19.43265038","7":"24.894372574","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07195"},{"1":"NEFL NF68 NFL","2":"NFL_HUMAN","3":"unknown","4":"Neurofilament light polypeptide (NF-L) (68 kDa neurofilament protein) (Neurofilament triplet L protein)","5":"Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. May additionally cooperate with the neuronal intermediate filament proteins PRPH and INA to form neuronal filamentous networks (By similarity). {ECO:0000250|UniProtKB:P08551}.","6":"-8.60291326","7":"-27.374993415","8":"ER","9":"ER,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07196"},{"1":"CENPB","2":"CENPB_HUMAN","3":"unknown","4":"Major centromere autoantigen B (Centromere protein B) (CENP-B)","5":"Interacts with centromeric heterochromatin in chromosomes and binds to a specific 17 bp subset of alphoid satellite DNA, called the CENP-B box (PubMed:11726497). May organize arrays of centromere satellite DNA into a higher-order structure which then directs centromere formation and kinetochore assembly in mammalian chromosomes (Probable). {ECO:0000269|PubMed:11726497, ECO:0000305}.","6":"-40.34938257","7":"22.311540009","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P07199"},{"1":"GPX1","2":"GPX1_HUMAN","3":"unknown","4":"Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)","5":"Protects the hemoglobin in erythrocytes from oxidative breakdown. In platelets, plays a crucial role of glutathione peroxidase in the arachidonic acid metabolism (PubMed:11115402). {ECO:0000269|PubMed:11115402}.","6":"-8.26865190","7":"-14.981230462","8":"MITOCHONDRIA","9":"Undefined,Undefined,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P07203"},{"1":"P4HB ERBA2L PDI PDIA1 PO4DB","2":"PDIA1_HUMAN","3":"ER","4":"Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)","5":"This multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. At the cell surface, seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. May therefore cause structural modifications of exofacial proteins. Inside the cell, seems to form/rearrange disulfide bonds of nascent proteins. At high concentrations, functions as a chaperone that inhibits aggregation of misfolded proteins. At low concentrations, facilitates aggregation (anti-chaperone activity). May be involved with other chaperones in the structural modification of the TG precursor in hormone biogenesis. Also acts a structural subunit of various enzymes such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein MTTP. Receptor for LGALS9; the interaction retains P4HB at the cell surface of Th2 T helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration (PubMed:21670307). {ECO:0000269|PubMed:10636893, ECO:0000269|PubMed:12485997, ECO:0000269|PubMed:21670307}.","6":"-20.62733750","7":"-21.830704025","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07237"},{"1":"H1-0 H1F0 H1FV","2":"H10_HUMAN","3":"unknown","4":"Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]","5":"Histones H1 are necessary for the condensation of nucleosome chains into higher-order structures. The histones H1.0 are found in cells that are in terminal stages of differentiation or that have low rates of cell division.","6":"-41.68659473","7":"23.864404227","8":"NUCLEUS","9":"NUCLEUS,Undefined,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P07305"},{"1":"ANXA2 ANX2 ANX2L4 CAL1H LPC2D","2":"ANXA2_HUMAN","3":"unknown","4":"Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)","5":"Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 (PubMed:18799458, PubMed:24808179, PubMed:22848640). {ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:22848640, ECO:0000269|PubMed:24808179}.","6":"5.45171850","7":"-33.985603817","8":"LYSOSOME","9":"LYSOSOME,Undefined,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P07355"},{"1":"CAPN1 CANPL1 PIG30","2":"CAN1_HUMAN","3":"unknown","4":"Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)","5":"Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction (PubMed:21531719, PubMed:2400579). Proteolytically cleaves CTBP1 at 'Asn-375', 'Gly-387' and 'His-409' (PubMed:23707407). {ECO:0000269|PubMed:21531719, ECO:0000269|PubMed:23707407, ECO:0000269|PubMed:2400579}.","6":"26.74966180","7":"8.136040539","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P07384"},{"1":"TUBB TUBB5 OK/SW-cl.56","2":"TBB5_HUMAN","3":"unknown","4":"Tubulin beta chain (Tubulin beta-5 chain)","5":"Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.","6":"26.67087688","7":"15.784281072","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P07437"},{"1":"PSAP GLBA SAP1","2":"SAP_HUMAN","3":"unknown","4":"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]","5":"Saposin-A and saposin-C stimulate the hydrolysis of glucosylceramide by beta-glucosylceramidase (EC 3.2.1.45) and galactosylceramide by beta-galactosylceramidase (EC 3.2.1.46). Saposin-C apparently acts by combining with the enzyme and acidic lipid to form an activated complex, rather than by solubilizing the substrate.; Saposin-B stimulates the hydrolysis of galacto-cerebroside sulfate by arylsulfatase A (EC 3.1.6.8), GM1 gangliosides by beta-galactosidase (EC 3.2.1.23) and globotriaosylceramide by alpha-galactosidase A (EC 3.2.1.22). Saposin-B forms a solubilizing complex with the substrates of the sphingolipid hydrolases.; Saposin-D is a specific sphingomyelin phosphodiesterase activator (EC 3.1.4.12).; [Prosaposin]: Behaves as a myelinotrophic and neurotrophic factor, these effects are mediated by its G-protein-coupled receptors, GPR37 and GPR37L1, undergoing ligand-mediated internalization followed by ERK phosphorylation signaling. {ECO:0000250|UniProtKB:Q61207, ECO:0000269|PubMed:10383054}.; Saposins are specific low-molecular mass non-enzymic proteins, they participate in the lysosomal degradation of sphingolipids, which takes place by the sequential action of specific hydrolases.","6":"1.92722631","7":"-38.915450593","8":"Undefined","9":"LYSOSOME,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07602"},{"1":"HEXB HCC7","2":"HEXB_HUMAN","3":"LYSOSOME","4":"Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]","5":"Hydrolyzes the non-reducing end N-acetyl-D-hexosamine and/or sulfated N-acetyl-D-hexosamine of glycoconjugates, such as the oligosaccharide moieties from proteins and neutral glycolipids, or from certain mucopolysaccharides (PubMed:11707436, PubMed:9694901, PubMed:8672428, PubMed:8123671). The isozyme B does not hydrolyze each of these substrates, however hydrolyzes efficiently neutral oligosaccharide (PubMed:11707436). Only the isozyme A is responsible for the degradation of GM2 gangliosides in the presence of GM2A (PubMed:9694901, PubMed:8672428, PubMed:8123671). During fertilization is responsible, at least in part, for the zona block to polyspermy. Present in the cortical granules of non-activated oocytes, is exocytosed during the cortical reaction in response to oocyte activation and inactivates the sperm galactosyltransferase-binding site, accounting for the block in sperm binding to the zona pellucida (By similarity). {ECO:0000250|UniProtKB:P20060, ECO:0000269|PubMed:11707436, ECO:0000269|PubMed:8123671, ECO:0000269|PubMed:8672428, ECO:0000269|PubMed:9694901}.","6":"12.29759086","7":"-42.661787738","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07686"},{"1":"CTSL CTSL1","2":"CATL1_HUMAN","3":"LYSOSOME","4":"Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]","5":"Thiol protease important for the overall degradation of proteins in lysosomes (Probable). Plays a critical for normal cellular functions such as general protein turnover, antigen processing and bone remodeling. Involved in the solubilization of cross-linked TG/thyroglobulin and in the subsequent release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (By similarity). In neuroendocrine chromaffin cells secretory vesicles, catalyzes the prohormone proenkephalin processing to the active enkephalin peptide neurotransmitter (By similarity). In thymus, regulates CD4(+) T cell positive selection by generating the major histocompatibility complex class II (MHCII) bound peptide ligands presented by cortical thymic epithelial cells. Also mediates invariant chain processing in cortical thymic epithelial cells (By similarity). Major elastin-degrading enzyme at neutral pH. Accumulates as a mature and active enzyme in the extracellular space of antigen presenting cells (APCs) to regulate degradation of the extracellular matrix in the course of inflammation (By similarity). Secreted form generates endostatin from COL18A1 (PubMed:10716919). Critical for cardiac morphology and function. Plays an important role in hair follicle morphogenesis and cycling, as well as epidermal differentiation (By similarity). Required for maximal stimulation of steroidogenesis by TIMP1 (By similarity). {ECO:0000250|UniProtKB:P06797, ECO:0000250|UniProtKB:P07154, ECO:0000250|UniProtKB:P25975, ECO:0000269|PubMed:10716919, ECO:0000305}.; [Isoform 2]: Functions in the regulation of cell cycle progression through proteolytic processing of the CUX1 transcription factor (PubMed:15099520). Translation initiation at downstream start sites allows the synthesis of isoforms that are devoid of a signal peptide and localize to the nucleus where they cleave the CUX1 transcription factor and modify its DNA binding properties (PubMed:15099520). {ECO:0000269|PubMed:15099520}.; (Microbial infection) Facilitates human coronaviruses SARS-CoV and SARS-CoV-2 infections via proteolysis of coronavirus spike (S) glycoproteins in lysosome for entry into host cell (PubMed:32142651, PubMed:32221306, PubMed:16339146, PubMed:18562523). Proteolysis within lysosomes is sufficient to activate membrane fusion by coronaviruses SARS-CoV and EMC (HCoV-EMC) S as well as Zaire ebolavirus glycoproteins (PubMed:16081529, PubMed:26953343, PubMed:18562523). {ECO:0000269|PubMed:16081529, ECO:0000269|PubMed:16339146, ECO:0000269|PubMed:18562523, ECO:0000269|PubMed:26953343, ECO:0000269|PubMed:32142651, ECO:0000269|PubMed:32221306, ECO:0000269|PubMed:32855215}.","6":"1.01030575","7":"-40.179215991","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07711"},{"1":"PFN1","2":"PROF1_HUMAN","3":"unknown","4":"Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)","5":"Binds to actin and affects the structure of the cytoskeleton. At high concentrations, profilin prevents the polymerization of actin, whereas it enhances it at low concentrations. By binding to PIP2, it inhibits the formation of IP3 and DG. Inhibits androgen receptor (AR) and HTT aggregation and binding of G-actin is essential for its inhibition of AR. {ECO:0000269|PubMed:18573880}.","6":"30.11914353","7":"10.996918595","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P07737"},{"1":"APRT","2":"APT_HUMAN","3":"CYTOSOL","4":"Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)","5":"Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis.","6":"6.43428931","7":"21.828378400","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07741"},{"1":"EPRS1 EPRS GLNS PARS QARS QPRS PIG32","2":"SYEP_HUMAN","3":"PROTEIN COMPLEX","4":"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)]","5":"Multifunctional protein which is primarily part of the aminoacyl-tRNA synthetase multienzyme complex, also know as multisynthetase complex, that catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA (PubMed:1756734, PubMed:24100331, PubMed:23263184). The phosphorylation of EPRS1, induced by interferon-gamma, dissociates the protein from the aminoacyl-tRNA synthetase multienzyme complex and recruits it to the GAIT complex that binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin), suppressing their translation. Interferon-gamma can therefore redirect, in specific cells, the EPRS1 function from protein synthesis to translation inhibition (PubMed:15479637, PubMed:23071094). Also functions as an effector of the mTORC1 signaling pathway by promoting, through SLC27A1, the uptake of long-chain fatty acid by adipocytes. Thereby, it also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239). {ECO:0000269|PubMed:15479637, ECO:0000269|PubMed:1756734, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:28178239}.","6":"14.95860599","7":"38.070936907","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07814"},{"1":"CTSB CPSB","2":"CATB_HUMAN","3":"LYSOSOME","4":"Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","5":"Thiol protease which is believed to participate in intracellular degradation and turnover of proteins (PubMed:12220505). Cleaves matrix extracellular phosphoglycoprotein MEPE (PubMed:12220505). Involved in the solubilization of cross-linked TG/thyroglobulin in the thyroid follicle lumen (By similarity). Has also been implicated in tumor invasion and metastasis (PubMed:3972105). {ECO:0000250|UniProtKB:P10605, ECO:0000269|PubMed:12220505, ECO:0000269|PubMed:3972105}.","6":"13.03345375","7":"-43.481349327","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07858"},{"1":"HSP90AA1 HSP90A HSPC1 HSPCA","2":"HS90A_HUMAN","3":"unknown","4":"Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)","5":"Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:11274138, PubMed:15577939, PubMed:15937123, PubMed:27353360, PubMed:29127155, PubMed:12526792). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself (PubMed:29127155). Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:27295069, PubMed:26991466). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels (PubMed:25973397). In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues(PubMed:25973397). Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment (PubMed:25973397). Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Mediates the association of TOMM70 with IRF3 or TBK1 in mitochodria outer membrane which promotes host antiviral response (PubMed:20628368, PubMed:25609812). {ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123, ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:25609812, ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.","6":"-16.75740741","7":"8.618807541","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P07900"},{"1":"GALT","2":"GALT_HUMAN","3":"unknown","4":"Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)","5":"Plays an important role in galactose metabolism. {ECO:0000269|PubMed:22461411, ECO:0000269|PubMed:27005423}.","6":"36.49073666","7":"5.307814187","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07902"},{"1":"HNRNPC HNRPC","2":"HNRPC_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2)","5":"Binds pre-mRNA and nucleates the assembly of 40S hnRNP particles (PubMed:8264621). Interacts with poly-U tracts in the 3'-UTR or 5'-UTR of mRNA and modulates the stability and the level of translation of bound mRNA molecules (PubMed:12509468, PubMed:16010978, PubMed:7567451, PubMed:8264621). Single HNRNPC tetramers bind 230-240 nucleotides. Trimers of HNRNPC tetramers bind 700 nucleotides (PubMed:8264621). May play a role in the early steps of spliceosome assembly and pre-mRNA splicing. N6-methyladenosine (m6A) has been shown to alter the local structure in mRNAs and long non-coding RNAs (lncRNAs) via a mechanism named 'm(6)A-switch', facilitating binding of HNRNPC, leading to regulation of mRNA splicing (PubMed:25719671). {ECO:0000269|PubMed:12509468, ECO:0000269|PubMed:16010978, ECO:0000269|PubMed:25719671, ECO:0000269|PubMed:7567451, ECO:0000269|PubMed:8264621}.","6":"-34.94303906","7":"21.074945362","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P07910"},{"1":"UQCRH","2":"QCR6_HUMAN","3":"MITOCHONDRIA","4":"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)","5":"Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. {ECO:0000250|UniProtKB:P00127}.","6":"-32.52948076","7":"-10.046304139","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P07919"},{"1":"LAMB1","2":"LAMB1_HUMAN","3":"unknown","4":"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)","5":"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neurons. Radial glial cells play a central role in cerebral cortical development, where they act both as the proliferative unit of the cerebral cortex and a scaffold for neurons migrating toward the pial surface. {ECO:0000269|PubMed:23472759}.","6":"-21.68578883","7":"-18.001659783","8":"PEROXISOME","9":"PEROXISOME,PEROXISOME,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P07942"},{"1":"YES1 YES","2":"YES_HUMAN","3":"unknown","4":"Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes)","5":"Non-receptor protein tyrosine kinase that is involved in the regulation of cell growth and survival, apoptosis, cell-cell adhesion, cytoskeleton remodeling, and differentiation. Stimulation by receptor tyrosine kinases (RTKs) including EGRF, PDGFR, CSF1R and FGFR leads to recruitment of YES1 to the phosphorylated receptor, and activation and phosphorylation of downstream substrates. Upon EGFR activation, promotes the phosphorylation of PARD3 to favor epithelial tight junction assembly. Participates in the phosphorylation of specific junctional components such as CTNND1 by stimulating the FYN and FER tyrosine kinases at cell-cell contacts. Upon T-cell stimulation by CXCL12, phosphorylates collapsin response mediator protein 2/DPYSL2 and induces T-cell migration. Participates in CD95L/FASLG signaling pathway and mediates AKT-mediated cell migration. Plays a role in cell cycle progression by phosphorylating the cyclin-dependent kinase 4/CDK4 thus regulating the G1 phase. Also involved in G2/M progression and cytokinesis. {ECO:0000269|PubMed:11901164, ECO:0000269|PubMed:18479465, ECO:0000269|PubMed:19276087, ECO:0000269|PubMed:21566460, ECO:0000269|PubMed:21713032}.","6":"-13.81371928","7":"-37.090982093","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07947"},{"1":"LYN JTK8","2":"LYN_HUMAN","3":"unknown","4":"Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)","5":"Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Phosphorylates SCIMP on 'Tyr-107'; this enhances binding of SCIMP to TLR4, promoting the phosphorylation of TLR4, and a selective cytokine response to lipopolysaccharide in macrophages (By similarity). Phosphorylates CLNK (By similarity). {ECO:0000250|UniProtKB:P25911, ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:10748115, ECO:0000269|PubMed:10891478, ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:11825908, ECO:0000269|PubMed:14726379, ECO:0000269|PubMed:15795233, ECO:0000269|PubMed:16467205, ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:17977829, ECO:0000269|PubMed:18056483, ECO:0000269|PubMed:18070987, ECO:0000269|PubMed:18235045, ECO:0000269|PubMed:18577747, ECO:0000269|PubMed:18802065, ECO:0000269|PubMed:19290919, ECO:0000269|PubMed:20037584, ECO:0000269|PubMed:7687428}.","6":"-2.99274565","7":"-39.631606323","8":"PM","9":"PM,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"P07948"},{"1":"TPM2 TMSB","2":"TPM2_HUMAN","3":"unknown","4":"Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2)","5":"Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. The non-muscle isoform may have a role in agonist-mediated receptor internalization. {ECO:0000250|UniProtKB:P58774, ECO:0000250|UniProtKB:P58775}.","6":"11.30207192","7":"-27.826289339","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P07951"},{"1":"FH","2":"FUMH_HUMAN","3":"unknown","4":"Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)","5":"Catalyzes the reversible stereospecific interconversion of fumarate to L-malate (PubMed:30761759). Experiments in other species have demonstrated that specific isoforms of this protein act in defined pathways and favor one direction over the other (Probable). {ECO:0000269|PubMed:30761759, ECO:0000305}.; [Isoform Mitochondrial]: Catalyzes the hydration of fumarate to L-malate in the tricarboxylic acid (TCA) cycle to facilitate a transition step in the production of energy in the form of NADH. {ECO:0000250|UniProtKB:P10173}.; [Isoform Cytoplasmic]: Catalyzes the dehydration of L-malate to fumarate (By similarity). Fumarate metabolism in the cytosol plays a role during urea cycle and arginine metabolism; fumarate being a by-product of the urea cycle and amino-acid catabolism (By similarity). Also plays a role in DNA repair by promoting non-homologous end-joining (NHEJ) (PubMed:20231875, PubMed:26237645). In response to DNA damage and phosphorylation by PRKDC, translocates to the nucleus and accumulates at DNA double-strand breaks (DSBs): acts by catalyzing formation of fumarate, an inhibitor of KDM2B histone demethylase activity, resulting in enhanced dimethylation of histone H3 'Lys-36' (H3K36me2) (PubMed:26237645). {ECO:0000250|UniProtKB:P97807, ECO:0000269|PubMed:20231875, ECO:0000269|PubMed:26237645}.","6":"-22.25484444","7":"-9.970581241","8":"Undefined","9":"PEROXISOME,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P07954"},{"1":"ERCC1","2":"ERCC1_HUMAN","3":"unknown","4":"DNA excision repair protein ERCC-1","5":"[Isoform 1]: Non-catalytic component of a structure-specific DNA repair endonuclease responsible for the 5'-incision during DNA repair. Responsible, in conjunction with SLX4, for the first step in the repair of interstrand cross-links (ICL). Participates in the processing of anaphase bridge-generating DNA structures, which consist in incompletely processed DNA lesions arising during S or G2 phase, and can result in cytokinesis failure. Also required for homology-directed repair (HDR) of DNA double-strand breaks, in conjunction with SLX4. {ECO:0000269|PubMed:17273966, ECO:0000269|PubMed:23623389, ECO:0000269|PubMed:24036546}.; [Isoform 2]: Not functional in the nucleotide excision repair pathway. {ECO:0000305|PubMed:24036546}.; [Isoform 3]: Not functional in the nucleotide excision repair pathway. {ECO:0000305|PubMed:24036546}.; [Isoform 4]: Not functional in the nucleotide excision repair pathway. {ECO:0000305|PubMed:24036546}.","6":"-0.61146438","7":"26.928965486","8":"PROTEIN COMPLEX","9":"Undefined,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P07992"},{"1":"THBS1 TSP TSP1","2":"TSP1_HUMAN","3":"unknown","4":"Thrombospondin-1 (Glycoprotein G)","5":"Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Binds heparin. May play a role in dentinogenesis and/or maintenance of dentin and dental pulp (By similarity). Ligand for CD36 mediating antiangiogenic properties. Plays a role in ER stress response, via its interaction with the activating transcription factor 6 alpha (ATF6) which produces adaptive ER stress response factors (By similarity). {ECO:0000250, ECO:0000269|PubMed:11134179, ECO:0000269|PubMed:15014436}.","6":"0.64553983","7":"-38.941987783","8":"PM","9":"Undefined,PM,PM","10":"Confident","11":"2","12":"1,3","_rn_":"P07996"},{"1":"SP1 TSFP1","2":"SP1_HUMAN","3":"unknown","4":"Transcription factor Sp1","5":"Transcription factor that can activate or repress transcription in response to physiological and pathological stimuli. Binds with high affinity to GC-rich motifs and regulates the expression of a large number of genes involved in a variety of processes such as cell growth, apoptosis, differentiation and immune responses. Highly regulated by post-translational modifications (phosphorylations, sumoylation, proteolytic cleavage, glycosylation and acetylation). Binds also the PDGFR-alpha G-box promoter. May have a role in modulating the cellular response to DNA damage. Implicated in chromatin remodeling. Plays an essential role in the regulation of FE65 gene expression. In complex with ATF7IP, maintains telomerase activity in cancer cells by inducing TERT and TERC gene expression. Isoform 3 is a stronger activator of transcription than isoform 1. Positively regulates the transcription of the core clock component ARNTL/BMAL1 (PubMed:10391891, PubMed:11371615, PubMed:11904305, PubMed:14593115, PubMed:16377629, PubMed:16478997, PubMed:16943418, PubMed:17049555, PubMed:18171990, PubMed:18199680, PubMed:18239466, PubMed:18513490, PubMed:18619531, PubMed:19193796, PubMed:20091743, PubMed:21798247, PubMed:21046154). Plays a role in the recruitment of SMARCA4/BRG1 on the c-FOS promoter. Plays a role in protecting cells against oxidative stress following brain injury by regulating the expression of RNF112 (By similarity). {ECO:0000250|UniProtKB:O89090, ECO:0000250|UniProtKB:Q01714, ECO:0000269|PubMed:10391891, ECO:0000269|PubMed:11371615, ECO:0000269|PubMed:11904305, ECO:0000269|PubMed:14593115, ECO:0000269|PubMed:16377629, ECO:0000269|PubMed:16478997, ECO:0000269|PubMed:16943418, ECO:0000269|PubMed:17049555, ECO:0000269|PubMed:18171990, ECO:0000269|PubMed:18199680, ECO:0000269|PubMed:18239466, ECO:0000269|PubMed:18513490, ECO:0000269|PubMed:18619531, ECO:0000269|PubMed:19193796, ECO:0000269|PubMed:20091743, ECO:0000269|PubMed:21046154, ECO:0000269|PubMed:21798247}.","6":"19.74078844","7":"20.878648436","8":"Undefined","9":"Undefined,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P08047"},{"1":"ANXA6 ANX6","2":"ANXA6_HUMAN","3":"unknown","4":"Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70)","5":"May associate with CD21. May regulate the release of Ca(2+) from intracellular stores.","6":"-14.71900582","7":"-37.328136462","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P08133"},{"1":"CD55 CR DAF","2":"DAF_HUMAN","3":"unknown","4":"Complement decay-accelerating factor (CD antigen CD55)","5":"This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage (PubMed:28657829). {ECO:0000269|PubMed:7525274, ECO:0000305|PubMed:28657829}.; (Microbial infection) Acts as a receptor for Coxsackievirus A21, coxsackieviruses B1, B3 and B5. {ECO:0000269|PubMed:9151867}.; (Microbial infection) Acts as a receptor for Human enterovirus 70 and D68 (Probable). {ECO:0000269|PubMed:8764022}.; (Microbial infection) Acts as a receptor for Human echoviruses 6, 7, 11, 12, 20 and 21. {ECO:0000269|PubMed:7525274, ECO:0000305|PubMed:12409401}.","6":"0.38964574","7":"-39.316639927","8":"Undefined","9":"LYSOSOME,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P08174"},{"1":"ABCB1 MDR1 PGY1","2":"MDR1_HUMAN","3":"PM","4":"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","5":"Translocates drugs and phospholipids across the membrane (PubMed:8898203, PubMed:2897240, PubMed:9038218). Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins (PubMed:8898203). Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells (PubMed:2897240, PubMed:9038218). {ECO:0000269|PubMed:2897240, ECO:0000269|PubMed:8898203, ECO:0000269|PubMed:9038218}.","6":"-19.34703027","7":"-29.457758945","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08183"},{"1":"SLC3A2 MDU1","2":"4F2_HUMAN","3":"unknown","4":"4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)","5":"Component of several heterodimeric complexes involved in amino acid transport (PubMed:11557028, PubMed:9829974, PubMed:9751058, PubMed:10391915, PubMed:10574970, PubMed:11311135, PubMed:30341327). The precise substrate specificity depends on the other subunit in the heterodimer (PubMed:9829974, PubMed:9751058, PubMed:10391915, PubMed:10574970, PubMed:30867591, PubMed:10903140). The complexes function as amino acid exchangers (PubMed:11557028, PubMed:10903140, PubMed:12117417, PubMed:12225859, PubMed:30867591). The homodimer functions as sodium-independent, high-affinity transporter that mediates uptake of large neutral amino acids such as phenylalanine, tyrosine, L-DOPA, leucine, histidine, methionine and tryptophan (PubMed:9751058, PubMed:11557028, PubMed:11311135, PubMed:11564694, PubMed:12117417, PubMed:12225859, PubMed:25998567, PubMed:30867591). The heterodimer formed by SLC3A2 and SLC7A6 or SLC3A2 and SLC7A7 mediates the uptake of dibasic amino acids (PubMed:9829974, PubMed:10903140). The heterodimer with SLC7A5/LAT1 mediates the transport of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane (PubMed:11564694, PubMed:12225859). The heterodimer with SLC7A5/LAT1 is involved in the uptake of toxic methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes (PubMed:12117417). The heterodimer with SLC7A5/LAT1 is involved in the uptake of leucine (PubMed:25998567, PubMed:30341327). When associated with LAPTM4B, the heterodimer with SLC7A5/LAT1 is recruited to lysosomes to promote leucine uptake into these organelles, and thereby mediates mTORC1 activation (PubMed:25998567). The heterodimer with SLC7A5/LAT1 may play a role in the transport of L-DOPA across the blood-brain barrier (By similarity). The heterodimer formed by SLC3A2 and SLC7A5/LAT1 or SLC3A2 and SLC7A8/LAT2 is involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane (PubMed:15769744). Together with ICAM1, regulates the transport activity of SLC7A8/LAT2 in polarized intestinal cells by generating and delivering intracellular signals (PubMed:12716892). Required for targeting of SLC7A5/LAT1 and SLC7A8/LAT2 to the plasma membrane and for channel activity (PubMed:9751058, PubMed:11311135, PubMed:30867591). Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine (PubMed:14603368). May mediate blood-to-retina L-leucine transport across the inner blood-retinal barrier (By similarity). {ECO:0000250|UniProtKB:P10852, ECO:0000250|UniProtKB:Q794F9, ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:10903140, ECO:0000269|PubMed:11311135, ECO:0000269|PubMed:11389679, ECO:0000269|PubMed:11557028, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:11742812, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:12716892, ECO:0000269|PubMed:14603368, ECO:0000269|PubMed:15769744, ECO:0000269|PubMed:15980244, ECO:0000269|PubMed:25998567, ECO:0000269|PubMed:30341327, ECO:0000269|PubMed:30867591, ECO:0000269|PubMed:9751058, ECO:0000269|PubMed:9829974, ECO:0000269|PubMed:9878049}.; (Microbial infection) In case of hepatitis C virus/HCV infection, the complex formed by SLC3A2 and SLC7A5/LAT1 plays a role in HCV propagation by facilitating viral entry into host cell and increasing L-leucine uptake-mediated mTORC1 signaling activation, thereby contributing to HCV-mediated pathogenesis. {ECO:0000269|PubMed:30341327}.","6":"-19.10640441","7":"-34.167915288","8":"Undefined","9":"ER,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"P08195"},{"1":"GUSB","2":"BGLR_HUMAN","3":"LYSOSOME","4":"Beta-glucuronidase (EC 3.2.1.31) (Beta-G1)","5":"Plays an important role in the degradation of dermatan and keratan sulfates.","6":"3.95264292","7":"-43.678697647","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08236"},{"1":"PFKM PFKX","2":"PFKAM_HUMAN","3":"unknown","4":"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)","5":"Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.","6":"39.10497593","7":"6.227901768","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P08237"},{"1":"HSP90AB1 HSP90B HSPC2 HSPCB","2":"HS90B_HUMAN","3":"unknown","4":"Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)","5":"Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478993, PubMed:19696785). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:27295069, PubMed:26991466). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery (PubMed:18239673). Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription (PubMed:20353823). Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:32272059, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.","6":"-16.20164103","7":"8.599074838","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P08238"},{"1":"SRPRA SRPR","2":"SRPRA_HUMAN","3":"ER","4":"Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)","5":"Component of the SRP (signal recognition particle) receptor. Ensures, in conjunction with the signal recognition particle, the correct targeting of the nascent secretory proteins to the endoplasmic reticulum membrane system.","6":"-16.66822941","7":"-29.389259803","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08240"},{"1":"ASNS TS11","2":"ASNS_HUMAN","3":"unknown","4":"Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)","5":"NA","6":"40.45586539","7":"4.998173419","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P08243"},{"1":"HMBS PBGD UPS","2":"HEM3_HUMAN","3":"CYTOSOL","4":"Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)","5":"Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen in several discrete steps.","6":"20.08810536","7":"-2.347059609","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08397"},{"1":"PDHA1 PHE1A","2":"ODPA_HUMAN","3":"MITOCHONDRIA","4":"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)","5":"The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:19081061, ECO:0000269|PubMed:7782287}.","6":"-41.55794793","7":"-9.882037758","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08559"},{"1":"COL4A2","2":"CO4A2_HUMAN","3":"unknown","4":"Collagen alpha-2(IV) chain [Cleaved into: Canstatin]","5":"Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; Canstatin, a cleavage product corresponding to the collagen alpha 2(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity. It inhibits proliferation and migration of endothelial cells, reduces mitochondrial membrane potential, and induces apoptosis. Specifically induces Fas-dependent apoptosis and activates procaspase-8 and -9 activity. Ligand for alphavbeta3 and alphavbeta5 integrins.","6":"-25.11028063","7":"-18.701170289","8":"PEROXISOME","9":"PEROXISOME,PEROXISOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P08572"},{"1":"CYC1","2":"CY1_HUMAN","3":"unknown","4":"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)","5":"Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. Cytochrome c1 is a catalytic core subunit containing a c-type heme. It transfers electrons from the [2Fe-2S] iron-sulfur cluster of the Rieske protein to cytochrome c. {ECO:0000250|UniProtKB:P07143}.","6":"-32.42152052","7":"-7.798545465","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P08574"},{"1":"SNRPB2","2":"RU2B_HUMAN","3":"NUCLEOPLASM-2","4":"U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')","5":"Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28502770, PubMed:28781166, PubMed:28076346). Associated with sn-RNP U2, where it contributes to the binding of stem loop IV of U2 snRNA (PubMed:9716128). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:9716128}.","6":"-12.81706420","7":"29.280342434","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08579"},{"1":"MELTF MAP97 MFI2","2":"TRFM_HUMAN","3":"PM","4":"Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)","5":"Involved in iron cellular uptake. Seems to be internalized and then recycled back to the cell membrane. Binds a single atom of iron per subunit. Could also bind zinc. {ECO:0000269|PubMed:7556058}.","6":"-4.04495220","7":"-38.159834412","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08582"},{"1":"SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1","2":"RU17_HUMAN","3":"unknown","4":"U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)","5":"Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome (PubMed:19325628, PubMed:25555158). SNRNP70 binds to the loop I region of U1-snRNA (PubMed:2467746, PubMed:19325628, PubMed:25555158). {ECO:0000269|PubMed:19325628, ECO:0000269|PubMed:2467746, ECO:0000269|PubMed:25555158}.; [Isoform 3]: Truncated isoforms that lack the RRM domain cannot bind U1-snRNA. {ECO:0000269|PubMed:2467746}.; [Isoform 4]: Truncated isoforms that lack the RRM domain cannot bind U1-snRNA. {ECO:0000269|PubMed:2467746}.","6":"-10.16237141","7":"27.249400585","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P08621"},{"1":"ITGA5 FNRA","2":"ITA5_HUMAN","3":"PM","4":"Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]","5":"Integrin alpha-5/beta-1 (ITGA5:ITGB1) is a receptor for fibronectin and fibrinogen. It recognizes the sequence R-G-D in its ligands. ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling (PubMed:29030430). ITGA5:ITGB3 is a receptor for soluble CD40LG and is required for CD40/CD40LG signaling (PubMed:31331973). {ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:31331973}.; (Microbial infection) Integrin ITGA5:ITGB1 acts as a receptor for Human metapneumovirus. {ECO:0000269|PubMed:12907437}.; (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human parvovirus B19. {ECO:0000269|PubMed:24478423}.; (Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}.","6":"6.92780812","7":"-39.665533272","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08648"},{"1":"NFIC NFI","2":"NFIC_HUMAN","3":"unknown","4":"Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein)","5":"Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.","6":"-10.62966212","7":"25.719225337","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P08651"},{"1":"RPS17 RPS17L","2":"RS17_HUMAN","3":"unknown","4":"40S ribosomal protein S17 (Small ribosomal subunit protein eS17)","5":"NA","6":"30.14487938","7":"-18.905860319","8":"RIBOSOME","9":"RIBOSOME,RIBOSOME,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P08708"},{"1":"GNAI3","2":"GNAI3_HUMAN","3":"PM","4":"Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3)","5":"Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:8774883, PubMed:18434541, PubMed:19478087). Signaling is mediated via effector proteins, such as adenylate cyclase. Inhibits adenylate cyclase activity, leading to decreased intracellular cAMP levels (PubMed:19478087). Stimulates the activity of receptor-regulated K(+) channels (PubMed:2535845). The active GTP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division (PubMed:17635935). {ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:2535845, ECO:0000269|PubMed:8774883}.","6":"-1.20034585","7":"-41.887003361","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08754"},{"1":"RPSA LAMBR LAMR1","2":"RSSA_HUMAN","3":"RIBOSOME","4":"40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)","5":"Required for the assembly and/or stability of the 40S ribosomal subunit. Required for the processing of the 20S rRNA-precursor to mature 18S rRNA in a late step of the maturation of 40S ribosomal subunits. Also functions as a cell surface receptor for laminin. Plays a role in cell adhesion to the basement membrane and in the consequent activation of signaling transduction pathways. May play a role in cell fate determination and tissue morphogenesis. Acts as a PPP1R16B-dependent substrate of PPP1CA. {ECO:0000255|HAMAP-Rule:MF_03016, ECO:0000269|PubMed:16263087, ECO:0000269|PubMed:6300843}.; (Microbial infection) Acts as a receptor for the Adeno-associated viruses 2,3,8 and 9. {ECO:0000269|PubMed:16973587}.; (Microbial infection) Acts as a receptor for the Dengue virus. {ECO:0000269|PubMed:15507651}.; (Microbial infection) Acts as a receptor for the Sindbis virus. {ECO:0000269|PubMed:1385835}.; (Microbial infection) Acts as a receptor for the Venezuelan equine encephalitis virus. {ECO:0000269|PubMed:1385835}.; (Microbial infection) Acts as a receptor for the pathogenic prion protein. {ECO:0000269|PubMed:11689427, ECO:0000269|PubMed:9396609}.; (Microbial infection) Acts as a receptor for bacteria. {ECO:0000269|PubMed:15516338}.","6":"30.43646387","7":"-21.223053137","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P08865"},{"1":"MRPL3 MRL3 RPML3","2":"RM03_HUMAN","3":"unknown","4":"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3) (Mitochondrial large ribosomal subunit protein uL3m)","5":"NA","6":"-37.81635096","7":"-16.686834679","8":"Undefined","9":"MITOCHONDRIA,MITOCHONDRIA,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P09001"},{"1":"SNRPA","2":"SNRPA_HUMAN","3":"unknown","4":"U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)","5":"Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. U1 snRNP is the first snRNP to interact with pre-mRNA. This interaction is required for the subsequent binding of U2 snRNP and the U4/U6/U5 tri-snRNP. SNRPA binds stem loop II of U1 snRNA. In a snRNP-free form (SF-A) may be involved in coupled pre-mRNA splicing and polyadenylation process. May bind preferentially to the 5'-UGCAC-3' motif on RNAs. {ECO:0000269|PubMed:9848648}.","6":"-7.96497066","7":"13.164969484","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09012"},{"1":"ENO2","2":"ENOG_HUMAN","3":"unknown","4":"Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)","5":"Has neurotrophic and neuroprotective properties on a broad spectrum of central nervous system (CNS) neurons. Binds, in a calcium-dependent manner, to cultured neocortical neurons and promotes cell survival (By similarity). {ECO:0000250}.","6":"19.68696093","7":"22.418114834","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09104"},{"1":"ACAA1 ACAA PTHIO","2":"THIK_HUMAN","3":"PEROXISOME","4":"3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Acetyl-CoA acyltransferase) (EC 2.3.1.9) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase)","5":"Responsible for the thiolytic cleavage of straight chain 3-oxoacyl-CoAs. Catalyzes the cleavage of short, medium and long straight chain 3-oxoacyl-CoAs, medium chain 3-oxoacyl-CoAs being the best substrates. {ECO:0000250|UniProtKB:P21775}.","6":"-20.02906017","7":"-16.802826981","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P09110"},{"1":"SRP19","2":"SRP19_HUMAN","3":"unknown","4":"Signal recognition particle 19 kDa protein (SRP19)","5":"Signal-recognition-particle assembly, binds directly to 7S RNA and mediates binding of the 54 kDa subunit of the SRP.","6":"19.12266371","7":"31.865113812","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P09132"},{"1":"LGALS1","2":"LEG1_HUMAN","3":"unknown","4":"Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1)","5":"Lectin that binds beta-galactoside and a wide array of complex carbohydrates. Plays a role in regulating apoptosis, cell proliferation and cell differentiation. Inhibits CD45 protein phosphatase activity and therefore the dephosphorylation of Lyn kinase. Strong inducer of T-cell apoptosis. {ECO:0000269|PubMed:14617626, ECO:0000269|PubMed:18796645, ECO:0000269|PubMed:19497882, ECO:0000269|PubMed:24945728}.","6":"9.87745696","7":"-23.629892583","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09382"},{"1":"QDPR DHPR SDR33C1","2":"DHPR_HUMAN","3":"unknown","4":"Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)","5":"The product of this enzyme, tetrahydrobiopterin (BH-4), is an essential cofactor for phenylalanine, tyrosine, and tryptophan hydroxylases.","6":"10.13326510","7":"0.583983778","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P09417"},{"1":"HMGB1 HMG1","2":"HMGB1_HUMAN","3":"unknown","4":"High mobility group protein B1 (High mobility group protein 1) (HMG-1)","5":"Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability (Ref.71). Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as danger associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury (PubMed:27362237). Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors. In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23519706, PubMed:23446148, PubMed:23994764, PubMed:25048472). Has proangiogdenic activity (By similarity). May be involved in platelet activation (By similarity). Binds to phosphatidylserine and phosphatidylethanolamide (By similarity). Bound to RAGE mediates signaling for neuronal outgrowth (By similarity). May play a role in accumulation of expanded polyglutamine (polyQ) proteins such as huntingtin (HTT) or TBP (PubMed:23303669, PubMed:25549101). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P12682, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:23303669, ECO:0000269|PubMed:25549101, ECO:0000269|PubMed:27362237, ECO:0000269|Ref.71, ECO:0000305|PubMed:23446148, ECO:0000305|PubMed:23519706, ECO:0000305|PubMed:23994764, ECO:0000305|PubMed:25048472}.; Nuclear functions are attributed to fully reduced HGMB1. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA, DNA-containing cruciforms or bent structures, supercoiled DNA and ZDNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:20123072). May have an enhancing role in nucleotide excision repair (NER) (By similarity). However, effects in NER using in vitro systems have been reported conflictingly (PubMed:19446504, PubMed:19360789). May be involved in mismatch repair (MMR) and base excision repair (BER) pathways (PubMed:15014079, PubMed:16143102, PubMed:17803946). May be involved in double strand break repair such as non-homologous end joining (NHEJ) (By similarity). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). In vitro can displace histone H1 from highly bent DNA (By similarity). Can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (By similarity). Enhances binding of sterol regulatory element-binding proteins (SREBPs) such as SREBF1 to their cognate DNA sequences and increases their transcriptional activities (By similarity). Facilitates binding of TP53 to DNA (PubMed:23063560). Proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating HSPB1; however, this function has been questioned (By similarity). Can modulate the activity of the telomerase complex and may be involved in telomere maintenance (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:15014079, ECO:0000269|PubMed:16143102, ECO:0000269|PubMed:17803946, ECO:0000269|PubMed:19446504, ECO:0000269|PubMed:23063560, ECO:0000305|PubMed:19360789, ECO:0000305|PubMed:20123072}.; In the cytoplasm proposed to dissociate the BECN1:BCL2 complex via competitive interaction with BECN1 leading to autophagy activation (PubMed:20819940). Involved in oxidative stress-mediated autophagy (PubMed:21395369). Can protect BECN1 and ATG5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (By similarity). In myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (By similarity). Involved in endosomal translocation and activation of TLR9 in response to CpG-DNA in macrophages (By similarity). {ECO:0000250|UniProtKB:P63158, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21395369}.; In the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. Fully reduced HGMB1 (which subsequently gets oxidized after release) in association with CXCL12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the CXCL12:HMGB1 complex triggers CXCR4 homodimerization (PubMed:22370717). Induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating AGER/RAGE and ITGAM (By similarity). Can bind to various types of DNA and RNA including microbial unmethylated CpG-DNA to enhance the innate immune response to nucleic acids. Proposed to act in promiscuous DNA/RNA sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). Promotes extracellular DNA-induced AIM2 inflammasome activation implicating AGER/RAGE (PubMed:24971542). Disulfide HMGB1 binds to transmembrane receptors, such as AGER/RAGE, TLR2, TLR4 and probably TREM1, thus activating their signal transduction pathways. Mediates the release of cytokines/chemokines such as TNF, IL-1, IL-6, IL-8, CCL2, CCL3, CCL4 and CXCL10 (PubMed:12765338, PubMed:18354232, PubMed:19264983, PubMed:20547845, PubMed:24474694). Promotes secretion of interferon-gamma by macrophage-stimulated natural killer (NK) cells in concert with other cytokines like IL-2 or IL-12 (PubMed:15607795). TLR4 is proposed to be the primary receptor promoting macrophage activation and signaling through TLR4 seems to implicate LY96/MD-2 (PubMed:20547845). In bacterial LPS- or LTA-mediated inflammatory responses binds to the endotoxins and transfers them to CD14 for signaling to the respective TLR4:LY96 and TLR2 complexes (PubMed:18354232, PubMed:21660935, PubMed:25660311). Contributes to tumor proliferation by association with ACER/RAGE (By similarity). Can bind to IL1-beta and signals through the IL1R1:IL1RAP receptor complex (PubMed:18250463). Binding to class A CpG activates cytokine production in plasmacytoid dendritic cells implicating TLR9, MYD88 and AGER/RAGE and can activate autoreactive B cells. Via HMGB1-containing chromatin immune complexes may also promote B cell responses to endogenous TLR9 ligands through a B-cell receptor (BCR)-dependent and ACER/RAGE-independent mechanism (By similarity). Inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-ADP-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (By similarity). In adaptive immunity may be involved in enhancing immunity through activation of effector T cells and suppression of regulatory T (TReg) cells (PubMed:15944249, PubMed:22473704). In contrast, without implicating effector or regulatory T-cells, required for tumor infiltration and activation of T-cells expressing the lymphotoxin LTA:LTB heterotrimer thus promoting tumor malignant progression (By similarity). Also reported to limit proliferation of T-cells (By similarity). Released HMGB1:nucleosome complexes formed during apoptosis can signal through TLR2 to induce cytokine production (PubMed:19064698). Involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ROS)-dependent oxidation specifically on Cys-106 (PubMed:18631454). During macrophage activation by activated lymphocyte-derived self apoptotic DNA (ALD-DNA) promotes recruitment of ALD-DNA to endosomes (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:12765338, ECO:0000269|PubMed:15607795, ECO:0000269|PubMed:15944249, ECO:0000269|PubMed:18250463, ECO:0000269|PubMed:18354232, ECO:0000269|PubMed:18631454, ECO:0000269|PubMed:19064698, ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:20547845, ECO:0000269|PubMed:21660935, ECO:0000269|PubMed:22370717, ECO:0000269|PubMed:22473704, ECO:0000269|PubMed:24474694, ECO:0000269|PubMed:24971542, ECO:0000269|PubMed:25660311, ECO:0000269|Ref.8}.; (Microbial infection) Critical for entry of human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63. Regulates the expression of the pro-viral genes ACE2 and CTSL through chromatin modulation. {ECO:0000269|Ref.71}.","6":"-9.50476840","7":"-2.232819094","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09429"},{"1":"RBP1 CRBP1","2":"RET1_HUMAN","3":"unknown","4":"Retinol-binding protein 1 (Cellular retinol-binding protein) (CRBP) (Cellular retinol-binding protein I) (CRBP-I)","5":"Cytoplasmic retinol-binding protein (PubMed:22665496, PubMed:26900151, PubMed:28057518). Accepts retinol from the transport protein STRA6, and thereby contributes to retinol uptake, storage and retinoid homeostasis (PubMed:15632377, PubMed:22665496). {ECO:0000269|PubMed:15632377, ECO:0000269|PubMed:22665496, ECO:0000269|PubMed:26900151, ECO:0000269|PubMed:28057518}.","6":"12.27121820","7":"-7.915828655","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09455"},{"1":"GNAO1","2":"GNAO_HUMAN","3":"unknown","4":"Guanine nucleotide-binding protein G(o) subunit alpha","5":"Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(o) protein function is not clear. Stimulated by RGS14.","6":"-14.17725619","7":"-37.926831930","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09471"},{"1":"SPARC ON","2":"SPRC_HUMAN","3":"unknown","4":"SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)","5":"Appears to regulate cell growth through interactions with the extracellular matrix and cytokines. Binds calcium and copper, several types of collagen, albumin, thrombospondin, PDGF and cell membranes. There are two calcium binding sites; an acidic domain that binds 5 to 8 Ca(2+) with a low affinity and an EF-hand loop that binds a Ca(2+) ion with a high affinity.","6":"3.94294573","7":"-40.294824241","8":"Undefined","9":"Undefined,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P09486"},{"1":"TPM1 C15orf13 TMSA","2":"TPM1_HUMAN","3":"unknown","4":"Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)","5":"Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.","6":"11.38829311","7":"-27.844202618","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09493"},{"1":"CLTA","2":"CLCA_HUMAN","3":"unknown","4":"Clathrin light chain A (Lca)","5":"Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge (PubMed:15858577, PubMed:21297582). {ECO:0000305|PubMed:15858577, ECO:0000305|PubMed:21297582}.","6":"25.42106590","7":"33.696748138","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P09496"},{"1":"CLTB","2":"CLCB_HUMAN","3":"unknown","4":"Clathrin light chain B (Lcb)","5":"Clathrin is the major protein of the polyhedral coat of coated pits and vesicles.","6":"25.38369819","7":"33.654416849","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P09497"},{"1":"ANXA4 ANX4","2":"ANXA4_HUMAN","3":"unknown","4":"Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)","5":"Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis. {ECO:0000250}.","6":"12.42658985","7":"-26.428729121","8":"Undefined","9":"GOLGI,Undefined,LYSOSOME","10":"Highly confident","11":"3","12":"1,2,3","_rn_":"P09525"},{"1":"CNP","2":"CN37_HUMAN","3":"PM","4":"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)","5":"May participate in RNA metabolism in the myelinating cell, CNP is the third most abundant protein in central nervous system myelin. {ECO:0000250}.","6":"4.35866811","7":"-34.948995901","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P09543"},{"1":"HMOX1 HO HO1","2":"HMOX1_HUMAN","3":"unknown","4":"Heme oxygenase 1 (HO-1) (EC 1.14.14.18)","5":"Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. Exhibits cytoprotective effects since excess of free heme sensitizes cells to undergo apoptosis.","6":"-2.14528962","7":"-44.616731451","8":"Undefined","9":"Undefined,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P09601"},{"1":"PDGFRB PDGFR PDGFR1","2":"PGFRB_HUMAN","3":"unknown","4":"Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b)","5":"Tyrosine-protein kinase that acts as cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration. Plays an essential role in blood vessel development by promoting proliferation, migration and recruitment of pericytes and smooth muscle cells to endothelial cells. Plays a role in the migration of vascular smooth muscle cells and the formation of neointima at vascular injury sites. Required for normal development of the cardiovascular system. Required for normal recruitment of pericytes (mesangial cells) in the kidney glomerulus, and for normal formation of a branched network of capillaries in kidney glomeruli. Promotes rearrangement of the actin cytoskeleton and the formation of membrane ruffles. Binding of its cognate ligands - homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFD -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PLCG1, PIK3R1, PTPN11, RASA1/GAP, CBL, SHC1 and NCK1. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to the activation of the AKT1 signaling pathway. Phosphorylation of SHC1, or of the C-terminus of PTPN11, creates a binding site for GRB2, resulting in the activation of HRAS, RAF1 and down-stream MAP kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation and activation of SRC family kinases. Promotes phosphorylation of PDCD6IP/ALIX and STAM. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. {ECO:0000269|PubMed:11297552, ECO:0000269|PubMed:11331881, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1396585, ECO:0000269|PubMed:1653029, ECO:0000269|PubMed:1709159, ECO:0000269|PubMed:1846866, ECO:0000269|PubMed:20494825, ECO:0000269|PubMed:20529858, ECO:0000269|PubMed:21098708, ECO:0000269|PubMed:21679854, ECO:0000269|PubMed:21733313, ECO:0000269|PubMed:2554309, ECO:0000269|PubMed:26599395, ECO:0000269|PubMed:2835772, ECO:0000269|PubMed:2850496, ECO:0000269|PubMed:7685273, ECO:0000269|PubMed:7691811, ECO:0000269|PubMed:7692233, ECO:0000269|PubMed:8195171}.","6":"-3.48086621","7":"-38.557066773","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P09619"},{"1":"DLD GCSL LAD PHE3","2":"DLDH_HUMAN","3":"MITOCHONDRIA","4":"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)","5":"Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex) (PubMed:15712224, PubMed:16442803, PubMed:16770810, PubMed:17404228, PubMed:20160912, PubMed:20385101). The 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion (PubMed:29211711). A fraction of the 2-oxoglutarate dehydrogenase complex also localizes in the nucleus and is required for lysine succinylation of histones: associates with KAT2A on chromatin and provides succinyl-CoA to histone succinyltransferase KAT2A (PubMed:29211711). In monomeric form may have additional moonlighting function as serine protease (PubMed:17404228). Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction (By similarity). {ECO:0000250|UniProtKB:Q811C4, ECO:0000269|PubMed:15712224, ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:20385101, ECO:0000269|PubMed:29211711}.","6":"-39.41550568","7":"-10.753559442","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P09622"},{"1":"HNRNPA1 HNRPA1","2":"ROA1_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]","5":"Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection (PubMed:17371836). May bind to specific miRNA hairpins (PubMed:28431233). Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating factor APAF1 (PubMed:31498791). {ECO:0000269|PubMed:17371836, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:31498791}.; (Microbial infection) May play a role in HCV RNA replication. {ECO:0000269|PubMed:17229681}.; (Microbial infection) Cleavage by Enterovirus 71 protease 3C results in increased translation of apoptosis protease activating factor APAF1, leading to apoptosis. {ECO:0000269|PubMed:17229681}.","6":"43.62545609","7":"-2.166680360","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P09651"},{"1":"SNRPA1","2":"RU2A_HUMAN","3":"unknown","4":"U2 small nuclear ribonucleoprotein A' (U2 snRNP A')","5":"Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28502770, PubMed:28781166, PubMed:28076346, PubMed:27035939). Associated with sn-RNP U2, where it contributes to the binding of stem loop IV of U2 snRNA (PubMed:9716128, PubMed:27035939). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:27035939, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:9716128}.","6":"-12.76176294","7":"28.917543230","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P09661"},{"1":"PARP1 ADPRT PPOL","2":"PARP1_HUMAN","3":"unknown","4":"Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)","5":"Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed:17177976, PubMed:18172500, PubMed:19344625, PubMed:19661379, PubMed:23230272, PubMed:25043379, PubMed:33186521, PubMed:32028527, PubMed:26344098). Mediates glutamate, aspartate, serine or tyrosine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units (PubMed:7852410, PubMed:9315851, PubMed:19764761, PubMed:25043379, PubMed:28190768, PubMed:29954836). Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (PubMed:33186521). Mainly mediates glutamate and aspartate ADP-ribosylation of target proteins in absence of HPF1 (PubMed:19764761, PubMed:25043379). Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 conferring serine specificity by completing the PARP1 active site (PubMed:28190768, PubMed:29954836, PubMed:33186521, PubMed:32028527). Also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1 (PubMed:30257210, PubMed:29954836). PARP1 initiates the repair of DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones, thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks (PubMed:17177976, PubMed:18172500, PubMed:19344625, PubMed:19661379, PubMed:23230272, PubMed:27067600). In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair: together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation (PubMed:26344098, PubMed:30356214). Mediates the poly(ADP-ribosyl)ation of a number of proteins, including itself, APLF and CHFR (PubMed:17396150, PubMed:19764761). In addition to proteins, also able to ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively (PubMed:27471034). Required for PARP9 and DTX3L recruitment to DNA damage sites (PubMed:23230272). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272). Acts as a regulator of transcription: positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150 (PubMed:19344625). Plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and EEF1A1 (PubMed:17177976). Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5 (PubMed:27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming (PubMed:27257257). {ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:17396150, ECO:0000269|PubMed:18172500, ECO:0000269|PubMed:19344625, ECO:0000269|PubMed:19661379, ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:23230272, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:26344098, ECO:0000269|PubMed:27067600, ECO:0000269|PubMed:27257257, ECO:0000269|PubMed:27471034, ECO:0000269|PubMed:28190768, ECO:0000269|PubMed:29954836, ECO:0000269|PubMed:30257210, ECO:0000269|PubMed:30356214, ECO:0000269|PubMed:32028527, ECO:0000269|PubMed:33186521, ECO:0000269|PubMed:7852410, ECO:0000269|PubMed:9315851}.","6":"0.34461849","7":"15.001974453","8":"Undefined","9":"PROTEIN COMPLEX,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P09874"},{"1":"POLA1 POLA","2":"DPOLA_HUMAN","3":"unknown","4":"DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)","5":"Catalytic subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis. During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, a regulatory subunit POLA2 and two primase subunits PRIM1 and PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1. The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively. The reason this transfer occurs is because the polymerase alpha has limited processivity and lacks intrinsic 3' exonuclease activity for proofreading error, and therefore is not well suited for replicating long complexes. In the cytosol, responsible for a substantial proportion of the physiological concentration of cytosolic RNA:DNA hybrids, which are necessary to prevent spontaneous activation of type I interferon responses (PubMed:27019227). {ECO:0000269|PubMed:27019227, ECO:0000269|PubMed:31006512, ECO:0000269|PubMed:9518481}.","6":"-1.17432386","7":"33.360823028","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P09884"},{"1":"ALOX5 LOG5","2":"LOX5_HUMAN","3":"unknown","4":"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","5":"Catalyzes the oxygenation of arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to 5-hydroperoxyeicosatetraenoate (5-HPETE) followed by the dehydration to 5,6- epoxyeicosatetraenoate (Leukotriene A4/LTA4), the first two steps in the biosynthesis of leukotrienes, which are potent mediators of inflammation (PubMed:8631361, PubMed:21233389, PubMed:22516296, PubMed:24282679, PubMed:19022417, PubMed:23246375, PubMed:8615788, PubMed:24893149, PubMed:31664810). Also catalyzes the oxygenation of arachidonate into 8-hydroperoxyicosatetraenoate (8-HPETE) and 12-hydroperoxyicosatetraenoate (12-HPETE) (PubMed:23246375). Displays lipoxin synthase activity being able to convert (15S)-HETE into a conjugate tetraene (PubMed:31664810). Although arachidonate is the preferred substrate, this enzyme can also metabolize oxidized fatty acids derived from arachidonate such as (15S)-HETE, eicosapentaenoate (EPA) such as (18R)- and (18S)-HEPE or docosahexaenoate (DHA) which lead to the formation of specialized pro-resolving mediators (SPM) lipoxin and resolvins E and D respectively, therefore it participates in anti-inflammatory responses (PubMed:21206090, PubMed:31664810, PubMed:8615788, PubMed:17114001, PubMed:32404334). Oxidation of DHA directly inhibits endothelial cell proliferation and sprouting angiogenesis via peroxisome proliferator-activated receptor gamma (PPARgamma) (By similarity). It does not catalyze the oxygenation of linoleic acid and does not convert (5S)-HETE to lipoxin isomers (PubMed:31664810). In addition to inflammatory processes, it participates in dendritic cell migration, wound healing through an antioxidant mechanism based on heme oxygenase-1 (HO-1) regulation expression, monocyte adhesion to the endothelium via ITGAM expression on monocytes (By similarity). Moreover, it helps establish an adaptive humoral immunity by regulating primary resting B cells and follicular helper T cells and participates in the CD40-induced production of reactive oxygen species (ROS) after CD40 ligation in B cells through interaction with PIK3R1 that bridges ALOX5 with CD40 (PubMed:21200133). Also may play a role in glucose homeostasis, regulation of insulin secretion and palmitic acid-induced insulin resistance via AMPK (By similarity). Can regulate bone mineralization and fat cell differentiation increases in induced pluripotent stem cells (By similarity). {ECO:0000250|UniProtKB:P48999, ECO:0000269|PubMed:17114001, ECO:0000269|PubMed:19022417, ECO:0000269|PubMed:21200133, ECO:0000269|PubMed:21206090, ECO:0000269|PubMed:21233389, ECO:0000269|PubMed:22516296, ECO:0000269|PubMed:23246375, ECO:0000269|PubMed:24282679, ECO:0000269|PubMed:24893149, ECO:0000269|PubMed:31664810, ECO:0000269|PubMed:32404334, ECO:0000269|PubMed:8615788, ECO:0000269|PubMed:8631361}.","6":"14.50753539","7":"-28.555704116","8":"GOLGI","9":"GOLGI,Undefined,GOLGI","10":"Highly confident","11":"2","12":"1,3","_rn_":"P09917"},{"1":"LTA4H LTA4","2":"LKHA4_HUMAN","3":"unknown","4":"Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)","5":"Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities. Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the proinflammatory mediator leukotriene B4 (LTB4) (PubMed:11917124, PubMed:12207002, PubMed:15078870, PubMed:18804029, PubMed:1897988, PubMed:1975494, PubMed:2244921). Has also aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (PubMed:20813919, PubMed:18804029). In addition to its proinflammatory EH activity, may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP9) and prolylendopeptidase (PREPL) (PubMed:20813919, PubMed:24591641). Involved also in the biosynthesis of resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid mediators that show potent anti-inflammatory and pro-resolving actions (PubMed:21206090). {ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:1975494, ECO:0000269|PubMed:20813919, ECO:0000269|PubMed:21206090, ECO:0000269|PubMed:2244921, ECO:0000269|PubMed:24591641}.","6":"28.71229437","7":"11.051841988","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P09960"},{"1":"C4A CO4 CPAMD2","2":"CO4A_HUMAN","3":"unknown","4":"Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]","5":"Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. C4A isotype is responsible for effective binding to form amide bonds with immune aggregates or protein antigens, while C4B isotype catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens.; Derived from proteolytic degradation of complement C4, C4a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes.","6":"11.76521578","7":"-39.586021381","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P0C0L4"},{"1":"ATXN1L BOAT BOAT1","2":"ATX1L_HUMAN","3":"unknown","4":"Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1)","5":"Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression (PubMed:21475249). Can suppress ATXN1 cytotoxicity in spinocerebellar ataxia type 1 (SCA1). In concert with CIC and ATXN1, involved in brain development (By similarity). {ECO:0000250|UniProtKB:P0C7T6, ECO:0000269|PubMed:21475249}.","6":"11.47896198","7":"28.510166313","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P0C7T5"},{"1":"ELFN1 PPP1R28","2":"ELFN1_HUMAN","3":"unknown","4":"Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28)","5":"Postsynaptic protein that regulates circuit dynamics in the central nervous system by modulating the temporal dynamics of interneuron recruitment. Specifically present in excitatory synapses onto oriens-lacunosum molecular (OLM) interneurons and acts as a regulator of presynaptic release probability to direct the formation of highly facilitating pyramidal-OLM synapses (By similarity). Inhibits phosphatase activity of protein phosphatase 1 (PP1) complexes. {ECO:0000250, ECO:0000269|PubMed:19389623}.","6":"-3.42713908","7":"-39.099231036","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P0C7U0"},{"1":"DCAF8L2 WDR42C","2":"DC8L2_HUMAN","3":"unknown","4":"DDB1- and CUL4-associated factor 8-like protein 2 (WD repeat-containing protein 42C)","5":"NA","6":"-4.34198320","7":"33.378561373","8":"Undefined","9":"NUCLEOPLASM-2,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P0C7V8"},{"1":"POLR2M GRINL1A","2":"GRL1A_HUMAN","3":"unknown","4":"DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A)","5":"Isoform 1 appears to be a stable component of the Pol II(G) complex form of RNA polymerase II (Pol II). Pol II synthesizes mRNA precursors and many functional non-coding RNAs and is the central component of the basal RNA polymerase II transcription machinery. Isoform 1 may play a role in the Mediator complex-dependent regulation of transcription activation. Isoform 1 acts in vitro as a negative regulator of transcriptional activation; this repression is relieved by the Mediator complex, which restores Pol II(G) activator-dependent transcription to a level equivalent to that of Pol II. {ECO:0000269|PubMed:16769904}.","6":"21.51024611","7":"32.714634076","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P0CAP2"},{"1":"RAB34 NARR","2":"NARR_HUMAN","3":"unknown","4":"Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats)","5":"NA","6":"7.86973307","7":"-14.476071292","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P0DI83"},{"1":"HSPA1B HSP72","2":"HS71B_HUMAN","3":"unknown","4":"Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2)","5":"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:26865365, PubMed:24318877). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}.","6":"7.85932776","7":"8.682746435","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P0DMV9"},{"1":"CBSL","2":"CBSL_HUMAN","3":"unknown","4":"Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)","5":"Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine. Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons. {ECO:0000250|UniProtKB:P32232, ECO:0000250|UniProtKB:P35520}.","6":"22.49033488","7":"23.416133515","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P0DN79"},{"1":"CALM3 CALML2 CAM3 CAMC CAMIII","2":"CALM3_HUMAN","3":"unknown","4":"Calmodulin-3","5":"Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Is a regulator of voltage-dependent L-type calcium channels (PubMed:31454269). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis. {ECO:0000250|UniProtKB:P0DP23, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:31454269}.","6":"8.92112638","7":"-22.450472283","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P0DP25"},{"1":"GLI2 THP","2":"GLI2_HUMAN","3":"unknown","4":"Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein)","5":"Functions as transcription regulator in the hedgehog (Hh) pathway (PubMed:18455992, PubMed:26565916). Functions as transcriptional activator (PubMed:9557682, PubMed:19878745, PubMed:24311597). May also function as transcriptional repressor (By similarity). Requires STK36 for full transcriptional activator activity. Required for normal embryonic development (PubMed:15994174, PubMed:20685856). {ECO:0000250|UniProtKB:Q0VGT2, ECO:0000269|PubMed:15994174, ECO:0000269|PubMed:18455992, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:9557682, ECO:0000305|PubMed:20685856}.; [Isoform 1]: Involved in the smoothened (SHH) signaling pathway. {ECO:0000269|PubMed:18455992}.; [Isoform 2]: Involved in the smoothened (SHH) signaling pathway. {ECO:0000269|PubMed:18455992}.; [Isoform 3]: Involved in the smoothened (SHH) signaling pathway. {ECO:0000269|PubMed:18455992}.; [Isoform 4]: Involved in the smoothened (SHH) signaling pathway. {ECO:0000269|PubMed:18455992}.; [Isoform 1]: Acts as a transcriptional activator in T-cell leukemia virus type 1 (HTLV-1)-infected cells in a Tax-dependent manner. Binds to the DNA sequence 5'-GAACCACCCA-3' which is part of the Tax-responsive element (TRE-2S) regulatory element that augments the Tax-dependent enhancer of HTLV-1 (PubMed:9557682). {ECO:0000269|PubMed:15994174, ECO:0000269|PubMed:9557682}.; [Isoform 2]: (Microbial infection) Acts as a transcriptional activators in T-cell leukemia virus type 1 (HTLV-1)-infected cells in a Tax-dependent manner. Binds to the DNA sequence 5'-GAACCACCCA-3' which is part of the Tax-responsive element (TRE-2S) regulatory element that augments the Tax-dependent enhancer of HTLV-1 (PubMed:9557682). {ECO:0000269|PubMed:15994174, ECO:0000269|PubMed:9557682}.; [Isoform 3]: (Microbial infection) Acts as a transcriptional activators in T-cell leukemia virus type 1 (HTLV-1)-infected cells in a Tax-dependent manner. Binds to the DNA sequence 5'-GAACCACCCA-3' which is part of the Tax-responsive element (TRE-2S) regulatory element that augments the Tax-dependent enhancer of HTLV-1 (PubMed:9557682). {ECO:0000269|PubMed:15994174, ECO:0000269|PubMed:9557682}.; [Isoform 4]: (Microbial infection) Acts as a transcriptional activators in T-cell leukemia virus type 1 (HTLV-1)-infected cells in a Tax-dependent manner. Binds to the DNA sequence 5'-GAACCACCCA-3' which is part of the Tax-responsive element (TRE-2S) regulatory element that augments the Tax-dependent enhancer of HTLV-1 (PubMed:9557682). {ECO:0000269|PubMed:15994174, ECO:0000269|PubMed:9557682}.; [Isoform 5]: Acts as a transcriptional repressor. {ECO:0000269|PubMed:15994174}.","6":"36.71099795","7":"11.158718106","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P10070"},{"1":"FDX1 ADX","2":"ADX_HUMAN","3":"MITOCHONDRIA","4":"Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)","5":"Essential for the synthesis of various steroid hormones (PubMed:20547883, PubMed:21636783). Participates in the reduction of mitochondrial cytochrome P450 for steroidogenesis (PubMed:20547883, PubMed:21636783). Transfers electrons from adrenodoxin reductase to CYP11A1, a cytochrome P450 that catalyzes cholesterol side-chain cleavage (PubMed:20547883, PubMed:21636783). Does not form a ternary complex with adrenodoxin reductase and CYP11A1 but shuttles between the two enzymes to transfer electrons (By similarity). {ECO:0000250|UniProtKB:P00257, ECO:0000269|PubMed:20547883, ECO:0000269|PubMed:21636783}.","6":"-29.12745095","7":"-18.706671311","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10109"},{"1":"RO60 SSA2 TROVE2","2":"RO60_HUMAN","3":"unknown","4":"60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2)","5":"RNA-binding protein that binds to misfolded non-coding RNAs, pre-5S rRNA, and several small cytoplasmic RNA molecules known as Y RNAs. May stabilize some of these RNAs and protect them from degradation (PubMed:18056422). Binds to endogenous Alu retroelements which are induced by type I interferon and stimulate porinflammaotry cytokine secretion. Regulates the expression of Alu retroelements as well as inflammatory genes (PubMed:26382853). {ECO:0000269|PubMed:18056422, ECO:0000269|PubMed:26382853}.; May play roles in cilia formation and/or maintenance. {ECO:0000250|UniProtKB:O08848}.","6":"-1.19374614","7":"16.348230606","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P10155"},{"1":"MYBL2 BMYB","2":"MYBB_HUMAN","3":"unknown","4":"Myb-related protein B (B-Myb) (Myb-like protein 2)","5":"Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene. {ECO:0000269|PubMed:10770937}.","6":"-0.31647521","7":"25.001276175","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P10244"},{"1":"GAA","2":"LYAG_HUMAN","3":"LYSOSOME","4":"Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]","5":"Essential for the degradation of glycogen in lysosomes (PubMed:1856189, PubMed:7717400, PubMed:14695532, PubMed:18429042). Has highest activity on alpha-1,4-linked glycosidic linkages, but can also hydrolyze alpha-1,6-linked glucans (PubMed:29061980). {ECO:0000269|PubMed:14695532, ECO:0000269|PubMed:18429042, ECO:0000269|PubMed:1856189, ECO:0000269|PubMed:29061980, ECO:0000269|PubMed:7717400}.","6":"4.29775702","7":"-43.810276022","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10253"},{"1":"RRAS","2":"RRAS_HUMAN","3":"PM","4":"Ras-related protein R-Ras (EC 3.6.5.-) (p23)","5":"Regulates the organization of the actin cytoskeleton (PubMed:16537651, PubMed:18270267). With OSPBL3, modulates integrin beta-1 (ITGB1) activity (PubMed:18270267). {ECO:0000269|PubMed:16537651, ECO:0000269|PubMed:18270267}.","6":"0.46957107","7":"-41.750454579","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10301"},{"1":"H1-4 H1F4 HIST1H1E","2":"H14_HUMAN","3":"unknown","4":"Histone H1.4 (Histone H1b) (Histone H1s-4)","5":"Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.","6":"-41.68018949","7":"23.834886433","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P10412"},{"1":"DLAT DLTA","2":"ODP2_HUMAN","3":"MITOCHONDRIA","4":"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","5":"The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle.","6":"-34.98053977","7":"-14.782755265","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10515"},{"1":"PTPRF LAR","2":"PTPRF_HUMAN","3":"unknown","4":"Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","5":"Possible cell adhesion receptor. It possesses an intrinsic protein tyrosine phosphatase activity (PTPase) and dephosphorylates EPHA2 regulating its activity.; The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one.","6":"-2.79240268","7":"-37.465240377","8":"PM","9":"PM,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P10586"},{"1":"COX5B","2":"COX5B_HUMAN","3":"MITOCHONDRIA","4":"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)","5":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix. {ECO:0000250|UniProtKB:P04037}.","6":"-43.02239494","7":"3.952476629","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10606"},{"1":"CTSA PPGB","2":"PPGB_HUMAN","3":"LYSOSOME","4":"Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]","5":"Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins. {ECO:0000269|PubMed:1907282}.","6":"11.46931020","7":"-38.440513101","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P10619"},{"1":"PRKAR1A PKR1 PRKAR1 TSE1","2":"KAP0_HUMAN","3":"unknown","4":"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1)","5":"Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. {ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:20215566, ECO:0000269|PubMed:26405036}.","6":"4.30719482","7":"-10.075258758","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P10644"},{"1":"ESD","2":"ESTD_HUMAN","3":"unknown","4":"S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56)","5":"Serine hydrolase involved in the detoxification of formaldehyde. {ECO:0000269|PubMed:3770744, ECO:0000269|PubMed:4768551}.","6":"26.57995712","7":"13.196498414","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P10768"},{"1":"HSPD1 HSP60","2":"CH60_HUMAN","3":"unknown","4":"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)","5":"Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:1346131, PubMed:11422376). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable). {ECO:0000269|PubMed:11422376, ECO:0000269|PubMed:1346131, ECO:0000305|PubMed:25918392}.","6":"-41.68674313","7":"-10.405265238","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P10809"},{"1":"CLU APOJ CLI KUB1 AAG4","2":"CLUS_HUMAN","3":"unknown","4":"Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]","5":"[Isoform 1]: Functions as extracellular chaperone that prevents aggregation of non native proteins (PubMed:11123922, PubMed:19535339). Prevents stress-induced aggregation of blood plasma proteins (PubMed:11123922, PubMed:12176985, PubMed:17260971, PubMed:19996109). Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro) (PubMed:12047389, PubMed:17412999, PubMed:17407782). Does not require ATP (PubMed:11123922). Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70 (PubMed:11123922). Does not refold proteins by itself (PubMed:11123922). Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation (PubMed:21505792). Protects cells against apoptosis and against cytolysis by complement (PubMed:2780565). Intracellular forms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:20068069). Promotes proteasomal degradation of COMMD1 and IKBKB (PubMed:20068069). Modulates NF-kappa-B transcriptional activity (PubMed:12882985). A mitochondrial form suppresses BAX-dependent release of cytochrome c into the cytoplasm and inhibit apoptosis (PubMed:16113678, PubMed:17689225). Plays a role in the regulation of cell proliferation (PubMed:19137541). An intracellular form suppresses stress-induced apoptosis by stabilizing mitochondrial membrane integrity through interaction with HSPA5 (PubMed:22689054). Secreted form does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Secreted form act as an important modulator during neuronal differentiation through interaction with STMN3 (By similarity). Plays a role in the clearance of immune complexes that arise during cell injury (By similarity). {ECO:0000250|UniProtKB:P05371, ECO:0000250|UniProtKB:Q06890, ECO:0000269|PubMed:11123922, ECO:0000269|PubMed:12047389, ECO:0000269|PubMed:12176985, ECO:0000269|PubMed:12882985, ECO:0000269|PubMed:16113678, ECO:0000269|PubMed:17260971, ECO:0000269|PubMed:17407782, ECO:0000269|PubMed:17412999, ECO:0000269|PubMed:17689225, ECO:0000269|PubMed:19137541, ECO:0000269|PubMed:19535339, ECO:0000269|PubMed:19996109, ECO:0000269|PubMed:20068069, ECO:0000269|PubMed:21505792, ECO:0000269|PubMed:22689054, ECO:0000269|PubMed:24073260, ECO:0000269|PubMed:2780565}.; [Isoform 6]: Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity. {ECO:0000269|PubMed:24073260}.; [Isoform 4]: Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Promotes cell death through interaction with BCL2L1 that releases and activates BAX (PubMed:21567405). {ECO:0000269|PubMed:21567405, ECO:0000269|PubMed:24073260}.","6":"3.54604280","7":"-42.862334267","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P10909"},{"1":"HAPLN1 CRTL1","2":"HPLN1_HUMAN","3":"unknown","4":"Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1) (Cartilage-link protein) (Proteoglycan link protein)","5":"Stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.","6":"7.53695109","7":"-36.623593706","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P10915"},{"1":"HSPA5 GRP78","2":"BIP_HUMAN","3":"unknown","4":"Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)","5":"Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) (PubMed:1550958, PubMed:19538957). In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1, allowing homodimerization and subsequent activation of ERN1/IRE1 (By similarity). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating. May also play a role in apoptosis and cell proliferation (PubMed:26045166). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029, ECO:0000269|PubMed:1550958, ECO:0000269|PubMed:19538957, ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:26045166, ECO:0000269|PubMed:28332555, ECO:0000269|PubMed:29719251}.; (Microbial infection) Plays an important role in viral binding to the host cell membrane and entry for several flaviruses such as Dengue virus, Zika virus and Japanese encephalitis virus (PubMed:33432092, PubMed:15098107, PubMed:28053106). Acts as a component of the cellular receptor for Dengue virus serotype 2/DENV-2 on human liver cells (PubMed:15098107). {ECO:0000269|PubMed:15098107, ECO:0000269|PubMed:28053106, ECO:0000269|PubMed:33432092}.","6":"-20.84716399","7":"-20.712181800","8":"PEROXISOME","9":"Undefined,PEROXISOME,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P11021"},{"1":"LAMC1 LAMB2","2":"LAMC1_HUMAN","3":"unknown","4":"Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma)","5":"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.","6":"-23.88738059","7":"-14.984240174","8":"PEROXISOME","9":"PEROXISOME,PEROXISOME,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P11047"},{"1":"ACP2","2":"PPAL_HUMAN","3":"unknown","4":"Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)","5":"NA","6":"14.80539199","7":"-39.988352194","8":"Undefined","9":"GOLGI,LYSOSOME,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P11117"},{"1":"HSPA8 HSC70 HSP73 HSPA10","2":"HSP7C_HUMAN","3":"unknown","4":"Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)","5":"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21150129, PubMed:21148293, PubMed:24732912, PubMed:27916661, PubMed:23018488). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:21150129, PubMed:21148293, PubMed:24732912, PubMed:27916661, PubMed:23018488, PubMed:12526792). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:21150129, PubMed:21148293, PubMed:24732912, PubMed:27916661, PubMed:23018488, PubMed:12526792). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24318877, PubMed:27474739, PubMed:24121476, PubMed:26865365). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). Interacts with VGF-derived peptide TLQP-21 (PubMed:28934328). {ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:28934328, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}.","6":"2.77701270","7":"9.693014652","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P11142"},{"1":"SLC2A1 GLUT1","2":"GTR1_HUMAN","3":"PM","4":"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)","5":"Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:10227690). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative transport of glucose into the brain (PubMed:10227690). In association with BSG and NXNL1, promotes retinal cone survival by increasing glucose uptake into photoreceptors (By similarity). {ECO:0000250|UniProtKB:P46896, ECO:0000269|PubMed:10227690, ECO:0000269|PubMed:18245775, ECO:0000269|PubMed:19449892, ECO:0000269|PubMed:25982116, ECO:0000269|PubMed:27078104}.","6":"4.17178993","7":"-44.283831289","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11166"},{"1":"EPB41 E41P","2":"EPB41_HUMAN","3":"unknown","4":"Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1)","5":"Protein 4.1 is a major structural element of the erythrocyte membrane skeleton. It plays a key role in regulating membrane physical properties of mechanical stability and deformability by stabilizing spectrin-actin interaction. Recruits DLG1 to membranes. Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}.","6":"-12.97549653","7":"-21.306663911","8":"Undefined","9":"ER,ER,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P11171"},{"1":"UMPS OK/SW-cl.21","2":"UMPS_HUMAN","3":"unknown","4":"Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)]","5":"NA","6":"19.68425009","7":"5.087595303","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P11172"},{"1":"PDHB PHE1B","2":"ODPB_HUMAN","3":"MITOCHONDRIA","4":"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)","5":"The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:17474719, ECO:0000269|PubMed:19081061}.","6":"-42.04270512","7":"-6.379054511","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11177"},{"1":"DBT BCATE2","2":"ODB2_HUMAN","3":"MITOCHONDRIA","4":"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)","5":"The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3). Within this complex, the catalytic function of this enzyme is to accept, and to transfer to coenzyme A, acyl groups that are generated by the branched-chain alpha-keto acid decarboxylase component.","6":"-34.56327157","7":"-0.997335897","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11182"},{"1":"PYGB","2":"PYGB_HUMAN","3":"unknown","4":"Glycogen phosphorylase, brain form (EC 2.4.1.1)","5":"Glycogen phosphorylase that regulates glycogen mobilization (PubMed:27402852). Phosphorylase is an important allosteric enzyme in carbohydrate metabolism (PubMed:3346228). Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates (PubMed:3346228). However, all known phosphorylases share catalytic and structural properties (PubMed:3346228). {ECO:0000269|PubMed:27402852, ECO:0000303|PubMed:3346228}.","6":"43.91838234","7":"0.012362939","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P11216"},{"1":"RALB","2":"RALB_HUMAN","3":"unknown","4":"Ras-related protein Ral-B (EC 3.6.5.2)","5":"Multifunctional GTPase involved in a variety of cellular processes including gene expression, cell migration, cell proliferation, oncogenic transformation and membrane trafficking (PubMed:10393179, PubMed:17875936, PubMed:18756269). Accomplishes its multiple functions by interacting with distinct downstream effectors. Acts as a GTP sensor for GTP-dependent exocytosis of dense core vesicles (By similarity). Required both to stabilize the assembly of the exocyst complex and to localize functional exocyst complexes to the leading edge of migrating cells (By similarity). Required for suppression of apoptosis (PubMed:17875936). In late stages of cytokinesis, upon completion of the bridge formation between dividing cells, mediates exocyst recruitment to the midbody to drive abscission (PubMed:18756269). Involved in ligand-dependent receptor mediated endocytosis of the EGF and insulin receptors (PubMed:10393179). {ECO:0000250|UniProtKB:P36860, ECO:0000269|PubMed:10393179, ECO:0000269|PubMed:17875936, ECO:0000269|PubMed:18756269}.","6":"0.17636809","7":"-38.466467850","8":"PM","9":"Undefined,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"P11234"},{"1":"LAMP1","2":"LAMP1_HUMAN","3":"unknown","4":"Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a)","5":"Presents carbohydrate ligands to selectins. Also implicated in tumor cell metastasis.; (Microbial infection) Acts as a receptor for Lassa virus protein. {ECO:0000269|PubMed:24970085}.","6":"21.19659043","7":"-34.785480043","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P11279"},{"1":"ACADM","2":"ACADM_HUMAN","3":"MITOCHONDRIA","4":"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7) (Medium chain acyl-CoA dehydrogenase) (MCADH)","5":"Medium-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats (PubMed:1970566, PubMed:8823175, PubMed:21237683, PubMed:2251268). The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (PubMed:2251268). Electron transfer flavoprotein (ETF) is the electron acceptor that transfers electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:25416781, PubMed:15159392). Among the different mitochondrial acyl-CoA dehydrogenases, medium-chain specific acyl-CoA dehydrogenase acts specifically on acyl-CoAs with saturated 6 to 12 carbons long primary chains (PubMed:1970566, PubMed:8823175, PubMed:21237683, PubMed:2251268). {ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:1970566, ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:2251268, ECO:0000269|PubMed:25416781, ECO:0000269|PubMed:8823175}.","6":"-34.63834337","7":"-12.689697487","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11310"},{"1":"TOP1","2":"TOP1_HUMAN","3":"unknown","4":"DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)","5":"Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Involved in the circadian transcription of the core circadian clock component ARNTL/BMAL1 by altering the chromatin structure around the ROR response elements (ROREs) on the ARNTL/BMAL1 promoter. {ECO:0000250|UniProtKB:Q13472, ECO:0000269|PubMed:14594810, ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:22904072, ECO:0000269|PubMed:2833744}.","6":"-39.65870863","7":"21.739655546","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P11387"},{"1":"TOP2A TOP2","2":"TOP2A_HUMAN","3":"unknown","4":"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)","5":"Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:17567603, PubMed:18790802, PubMed:22013166, PubMed:22323612). May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (By similarity). {ECO:0000250|UniProtKB:Q01320, ECO:0000269|PubMed:17567603, ECO:0000269|PubMed:18790802, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22323612}.","6":"-39.90578227","7":"21.266276169","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P11388"},{"1":"G6PD","2":"G6PD_HUMAN","3":"unknown","4":"Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)","5":"Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis. {ECO:0000269|PubMed:15858258, ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:26479991, ECO:0000269|PubMed:743300}.","6":"35.99193041","7":"2.842280415","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P11413"},{"1":"UBL4A DXS254E GDX UBL4","2":"UBL4A_HUMAN","3":"unknown","4":"Ubiquitin-like protein 4A (Ubiquitin-like protein GDX)","5":"As part of a cytosolic protein quality control complex, the BAG6/BAT3 complex, maintains misfolded and hydrophobic patches-containing proteins in a soluble state and participates in their proper delivery to the endoplasmic reticulum or alternatively can promote their sorting to the proteasome where they undergo degradation (PubMed:20676083, PubMed:21636303, PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is involved in the post-translational delivery of tail-anchored/type II transmembrane proteins to the endoplasmic reticulum membrane. Recruited to ribosomes, it interacts with the transmembrane region of newly synthesized tail-anchored proteins and together with SGTA and ASNA1 mediates their delivery to the endoplasmic reticulum (PubMed:20676083, PubMed:28104892, PubMed:25535373). Client proteins that cannot be properly delivered to the endoplasmic reticulum are ubiquitinated and sorted to the proteasome (PubMed:28104892). Similarly, the BAG6/BAT3 complex also functions as a sorting platform for proteins of the secretory pathway that are mislocalized to the cytosol either delivering them to the proteasome for degradation or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the endoplasmic reticulum-associated degradation (ERAD), a quality control mechanism that eliminates unwanted proteins of the endoplasmic reticulum through their retrotranslocation to the cytosol and their targeting to the proteasome. It maintains these retrotranslocated proteins in an unfolded yet soluble state condition in the cytosol to ensure their proper delivery to the proteasome (PubMed:21636303). {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:28104892}.","6":"13.48913380","7":"31.448804858","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P11441"},{"1":"PC","2":"PYC_HUMAN","3":"MITOCHONDRIA","4":"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)","5":"Pyruvate carboxylase catalyzes a 2-step reaction, involving the ATP-dependent carboxylation of the covalently attached biotin in the first step and the transfer of the carboxyl group to pyruvate in the second. Catalyzes in a tissue specific manner, the initial reactions of glucose (liver, kidney) and lipid (adipose tissue, liver, brain) synthesis from pyruvate.","6":"-34.29301680","7":"-1.535937592","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11498"},{"1":"MTHFD1 MTHFC MTHFD","2":"C1TC_HUMAN","3":"unknown","4":"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","5":"NA","6":"41.77152178","7":"3.422770119","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P11586"},{"1":"IGF2R MPRI","2":"MPRI_HUMAN","3":"unknown","4":"Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222)","5":"Mediates the transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes (PubMed:2963003, PubMed:18817523). Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex (PubMed:2963003, PubMed:18817523). The receptor is then recycled back to the Golgi for another round of trafficking through its binding to the retromer (PubMed:18817523). This receptor also binds IGF2 (PubMed:18046459). Acts as a positive regulator of T-cell coactivation by binding DPP4 (PubMed:10900005). {ECO:0000269|PubMed:10900005, ECO:0000269|PubMed:18046459, ECO:0000269|PubMed:18817523, ECO:0000269|PubMed:2963003}.","6":"21.78478192","7":"-34.455650312","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P11717"},{"1":"ADH5 ADHX FDH","2":"ADHX_HUMAN","3":"CYTOSOL","4":"Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)","5":"Catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione (PubMed:8460164). Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (PubMed:16081420). Class-III ADH is remarkably ineffective in oxidizing ethanol (PubMed:8460164). {ECO:0000269|PubMed:16081420, ECO:0000269|PubMed:8460164}.","6":"29.63822775","7":"10.635444854","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P11766"},{"1":"CDK4","2":"CDK4_HUMAN","3":"unknown","4":"Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)","5":"Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. {ECO:0000269|PubMed:15241418, ECO:0000269|PubMed:18827403, ECO:0000269|PubMed:9003781}.","6":"13.47651332","7":"7.253117489","8":"CYTOSOL","9":"Undefined,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P11802"},{"1":"PRPS2","2":"PRPS2_HUMAN","3":"unknown","4":"Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II)","5":"Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis.","6":"19.43779566","7":"36.674766733","8":"Undefined","9":"PROTEIN COMPLEX,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P11908"},{"1":"PABPC1 PAB1 PABP1 PABPC2","2":"PABP1_HUMAN","3":"unknown","4":"Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)","5":"Binds the poly(A) tail of mRNA, including that of its own transcript, and regulates processes of mRNA metabolism such as pre-mRNA splicing and mRNA stability (PubMed:11051545, PubMed:17212783, PubMed:25480299). Its function in translational initiation regulation can either be enhanced by PAIP1 or repressed by PAIP2 (PubMed:11051545, PubMed:20573744). Can probably bind to cytoplasmic RNA sequences other than poly(A) in vivo. Involved in translationally coupled mRNA turnover (PubMed:11051545). Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain (PubMed:11051545). Involved in regulation of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons; for the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed (PubMed:18447585). By binding to long poly(A) tails, may protect them from uridylation by ZCCHC6/ZCCHC11 and hence contribute to mRNA stability (PubMed:25480299). {ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:17212783, ECO:0000269|PubMed:18447585, ECO:0000269|PubMed:20573744, ECO:0000269|PubMed:25480299}.; (Microbial infection) Positively regulates the replication of dengue virus (DENV). {ECO:0000269|PubMed:26735137}.","6":"25.57934337","7":"-16.240143687","8":"RIBOSOME","9":"RIBOSOME,Undefined,RIBOSOME","10":"Confident","11":"2","12":"1,3","_rn_":"P11940"},{"1":"PCNA","2":"PCNA_HUMAN","3":"unknown","4":"Proliferating cell nuclear antigen (PCNA) (Cyclin)","5":"Auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways (PubMed:24939902). Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: Monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion (PubMed:24695737). {ECO:0000269|PubMed:18719106, ECO:0000269|PubMed:19443450, ECO:0000269|PubMed:24695737, ECO:0000269|PubMed:24939902}.","6":"-12.69883434","7":"1.948270757","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P12004"},{"1":"COL11A1 COLL6","2":"COBA1_HUMAN","3":"unknown","4":"Collagen alpha-1(XI) chain","5":"May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils.","6":"-23.32843128","7":"-14.753880852","8":"Undefined","9":"PEROXISOME,ER,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P12107"},{"1":"COL6A1","2":"CO6A1_HUMAN","3":"unknown","4":"Collagen alpha-1(VI) chain","5":"Collagen VI acts as a cell-binding protein.","6":"-21.23722972","7":"-18.913589185","8":"Undefined","9":"ER,PEROXISOME,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P12109"},{"1":"COL6A2","2":"CO6A2_HUMAN","3":"unknown","4":"Collagen alpha-2(VI) chain","5":"Collagen VI acts as a cell-binding protein.","6":"-20.37346976","7":"-22.692888520","8":"Undefined","9":"ER,PEROXISOME,ER","10":"NA","11":"NA","12":"NA","_rn_":"P12110"},{"1":"COL6A3","2":"CO6A3_HUMAN","3":"unknown","4":"Collagen alpha-3(VI) chain","5":"Collagen VI acts as a cell-binding protein.","6":"-21.83848667","7":"-20.991205352","8":"Undefined","9":"ER,Undefined,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P12111"},{"1":"IMPDH2 IMPD2","2":"IMDH2_HUMAN","3":"unknown","4":"Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (Inosine-5'-monophosphate dehydrogenase type II) (IMP dehydrogenase II) (IMPDH-II)","5":"Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth (PubMed:7903306, PubMed:7763314). Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism (PubMed:14766016). It may also have a role in the development of malignancy and the growth progression of some tumors. {ECO:0000269|PubMed:14766016, ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}.","6":"46.15632776","7":"-1.048866453","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P12268"},{"1":"TPR","2":"TPR_HUMAN","3":"unknown","4":"Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","5":"Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. According to some authors, plays a limited role in the regulation of nuclear protein export (PubMed:22253824 and PubMed:11952838). Plays also a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases. {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:15654337, ECO:0000269|PubMed:17897941, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:20407419, ECO:0000269|PubMed:21613532, ECO:0000269|PubMed:22253824, ECO:0000269|PubMed:9864356}.","6":"-19.89553958","7":"12.806943366","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P12270"},{"1":"CKB CKBB","2":"KCRB_HUMAN","3":"CYTOSOL","4":"Creatine kinase B-type (EC 2.7.3.2) (Brain creatine kinase) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type) (CPK-B)","5":"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.","6":"6.53623712","7":"9.907307486","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P12277"},{"1":"ANXA3 ANX3","2":"ANXA3_HUMAN","3":"unknown","4":"Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)","5":"Inhibitor of phospholipase A2, also possesses anti-coagulant properties. Also cleaves the cyclic bond of inositol 1,2-cyclic phosphate to form inositol 1-phosphate.","6":"11.46662416","7":"-6.128031297","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P12429"},{"1":"CKMT1A CKMT; CKMT1B CKMT","2":"KCRU_HUMAN","3":"unknown","4":"Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)","5":"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.","6":"-30.01081807","7":"-2.074397326","8":"Undefined","9":"PEROXISOME,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P12532"},{"1":"BCKDHA","2":"ODBA_HUMAN","3":"MITOCHONDRIA","4":"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)","5":"The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).","6":"-32.92964063","7":"1.844072294","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P12694"},{"1":"ACTN1","2":"ACTN1_HUMAN","3":"unknown","4":"Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)","5":"F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein.","6":"-7.79027699","7":"-11.778747951","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P12814"},{"1":"SRC SRC1","2":"SRC_HUMAN","3":"unknown","4":"Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)","5":"Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (PubMed:21411625). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity). Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1 (PubMed:11389730). Plays a role in EGF-mediated calcium-activated chloride channel activation (PubMed:18586953). Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable). Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus (PubMed:7853507). Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed:8755529, PubMed:14585963). Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase (PubMed:12615910). Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation (PubMed:16186108). Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731' (PubMed:20100835, PubMed:21309750). Enhances DDX58/RIG-I-elicited antiviral signaling (PubMed:19419966). Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (PubMed:14585963). Phosphorylates BCAR1 at 'Tyr-128' (PubMed:22710723). Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity (PubMed:20525694). Involved in anchorage-independent cell growth (PubMed:19307596). Required for podosome formation (By similarity). Mediates IL6 signaling by activating YAP1-NOTCH pathway to induce inflammation-induced epithelial regeneration (PubMed:25731159). {ECO:0000250|UniProtKB:P05480, ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:12615910, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:16186108, ECO:0000269|PubMed:18586953, ECO:0000269|PubMed:19307596, ECO:0000269|PubMed:19419966, ECO:0000269|PubMed:20100835, ECO:0000269|PubMed:20525694, ECO:0000269|PubMed:21309750, ECO:0000269|PubMed:21411625, ECO:0000269|PubMed:22710723, ECO:0000269|PubMed:25731159, ECO:0000269|PubMed:7853507, ECO:0000269|PubMed:8755529, ECO:0000269|PubMed:8759729, ECO:0000305|PubMed:11964124, ECO:0000305|PubMed:8672527, ECO:0000305|PubMed:9442882}.","6":"-0.31778070","7":"-28.046639827","8":"Undefined","9":"PM,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"P12931"},{"1":"PEPD PRD","2":"PEPD_HUMAN","3":"unknown","4":"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","5":"Splits dipeptides with a prolyl or hydroxyprolyl residue in the C-terminal position. Plays an important role in collagen metabolism because the high level of iminoacids in collagen.","6":"38.28236255","7":"7.991784601","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P12955"},{"1":"XRCC6 G22P1","2":"XRCC6_HUMAN","3":"unknown","4":"X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6)","5":"Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. Required for osteocalcin gene expression. Probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. 5'-dRP lyase activity allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:20383123, ECO:0000269|PubMed:20493174, ECO:0000269|PubMed:2466842, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:7957065, ECO:0000269|PubMed:8621488, ECO:0000269|PubMed:9742108}.","6":"-3.73690571","7":"23.662613023","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P12956"},{"1":"XRCC5 G22P2","2":"XRCC5_HUMAN","3":"unknown","4":"X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))","5":"Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together (PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. In association with NAA15, the XRCC5/6 dimer binds to the osteocalcin promoter and activates osteocalcin expression (PubMed:20383123). The XRCC5/6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription (PubMed:8621488). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:20383123, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:7957065, ECO:0000269|PubMed:8621488}.","6":"-3.85697593","7":"23.738244674","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P13010"},{"1":"UNG DGU UNG1 UNG15","2":"UNG_HUMAN","3":"unknown","4":"Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)","5":"Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine.","6":"-6.46957538","7":"-13.891150818","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"Highly confident","11":"2","12":"2,3","_rn_":"P13051"},{"1":"COX4I1 COX4","2":"COX41_HUMAN","3":"MITOCHONDRIA","4":"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)","5":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunbit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix. {ECO:0000250|UniProtKB:P00424}.","6":"-42.18404859","7":"3.284843989","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13073"},{"1":"LAMP2","2":"LAMP2_HUMAN","3":"unknown","4":"Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)","5":"Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125, PubMed:27628032). Functions by binding target proteins, such as GAPDH and MLLT11, and targeting them for lysosomal degradation (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125). Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy (PubMed:27628032). Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes (PubMed:27628032). Required for normal degradation of the contents of autophagosomes (PubMed:27628032). Required for efficient MHCII-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHCII subunits (PubMed:20518820). Is not required for efficient MHCII-mediated presentation of endogenous antigens (PubMed:20518820). {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:11082038, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:20518820, ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:27628032, ECO:0000269|PubMed:8662539}.; [Isoform LAMP-2C]: Modulates chaperone-mediated autophagy. Decreases presentation of endogenous antigens by MHCII. Does not play a role in the presentation of exogenous and membrane-derived antigens by MHCII. {ECO:0000269|PubMed:26856698}.","6":"19.46882896","7":"-35.099431369","8":"GOLGI","9":"GOLGI,GOLGI,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P13473"},{"1":"RNH1 PRI RNH","2":"RINI_HUMAN","3":"CYTOSOL","4":"Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI)","5":"Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. {ECO:0000269|PubMed:12578357, ECO:0000269|PubMed:14515218, ECO:0000269|PubMed:17292889}.","6":"7.14215119","7":"14.309764361","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13489"},{"1":"BMP1 PCOLC","2":"BMP1_HUMAN","3":"unknown","4":"Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP)","5":"Metalloprotease that plays key roles in regulating the formation of the extracellular matrix (ECM) via processing of various precursor proteins into mature functional enzymes or structural proteins (PubMed:33206546). Thereby participates in several developmental and physiological processes such as cartilage and bone formation, muscle growth and homeostasis, wound healing and tissue repair (PubMed:33169406, PubMed:32636307). Roles in ECM formation include cleavage of the C-terminal propeptides from procollagens such as procollagen I, II and III or the proteolytic activation of the enzyme lysyl oxidase LOX, necessary to formation of covalent cross-links in collagen and elastic fibers (PubMed:31152061, PubMed:33206546). Additional substrates include matricellular thrombospondin-1/THBS1 whose cleavage leads to cell adhesion disruption and TGF-beta activation (PubMed:32636307). {ECO:0000269|PubMed:31152061, ECO:0000269|PubMed:32636307, ECO:0000269|PubMed:33169406, ECO:0000269|PubMed:33206546}.; [Isoform BMP1-3]: Plays an important role in bone repair by acting as a coactivator of BMP7. {ECO:0000269|PubMed:21453682}.","6":"-9.42844204","7":"-33.358861890","8":"Undefined","9":"PM,Undefined,ER","10":"Highly confident","11":"2","12":"1,3","_rn_":"P13497"},{"1":"NCAM1 NCAM","2":"NCAM1_HUMAN","3":"PM","4":"Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)","5":"This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.; (Microbial infection) Acts as a receptor for rabies virus. {ECO:0000269|PubMed:9696812}.; (Microbial infection) Acts as a receptor for Zika virus. {ECO:0000269|PubMed:32753727}.","6":"-13.86939670","7":"-37.203628701","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13591"},{"1":"ATP1A3","2":"AT1A3_HUMAN","3":"unknown","4":"Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3)","5":"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients.","6":"-18.74767238","7":"-34.763332235","8":"Undefined","9":"ER,LYSOSOME,ER","10":"NA","11":"NA","12":"NA","_rn_":"P13637"},{"1":"EEF2 EF2","2":"EF2_HUMAN","3":"unknown","4":"Elongation factor 2 (EF-2)","5":"Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.","6":"23.84518764","7":"15.821585706","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P13639"},{"1":"PDIA4 ERP70 ERP72","2":"PDIA4_HUMAN","3":"ER","4":"Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)","5":"NA","6":"-20.12366473","7":"-22.590590110","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13667"},{"1":"P4HA1 P4HA","2":"P4HA1_HUMAN","3":"ER","4":"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)","5":"Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins.","6":"-24.75407550","7":"-16.701369973","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13674"},{"1":"TPT1","2":"TCTP_HUMAN","3":"unknown","4":"Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23)","5":"Involved in calcium binding and microtubule stabilization.","6":"-7.48914896","7":"-0.828155946","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P13693"},{"1":"PLS3","2":"PLST_HUMAN","3":"unknown","4":"Plastin-3 (T-plastin)","5":"Actin-bundling protein found in intestinal microvilli, hair cell stereocilia, and fibroblast filopodia. May play a role in the regulation of bone development.","6":"6.21137310","7":"-7.360459083","8":"Undefined","9":"CYTOSOL,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P13797"},{"1":"APEH D3F15S2 D3S48E DNF15S2","2":"ACPH_HUMAN","3":"CYTOSOL","4":"Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)","5":"This enzyme catalyzes the hydrolysis of the N-terminal peptide bond of an N-acetylated peptide to generate an N-acetylated amino acid and a peptide with a free N-terminus. It preferentially cleaves off Ac-Ala, Ac-Met and Ac-Ser. {ECO:0000269|PubMed:1861871, ECO:0000269|PubMed:2006156}.","6":"17.50500419","7":"30.031034754","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13798"},{"1":"ETFA","2":"ETFA_HUMAN","3":"MITOCHONDRIA","4":"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)","5":"Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:27499296, PubMed:15159392, PubMed:15975918, PubMed:9334218, PubMed:10356313). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1882842, PubMed:1430199). {ECO:0000269|PubMed:10356313, ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218, ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}.","6":"-39.70674087","7":"-14.190351980","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13804"},{"1":"GYS1 GYS","2":"GYS1_HUMAN","3":"unknown","4":"Glycogen [starch] synthase, muscle (EC 2.4.1.11)","5":"Transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan.","6":"26.22444840","7":"34.766463241","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P13807"},{"1":"PRKAR2A PKR2 PRKAR2","2":"KAP2_HUMAN","3":"unknown","4":"cAMP-dependent protein kinase type II-alpha regulatory subunit","5":"Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase.","6":"-10.30252160","7":"6.747990754","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P13861"},{"1":"ENO3","2":"ENOB_HUMAN","3":"unknown","4":"Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)","5":"Appears to have a function in striated muscle development and regeneration.","6":"29.97296048","7":"10.274166299","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P13929"},{"1":"GTF2F2 RAP30","2":"T2FB_HUMAN","3":"unknown","4":"General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP-dependent helicase GTF2F2) (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30)","5":"TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation. This subunit shows ATP-dependent DNA-helicase activity. {ECO:0000269|PubMed:2477704}.","6":"-1.26722925","7":"11.313885642","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P13984"},{"1":"CD59 MIC11 MIN1 MIN2 MIN3 MSK21","2":"CD59_HUMAN","3":"unknown","4":"CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59)","5":"Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase.; The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.","6":"-22.62417834","7":"-29.026373602","8":"Undefined","9":"ER,MITOCHONDRIA,ER","10":"NA","11":"NA","12":"NA","_rn_":"P13987"},{"1":"MTHFD2 NMDMC","2":"MTDC_HUMAN","3":"MITOCHONDRIA","4":"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]","5":"Although its dehydrogenase activity is NAD-specific, it can also utilize NADP at a reduced efficiency. {ECO:0000269|PubMed:16100107}.","6":"-34.05502845","7":"-16.297923453","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P13995"},{"1":"MIF GLIF MMIF","2":"MIF_HUMAN","3":"unknown","4":"Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)","5":"Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity. {ECO:0000269|PubMed:15908412, ECO:0000269|PubMed:17443469, ECO:0000269|PubMed:23776208}.","6":"28.99496543","7":"14.784524795","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P14174"},{"1":"PRKCSH G19P1","2":"GLU2B_HUMAN","3":"ER","4":"Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)","5":"Regulatory subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for efficient PKD1/Polycystin-1 biogenesis and trafficking to the plasma membrane of the primary cilia (By similarity). {ECO:0000250|UniProtKB:O08795, ECO:0000269|PubMed:10929008}.","6":"-15.42160400","7":"-25.585217785","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P14314"},{"1":"FDPS FPS KIAA1293","2":"FPPS_HUMAN","3":"unknown","4":"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)","5":"Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate.","6":"4.96486910","7":"11.778274262","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P14324"},{"1":"TRIM27 RFP RNF76","2":"TRI27_HUMAN","3":"unknown","4":"Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27)","5":"E3 ubiquitin-protein ligase that mediates ubiquitination of PIK3C2B and inhibits its activity; mediates the formation of 'Lys-48'-linked polyubiquitin chains; the function inhibits CD4 T-cell activation. Acts as a regulator of retrograde transport: together with MAGEL2, mediates the formation of 'Lys-63'-linked polyubiquitin chains at 'Lys-220' of WASHC1, leading to promote endosomal F-actin assembly (PubMed:23452853). Has a transcriptional repressor activity by cooperating with EPC1. Induces apoptosis by activating Jun N-terminal kinase and p38 kinase and also increases caspase-3-like activity independently of mitochondrial events. May function in male germ cell development. Has DNA-binding activity and preferentially bound to double-stranded DNA. {ECO:0000269|PubMed:10976108, ECO:0000269|PubMed:12807881, ECO:0000269|PubMed:22128329, ECO:0000269|PubMed:23452853}.","6":"-0.67156775","7":"-8.160552851","8":"RIBOSOME","9":"Undefined,Undefined,RIBOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P14373"},{"1":"AKR1A1 ALDR1 ALR","2":"AK1A1_HUMAN","3":"unknown","4":"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)","5":"Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides and bile acids, with a preference for negatively charged substrates, such as glucuronate and succinic semialdehyde (PubMed:10510318). Functions as a detoxifiying enzyme by reducing a range of toxic aldehydes. Reduces methylglyoxal and 3-deoxyglucosone, which are present at elevated levels under hyperglycemic conditions and are cytotoxic. Involved also in the detoxification of lipid-derived aldehydes like acrolein (By similarity). Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN) (PubMed:18276838, PubMed:11306097). Displays no reductase activity towards retinoids (By similarity). {ECO:0000250|UniProtKB:P50578, ECO:0000250|UniProtKB:P51635, ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:11306097, ECO:0000269|PubMed:18276838}.","6":"33.13165018","7":"-0.541941961","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P14550"},{"1":"PKM OIP3 PK2 PK3 PKM2","2":"KPYM_HUMAN","3":"unknown","4":"Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)","5":"Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP (PubMed:15996096, PubMed:1854723). The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production (PubMed:15996096, PubMed:1854723). The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival (PubMed:15996096, PubMed:1854723). In addition to its role in glycolysis, also regulates transcription (PubMed:18191611, PubMed:21620138). Stimulates POU5F1-mediated transcriptional activation (PubMed:18191611). Promotes in a STAT1-dependent manner, the expression of the immune checkpoint protein CD274 in ARNTL/BMAL1-deficient macrophages (By similarity). Also acts as a translation regulator for a subset of mRNAs, independently of its pyruvate kinase activity: associates with subpools of endoplasmic reticulum-associated ribosomes, binds directly to the mRNAs translated at the endoplasmic reticulum and promotes translation of these endoplasmic reticulum-destined mRNAs (By similarity). Plays a general role in caspase independent cell death of tumor cells (PubMed:17308100). {ECO:0000250|UniProtKB:P52480, ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:17308100, ECO:0000269|PubMed:18191611, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:21620138}.","6":"40.57426140","7":"4.369728880","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P14618"},{"1":"HSP90B1 GRP94 TRA1","2":"ENPL_HUMAN","3":"unknown","4":"Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)","5":"Molecular chaperone that functions in the processing and transport of secreted proteins (By similarity). When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD) (PubMed:18264092). Has ATPase activity (By similarity). May participate in the unfolding of cytosolic leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1 to facilitate their translocation into the ERGIC (endoplasmic reticulum-Golgi intermediate compartment) and secretion; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000250|UniProtKB:P08113, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:32272059}.","6":"-17.45798708","7":"-25.665051574","8":"ER","9":"ER,ER,ER","10":"NA","11":"NA","12":"NA","_rn_":"P14625"},{"1":"CCNB1 CCNB","2":"CCNB1_HUMAN","3":"unknown","4":"G2/mitotic-specific cyclin-B1","5":"Essential for the control of the cell cycle at the G2/M (mitosis) transition. {ECO:0000269|PubMed:17495531, ECO:0000269|PubMed:17495533}.","6":"7.38587804","7":"8.038454523","8":"Undefined","9":"CYTOSOL,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P14635"},{"1":"MYL6B MLC1SA","2":"MYL6B_HUMAN","3":"unknown","4":"Myosin light chain 6B (Myosin light chain 1 slow-twitch muscle A isoform) (MLC1sa) (Smooth muscle and nonmuscle myosin light chain alkali 6B)","5":"Regulatory light chain of myosin. Does not bind calcium.","6":"-10.68039035","7":"17.418280181","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P14649"},{"1":"SNRPB COD SNRPB1","2":"RSMB_HUMAN","3":"unknown","4":"Small nuclear ribonucleoprotein-associated proteins B and B' (snRNP-B) (Sm protein B/B') (Sm-B/B') (SmB/B')","5":"Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome (PubMed:11991638, PubMed:18984161, PubMed:19325628, PubMed:25555158, PubMed:26912367, PubMed:28502770, PubMed:28781166, PubMed:28076346). Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes (PubMed:11991638, PubMed:28502770, PubMed:28781166, PubMed:28076346). Is also a component of the minor U12 spliceosome (PubMed:15146077). As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing (PubMed:12975319). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12975319, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:19325628, ECO:0000269|PubMed:25555158, ECO:0000269|PubMed:26912367, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166}.","6":"-12.89071487","7":"28.448860578","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P14678"},{"1":"IDE","2":"IDE_HUMAN","3":"unknown","4":"Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)","5":"Plays a role in the cellular breakdown of insulin, APP peptides, IAPP peptides, natriuretic peptides, glucagon, bradykinin, kallidin, and other peptides, and thereby plays a role in intercellular peptide signaling (PubMed:2293021, PubMed:10684867, PubMed:26968463, PubMed:17051221, PubMed:17613531, PubMed:18986166, PubMed:19321446, PubMed:23922390, PubMed:24847884, PubMed:26394692, PubMed:29596046, PubMed:21098034). Substrate binding induces important conformation changes, making it possible to bind and degrade larger substrates, such as insulin (PubMed:23922390, PubMed:26394692, PubMed:29596046). Contributes to the regulation of peptide hormone signaling cascades and regulation of blood glucose homeostasis via its role in the degradation of insulin, glucagon and IAPP (By similarity). Plays a role in the degradation and clearance of APP-derived amyloidogenic peptides that are secreted by neurons and microglia (PubMed:9830016, PubMed:26394692) (Probable). Degrades the natriuretic peptides ANP, BNP and CNP, inactivating their ability to raise intracellular cGMP (PubMed:21098034). Also degrades an aberrant frameshifted 40-residue form of NPPA (fsNPPA) which is associated with familial atrial fibrillation in heterozygous patients (PubMed:21098034). Involved in antigen processing. Produces both the N terminus and the C terminus of MAGEA3-derived antigenic peptide (EVDPIGHLY) that is presented to cytotoxic T lymphocytes by MHC class I. {ECO:0000250|UniProtKB:Q9JHR7, ECO:0000269|PubMed:10684867, ECO:0000269|PubMed:17051221, ECO:0000269|PubMed:17613531, ECO:0000269|PubMed:18986166, ECO:0000269|PubMed:19321446, ECO:0000269|PubMed:20364150, ECO:0000269|PubMed:21098034, ECO:0000269|PubMed:2293021, ECO:0000269|PubMed:23922390, ECO:0000269|PubMed:24847884, ECO:0000269|PubMed:26394692, ECO:0000269|PubMed:26968463, ECO:0000269|PubMed:29596046, ECO:0000269|PubMed:9830016, ECO:0000305|PubMed:23922390}.; (Microbial infection) The membrane-associated isoform acts as an entry receptor for varicella-zoster virus (VZV). {ECO:0000269|PubMed:17055432, ECO:0000269|PubMed:17553876}.","6":"22.40361149","7":"7.265909041","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P14735"},{"1":"COX6B1 COX6B","2":"CX6B1_HUMAN","3":"unknown","4":"Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1)","5":"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix. {ECO:0000250|UniProtKB:Q01519}.","6":"-43.35961203","7":"4.386783744","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P14854"},{"1":"POU2F1 OCT1 OTF1","2":"PO2F1_HUMAN","3":"unknown","4":"POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)","5":"Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and activates the promoters of the genes for some small nuclear RNAs (snRNA) and of genes such as those for histone H2B and immunoglobulins. Modulates transcription transactivation by NR3C1, AR and PGR. {ECO:0000269|PubMed:10480874, ECO:0000269|PubMed:1684878, ECO:0000269|PubMed:7859290}.; (Microbial infection) In case of human herpes simplex virus (HSV) infection, POU2F1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and HCFC1 thereby enabling the transcription of the viral immediate early genes. {ECO:0000305|PubMed:12826401}.","6":"-1.33913130","7":"12.803338780","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P14859"},{"1":"HNRNPL HNRPL P/OKcl.14","2":"HNRPL_HUMAN","3":"unknown","4":"Heterogeneous nuclear ribonucleoprotein L (hnRNP L)","5":"Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements (PubMed:11809897, PubMed:22570490, PubMed:24164894, PubMed:25623890, PubMed:26051023). Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts (PubMed:2687284). Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter (PubMed:11809897). {ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490, ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023, ECO:0000269|PubMed:2687284}.","6":"14.07772804","7":"21.859387261","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P14866"},{"1":"DARS1 DARS PIG40","2":"SYDC_HUMAN","3":"PROTEIN COMPLEX","4":"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)","5":"Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}.","6":"12.14775714","7":"33.238937211","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P14868"},{"1":"ETS1 EWSR2","2":"ETS1_HUMAN","3":"unknown","4":"Protein C-ets-1 (p54)","5":"Transcription factor. Directly controls the expression of cytokine and chemokine genes in a wide variety of different cellular contexts. May control the differentiation, survival and proliferation of lymphoid cells. May also regulate angiogenesis through regulation of expression of genes controlling endothelial cell migration and invasion. {ECO:0000269|PubMed:10698492, ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518}.","6":"5.21254488","7":"9.671279853","8":"Undefined","9":"CYTOSOL,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P14921"},{"1":"JUP CTNNG DP3","2":"PLAK_HUMAN","3":"unknown","4":"Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3)","5":"Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in endothelial cells. Can replace beta-catenin in E-cadherin/catenin adhesion complexes which are proposed to couple cadherins to the actin cytoskeleton (By similarity). {ECO:0000250}.","6":"-7.41426217","7":"-34.990294404","8":"PM","9":"PM,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P14923"},{"1":"UQCRB UQBP","2":"QCR7_HUMAN","3":"unknown","4":"Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)","5":"Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. {ECO:0000250|UniProtKB:P00128}.","6":"-42.56979321","7":"3.428771636","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P14927"},{"1":"AKR1B1 ALDR1 ALR2","2":"ALDR_HUMAN","3":"unknown","4":"Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21)","5":"Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosacharides, bile acids and xenobiotics substrates. Key enzyme in the polyol pathway, catalyzes reduction of glucose to sorbitol during hyperglycemia (PubMed:1936586). Reduces steroids and their derivatives and prostaglandins. Displays low enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal (PubMed:12732097, PubMed:19010934, PubMed:8343525). Catalyzes the reduction of diverse phospholipid aldehydes such as 1-palmitoyl-2-(5-oxovaleroyl)-sn -glycero-3-phosphoethanolamin (POVPC) and related phospholipid aldehydes that are generated from the oxydation of phosphotidylcholine and phosphatdyleethanolamides (PubMed:17381426). Plays a role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their glutathione-conjugates carbonyls (GS-carbonyls) (PubMed:21329684). {ECO:0000269|PubMed:12732097, ECO:0000269|PubMed:17381426, ECO:0000269|PubMed:19010934, ECO:0000269|PubMed:1936586, ECO:0000269|PubMed:21329684, ECO:0000269|PubMed:8343525}.","6":"26.74116962","7":"7.684042403","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P15121"},{"1":"PVR PVS","2":"PVR_HUMAN","3":"unknown","4":"Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155)","5":"Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytotoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration. {ECO:0000269|PubMed:15471548, ECO:0000269|PubMed:15607800}.; (Microbial infection) Acts as a receptor for poliovirus. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport. {ECO:0000269|PubMed:2538245}.; (Microbial infection) Acts as a receptor for Pseudorabies virus. {ECO:0000269|PubMed:9616127}.; (Microbial infection) Is prevented to reach cell surface upon infection by Human cytomegalovirus /HHV-5, presumably to escape immune recognition of infected cell by NK cells. {ECO:0000269|PubMed:15640804}.","6":"-2.83140892","7":"-39.548577991","8":"PM","9":"PM,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"P15151"},{"1":"GSPT1 ERF3A","2":"ERF3A_HUMAN","3":"unknown","4":"Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)","5":"Involved in translation termination in response to the termination codons UAA, UAG and UGA (By similarity). Stimulates the activity of ETF1 (By similarity). Involved in regulation of mammalian cell growth (PubMed:2511002). Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:24486019). Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes (PubMed:30682371). {ECO:0000250|UniProtKB:Q8IYD1, ECO:0000269|PubMed:24486019, ECO:0000269|PubMed:2511002, ECO:0000269|PubMed:30682371}.","6":"-0.55065773","7":"10.509445577","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15170"},{"1":"ARSA","2":"ARSA_HUMAN","3":"LYSOSOME","4":"Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C]","5":"Hydrolyzes cerebroside sulfate. {ECO:0000269|PubMed:10751093, ECO:0000269|PubMed:24294900}.","6":"10.67083005","7":"-43.672603351","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P15289"},{"1":"B4GALT1 GGTB2","2":"B4GT1_HUMAN","3":"unknown","4":"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","5":"[Beta-1,4-galactosyltransferase 1]: The Golgi complex form catalyzes the production of lactose in the lactating mammary gland and could also be responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. {ECO:0000269|PubMed:16157350}.; [Processed beta-1,4-galactosyltransferase 1]: The cell surface form functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, as those occurring during development and egg fertilization, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix. {ECO:0000269|PubMed:16157350}.","6":"22.63244304","7":"-34.576132332","8":"GOLGI","9":"GOLGI,Undefined,GOLGI","10":"NA","11":"NA","12":"NA","_rn_":"P15291"},{"1":"EZR VIL2","2":"EZRI_HUMAN","3":"unknown","4":"Ezrin (Cytovillin) (Villin-2) (p81)","5":"Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis. {ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18270268, ECO:0000269|PubMed:19111582}.","6":"4.11187151","7":"-14.897818542","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15311"},{"1":"FOLR1 FOLR","2":"FOLR1_HUMAN","3":"unknown","4":"Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)","5":"Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release. Required for normal embryonic development and normal cell proliferation. {ECO:0000269|PubMed:23851396, ECO:0000269|PubMed:23934049, ECO:0000269|PubMed:2527252, ECO:0000269|PubMed:8033114, ECO:0000269|PubMed:8567728}.","6":"3.15166722","7":"-37.926070060","8":"LYSOSOME","9":"LYSOSOME,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15328"},{"1":"UCHL3","2":"UCHL3_HUMAN","3":"unknown","4":"Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3)","5":"Deubiquitinating enzyme (DUB) that controls levels of cellular ubiquitin through processing of ubiquitin precursors and ubiquitinated proteins. Thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of either ubiquitin or NEDD8. Has a 10-fold preference for Arg and Lys at position P3'', and exhibits a preference towards 'Lys-48'-linked ubiquitin chains. Deubiquitinates ENAC in apical compartments, thereby regulating apical membrane recycling. Indirectly increases the phosphorylation of IGFIR, AKT and FOXO1 and promotes insulin-signaling and insulin-induced adipogenesis. Required for stress-response retinal, skeletal muscle and germ cell maintenance. May be involved in working memory. Can hydrolyze UBB(+1), a mutated form of ubiquitin which is not effectively degraded by the proteasome and is associated with neurogenerative disorders. {ECO:0000269|PubMed:19154770, ECO:0000269|PubMed:21762696, ECO:0000269|PubMed:22689415, ECO:0000269|PubMed:2530630, ECO:0000269|PubMed:9790970}.","6":"-8.69275023","7":"-0.342200205","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15374"},{"1":"FOSL1 FRA1","2":"FOSL1_HUMAN","3":"unknown","4":"Fos-related antigen 1 (FRA-1)","5":"NA","6":"-3.28644567","7":"21.728626805","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P15407"},{"1":"FOSL2 FRA2","2":"FOSL2_HUMAN","3":"unknown","4":"Fos-related antigen 2 (FRA-2)","5":"Controls osteoclast survival and size. As a dimer with JUN, activates LIF transcription. Activates CEBPB transcription in PGE2-activated osteoblasts. {ECO:0000250}.","6":"-13.27708378","7":"10.730128697","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P15408"},{"1":"CD46 MCP MIC10","2":"MCP_HUMAN","3":"unknown","4":"Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46)","5":"Acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue. May be involved in the fusion of the spermatozoa with the oocyte during fertilization. Also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. T-regulatory 1 cells suppress immune responses by secreting interleukin-10, and therefore are thought to prevent autoimmunity. {ECO:0000269|PubMed:10843656, ECO:0000269|PubMed:12540904}.; (Microbial infection) A number of viral and bacterial pathogens seem to bind MCP in order to exploit its immune regulation property and directly induce an immunosuppressive phenotype in T-cells.; (Microbial infection) Acts as a receptor for Adenovirus subgroup B2 and Ad3. {ECO:0000269|PubMed:12915534, ECO:0000269|PubMed:14566335, ECO:0000269|PubMed:15047806, ECO:0000269|PubMed:15078926, ECO:0000269|PubMed:15919905, ECO:0000269|PubMed:16254377}.; (Microbial infection) Acts as a receptor for cultured Measles virus. {ECO:0000269|PubMed:10972291}.; (Microbial infection) Acts as a receptor for Herpesvirus 6/HHV-6. {ECO:0000269|PubMed:12663806, ECO:0000269|PubMed:12724329}.; (Microbial infection) May act as a receptor for pathogenic bacteria Neisseria and Streptococcus pyogenes (PubMed:7708671, PubMed:9379894, PubMed:11260136, PubMed:11971006).","6":"1.26418641","7":"-38.894819586","8":"PM","9":"Undefined,PM,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15529"},{"1":"NME1 NDPKA NM23","2":"NDKA_HUMAN","3":"unknown","4":"Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)","5":"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. Involved in cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor endocytosis, and gene expression. Required for neural development including neural patterning and cell fate determination. During GZMA-mediated cell death, works in concert with TREX1. NME1 nicks one strand of DNA and TREX1 removes bases from the free 3' end to enhance DNA damage and prevent DNA end reannealing and rapid repair. {ECO:0000269|PubMed:12628186, ECO:0000269|PubMed:16818237, ECO:0000269|PubMed:8810265}.","6":"26.68144176","7":"10.750886508","8":"Undefined","9":"NUCLEOPLASM-1,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P15531"},{"1":"GNS","2":"GNS_HUMAN","3":"LYSOSOME","4":"N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)","5":"NA","6":"10.94549660","7":"-42.598278403","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P15586"},{"1":"ARSB","2":"ARSB_HUMAN","3":"LYSOSOME","4":"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","5":"Removes sulfate groups from chondroitin-4-sulfate (C4S) and regulates its degradation (PubMed:19306108). Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium (PubMed:19306108). In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity). {ECO:0000250|UniProtKB:P50430, ECO:0000269|PubMed:19306108}.","6":"3.93459505","7":"-40.545464598","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P15848"},{"1":"RPS2 RPS4","2":"RS2_HUMAN","3":"RIBOSOME","4":"40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)","5":"NA","6":"30.61541493","7":"-20.939729937","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P15880"},{"1":"TCF3 BHLHB21 E2A ITF1","2":"TFE2_HUMAN","3":"unknown","4":"Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1)","5":"Transcriptional regulator involved in the initiation of neuronal differentiation and mesenchymal to epithelial transition. Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation. Together with TCF15, required for the mesenchymal to epithelial transition. Dimers bind DNA on E-box motifs: 5'-CANNTG-3' (By similarity). Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer (PubMed:2493990). Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region (By similarity). {ECO:0000250|UniProtKB:P15806, ECO:0000269|PubMed:2493990}.","6":"21.90163897","7":"1.902573799","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P15923"},{"1":"DSP","2":"DESP_HUMAN","3":"unknown","4":"Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen)","5":"Major high molecular weight protein of desmosomes. Involved in the organization of the desmosomal cadherin-plakoglobin complexes into discrete plasma membrane domains and in the anchoring of intermediate filaments to the desmosomes.","6":"12.37404549","7":"-24.464871906","8":"GOLGI","9":"GOLGI,Undefined,Undefined","10":"Highly confident","11":"2","12":"2,3","_rn_":"P15924"},{"1":"CD44 LHR MDU2 MDU3 MIC4","2":"CD44_HUMAN","3":"unknown","4":"CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44)","5":"Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment (PubMed:16541107, PubMed:19703720, PubMed:22726066). Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection (PubMed:7528188). Engages, through its ectodomain, extracellular matrix components such as hyaluronan/HA, collagen, growth factors, cytokines or proteases and serves as a platform for signal transduction by assembling, via its cytoplasmic domain, protein complexes containing receptor kinases and membrane proteases (PubMed:18757307, PubMed:23589287). Such effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and phospholipase C that coordinate signaling pathways promoting calcium mobilization and actin-mediated cytoskeleton reorganization essential for cell migration and adhesion (PubMed:15123640). {ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:16541107, ECO:0000269|PubMed:18757307, ECO:0000269|PubMed:19703720, ECO:0000269|PubMed:22726066, ECO:0000269|PubMed:23589287, ECO:0000269|PubMed:7528188}.","6":"-14.21158724","7":"-38.757107721","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P16070"},{"1":"H2AX H2AFX","2":"H2AX_HUMAN","3":"unknown","4":"Histone H2AX (H2a/x) (Histone H2A.X)","5":"Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Required for checkpoint-mediated arrest of cell cycle progression in response to low doses of ionizing radiation and for efficient repair of DNA double strand breaks (DSBs) specifically when modified by C-terminal phosphorylation. {ECO:0000269|PubMed:10959836, ECO:0000269|PubMed:12419185, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:15201865}.","6":"-41.65882519","7":"23.808798771","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P16104"},{"1":"CBR1 CBR CRN SDR21C1","2":"CBR1_HUMAN","3":"unknown","4":"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)","5":"NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol (PubMed:18449627, PubMed:15799708, PubMed:17912391, PubMed:7005231). Can convert prostaglandin E to prostaglandin F2-alpha (By similarity). Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione (PubMed:18826943, PubMed:17344335). {ECO:0000250|UniProtKB:Q28960, ECO:0000269|PubMed:15799708, ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:17912391, ECO:0000269|PubMed:18449627, ECO:0000269|PubMed:18826943, ECO:0000269|PubMed:7005231}.","6":"22.10931961","7":"-1.983054764","8":"CYTOSOL","9":"Undefined,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P16152"},{"1":"ACADS","2":"ACADS_HUMAN","3":"MITOCHONDRIA","4":"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)","5":"Short-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats (By similarity). The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (By similarity). Among the different mitochondrial acyl-CoA dehydrogenases, short-chain specific acyl-CoA dehydrogenase acts specifically on acyl-CoAs with saturated 4 to 6 carbons long primary chains (PubMed:21237683, PubMed:11134486). {ECO:0000250|UniProtKB:P15651, ECO:0000269|PubMed:11134486, ECO:0000269|PubMed:21237683}.","6":"-38.02273931","7":"-14.342436212","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P16219"},{"1":"CREB1","2":"CREB1_HUMAN","3":"unknown","4":"Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)","5":"Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-119 phosphorylation. Involved in different cellular processes including the synchronization of circadian rhythmicity and the differentiation of adipose cells.","6":"-14.41959327","7":"7.760927929","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P16220"},{"1":"GLB1 ELNR1","2":"BGAL_HUMAN","3":"unknown","4":"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)","5":"[Isoform 1]: Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans. {ECO:0000269|PubMed:15714521, ECO:0000269|PubMed:19472408, ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:25936995, ECO:0000269|PubMed:8200356}.; [Isoform 2]: Has no beta-galactosidase catalytic activity, but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP), a major component of the non-integrin cell surface receptor expressed on fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. In elastin producing cells, associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers. {ECO:0000269|PubMed:10841810, ECO:0000269|PubMed:8922281}.","6":"10.53008505","7":"-41.234840294","8":"LYSOSOME","9":"LYSOSOME,LYSOSOME,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P16278"},{"1":"PPP3CB CALNA2 CALNB CNA2","2":"PP2BB_HUMAN","3":"unknown","4":"Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)","5":"Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:19154138, PubMed:26794871). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). {ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:26794871}.","6":"14.19274949","7":"0.383611185","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P16298"},{"1":"NCK1 NCK","2":"NCK1_HUMAN","3":"unknown","4":"Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha)","5":"Adapter protein which associates with tyrosine-phosphorylated growth factor receptors, such as KDR and PDGFRB, or their cellular substrates. Maintains low levels of EIF2S1 phosphorylation by promoting its dephosphorylation by PP1. Plays a role in the DNA damage response, not in the detection of the damage by ATM/ATR, but for efficient activation of downstream effectors, such as that of CHEK2. Plays a role in ELK1-dependent transcriptional activation in response to activated Ras signaling. Modulates the activation of EIF2AK2/PKR by dsRNA. May play a role in cell adhesion and migration through interaction with ephrin receptors. {ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:16835242, ECO:0000269|PubMed:17803907, ECO:0000269|PubMed:18835251, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:9430661}.","6":"6.59498241","7":"-7.429306727","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P16333"},{"1":"GCFC2 C2orf3 GCF TCF9","2":"GCFC2_HUMAN","3":"unknown","4":"Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9) (TCF-9)","5":"Involved in pre-mRNA splicing through regulating spliceosome C complex formation (PubMed:24304693). May play a role during late-stage splicing events and turnover of excised introns (PubMed:24304693). {ECO:0000269|PubMed:24304693}.","6":"13.38775962","7":"26.965365473","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P16383"},{"1":"H1-2 H1F2 HIST1H1C","2":"H12_HUMAN","3":"unknown","4":"Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1)","5":"Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.","6":"-41.17930619","7":"23.497065905","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P16403"},{"1":"POR CYPOR","2":"NCPR_HUMAN","3":"ER","4":"NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)","5":"This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5. {ECO:0000255|HAMAP-Rule:MF_03212}.","6":"-7.02658017","7":"-38.582188397","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P16435"},{"1":"MGMT","2":"MGMT_HUMAN","3":"unknown","4":"Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase)","5":"Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated.","6":"19.94593585","7":"4.346404175","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P16455"},{"1":"ATP2A2 ATP2B","2":"AT2A2_HUMAN","3":"ER","4":"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)","5":"This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). {ECO:0000269|PubMed:16402920, ECO:0000269|PubMed:28890335}.; [Isoform 2]: Involved in the regulation of the contraction/relaxation cycle. Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca(2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca(2+) signaling cascades that promote osteoclast differentiation and activation. {ECO:0000250|UniProtKB:O55143}.","6":"-7.31087750","7":"-38.871172631","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P16615"},{"1":"PLCG2","2":"PLCG2_HUMAN","3":"unknown","4":"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2)","5":"The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. It is a crucial enzyme in transmembrane signaling. {ECO:0000269|PubMed:23000145}.","6":"40.23941113","7":"7.036748034","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P16885"},{"1":"FAH","2":"FAAA_HUMAN","3":"CYTOSOL","4":"Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)","5":"NA","6":"34.33394386","7":"13.978849832","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P16930"},{"1":"STMN1 C1orf215 LAP18 OP18","2":"STMN1_HUMAN","3":"unknown","4":"Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17)","5":"Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.","6":"-8.70123647","7":"-1.068864772","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P16949"},{"1":"YBX3 CSDA DBPA","2":"YBOX3_HUMAN","3":"unknown","4":"Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB)","5":"Binds to the GM-CSF promoter. Seems to act as a repressor. Binds also to full-length mRNA and to short RNA sequences containing the consensus site 5'-UCCAUCA-3'. May have a role in translation repression (By similarity). {ECO:0000250}.","6":"24.13605554","7":"-16.794589547","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P16989"},{"1":"ZNF22 KOX15 KROX26","2":"ZNF22_HUMAN","3":"unknown","4":"Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26)","5":"Binds DNA through the consensus sequence 5'-CAATG-3'. May be involved in transcriptional regulation and may play a role in tooth formation (By similarity). {ECO:0000250}.","6":"-38.10631517","7":"21.895801994","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P17026"},{"1":"NAGA","2":"NAGAB_HUMAN","3":"LYSOSOME","4":"Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)","5":"Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids. {ECO:0000269|PubMed:9741689}.","6":"11.48869300","7":"-41.948997415","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P17050"},{"1":"HMGA1 HMGIY","2":"HMGA1_HUMAN","3":"unknown","4":"High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R)","5":"HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions.","6":"-22.43967404","7":"7.225858656","8":"NUCLEUS","9":"Undefined,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P17096"},{"1":"GOT1","2":"AATC_HUMAN","3":"CYTOSOL","4":"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)","5":"Biosynthesis of L-glutamate from L-aspartate or L-cysteine. Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen sulfide. Mercaptopyruvate is converted into H(2)S via the action of 3-mercaptopyruvate sulfurtransferase (3MST). Hydrogen sulfide is an important synaptic modulator and neuroprotectant in the brain. {ECO:0000269|PubMed:16039064}.","6":"28.04500061","7":"13.554031053","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P17174"},{"1":"PRKCA PKCA PRKACA","2":"KPCA_HUMAN","3":"unknown","4":"Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)","5":"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteosomal degradation (By similarity). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.","6":"6.27560958","7":"-2.871227828","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P17252"},{"1":"JUNB","2":"JUNB_HUMAN","3":"unknown","4":"Transcription factor jun-B","5":"Transcription factor involved in regulating gene activity following the primary growth factor response. Binds to the DNA sequence 5'-TGA[CG]TCA-3'.","6":"-10.97266806","7":"25.062880833","8":"NUCLEOPLASM-2","9":"NUCLEOPLASM-2,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P17275"},{"1":"ITGA2 CD49B","2":"ITA2_HUMAN","3":"PM","4":"Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)","5":"Integrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin. It recognizes the proline-hydroxylated sequence G-F-P-G-E-R in collagen. It is responsible for adhesion of platelets and other cells to collagens, modulation of collagen and collagenase gene expression, force generation and organization of newly synthesized extracellular matrix.; (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human rotavirus A. {ECO:0000269|PubMed:12941907}.; (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human echoviruses 1 and 8. {ECO:0000269|PubMed:8411387}.","6":"-12.96900352","7":"-36.155451820","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P17301"},{"1":"GJA1 GJAL","2":"CXA1_HUMAN","3":"unknown","4":"Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein)","5":"Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, thus sensitizing bladder muscles to cholinergic neural stimuli and causing them to contract (By similarity). May play a role in cell growth inhibition through the regulation of NOV expression and localization. Plays an essential role in gap junction communication in the ventricles (By similarity). {ECO:0000250|UniProtKB:P08050, ECO:0000250|UniProtKB:P23242}.","6":"-2.50460902","7":"-40.800168959","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P17302"},{"1":"SMPD1 ASM","2":"ASM_HUMAN","3":"unknown","4":"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)","5":"Converts sphingomyelin to ceramide (PubMed:1840600, PubMed:18815062, PubMed:27659707, PubMed:25920558, PubMed:25339683, PubMed:33163980, PubMed:12563314). Exists as two enzymatic forms that arise from alternative trafficking of a single protein precursor, one that is targeted to the endolysosomal compartment, whereas the other is released extracellularly (PubMed:21098024, PubMed:9660788, PubMed:20807762). However, in response to various forms of stress, lysosomal exocytosis may represent a major source of the secretory form (PubMed:20530211, PubMed:12563314, PubMed:20807762, PubMed:9393854, PubMed:22573858). {ECO:0000269|PubMed:12563314, ECO:0000269|PubMed:1840600, ECO:0000269|PubMed:18815062, ECO:0000269|PubMed:20530211, ECO:0000269|PubMed:20807762, ECO:0000269|PubMed:21098024, ECO:0000269|PubMed:22573858, ECO:0000269|PubMed:25339683, ECO:0000269|PubMed:25920558, ECO:0000269|PubMed:27659707, ECO:0000269|PubMed:33163980, ECO:0000269|PubMed:9393854, ECO:0000269|PubMed:9660788, ECO:0000305}.; In the lysosomes, converts sphingomyelin to ceramide (PubMed:20807762, PubMed:21098024). Plays an important role in the export of cholesterol from the intraendolysosomal membranes (PubMed:25339683). Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol (PubMed:25339683). Modulates stress-induced apoptosis through the production of ceramide (PubMed:8706124). {ECO:0000269|PubMed:20807762, ECO:0000269|PubMed:21098024, ECO:0000269|PubMed:25339683, ECO:0000269|PubMed:8706124}.; When secreted, modulates cell signaling with its ability to reorganize the plasma membrane by converting sphingomyelin to ceramide (PubMed:12563314, PubMed:20807762, PubMed:17303575). Secreted form is increased in response to stress and inflammatory mediators such as IL1B, IFNG or TNF as well as upon infection with bacteria and viruses. Produces the release of ceramide in the outer leaflet of the plasma membrane playing a central role in host defense (PubMed:12563314, PubMed:20807762, PubMed:9393854). Ceramide reorganizes these rafts into larger signaling platforms that are required to internalize P. aeruginosa, induce apoptosis and regulate the cytokine response in infected cells (PubMed:12563314). In wounded cells, the lysosomal form is released extracellularly in the presence of Ca(2+) and promotes endocytosis and plasma membrane repair (PubMed:20530211). {ECO:0000269|PubMed:12563314, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:20530211, ECO:0000269|PubMed:20807762, ECO:0000269|PubMed:9393854}.; [Isoform 2]: Lacks residues that bind the cofactor Zn(2+) and has no enzyme activity. {ECO:0000269|PubMed:1840600, ECO:0000305}.; [Isoform 3]: Lacks residues that bind the cofactor Zn(2+) and has no enzyme activity. {ECO:0000269|PubMed:1840600, ECO:0000305}.; (Microbial infection) Secretion is activated by bacteria such as P. aeruginos, N. gonorrhoeae and others, this activation results in the release of ceramide in the outer leaflet of the plasma membrane which facilitates the infection. {ECO:0000269|PubMed:12563314, ECO:0000269|PubMed:9393854, ECO:0000305|PubMed:31155842}.; (Microbial infection) Secretion is activated by human coronaviruses SARS-CoV and SARS-CoV-2 as well as Zaire ebolavirus, this activation results in the release of ceramide in the outer leaflet of the plasma membrane which facilitates the infection. {ECO:0000269|PubMed:22573858, ECO:0000269|PubMed:33163980}.","6":"13.30866299","7":"-43.166801326","8":"GOLGI","9":"GOLGI,Undefined,GOLGI","10":"Highly confident","11":"2","12":"1,3","_rn_":"P17405"},{"1":"UBTF UBF UBF1","2":"UBF1_HUMAN","3":"unknown","4":"Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1) (UBF-1)","5":"Recognizes the ribosomal RNA gene promoter and activates transcription mediated by RNA polymerase I through cooperative interactions with the transcription factor SL1/TIF-IB complex. It binds specifically to the upstream control element. {ECO:0000269|PubMed:28777933, ECO:0000269|PubMed:7982918}.","6":"-34.85366998","7":"15.627074743","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P17480"},{"1":"JUND","2":"JUND_HUMAN","3":"unknown","4":"Transcription factor jun-D","5":"Transcription factor binding AP-1 sites. {ECO:0000269|PubMed:9989505}.","6":"-14.70258411","7":"8.823808641","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P17535"},{"1":"NDUFB7","2":"NDUB7_HUMAN","3":"unknown","4":"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18) (CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit)","5":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","6":"-39.21770194","7":"-0.109447492","8":"MITOCHONDRIA","9":"MITOCHONDRIA,MITOCHONDRIA,MITOCHONDRIA","10":"NA","11":"NA","12":"NA","_rn_":"P17568"},{"1":"PRKACA PKACA","2":"KAPCA_HUMAN","3":"unknown","4":"cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)","5":"Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984}.; [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.","6":"-2.08450937","7":"0.211345186","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P17612"},{"1":"CAPN2 CANPL2","2":"CAN2_HUMAN","3":"unknown","4":"Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)","5":"Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Proteolytically cleaves MYOC at 'Arg-226' (PubMed:17650508). Proteolytically cleaves CPEB3 following neuronal stimulation which abolishes CPEB3 translational repressor activity, leading to translation of CPEB3 target mRNAs (By similarity). {ECO:0000250|UniProtKB:O08529, ECO:0000269|PubMed:17650508}.","6":"16.56632323","7":"22.798141294","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P17655"},{"1":"GAP43","2":"NEUM_HUMAN","3":"PM","4":"Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46)","5":"This protein is associated with nerve growth. It is a major component of the motile 'growth cones' that form the tips of elongating axons. Plays a role in axonal and dendritic filopodia induction. {ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:21152083}.","6":"0.96920630","7":"-33.803573391","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P17677"},{"1":"PTPN2 PTPT","2":"PTN2_HUMAN","3":"unknown","4":"Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP)","5":"Non-receptor type tyrosine-specific phosphatase that dephosphorylates receptor protein tyrosine kinases including INSR, EGFR, CSF1R, PDGFR. Also dephosphorylates non-receptor protein tyrosine kinases like JAK1, JAK2, JAK3, Src family kinases, STAT1, STAT3 and STAT6 either in the nucleus or the cytoplasm. Negatively regulates numerous signaling pathways and biological processes like hematopoiesis, inflammatory response, cell proliferation and differentiation, and glucose homeostasis. Plays a multifaceted and important role in the development of the immune system. Functions in T-cell receptor signaling through dephosphorylation of FYN and LCK to control T-cells differentiation and activation. Dephosphorylates CSF1R, negatively regulating its downstream signaling and macrophage differentiation. Negatively regulates cytokine (IL2/interleukin-2 and interferon)-mediated signaling through dephosphorylation of the cytoplasmic kinases JAK1, JAK3 and their substrate STAT1, that propagate signaling downstream of the cytokine receptors. Also regulates the IL6/interleukin-6 and IL4/interleukin-4 cytokine signaling through dephosphorylation of STAT3 and STAT6 respectively. In addition to the immune system, it is involved in anchorage-dependent, negative regulation of EGF-stimulated cell growth. Activated by the integrin ITGA1/ITGB1, it dephosphorylates EGFR and negatively regulates EGF signaling. Dephosphorylates PDGFRB and negatively regulates platelet-derived growth factor receptor-beta signaling pathway and therefore cell proliferation. Negatively regulates tumor necrosis factor-mediated signaling downstream via MAPK through SRC dephosphorylation. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of the hepatocyte growth factor receptor MET. Plays also an important role in glucose homeostasis. For instance, negatively regulates the insulin receptor signaling pathway through the dephosphorylation of INSR and control gluconeogenesis and liver glucose production through negative regulation of the IL6 signaling pathways. May also bind DNA. {ECO:0000269|PubMed:10734133, ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:12138178, ECO:0000269|PubMed:12612081, ECO:0000269|PubMed:14966296, ECO:0000269|PubMed:15592458, ECO:0000269|PubMed:18819921, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:9488479}.","6":"0.80726884","7":"-24.214637171","8":"PM","9":"Undefined,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P17706"},{"1":"CTPS1 CTPS","2":"PYRG1_HUMAN","3":"unknown","4":"CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)","5":"This enzyme is involved in the de novo synthesis of CTP, a precursor of DNA, RNA and phospholipids. Catalyzes the ATP-dependent amination of UTP to CTP with either L-glutamine or ammonia as a source of nitrogen. This enzyme and its product, CTP, play a crucial role in the proliferation of activated lymphocytes and therefore in immunity. {ECO:0000269|PubMed:16179339, ECO:0000269|PubMed:24870241}.","6":"41.36984894","7":"2.642668230","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P17812"},{"1":"DDX5 G17P1 HELR HLR1","2":"DDX5_HUMAN","3":"unknown","4":"Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)","5":"Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Synergizes with DDX17 and SRA1 RNA to activate MYOD1 transcriptional activity and involved in skeletal muscle differentiation. Transcriptional coactivator for p53/TP53 and involved in p53/TP53 transcriptional response to DNA damage and p53/TP53-dependent apoptosis. Transcriptional coactivator for RUNX2 and involved in regulation of osteoblast differentiation. Acts as transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as HDAC1. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. {ECO:0000269|PubMed:12527917, ECO:0000269|PubMed:15298701, ECO:0000269|PubMed:15660129, ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:17960593, ECO:0000269|PubMed:18829551, ECO:0000269|PubMed:19718048, ECO:0000269|PubMed:21343338}.","6":"43.75594985","7":"2.249877520","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P17844"},{"1":"PFKL","2":"PFKAL_HUMAN","3":"unknown","4":"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)","5":"Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis (PubMed:22923583). Negatively regulates the phagocyte oxidative burst in response to bacterial infection by controlling cellular NADPH biosynthesis and NADPH oxidase-derived reactive oxygen species. Upon macrophage activation, drives the metabolic switch toward glycolysis, thus preventing glucose turnover that produces NADPH via pentose phosphate pathway (By similarity). {ECO:0000250|UniProtKB:P12382, ECO:0000255|HAMAP-Rule:MF_03184, ECO:0000269|PubMed:22923583}.","6":"42.66666606","7":"1.202794184","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,NUCLEOPLASM-1","10":"NA","11":"NA","12":"NA","_rn_":"P17858"},{"1":"LGALS3 MAC2","2":"LEG3_HUMAN","3":"unknown","4":"Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)","5":"Galactose-specific lectin which binds IgE. May mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (By similarity). In the nucleus: acts as a pre-mRNA splicing factor. Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells. Together with TRIM16, coordinates the recognition of membrane damage with mobilization of the core autophagy regulators ATG16L1 and BECN1 in response to damaged endomembranes. {ECO:0000250, ECO:0000269|PubMed:15181153, ECO:0000269|PubMed:19594635, ECO:0000269|PubMed:19616076, ECO:0000269|PubMed:27693506}.","6":"17.95456291","7":"-5.727513672","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P17931"},{"1":"PSMC3 TBP1","2":"PRS6A_HUMAN","3":"unknown","4":"26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)","5":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {ECO:0000269|PubMed:1317798}.","6":"-3.33683054","7":"37.075570521","8":"PROTEIN COMPLEX","9":"Undefined,PROTEIN COMPLEX,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P17980"},{"1":"TCP1 CCT1 CCTA","2":"TCPA_HUMAN","3":"unknown","4":"T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)","5":"Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis (PubMed:25467444). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). The TRiC complex plays a role in the folding of actin and tubulin (Probable). {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444, ECO:0000305}.","6":"21.13578343","7":"18.476020116","8":"Undefined","9":"PROTEIN COMPLEX,CYTOSOL,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P17987"},{"1":"PTPN1 PTP1B","2":"PTN1_HUMAN","3":"unknown","4":"Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B)","5":"Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of MET. {ECO:0000269|PubMed:18819921, ECO:0000269|PubMed:21135139, ECO:0000269|PubMed:22169477}.","6":"-6.06358127","7":"-41.607807033","8":"PM","9":"PM,Undefined,PM","10":"NA","11":"NA","12":"NA","_rn_":"P18031"},{"1":"ERCC2 XPD XPDC","2":"ERCC2_HUMAN","3":"unknown","4":"General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein)","5":"ATP-dependent 5'-3' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATP-dependent helicase activity of XPD/ERCC2 is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. XPD/ERCC2 acts by forming a bridge between CAK and the core-TFIIH complex. Involved in the regulation of vitamin-D receptor activity. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation. Might have a role in aging process and could play a causative role in the generation of skin cancers. {ECO:0000269|PubMed:10024882, ECO:0000269|PubMed:15494306, ECO:0000269|PubMed:20797633, ECO:0000269|PubMed:8413672}.","6":"39.50447139","7":"7.739042215","8":"NUCLEOPLASM-1","9":"NUCLEOPLASM-1,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P18074"},{"1":"RPL35A GIG33","2":"RL35A_HUMAN","3":"RIBOSOME","4":"60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33)","5":"Required for the proliferation and viability of hematopoietic cells. Plays a role in 60S ribosomal subunit formation. The protein was found to bind to both initiator and elongator tRNAs and consequently was assigned to the P site or P and A site. {ECO:0000269|PubMed:18535205}.","6":"27.45619260","7":"-20.135518593","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P18077"},{"1":"ITGB5","2":"ITB5_HUMAN","3":"unknown","4":"Integrin beta-5","5":"Integrin alpha-V/beta-5 (ITGAV:ITGB5) is a receptor for fibronectin. It recognizes the sequence R-G-D in its ligand.; (Microbial infection) Integrin ITGAV:ITGB5 acts as a receptor for adenovirus type C. {ECO:0000269|PubMed:20615244}.","6":"3.83185119","7":"-40.076526120","8":"Undefined","9":"LYSOSOME,PM,LYSOSOME","10":"NA","11":"NA","12":"NA","_rn_":"P18084"},{"1":"ARF4 ARF2","2":"ARF4_HUMAN","3":"unknown","4":"ADP-ribosylation factor 4","5":"GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.","6":"-4.67699381","7":"-2.946523701","8":"Undefined","9":"Undefined,Undefined,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P18085"},{"1":"RPL7","2":"RL7_HUMAN","3":"RIBOSOME","4":"60S ribosomal protein L7 (Large ribosomal subunit protein uL30)","5":"Component of the large ribosomal subunit (PubMed:12962325). Binds to G-rich structures in 28S rRNA and in mRNAs. Plays a regulatory role in the translation apparatus; inhibits cell-free translation of mRNAs. {ECO:0000305|PubMed:12962325}.","6":"27.92820232","7":"-20.079039787","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P18124"},{"1":"VCL","2":"VINC_HUMAN","3":"unknown","4":"Vinculin (Metavinculin) (MV)","5":"Actin filament (F-actin)-binding protein involved in cell-matrix adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin expression and potentiates mechanosensing by the E-cadherin complex. May also play important roles in cell morphology and locomotion. {ECO:0000269|PubMed:20484056}.","6":"36.39768787","7":"5.222250107","8":"Undefined","9":"NUCLEOPLASM-1,NUCLEOPLASM-1,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P18206"},{"1":"SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312","2":"SON_HUMAN","3":"unknown","4":"Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3)","5":"RNA-binding protein that acts as a mRNA splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. Specifically promotes splicing of many cell-cycle and DNA-repair transcripts that possess weak splice sites, such as TUBG1, KATNB1, TUBGCP2, AURKB, PCNT, AKT1, RAD23A, and FANCG. Probably acts by facilitating the interaction between Serine/arginine-rich proteins such as SRSF2 and the RNA polymerase II. Also binds to DNA; binds to the consensus DNA sequence: 5'-GA[GT]AN[CG][AG]CC-3'. May indirectly repress hepatitis B virus (HBV) core promoter activity and transcription of HBV genes and production of HBV virions. Essential for correct RNA splicing of multiple genes critical for brain development, neuronal migration and metabolism, including TUBG1, FLNA, PNKP, WDR62, PSMD3, PCK2, PFKL, IDH2, and ACY1 (PubMed:27545680). {ECO:0000269|PubMed:20581448, ECO:0000269|PubMed:21504830, ECO:0000269|PubMed:27545680}.","6":"-35.99339783","7":"16.833691552","8":"NUCLEUS","9":"NUCLEUS,NUCLEUS,NUCLEUS","10":"NA","11":"NA","12":"NA","_rn_":"P18583"},{"1":"NELFE RD RDBP","2":"NELFE_HUMAN","3":"unknown","4":"Negative elongation factor E (NELF-E) (RNA-binding protein RD)","5":"Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II (PubMed:10199401). The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex (PubMed:11940650, PubMed:12612062). Provides the strongest RNA binding activity of the NELF complex and may initially recruit the NELF complex to RNA (PubMed:18303858, PubMed:27282391). {ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:11940650, ECO:0000269|PubMed:12612062, ECO:0000269|PubMed:18303858, ECO:0000269|PubMed:27282391}.; (Microbial infection) The NELF complex is involved in HIV-1 latency possibly involving recruitment of PCF11 to paused RNA polymerase II. {ECO:0000269|PubMed:23884411}.","6":"11.96112227","7":"27.016235690","8":"PROTEIN COMPLEX","9":"PROTEIN COMPLEX,Undefined,PROTEIN COMPLEX","10":"NA","11":"NA","12":"NA","_rn_":"P18615"},{"1":"RPL17","2":"RL17_HUMAN","3":"RIBOSOME","4":"60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)","5":"Component of the large ribosomal subunit. {ECO:0000305|PubMed:12962325}.","6":"28.39901648","7":"-18.731380295","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P18621"},{"1":"PGAM1 PGAMA CDABP0006","2":"PGAM1_HUMAN","3":"unknown","4":"Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)","5":"Interconversion of 3- and 2-phosphoglycerate with 2,3-bisphosphoglycerate as the primer of the reaction. Can also catalyze the reaction of EC 5.4.2.4 (synthase), but with a reduced activity.","6":"11.77523829","7":"8.200308013","8":"CYTOSOL","9":"CYTOSOL,CYTOSOL,Undefined","10":"NA","11":"NA","12":"NA","_rn_":"P18669"},{"1":"RCC1 CHC1","2":"RCC1_HUMAN","3":"unknown","4":"Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1)","5":"Guanine-nucleotide releasing factor that promotes the exchange of Ran-bound GDP by GTP, and thereby plays an important role in RAN-mediated functions in nuclear import and mitosis (PubMed:1944575, PubMed:17435751, PubMed:20668449, PubMed:22215983, PubMed:11336674). Contributes to the generation of high levels of chromosome-associated, GTP-bound RAN, which is important for mitotic spindle assembly and normal progress through mitosis (PubMed:12194828, PubMed:17435751, PubMed:22215983). Via its role in maintaining high levels of GTP-bound RAN in the nucleus, contributes to the release of cargo proteins from importins after nuclear import (PubMed:22215983). Involved in the regulation of onset of chromosome condensation in the S phase (PubMed:3678831). Binds both to the nucleosomes and double-stranded DNA (PubMed:17435751, PubMed:18762580). {ECO:0000269|PubMed:11336674, ECO:0000269|PubMed:12194828, ECO:0000269|PubMed:17435751, ECO:0000269|PubMed:18762580, ECO:0000269|PubMed:1944575, ECO:0000269|PubMed:20668449, ECO:0000269|PubMed:22215983, ECO:0000269|PubMed:3678831}.","6":"-2.31987905","7":"11.914835313","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P18754"},{"1":"ATF6","2":"ATF6A_HUMAN","3":"unknown","4":"Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha]","5":"[Cyclic AMP-dependent transcription factor ATF-6 alpha]: Precursor of the transcription factor form (Processed cyclic AMP-dependent transcription factor ATF-6 alpha), which is embedded in the endoplasmic reticulum membrane (PubMed:10564271, PubMed:11158310, PubMed:11779464). Endoplasmic reticulum stress promotes processing of this form, releasing the transcription factor form that translocates into the nucleus, where it activates transcription of genes involved in the unfolded protein response (UPR) (PubMed:10564271, PubMed:11158310, PubMed:11779464). {ECO:0000269|PubMed:10564271, ECO:0000269|PubMed:11158310, ECO:0000269|PubMed:11779464}.; [Processed cyclic AMP-dependent transcription factor ATF-6 alpha]: Transcription factor that initiates the unfolded protein response (UPR) during endoplasmic reticulum stress by activating transcription of genes involved in the UPR (PubMed:10564271, PubMed:11163209, PubMed:11158310, PubMed:11779464). Binds DNA on the 5'-CCAC[GA]-3'half of the ER stress response element (ERSE) (5'-CCAAT-N(9)-CCAC[GA]-3') and of ERSE II (5'-ATTGG-N-CCACG-3') (PubMed:10564271, PubMed:11158310, PubMed:11779464). Binding to ERSE requires binding of NF-Y to ERSE. Could also be involved in activation of transcription by the serum response factor (PubMed:10564271, PubMed:11158310, PubMed:11779464). May play a role in foveal development and cone function in the retina (PubMed:26029869). {ECO:0000269|PubMed:10564271, ECO:0000269|PubMed:11158310, ECO:0000269|PubMed:11163209, ECO:0000269|PubMed:11779464, ECO:0000269|PubMed:26029869}.","6":"-19.29938139","7":"-17.780755342","8":"Undefined","9":"ER,ER,PEROXISOME","10":"NA","11":"NA","12":"NA","_rn_":"P18850"},{"1":"LIG1","2":"DNLI1_HUMAN","3":"unknown","4":"DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)","5":"DNA ligase that seals nicks in double-stranded DNA during DNA replication, DNA recombination and DNA repair.","6":"-13.46865084","7":"8.604367299","8":"Undefined","9":"CYTOSOL,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P18858"},{"1":"XRCC1","2":"XRCC1_HUMAN","3":"unknown","4":"DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)","5":"Involved in DNA single-strand break repair by mediating the assembly of DNA break repair protein complexes. Probably during DNA repair, negatively regulates ADP-ribose levels by modulating ADP-ribosyltransferase PARP1 activity. {ECO:0000269|PubMed:28002403}.","6":"-3.94773081","7":"21.364796746","8":"NUCLEOPLASM-2","9":"Undefined,NUCLEOPLASM-2,NUCLEOPLASM-2","10":"NA","11":"NA","12":"NA","_rn_":"P18887"},{"1":"PAM","2":"AMD_HUMAN","3":"unknown","4":"Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]","5":"Bifunctional enzyme that catalyzes the post-translational modification of inactive peptidylglycine precursors to the corresponding bioactive alpha-amidated peptides, a terminal modification in biosynthesis of many neural and endocrine peptides (PubMed:12699694). Alpha-amidation involves two sequential reactions, both of which are catalyzed by separate catalytic domains of the enzyme. The first step, catalyzed by peptidyl alpha-hydroxylating monoxygenase (PHM) domain, is the copper-, ascorbate-, and O2- dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate (PubMed:12699694). The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate (PubMed:12699694). Similarly, catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate (By similarity). {ECO:0000250|UniProtKB:P14925, ECO:0000269|PubMed:12699694}.","6":"2.26140678","7":"-35.085990846","8":"Undefined","9":"LYSOSOME,PM,PM","10":"NA","11":"NA","12":"NA","_rn_":"P19021"},{"1":"CDH2 CDHN NCAD","2":"CADH2_HUMAN","3":"PM","4":"Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325)","5":"Calcium-dependent cell adhesion protein; preferentially mediates homotypic cell-cell adhesion by dimerization with a CDH2 chain from another cell. Cadherins may thus contribute to the sorting of heterogeneous cell types. Acts as a regulator of neural stem cells quiescence by mediating anchorage of neural stem cells to ependymocytes in the adult subependymal zone: upon cleavage by MMP24, CDH2-mediated anchorage is affected, leading to modulate neural stem cell quiescence. Plays a role in cell-to-cell junction formation between pancreatic beta cells and neural crest stem (NCS) cells, promoting the formation of processes by NCS cells (By similarity). CDH2 may be involved in neuronal recognition mechanism. In hippocampal neurons, may regulate dendritic spine density. {ECO:0000250|UniProtKB:P15116, ECO:0000269|PubMed:31585109}.","6":"-3.38065972","7":"-40.441143509","8":"NA","9":"NA","10":"NA","11":"NA","12":"NA","_rn_":"P19022"},{"1":"GNAZ","2":"GNAZ_HUMAN","3":"unknown","4":"Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha)","5":"Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems.","6":"-12.33331635","7":"-35.621290795","8":"Undefined","9":"PM,PM,ER","10":"NA","11":"NA","12":"NA","_rn_":"P19086"},{"1":"PLCG1 PLC1","2":"PLCG1_HUMAN","3":"unknown","4":"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)","5":"Mediates the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Plays an important role in the regulation of intracellular signaling cascades. Becomes activated in response to ligand-mediated activation of receptor-type tyrosine kinases, such as PDGFRA, PDGFRB, EGFR, FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Plays a role in actin reorganization and cell migration (PubMed:17229814). {ECO:0000250|UniProtKB:P10686, ECO:0000269|PubMed:17229814}.","6":"34.55020400","7":"8.906819244","8":"Undefined","9":"NUCLEOPLASM-1,Undefined,CYTOSOL","10":"NA","11":"NA","12":"NA","_rn_":"P19174"}],"options":{"columns":{"min":{},"max":[10],"total":[12]},"rows":{"min":[10],"max":[10],"total":[5314]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuXG5mZWF0dXJlX2RhdGEgPC0gZGxvcGl0ICU+JSBsYXBwbHkoZnVuY3Rpb24oeCl7XG4gIGZEYXRhKHgpICU+JSB0aWJibGU6OnJvd25hbWVzX3RvX2NvbHVtbigndW5pcHJvdF9pZCcpXG4gIH0pXG5cbmBgYCJ9 -->
<pre class="r"><code>
feature_data &lt;- dlopit %&gt;% lapply(function(x){
  fData(x) %&gt;% tibble::rownames_to_column(&#39;uniprot_id&#39;)
  })
</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuZmVhdHVyZV9kYXRhX3RvX3dyaXRlIDwtIGxpc3QoJ2NvbnRyb2wnPWZlYXR1cmVfZGF0YSRETVNPLFxuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgJ3Vwcic9ZmVhdHVyZV9kYXRhJFRoYXBzaWdhcmdpbilcblxuXG53cml0ZV94bHN4KFxuICBmZWF0dXJlX2RhdGFfdG9fd3JpdGUsXG4gIHBhdGggPSBcIi4vTE9QSVQueGxzeFwiLFxuICBjb2xfbmFtZXMgPSBUUlVFLFxuICBmb3JtYXRfaGVhZGVycyA9IFRSVUUsXG4gIHVzZV96aXA2NCA9IEZBTFNFXG4pXG5cbmBgYCJ9 -->
<pre class="r"><code>feature_data_to_write &lt;- list(&#39;control&#39;=feature_data$DMSO,
                              &#39;upr&#39;=feature_data$Thapsigargin)


write_xlsx(
  feature_data_to_write,
  path = &quot;./LOPIT.xlsx&quot;,
  col_names = TRUE,
  format_headers = TRUE,
  use_zip64 = FALSE
)
</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->

<div id="rmd-source-code">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</div>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});

$(document).ready(function () {
  $('.knitsql-table').addClass('kable-table');
  var container = $('.kable-table');
  container.each(function() {

    // move the caption out of the table
    var table = $(this).children('table');
    var caption = table.children('caption').detach();
    caption.insertBefore($(this)).css('display', 'inherit');
  });
});

</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->
<script>
$(document).ready(function () {
  window.initializeSourceEmbed("3_protein_results.Rmd");
  window.initializeCodeFolding("show" === "show");
});
</script>


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
